Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NC_000018.10:g.60033942_60033993del			Autosomal recessive osteopetrosis 7	Pathogenic(Last reviewed: Apr 24, 2021)	no assertion criteria provided	VCV001064753	18	57701174 - 57701225	18	60033942 - 60033993	1064753	1053045		
GRCh37/hg19 7q36.2(chr7:154213813-154420513)x1			not provided	Uncertain significance(Last reviewed: Jun 26, 2018)	no assertion criteria provided	VCV000688319	7	154213813 - 154420513			688319	675911		
GRCh37/hg19 7q36.2(chr7:154213813-154420513)x1			not provided	Uncertain significance(Last reviewed: Jun 26, 2018)	no assertion criteria provided	VCV000688318	7	154213813 - 154420513			688318	675910		
GRCh37/hg19 14q31.1(chr14:79377325-79425028)x1			not provided	Uncertain significance(Last reviewed: Feb 12, 2018)	no assertion criteria provided	VCV000686401	14	79377325 - 79425028			686401	673993		
GRCh37/hg19 Xq28(chrX:154946934-155233731)x1			not provided	Uncertain significance(Last reviewed: Mar 16, 2018)	no assertion criteria provided	VCV000686351	X	154946934 - 155233731			686351	673943		
GRCh37/hg19 Xq28(chrX:154941868-155233731)x1			not provided	Uncertain significance(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000685661	X	154941868 - 155233731			685661	673253		
GRCh37/hg19 Xq21.33(chrX:96989691-97267716)x0			not provided	Benign(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000617046	X	96989691 - 97267716			617046	608382		
GRCh37/hg19 1q31.2(chr1:192675649-192694935)x1			not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000612652	1	192675649 - 192694935			612652	603988		
GRCh37/hg19 8q11.21(chr8:50001946-50009248)x0			not provided	Benign(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000610905	8	50001946 - 50009248			610905	602241		
GRCh37/hg19 6q13(chr6:71330911-71337296)x1			not provided	Benign(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000609198	6	71330911 - 71337296			609198	600534		
GRCh37/hg19 5p15.33(chr5:83551-85450)x1			not provided	Benign(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000607688	5	83551 - 85450			607688	599024		
GRCh37/hg19 22q12.3(chr22:34900205-34903156)x0			not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000605296	22	34900205 - 34903156			605296	596632		
GRCh37/hg19 20q11.23(chr20:36115937-36116301)x0			not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000604554	20	36115937 - 36116301			604554	595890		
GRCh37/hg19 2q37.3(chr2:241207225-241216673)x1			not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000604391	2	241207225 - 241216673			604391	595727		
GRCh37/hg19 19p13.3(chr19:564268-568411)x1			not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000603301	19	564268 - 568411			603301	594637		
GRCh37/hg19 17q22(chr17:50399144-50456374)x1			not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000602984	17	50399144 - 50456374			602984	594320		
Single allele			not provided	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000559472					559472	550196		
Single allele			not provided	Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000559469					559469	550193		
NCBI36/hg18 6q14.1-14.3(chr6:79678455-84862865)x1			See cases	Likely pathogenic(Last reviewed: Nov 4, 2011)	no assertion criteria provided	VCV000443701					443701	437363		
Single allele			Chromosome 10q22.3-q23.2 deletion syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided	VCV000441234					441234	434864		
17q21.31 Microdeletion			Koolen-de Vries syndrome	Pathogenic(Last reviewed: Nov 20, 2012)	no assertion criteria provided	VCV000040974					40974	49396		
NM_015665.6(AAAS):c.250del (p.Trp84fs)	AAAS	W84fs	Glucocorticoid deficiency with achalasia	Pathogenic(Last reviewed: May 18, 2021)	no assertion criteria provided	VCV001119992	12	53714350	12	53320566	1119992	1108769		NC_000012.12:53320565:AAA:AA
Single allele	ABCA2|C8G|CACNA1B|ENTPD2|FUT7|GRIN1|PTGDS|TRAF2|SSNA1|CLIC3|TUBB4B|NOXA1|MAN1B1|NELFB|NSMF|NDOR1|ANAPC2|DPP7|FBXW5|TOR4A|EXD3|NPDC1|MRPL41|EHMT1|SAPCD2|UAP1L1|ARRDC1|DPH7|TMEM203|ZMYND19|SLC34A3|LCN12|PAXX|TPRN|PNPLA7|CYSRT1|ENTPD8|LRRC26|LCNL1|LINC02908|FAM166A|STPG3|NRARP|RNF224|LOC651337|RNF208|TMEM210		Epilepsy|Intellectual disability	Pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV000997822	9	139764148 - 141066491			997822	985540		
GRCh37/hg19 16p13.11(chr16:15493046-16053729)	ABCC1|MYH11|MARF1|NDE1|BMERB1|CEP20|MPV17L		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625573	16	15493046 - 16053729			625573	613877		
GRCh37/hg19 16p13.11(chr16:15395312-16210889)	ABCC1|MYH11|MARF1|NDE1|BMERB1|CEP20|MPV17L|NPIPA5		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625571	16	15395312 - 16210889			625571	613875		
GRCh38/hg38 16p13.11-12.3(chr16:15398450-18272881)x1	ABCC1|ABCC6|BMERB1|CEP20|LOC102723692|LOC111365165|LOC112340379|LOC112340380|LOC112340381|LOC112340382|LOC112340383|LOC113939949|MARF1|MIR3179-2|MIR3180-2|MIR3670-2|MIR484|MIR6506|MIR6511A2|MIR6511A3|MIR6770-2|MPV17L|MYH11|NDE1|NOMO3|NPIPA7|XYLT1		See cases	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2013)	no assertion criteria provided	VCV000155137	16	15492307 - 18366738	16	15398450 - 18272881	155137	164891		
GRCh37/hg19 16p13.11(chr16:16247252-16258276)x1	ABCC6		not provided	Pathogenic(Last reviewed: Jun 20, 2018)	no assertion criteria provided	VCV000686253	16	16247252 - 16258276			686253	673845		
GRCh37/hg19 16p13.11(chr16:15125627-16291983)	ABCC6|ABCC1|MYH11|MARF1|PDXDC1|RRN3|NDE1|BMERB1|NTAN1|CEP20|MPV17L|NPIPA5		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625687	16	15125627 - 16291983			625687	613991		
GRCh37/hg19 16p13.11-12.3(chr16:15548310-17988303)	ABCC6|ABCC1|MYH11|MARF1|NDE1|XYLT1|BMERB1|CEP20|NOMO3		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625575	16	15548310 - 17988303			625575	613879		
GRCh37/hg19 16p13.11(chr16:15521713-16292235)	ABCC6|ABCC1|MYH11|MARF1|NDE1|BMERB1|CEP20		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625574	16	15521713 - 16292235			625574	613878		
GRCh37/hg19 16p13.11(chr16:15493046-16291983)	ABCC6|ABCC1|MYH11|MARF1|NDE1|BMERB1|CEP20|MPV17L		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625572	16	15493046 - 16291983			625572	613876		
GRCh37/hg19 17p13.3(chr17:55804-1310807)x1	ABR|YWHAE|RPH3AL|TIMM22|GEMIN4|GLOD4|MRM3|VPS53|NXN|TLCD3A|TRARG1|RFLNB|C17orf97|BHLHA9		not provided	Uncertain significance(Last reviewed: Jan 12, 2018)	no assertion criteria provided	VCV000686486	17	55804 - 1310807			686486	674078		
GRCh38/hg38 17p13.3-13.1(chr17:162016-7697012)x1	ABR|ABR-AS1|ACADVL|ACAP1|AIPL1|ALOX12|ALOX12-AS1|ALOX15|ANKFY1|ARRB2|ASGR1|ASGR2|ASPA|ATP1B2|ATP2A3|BCL6B|BHLHA9|C17orf100|C17orf107|C17orf49|C17orf97|C1QBP|CAMKK1|CAMTA2|CAMTA2-AS1|CCDC92B|CD68|CHRNB1|CHRNE|CLDN7|CLEC10A|CLUH|CRK|CTDNEP1|CTNS|CXCL16|CYB5D2|DERL2|DHX33|DHX33-DT|DLG4|DOC2B|DPH1|DVL2|EIF4A1|EIF5A|ELP5|EMC6|ENO3|FBXO39|FGF11|FXR2|GABARAP|GEMIN4|GGT6|GLOD4|GLTPD2|GP1BA|GPS2|HASPIN|HIC1|INCA1|INPP5K|ITGAE|KCTD11|KIAA0753|KIF1C|KIF1C-AS1|LINC01975|LINC01996|LINC02091|LOC100288728|LOC100996842|LOC101927727|LOC101927839|LOC101927911|LOC105371430|LOC105371485|LOC105371592|LOC106799838|LOC107984973|LOC107988047|LOC110120951|LOC110121369|LOC111413025|LOC111556120|LOC112529892|LOC112529893|LOC112529901|LOC112529915|LOC112533656|LOC112533657|LOC112533664|LOC284009|LOC339166|LOC728392|MED11|MED31|METTL16|MINK1|MIR1253|MIR132|MIR195|MIR212|MIR22|MIR22HG|MIR3183|MIR324|MIR4520-1|MIR4520-2|MIR497|MIR497HG|MIR6776|MIR6864|MIR6865|MIS12|MNT|MPDU1|MRM3|MYBBP1A|MYO1C|NCBP3|NEURL4|NLGN2|NLRP1|NUP88|NXN|OR1A1|OR1A2|OR1D2|OR1D4|OR1D5|OR1E1|OR1E2|OR1G1|OR1R1P|OR3A1|OR3A2|OR3A3|OVCA2|P2RX1|P2RX5|P2RX5-TAX1BP3|PAFAH1B1|PELP1|PELP1-DT|PFN1|PHF23|PIMREG|PITPNA|PITPNA-AS1|PITPNM3|PLD2|PLSCR3|POLR2A|PRPF8|PSMB6|RABEP1|RAP1GAP2|RFLNB|RILP|RNASEK|RNASEK-C17orf49|RNF167|RPA1|RPAIN|RPH3AL|RPH3AL-AS1|RTN4RL1|SAT2|SCARF1|SCIMP|SENP3|SENP3-EIF4A1|SERPINF1|SERPINF2|SGSM2|SHBG|SHPK|SLC13A5|SLC16A11|SLC16A13|SLC25A11|SLC2A4|SLC35G6|SLC43A2|SLC52A1|SMG6|SMTNL2|SMYD4|SNORA48|SNORA67|SNORD10|SNORD91A|SNORD91B|SOX15|SPAG7|SPATA22|SPEM1|SPEM2|SPEM3|SPNS2|SPNS3|SRR|TAX1BP3|TEKT1|TIMM22|TLCD2|TLCD3A|TM4SF5|TMEM102|TMEM256|TMEM256-PLSCR3|TMEM95|TNFSF12|TNFSF12-TNFSF13|TNFSF13|TNK1|TP53|TRARG1|TRPV1|TRPV3|TSR1|TXNDC17|UBE2G1|USP6|VMO1|VPS53|WDR81|WRAP53|WSCD1|XAF1|YBX2|YWHAE|ZBTB4|ZFP3|ZMYND15|ZNF232|ZNF232-AS1|ZNF594|ZNF594-DT|ZZEF1		See cases	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000149158	17	45835 - 7600330	17	162016 - 7697012	149158	158909		
GRCh37/hg19 15q25.2-26.1(chr15:83883823-92165844)	ACAN|ANPEP|BLM|BNC1|FES|IDH2|ISG20|MAN2A2|MFGE8|NMB|NTRK3|FURIN|PDE8A|PLIN1|POLG|RLBP1|SH3GL3|PEX11A|IQGAP1|PRC1|SLC28A1|ZNF592|SV2B|AP3S2|SEMA4B|CIB1|ABHD2|AKAP13|SEC11A|VPS33B|MRPL46|NGRN|RHCG|ZSCAN2|DET1|FANCI|MESP1|UNC45A|WDR93|ADAMTSL3|ALPK3|KLHL25|AEN|CRTC3|MRPS11|WDR73|TICRR|RCCD1|AGBL1|HAPLN3|MESP2|LINC00928|ZNF774|ARPIN|KIF7|ZNF710|HDDC3|GDPGP1|MIR9-3|ARPIN-AP3S2		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625751	15	83883823 - 92165844			625751	614055		
GRCh38/hg38 1p36.33-36.23(chr1:844347-7870545)x1	ACAP3|ACOT7|ACTRT2|AGRN|AJAP1|ANKRD65|ANKRD65-AS1|ARHGEF16|ATAD3A|ATAD3B|ATAD3C|AURKAIP1|B3GALT6|C1QTNF12|C1orf159|C1orf174|CALML6|CAMTA1|CAMTA1-AS1|CAMTA1-AS2|CAMTA1-DT|CAMTA1-IT1|CCDC27|CCNL2|CDK11A|CDK11B|CEP104|CFAP74|CHD5|CPTP|DFFB|DNAJC11|DVL1|ESPN|FAAP20|FAM41C|FNDC10|GABRD|GNB1|GNB1-DT|GPR153|HES2|HES3|HES4|HES5|ICMT|ICMT-DT|INTS11|ISG15|KCNAB2|KLHL17|KLHL21|LINC01128|LINC01134|LINC01342|LINC01345|LINC01346|LINC01646|LINC01672|LINC01770|LINC01777|LINC01786|LINC02593|LINC02782|LOC100288175|LOC100996583|LOC105378586|LOC105378948|LOC106783496|LOC107985728|LOC108281140|LOC108281186|LOC110120751|LOC110121223|LOC110599576|LOC112268219|LOC112577469|LOC112577524|LOC112577525|LOC112577578|LOC112577579|LOC112577581|LOC112590813|LOC115801415|LOC120851201|LOC120851202|LRRC47|MEGF6|MIB2|MIR200A|MIR200B|MIR4251|MIR4252|MIR429|MIR4417|MIR4689|MIR551A|MIR6726|MIR6727|MIR6808|MMEL1|MMEL1-AS1|MMP23B|MORN1|MRPL20|MRPL20-AS1|MRPL20-DT|MXRA8|NADK|NOC2L|NOL9|NPHP4|PANK4|PER3|PERM1|PEX10|PHF13|PLCH2|PLEKHG5|PLEKHN1|PRDM16|PRDM16-DT|PRKCZ|PRKCZ-AS1|PRKCZ-DT|PRXL2B|PUSL1|RER1|RNF207|RNF207-AS1|RNF223|RPL22|SAMD11|SCNN1D|SDF4|SKI|SLC35E2A|SLC35E2B|SMIM1|SNORD167|SSU72|TAS1R1|TAS1R3|THAP3|TMEM240|TMEM52|TMEM88B|TNFRSF14|TNFRSF14-AS1|TNFRSF18|TNFRSF25|TNFRSF4|TP73|TP73-AS1|TP73-AS3|TPRG1L|TTC34|TTLL10|TTLL10-AS1|UBE2J2|UTS2|VAMP3|VWA1|WRAP73|ZBTB48		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000154642	1	779727 - 7930605	1	844347 - 7870545	154642	164396		
Single allele	ACR|ADM2|ALG12|ARSA|BRD1|CHKB|CPT1B|CRELD2|DENND6B|HDAC10|IL17REL|KLHDC7B|LMF2|MAPK11|MAPK12|MAPK8IP2|MIOX|MLC1|MOV10L1|NCAPH2|ODF3B|PANX2|PIM3|PLXNB2|PPP6R2|SBF1|SCO2|SELENOO|SHANK3|SYCE3|TAFA5|TRABD|TTLL8|TUBGCP6|TYMP|ZBED4		Epilepsy|Autism spectrum disorder	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000223119	22	49033233 - 51193680			223119	224845		
Single allele	ACR|ARSA|MAPK8IP2|RABL2B|SHANK3		Epilepsy|Autism spectrum disorder	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000223117	22	51027581 - 51234443			223117	224843		
NC_000007.13:g.(?_5567359)_(5569308_?)del	ACTB		Baraitser-Winter syndrome 1	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001064060	7	5567359 - 5569308			1064060	1039109		
NM_001101.5(ACTB):c.7_8delinsTT (p.Asp3Phe)	ACTB	D3F	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000968546	7	5569281 - 5569282	7	5529650 - 5529651	968546	955181		NC_000007.14:5529649:TC:AA
NM_001101.5(ACTB):c.329del (p.Leu110fs)	ACTB	L110fs	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Mar 8, 2018)	no assertion criteria provided	VCV000495296	7	5568826	7	5529195	495296	486793	rs1554329523	NC_000007.14:5529194:A:
NM_001101.5(ACTB):c.269_271del (p.Phe90del)	ACTB	F90del	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488462	7	5568884 - 5568886	7	5529253 - 5529255	488462	481330	rs1554329546	NC_000007.14:5529252:AGAAG:AG
NM_016188.5(ACTL6B):c.695del (p.Pro232fs)	ACTL6B	P232fs	ACTL6B-related recessive epilepsy|ACTL6B-related BAFopathy	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000828180	7	100245131	7	100647508	828180	816517	rs779550102	NC_000007.14:100647507:GGGGGGG:GGGGGG
NM_016188.5(ACTL6B):c.1279del (p.Ter427AspextTer?)	ACTL6B		ACTL6B-related recessive epilepsy|Developmental and epileptic encephalopathy, 76	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2020)	no assertion criteria provided	VCV000635102	7	100240871	7	100643248	635102	622939	rs998928845	NC_000007.14:100643247:A:
GRCh37/hg19 15q26.3(chr15:100736690-100785790)x1	ADAMTS17		not provided	Pathogenic(Last reviewed: Jul 30, 2018)	no assertion criteria provided	VCV000687803	15	100736690 - 100785790			687803	675395		
GRCh38/hg38 10p15.3-15.2(chr10:538646-3636571)x1	ADARB2|ADARB2-AS1|DIP2C|DIP2C-AS1|GTPBP4|IDI1|IDI2|IDI2-AS1|LARP4B|LARP4B-DT|LINC00200|LINC00700|LINC00701|LINC02645|LINC02662|LINC02668|LINC02669|LOC101930421|LOC105376353|LOC105376360|LOC110121467|LOC111589206|LOC111832674|MIR5699|MIR6072|PFKP|PFKP-DT|PITRM1|PITRM1-AS1|SNORD142|WDR37		See cases	Uncertain significance(Last reviewed: Apr 16, 2012)	no assertion criteria provided	VCV000149271	10	584586 - 3678763	10	538646 - 3636571	149271	159022		
GRCh37/hg19 4p16.3-16.1(chr4:75742-8672411)	ADD1|ADRA2C|ATP5ME|CRMP1|CTBP1|DGKQ|EVC|FGFR3|GAK|GRK4|HTT|HGFAC|IDUA|LETM1|LRPAP1|MSX1|MYL5|PDE6B|PPP2R2C|RGS12|RNF4|S100P|SH3BP2|WFS1|NSD2|NELFA|ZNF141|SLBP|ACOX3|CPZ|NOP14|FAM193A|KIAA0232|LINC01587|MFSD10|MAEA|PCGF3|SPON2|TACC3|MXD4|CPLX1|SLC26A1|MAN2B2|NSG1|GPR78|STX18|FGFRL1|CYTL1|SH3TC1|NKX1-1|PIGG|BLOC1S4|STK32B|LYAR|TBC1D14|SORCS2|UVSSA|ZFYVE28|AFAP1|TNIP2|HAUS3|GRPEL1|SLC49A3|TMEM175|ABLIM2|TMEM128|TMEM129|MRFAP1|TADA2B|HTRA3|MRFAP1L1|EVC2|OTOP1|ZNF595|JAKMIP1|FAM53A|TRMT44|ZBTB49|ZNF721|ZNF718|CCDC96|CRIPAK|DOK7|RNF212|NAT8L|MSANTD1|POLN|C4orf50|C4orf48|MIR95|ZNF732|PSAPL1		4p partial monosomy syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625664	4	75742 - 8672411			625664	613968		
NM_201525.4(ADGRG1):c.843_844delinsGC (p.Ser281_Gly282delinsArgArg)	ADGRG1		Polymicrogyria, bilateral perisylvian, autosomal recessive|Polymicrogyria, bilateral frontoparietal|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000372698	16	57689385 - 57689386	16	57655473 - 57655474	372698	360182	rs1057517931	NC_000016.10:57655472:CG:GC
NM_201525.4(ADGRG1):c.1216del (p.Leu406fs)	ADGRG1	L231fs, L354fs, L411fs, L236fs, L405fs, L406fs	Polymicrogyria, bilateral frontoparietal|not provided	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000211093	16	57691332	16	57657420	211093	208293	rs797045600	NC_000016.10:57657419:CC:C
NM_201525.4(ADGRG1):c.739_745del (p.Gln247fs)	ADGRG1	Q247fs, Q77fs, Q195fs, Q72fs, Q252fs	not provided|Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Jun 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005828	16	57688015 - 57688021	16	57654103 - 57654109	5828	20867	rs587776625	NC_000016.10:57654102:CCAGGACC:C
NM_000682.7(ADRA2B):c.675_686delinsGTTTGGCAG (p.His225_Leu229delinsGlnPheGlyArg)	ADRA2B		Epilepsy, familial adult myoclonic 2	Uncertain significance(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000192366	2	96781203 - 96781214	2	96115464 - 96115475	192366	190153	rs879255577	NC_000002.12:96115463:AAAGCCCCACCA:CTGCCAAAC
GRCh38/hg38 22q11.21(chr22:20711594-21151128)x1	AIFM3|CRKL|LINC01637|LOC112694767|LRRC74B|LZTR1|MIR649|P2RX6|PI4KA|SERPIND1|SLC7A4|SNAP29|THAP7|THAP7-AS1		See cases	Uncertain significance(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000150399	22	21065882 - 21505417	22	20711594 - 21151128	150399	160150		
GRCh37/hg19 4q24(chr4:107253424-107448046)x1	AIMP1|GIMD1		not provided	Uncertain significance(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000686363	4	107253424 - 107448046			686363	673955		
NC_000009.11:g.(?_129376729)_(131016993_?)del	AK1|ENG|FPGS|LCN2|LMX1B|RPL12|STXBP1|ZNF79|DPM2|RALGPS1|SH2D3C|ZBTB43|BBLN|PTGES2|GARNL3|LRSAM1|SLC25A25|PTRH1|PIP5KL1|TTC16|NAIF1|CFAP157|FAM102A|ZBTB34|MIR199B|MIR2861|ANGPTL2|CIZ1|ST6GALNAC4|TOR2A|SLC2A8|ST6GALNAC6|NIBAN2|CDK9|DNM1		Early infantile epileptic encephalopathy with suppression bursts|Epileptic encephalopathy, early infantile, 31	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2020)	criteria provided, conflicting interpretations	VCV001056169	9	129376729 - 131016993			1056169	1039126		
NC_000006.11:g.(?_24505087)_(24533940_?)del	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001076224	6	24505087 - 24533940			1076224	1057206		
NM_001080.3(ALDH5A1):c.276del (p.Cys93fs)	ALDH5A1	C93fs	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV001070905	6	24495500	6	24495272	1070905	1060645		NC_000006.12:24495271:C:
NC_000006.11:g.(?_24533732_24539525del	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV001022609					1022609	1001518		
NM_001080.3(ALDH5A1):c.621del (p.Ser208fs)	ALDH5A1	S208fs	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000664746	6	24505105	6	24504877	664746	634795	rs1306678453	NC_000006.12:24504876:CCCC:CCC
NC_000006.12:g.(?_24527977)_(24528186_?)del	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000583913	6	24528205 - 24528414	6	24527977 - 24528186	583913	565248		
NM_001080.3(ALDH5A1):c.300_311del (p.Val102_Ala105del)	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Uncertain significance(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000529486	6	24495519 - 24495530	6	24495291 - 24495302	529486	521817	rs1283990436	NC_000006.12:24495290:CGCGCCGCCGTGCGCGC:CGCGC
NM_001080.3(ALDH5A1):c.819del (p.Asp274fs)	ALDH5A1	D274fs, D287fs	Succinate-semialdehyde dehydrogenase deficiency|Inborn genetic diseases	Pathogenic(Last reviewed: May 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521941	6	24515487	6	24515259	521941	511649	rs778127154	NC_000006.12:24515258:T:
NM_001080.3(ALDH5A1):c.*2778del	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356186	6	24536716	6	24536488	356186	302303	rs771652776	NC_000006.12:24536487:TTT:TT
NM_001080.3(ALDH5A1):c.*652_*655del	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356152	6	24534590 - 24534593	6	24534362 - 24534365	356152	299688	rs779688377	NC_000006.12:24534361:AAAGAA:AA
NM_001080.3(ALDH5A1):c.1343+1_1343+3delinsTT	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2016)	no assertion criteria provided	VCV000225890	6	24528395 - 24528397	6	24528167 - 24528169	225890	227703	rs875989801	NC_000006.12:24528166:GTA:TT
NM_001080.3(ALDH5A1):c.1014+723_1173+796del	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 18, 2020)	no assertion criteria provided	VCV000001360	6	24521492 - 24523946	6	24521264 - 24523718	1360	16399		
NC_000005.9:g.(?_125880657)_(125930890_?)del	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV001071019	5	125880657 - 125930890			1071019	1057125		
NC_000005.9:g.(?_125896755)_(125896836_?)del	ALDH7A1		Pyridoxine-dependent epilepsy	Likely pathogenic(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV001066900	5	125896755 - 125896836			1066900	1054360		
NM_001182.5(ALDH7A1):c.1412_1415+9delinsGTTGGG	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV001033773	5	125885879 - 125885891	5	126550187 - 126550199	1033773	1020033		NC_000005.10:126550186:AAGTTGTACCCAA:CCCAAC
NM_001182.5(ALDH7A1):c.91_92del (p.Thr31fs)	ALDH7A1	T31fs, T3fs	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000958387	5	125930799 - 125930800	5	126595107 - 126595108	958387	944266		NC_000005.10:126595106:GTG:G
NM_001182.5(ALDH7A1):c.651-3_651-1del	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000947599	5	125911157 - 125911159	5	126575465 - 126575467	947599	940793		NC_000005.10:126575464:CTT:
NM_001182.5(ALDH7A1):c.1301_1302del (p.Tyr434fs)	ALDH7A1	Y370fs, Y406fs, Y434fs	Pyridoxine-dependent epilepsy	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000863921	5	125887728 - 125887729	5	126552036 - 126552037	863921	829860		NC_000005.10:126552035:ATA:A
NM_001182.5(ALDH7A1):c.19_32delinsCACATACTGAGCC (p.Ala7fs)	ALDH7A1	A7fs	Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000857207	5	125930859 - 125930872	5	126595167 - 126595180	857207	829886		NC_000005.10:126595166:TGCACACACAGCGC:GGCTCAGTATGTG
NC_000005.10:g.(?_126582831)_(126584032_?)del	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jul 27, 2019)	criteria provided, single submitter	VCV000832420	5	125918523 - 125919724			832420	819531		
NM_001182.5(ALDH7A1):c.244del (p.Gln82fs)	ALDH7A1	Q54fs, Q82fs	Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000631953	5	125929045	5	126593353	631953	620178	rs1317880376	NC_000005.10:126593352:G:
NC_000005.10:g.(?_126575400)_(126575484_?)del	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000584164	5	125911092 - 125911176	5	126575400 - 126575484	584164	559827		
NM_001182.5(ALDH7A1):c.532_542del (p.Leu178fs)	ALDH7A1	L150fs, L178fs	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000465331	5	125912879 - 125912889	5	126577187 - 126577197	465331	454973	rs765119568	NC_000005.10:126577186:TGCTCAATCAGTGC:TGC
NM_001182.5(ALDH7A1):c.503_506del (p.Ile168fs)	ALDH7A1	I168fs, I140fs	not provided|Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420018	5	125918554 - 125918557	5	126582862 - 126582865	420018	406608	rs1064794241	NC_000005.10:126582861:AAGA:
NM_001182.5(ALDH7A1):c.901_902del (p.Asn301fs)	ALDH7A1	N273fs, N301fs	not provided|Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420017	5	125896786 - 125896787	5	126561094 - 126561095	420017	406607	rs1064794240	NC_000005.10:126561093:TT:
NM_001182.5(ALDH7A1):c.34del (p.Ala12fs)	ALDH7A1	A12fs	not provided|Pyridoxine-dependent epilepsy|Seizures	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2021)	criteria provided, conflicting interpretations	VCV000372663	5	125930857	5	126595165	372663	359534	rs750693623	NC_000005.10:126595164:C:
NM_001182.5(ALDH7A1):c.*409del	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350577	5	125880248	5	126544556	350577	295071	rs556732113	NC_000005.10:126544555:CCCCCC:CCCCC
NM_001182.5(ALDH7A1):c.*898_*900del	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350569	5	125879757 - 125879759	5	126544065 - 126544067	350569	300635	rs543290589	NC_000005.10:126544064:CTCCT:CT
NM_001182.5(ALDH7A1):c.*980del	ALDH7A1|LOC112997555		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350568	5	125879677	5	126543985	350568	295062	rs886059846	NC_000005.10:126543984:G:
NM_001182.5(ALDH7A1):c.*1002del	ALDH7A1|LOC112997555		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350564	5	125879655	5	126543963	350564	296870	rs886059845	NC_000005.10:126543962:A:
NM_001182.5(ALDH7A1):c.*1702del	ALDH7A1		Pyridoxine-dependent epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350549	5	125878955	5	126543263	350549	300605	rs5871218	NC_000005.10:126543262:AAAAAAAA:AAAAAAA
NM_001182.5(ALDH7A1):c.*1748_*1749delinsAT	ALDH7A1		Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350545	5	125878908 - 125878909	5	126543216 - 126543217	350545	296855	rs386692155	NC_000005.10:126543215:CA:AT
NM_001182.5(ALDH7A1):c.31_33delinsGAG (p.His11Glu)	ALDH7A1	H11E	not specified|Pyridoxine-dependent epilepsy	Uncertain significance(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000204861	5	125930858 - 125930860	5	126595166 - 126595168	204861	201843	rs796052269	NC_000005.10:126595165:GTG:CTC
NM_001182.5(ALDH7A1):c.1597del (p.Ala533fs)	ALDH7A1	A469fs, A505fs, A533fs	Pyridoxine-dependent epilepsy|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000017999	5	125880680	5	126544988	17999	33038	rs387906574	NC_000005.10:126544987:CC:C
GRCh37/hg19 1q23.1-24.2(chr1:157321299-167391423)x1	ALDH9A1|APCS|APOA2|ATP1A2|ATP1A4|CASQ1|CD1A|CD1B|CD1C|CD1D|CD1E|CD5L|CD48|COPA|CRP|FCER1A|FCER1G|FCGR2A|FCGR2B|FCGR3A|FCGR3B|ACKR1|HSPA6|IFI16|KCNJ9|KCNJ10|LMX1A|LY9|MGST3|MNDA|MPZ|NDUFS2|NHLH1|NIT1|DDR2|PBX1|PFDN2|POU2F1|PPOX|PEX19|RGS4|RXRG|SDHC|SLAMF1|UAP1|SPTA1|UCK2|USF1|TAGLN2|RGS5|PEA15|B4GALT3|CD84|FCGR2C|DEDD|AIM2|ADAMTS4|NOS1AP|NR1I3|GPA33|DUSP12|ATF6|NCSTN|CFAP45|OLFML2B|OR10J1|USP21|DCAF8|F11R|HSD17B7|UFC1|CD244|TMCO1|DUSP23|KIRREL1|ITLN1|SLAMF8|VANGL2|IGSF9|POGK|SLAMF7|CADM3|FCRL2|OR6N2|OR6K2|NECTIN4|FCRL5|FCRL4|NUF2|TOMM40L|FCRLA|MAEL|SLAMF9|STYXL2|PIGM|IGSF8|SLAMF6|FCRL1|FCRL3|TADA1|SH2D1B|KLHDC9|OR10J5|UHMK1|FCRLB|OR10T2|OR6P1|OR10X1|OR10Z1|OR6K6|OR6N1|ITLN2|FAM78B|PYHIN1|ARHGAP30|CFAP126|SNHG28|SPATA46|CCDC190|OR10R2|FCRL6|ILDR2|OR10K2|OR10K1|OR6Y1|OR6K3|VSIG8|C1orf226|LRRC52|OR10J3|PCP4L1|TSTD1|LOC100287049|KIRREL1-IT1		not provided	Pathogenic(Last reviewed: May 2, 2017)	no assertion criteria provided	VCV000688082	1	157321299 - 167391423			688082	675674		
NC_000016.9:g.(?_29802081)_(30200285_?)del	ALDOA|TLCD3B|YPEL3|MAPK3|TAOK2|INO80E|GDPD3|SEZ6L2|MVP|KCTD13|CDIPT|ASPHD1|PAGR1|TMEM219|PRRT2|C16orf92|KIF22|MAZ|CORO1A|PPP4C|DOC2A|HIRIP3|TBX6		Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001075384	16	29802081 - 30200285			1075384	1057773		
GRCh38/hg38 16p11.2(chr16:29581462-30179247)x1	ALDOA|ASPHD1|C16orf54|C16orf92|CDIPT|CDIPTOSP|DOC2A|GDPD3|HIRIP3|INO80E|KCTD13|KIF22|LOC112352679|LOC112352680|LOC112694756|LOC116276452|MAPK3|MAZ|MIR3680-2|MVP|PAGR1|PPP4C|PRRT2|QPRT|SEZ6L2|SPN|TAOK2|TBX6|TLCD3B|TMEM219|YPEL3|YPEL3-DT|ZG16		See cases	Pathogenic(Last reviewed: Aug 5, 2011)	no assertion criteria provided	VCV000031956	16	29592783 - 30190568	16	29581462 - 30179247	31956	40621		
Single allele	ALX3|AMPD2|CSF1|CELSR2|GNAI3|GNAT2|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|KCNA2|KCNA10|KCNC4|PSMA5|SORT1|SARS1|STXBP3|TAF13|SLC16A4|VAV3|LAMTOR5|AHCYL1|NTNG1|WDR47|CLCC1|GPSM2|SLC25A24|PRPF38B|TMEM167B|AMIGO1|ELAPOR1|RBM15|EPS8L3|GPR61|PROK1|PSRC1|STRIP1|HENMT1|ATXN7L2|C1orf194|NBPF4|FNDC7|UBL4B|AKNAD1|FAM102B|SYPL2|CYB561D1|MYBPHL|SLC6A17|MIR197|NBPF6		1p13.3 deletion syndrome	Likely pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000635280	1	107779092 - 111199205			635280	623114		
NM_021926.4(ALX4):c.976_985delinsCTAAGATCTCAACAGAGATGGCAACT (p.Asp326fs)	ALX4	D326fs	Parietal foramina 2	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000155904	11	44286655 - 44286664	11	44265105 - 44265114	155904	165649	rs587777702	NC_000011.10:44265104:GCACCGGGTC:AGTTGCCATCTCTGTTGAGATCTTAG
NM_021926.4(ALX4):c.385_394del (p.Cys129fs)	ALX4	C129fs	Parietal foramina 2	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000005019	11	44331219 - 44331228	11	44309669 - 44309678	5019	20058	rs387906325	NC_000011.10:44309668:GCGTCTTGCAG:G
NM_021926.4(ALX4):c.504del (p.Asp169fs)	ALX4	D169fs	Parietal foramina 2	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000005016	11	44297171	11	44275621	5016	20055	rs587776614	NC_000011.10:44275620:A:
GRCh38/hg38 16p13.3(chr16:2365461-2532960)x1	AMDHD2|ATP6V0C|CCNF|CEMP1|LOC106783500|LOC112340388|MIR3178|MIR6767|MIR6768|NTN3|TBC1D24|TEDC2|TEDC2-AS1		See cases	Uncertain significance(Last reviewed: May 14, 2012)	no assertion criteria provided	VCV000150039	16	2415462 - 2582961	16	2365461 - 2532960	150039	159790		
NM_001164710.2(AMT):c.340-552del	AMT		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV001076854	3	49457773	3	49420340	1076854	1059849		NC_000003.12:49420339:CCCC:CCC
NM_000481.4(AMT):c.168_171del (p.Leu57fs)	AMT	L57fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001072385	3	49459624 - 49459627	3	49422191 - 49422194	1072385	1059854		NC_000003.12:49422190:CAGAC:C
NM_000481.4(AMT):c.602_603del (p.Lys201fs)	AMT	K145fs, K157fs, K201fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 12, 2021)	criteria provided, single submitter	VCV001013618	3	49456786 - 49456787	3	49419353 - 49419354	1013618	1001333	rs933458798	NC_000003.12:49419352:TTT:T
NM_032316.3(NICN1):c.*2359_*2468del	AMT|NICN1		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000965232	3	49459798 - 49459907	3	49422365 - 49422474	965232	960518		
NM_000481.4(AMT):c.1107_1108del (p.Tyr369_Ser370delinsTer)	AMT		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV000962887	3	49455077 - 49455078	3	49417644 - 49417645	962887	943618		NC_000003.12:49417643:TGT:T
NM_000481.4(AMT):c.1056del (p.Ser353fs)	AMT	S309fs, S297fs, S353fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000954185	3	49455129	3	49417696	954185	943619		NC_000003.12:49417695:GGGG:GGG
NM_000481.4(AMT):c.734_735del (p.Thr245fs)	AMT	T201fs, T189fs, T245fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000851973	3	49456546 - 49456547	3	49419113 - 49419114	851973	828321		NC_000003.12:49419112:TGT:T
NC_000003.12:g.(?_49421482)_(49424348_?)del	AMT|NICN1		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000832706	3	49458915 - 49461781			832706	819409		
NM_000481.4(AMT):c.478del (p.Val160fs)	AMT	V160fs, V104fs, V116fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801972	3	49457215	3	49419782	801972	790406	rs1575305901	NC_000003.12:49419781:CC:C
NM_000481.4(AMT):c.908del (p.Pro303fs)	AMT	P247fs, P303fs, P259fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000801971	3	49455376	3	49417943	801971	790405	rs1575303218	NC_000003.12:49417942:GGG:GG
NM_000481.4(AMT):c.348_349del (p.Ser117fs)	AMT	S61fs, S117fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000558045	3	49457766 - 49457767	3	49420333 - 49420334	558045	543258	rs1553638649	NC_000003.12:49420332:ACA:A
NM_000481.4(AMT):c.982del (p.Ala328fs)	AMT	A272fs, A284fs, A328fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000557221	3	49455302	3	49417869	557221	543127	rs1553638266	NC_000003.12:49417868:CCCCC:CCCC
NM_000481.4(AMT):c.695_696+21del	AMT		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	VCV000555079	3	49456672 - 49456694	3	49419239 - 49419261	555079	542990	rs1553638457	NC_000003.12:49419238:CCACACCACTTCTTGACACACCTCCACACCA:CCACACCA
NM_000481.4(AMT):c.1209del (p.Lys403fs)	AMT	K347fs, K359fs, K403fs	Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554761	3	49454976	3	49417543	554761	543123	rs1553638189	NC_000003.12:49417542:C:
NM_000481.4(AMT):c.165del (p.Gly54_Trp55insTer)	AMT		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000553319	3	49459630	3	49422197	553319	543260	rs1483890972	NC_000003.12:49422196:CC:C
NM_000481.4(AMT):c.1199_1202delinsTAT (p.Tyr400fs)	AMT	Y344fs, Y356fs, Y400fs	Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000553002	3	49454983 - 49454986	3	49417550 - 49417553	553002	542982	rs1553638191	NC_000003.12:49417549:GTAT:ATA
NM_000481.4(AMT):c.875del (p.Leu292fs)	AMT	L248fs, L236fs, L292fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000552871	3	49456406	3	49418973	552871	542985	rs1553638405	NC_000003.12:49418972:A:
NM_000481.4(AMT):c.15_18del (p.Ser6fs)	AMT|NICN1	S6fs	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552502	3	49459866 - 49459869	3	49422433 - 49422436	552502	543158	rs1553638904	NC_000003.12:49422432:ACTTAC:AC
NM_000481.4(AMT):c.144_148del (p.Lys48fs)	AMT	K48fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000551785	3	49459647 - 49459651	3	49422214 - 49422218	551785	543266	rs1553638822	NC_000003.12:49422213:CCATT:
NM_000481.4(AMT):c.982_983delinsT (p.Ala328fs)	AMT	A272fs, A328fs, A284fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056241	3	49455301 - 49455302	3	49417868 - 49417869	56241	70880	rs386833692	NC_000003.12:49417867:GC:A
NM_000481.4(AMT):c.970_972del (p.Met324del)	AMT	M268del, M280del, M324del	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056240	3	49455312 - 49455314	3	49417879 - 49417881	56240	70879	rs386833691	NC_000003.12:49417878:CATCA:CA
NM_000481.4(AMT):c.61del (p.Ala21fs)	AMT|NICN1	A21fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056236	3	49459823	3	49422390	56236	70875	rs386833687	NC_000003.12:49422389:CC:C
NM_000481.4(AMT):c.59del (p.Pro20fs)	AMT|NICN1	P20fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056235	3	49459825	3	49422392	56235	70874	rs386833686	NC_000003.12:49422391:GGGGGG:GGGGG
NM_000481.4(AMT):c.535del (p.Leu179fs)	AMT	L135fs, L179fs, L123fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056234	3	49457158	3	49419725	56234	70873	rs386833685	NC_000003.12:49419724:GGG:GG
NM_000481.4(AMT):c.452_466del (p.Lys151_Leu155del)	AMT		not provided|Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056232	3	49457649 - 49457663	3	49420216 - 49420230	56232	70871	rs386833683	NC_000003.12:49420215:TGAGGGCCAAATCTTT:T
NM_000481.4(AMT):c.148del (p.Val50fs)	AMT	V50fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056227	3	49459647	3	49422214	56227	70866	rs386833678	NC_000003.12:49422213:CC:C
AMT, 1-BP DEL, 183C	AMT		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000011977					11977	27016		
GRCh38/hg38 20p13(chr20:89939-1852477)x1	ANGPT4|C20orf202|C20orf96|CSNK2A1|DEFB125|DEFB126|DEFB127|DEFB128|DEFB129|DEFB132|FAM110A|FKBP1A|FKBP1A-SDCBP2|LOC105372493|LOC112694731|LOC113939990|LOC116286198|LOC116286199|MIR6869|NRSN2|NRSN2-AS1|NSFL1C|PSMF1|RAD21L1|RBCK1|RSPO4|SCRT2|SDCBP2|SDCBP2-AS1|SIRPB1|SIRPB2|SIRPD|SIRPG|SIRPG-AS1|SLC52A3|SNPH|SOX12|SRXN1|TBC1D20|TCF15|TMEM74B|TRIB3|ZCCHC3		See cases	Pathogenic(Last reviewed: Aug 5, 2011)	no assertion criteria provided	VCV000035265	20	70580 - 1833123	20	89939 - 1852477	35265	43930		
NM_001148.6(ANK2):c.3490_3493del (p.Ile1164fs)	ANK2	I1089fs, I1098fs, I1117fs, I1130fs, I1154fs, I1164fs, I1176fs, I1178fs, I1179fs, I1190fs, I340fs, I347fs, I1069fs, I1077fs, I1093fs, I1097fs, I1109fs, I1131fs, I1147fs, I1163fs, I1168fs, I1102fs, I1036fs, I1064fs, I1110fs, I1121fs, I1142fs, I1143fs, I1155fs, I1157fs, I352fs, I1003fs, I1112fs, I1119fs, I1159fs, I1183fs, I1203fs, I1211fs	not provided	Likely pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000818077	4	114257110 - 114257113	4	113335954 - 113335957	818077	805377	rs1588487990	NC_000004.12:113335953:TGATTG:TG
NM_013275.6(ANKRD11):c.4067del (p.Ser1356fs)	ANKRD11	S1356fs	Intellectual disability	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000973135	16	89348883	16	89282475	973135	961457		NC_000016.10:89282474:G:
NM_013275.6(ANKRD11):c.6882_6883del (p.Glu2295fs)	ANKRD11	E2295fs	Intellectual disability	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000973134	16	89346067 - 89346068	16	89279659 - 89279660	973134	961453		NC_000016.10:89279658:CA:
NM_013275.6(ANKRD11):c.3770_3773del (p.Lys1257fs)	ANKRD11	K1257fs	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560941	16	89349177 - 89349180	16	89282769 - 89282772	560941	552192	rs1567571990	NC_000016.10:89282768:TCTTT:T
GRCh37/hg19 11p14.2(chr11:26469479-26610375)x1	ANO3|MUC15		not provided	Uncertain significance(Last reviewed: Oct 5, 2017)	no assertion criteria provided	VCV000689302	11	26469479 - 26610375			689302	676894		
NC_000016.9:g.(?_765584)_(1204036_?)del	ANTKMT|C1QTNF8|CACNA1H|CCDC78|CHTF18|CIAO3|GNG13|HAGHL|LMF1|METRN|MSLN|PRR25|RPUSD1|SOX8|SSTR5		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV001047658	16	765584 - 1204036			1047658	1022369		
GRCh37/hg19 11p15.5(chr11:1010694-1018456)x1	AP2A2|MUC6		not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000600737	11	1010694 - 1018456			600737	592073		
NC_000016.10:g.(?_28487456)_(28595930_?)del	APOBR|CLN3|IL27|NUPR1|SGF29|SULT1A2		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000584086	16	28498777 - 28607251	16	28487456 - 28595930	584086	573658		
GRCh38/hg38 16p12.1-11.2(chr16:28327346-29342070)x1	APOBR|ATP2A1|ATP2A1-AS1|ATXN2L|CD19|CLN3|EIF3C|EIF3CL|IL27|LAT|LOC108281183|LOC112340392|LOC112340393|MIR4517|MIR4721|MIR6862-1|MIR6862-2|NFATC2IP|NPIPB6|NPIPB7|NPIPB8|NPIPB9|NUPR1|RABEP2|SGF29|SH2B1|SPNS1|SULT1A1|SULT1A2|TUFM		See cases	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000148782	16	28338667 - 29353391	16	28327346 - 29342070	148782	158533		
GRCh37/hg19 7q31.32-32.2(chr7:121480906-129389003)x1	ARF5|OPN1SW|CALU|FLNC|GPR37|GRM8|IMPDH1|IRF5|LEP|NDUFA5|NRF1|PAX4|PTPRZ1|SLC13A1|SMO|SPAM1|WASL|ATP6V1F|AASS|AHCYL2|TNPO3|HYAL4|POT1|SND1|HILPDA|FSCN3|TAS2R16|RBM28|METTL2B|STRIP2|LRRC4|CCDC136|GCC1|FAM71F1|CADPS2|ASB15|IQUB|RNF133|ZNF800|TSPAN33|FAM71F2|KCP|RNF148|FEZF1|PRRT4|LMOD2|TMEM229A|SMKR1		not provided	Pathogenic(Last reviewed: Oct 10, 2017)	no assertion criteria provided	VCV000687212	7	121480906 - 129389003			687212	674804		
NM_006421.5(ARFGEF1):c.1006del (p.Met336fs)	ARFGEF1	M336fs	Behavioral abnormality|Global developmental delay|Delayed speech and language development|Intellectual disability	Pathogenic	criteria provided, single submitter	VCV000996318	8	68200211	8	67287976	996318	984035		NC_000008.11:67287975:TTT:TT
NM_006421.5(ARFGEF1):c.2158del (p.Leu720fs)	ARFGEF1	L720fs	Behavioral abnormality|Global developmental delay|Delayed speech and language development|Intellectual disability	Pathogenic	criteria provided, single submitter	VCV000996315	8	68172127	8	67259892	996315	984033		NC_000008.11:67259891:GG:G
GRCh37/hg19 4q21.23(chr4:86532910-86644539)x1	ARHGAP24		not provided	Uncertain significance(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000688870	4	86532910 - 86644539			688870	676462		
NM_173728.4(ARHGEF15):c.709_723del (p.Val237_Ala241del)	ARHGEF15		Early infantile epileptic encephalopathy with suppression bursts	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495290	17	8216347 - 8216361	17	8313029 - 8313043	495290	486769	rs1555546796	NC_000017.11:8313028:GTCCCCCGTCGGGCC:
NC_000023.10:g.(?_62875364)_(62944601_?)del	ARHGEF9		Early infantile epileptic encephalopathy 8	Likely pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001068454	X	62875364 - 62944601			1068454	1054717		
NM_001353921.2(ARHGEF9):c.740del (p.Leu246_Leu247insTer)	ARHGEF9		Early infantile epileptic encephalopathy 8	Uncertain significance(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000976407	X	62898295	X	63678415	976407	964628		NC_000023.11:63678414:AAAA:AAA
NM_001353921.2(ARHGEF9):c.1306del (p.Glu436fs)	ARHGEF9	E247fs, E327fs, E364fs, E369fs, E376fs, E385fs, E392fs, E408fs, E429fs, E436fs, E442fs	Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804241	X	62875389	X	63655509	804241	792611	rs1602253296	NC_000023.11:63655508:CC:C
NM_001374828.1(ARID1B):c.7069del (p.Leu2357fs)	ARID1B	L1524fs, L2234fs, L2304fs, L2317fs, L2357fs	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560954	6	157528975	6	157207841	560954	552103	rs1562355401	NC_000006.12:157207840:C:
NM_001374828.1(ARID1B):c.5258del (p.Asp1753fs)	ARID1B	D1630fs, D920fs, D1700fs, D1713fs, D1753fs	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560953	6	157522617	6	157201483	560953	552102	rs1562347066	NC_000006.12:157201482:A:
Single allele	ARL17B|KANSL1|KANSL1-AS1|LOC112533643|LRRC37A		Koolen-de Vries syndrome	Pathogenic(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000978035			17	46096853 - 46403941	978035	966174		
Single allele	ARVCF|LZTR1|CLTCL1|ESS2|CDC45|DGCR2|TXNRD2|TSSK2|TBX1|CLDN5|HIRA|UFD1|ZNF74|TRMT2A|ZDHHC8|P2RX6|SNAP29|MED15|DGCR8|GNB1L|MRPL40|RTN4R|RTL10|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|AIFM3|USP41|FAM230A|GGTLC3|TMEM191B|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPTIN5|PRODH|RANBP1|SLC7A4|SLC25A1|DGCR6		Epilepsy|Intellectual disability	Pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV000997809	22	18889490 - 21463730			997809	985527		
NM_139058.3(ARX):c.1406_1415del (p.Ala469fs)	ARX	A469fs	X-linked spasticity-intellectual disability-epilepsy syndrome	Pathogenic(Last reviewed: May 20, 2021)	criteria provided, single submitter	VCV001164076	X	25025261 - 25025270	X	25007144 - 25007153	1164076	1153076		NC_000023.11:25007143:CGGAACACTGC:C
NM_139058.3(ARX):c.441_464del (p.Ala148_Ala155del)	ARX|LOC109610631		not provided|History of neurodevelopmental disorder|Epileptic encephalopathy, early infantile, 1|Mental retardation, with or without seizures, ARX-related, X-linked|not specified|Mental retardation, with or without seizures, ARX-related, X-linked	Benign/Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096454	X	25031648 - 25031671	X	25013531 - 25013554	96454	102348	rs398124510	NC_000023.11:25013530:GCCGCGGCGGCCGCGGCCGCGGCTGCCGCGGCGGCC:GCCGCGGCGGCC
NM_177924.5(ASAH1):c.410_411del (p.Phe136_Tyr137insTer)	ASAH1		Farber lipogranulomatosis	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000812471	8	17922012 - 17922013	8	18064503 - 18064504	812471	800733	rs1281024431	NC_000008.11:18064502:ATA:A
NM_177924.5(ASAH1):c.125+211_383-1330del	ASAH1		Farber lipogranulomatosis	Pathogenic(Last reviewed: Jan 31, 2018)	no assertion criteria provided	VCV000545564	8	17923370 - 17932839	8	18065861 - 18075330	545564	536066		
NM_177924.5(ASAH1):c.*176_*177del	ASAH1		Farber lipogranulomatosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362369	8	17914866 - 17914867	8	18057357 - 18057358	362369	304745	rs374131883	NC_000008.11:18057356:AG:
NM_177924.5(ASAH1):c.*708_*711del	ASAH1		Farber lipogranulomatosis	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362357	8	17914332 - 17914335	8	18056823 - 18056826	362357	313622	rs35838806	NC_000008.11:18056822:CTTCCTT:CTT
NC_000008.11:g.(?_18051554)_(18107050_?)del	ASAH1|ASAH1-AS1		Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035545	8	17909063 - 17964559	8	18051554 - 18107050	35545	44216		
NC_000016.10:g.(?_29813055)_(29904965_?)del	ASPHD1|CDIPT|CDIPTOSP|LOC112352680|MVP|PAGR1|PRRT2|SEZ6L2		Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000584215	16	29824376 - 29916286	16	29813055 - 29904965	584215	569809		
GRCh37/hg19 9q33.1(chr9:119666574-119745592)x1	ASTN2		not provided	Uncertain significance(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000686860	9	119666574 - 119745592			686860	674452		
NM_015338.6(ASXL1):c.2763_2770delinsCAA (p.Val922fs)	ASXL1	V861fs, V922fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000521462	20	31023278 - 31023285	20	32435475 - 32435482	521462	512445	rs1555912285	NC_000020.11:32435474:TGTTGAGC:CAA
GRCh38/hg38 1p36.33-36.32(chr1:911300-2963389)x1	ATAD3A|ACAP3|AGRN|ANKRD65|ANKRD65-AS1|ATAD3B|ATAD3C|AURKAIP1|B3GALT6|C1QTNF12|C1orf159|CALML6|CCNL2|CDK11A|CDK11B|CFAP74|CPTP|DVL1|FAAP20|FNDC10|GABRD|GNB1|GNB1-DT|HES4|HES5|INTS11|ISG15|KLHL17|LINC01342|LINC01770|LINC01786|LINC02593|LOC100288175|LOC100996583|LOC105378586|LOC105378948|LOC106783496|LOC107985728|LOC110599576|LOC112268219|LOC112577469|LOC112577524|LOC112577525|LOC115801415|MIB2|MIR200A|MIR200B|MIR429|MIR6726|MIR6727|MIR6808|MMEL1|MMEL1-AS1|MMP23B|MORN1|MRPL20|MRPL20-AS1|MRPL20-DT|MXRA8|NADK|NOC2L|PANK4|PERM1|PEX10|PLCH2|PLEKHN1|PRKCZ|PRKCZ-AS1|PRKCZ-DT|PRXL2B|PUSL1|RER1|RNF223|SAMD11|SCNN1D|SDF4|SKI|SLC35E2A|SLC35E2B|SNORD167|SSU72|TAS1R3|TMEM240|TMEM52|TMEM88B|TNFRSF14|TNFRSF14-AS1|TNFRSF18|TNFRSF4|TTC34|TTLL10|TTLL10-AS1|UBE2J2|VWA1		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000154687	1	846680 - 2879954	1	911300 - 2963389	154687	164441		
NM_001940.4(ATN1):c.3165_3176del (p.Ile1057_His1060del)	ATN1		Congenital hypotonia, epilepsy, developmental delay, and digital anomalies	Pathogenic	criteria provided, single submitter	VCV001012272	12	7048286 - 7048297	12	6939123 - 6939134	1012272	1000003		NC_000012.12:6939122:CACTCCCACATCCACTC:CACTC
NM_000702.4(ATP1A2):c.835del (p.Arg279fs)	ATP1A2	R279fs	not provided|Abnormality of neuronal migration|Hydrops fetalis|Arthrogryposis multiplex congenita|Epilepsy	Likely pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000586989	1	160097428	1	160127638	586989	578035	rs1558005340	NC_000001.11:160127637:C:
NM_000702.4(ATP1A2):c.2105_2106del (p.Cys702fs)	ATP1A2	C702fs	Epilepsy|Arthrogryposis multiplex congenita|Hydrops fetalis|Abnormality of neuronal migration	Likely pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000562228	1	160105074 - 160105075	1	160135284 - 160135285	562228	553412	rs1558008455	NC_000001.11:160135283:TGT:T
NM_000702.4(ATP1A2):c.13-13del	ATP1A2		not specified	Benign(Last reviewed: Sep 7, 2012)	criteria provided, single submitter	VCV000204880	1	160090681	1	160120891	204880	201066	rs796052275	NC_000001.11:160120890:CCC:CC
NM_000702.4(ATP1A2):c.13-11_13-8del	ATP1A2		Alternating hemiplegia of childhood|Alternating hemiplegia of childhood 1|Familial hemiplegic migraine|not specified|not provided	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000166705	1	160090682 - 160090685	1	160120892 - 160120895	166705	177497	rs373796693	NC_000001.11:160120891:CCTTCCT:CCT
NM_152296.5(ATP1A3):c.1115del (p.Thr372fs)	ATP1A3	T372fs, T383fs, T385fs	Benign familial neonatal seizures 1	Pathogenic	no assertion criteria provided	VCV001264345	19	42486137	19	41981985	1264345	1254245		NC_000019.10:41981984:G:
NM_152296.5(ATP1A3):c.376_387del (p.Leu126_Val129del)	ATP1A3		Dystonia 12	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001053961	19	42490352 - 42490363	19	41986200 - 41986211	1053961	1051343		NC_000019.10:41986199:CACGGCCGCCAGCACG:CACG
NM_152296.5(ATP1A3):c.2563_2565del (p.Gly855del)	ATP1A3	G855del, G868del, G866del	Dystonia 12	Uncertain significance(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000844663	19	42473710 - 42473712	19	41969558 - 41969560	844663	847742		NC_000019.10:41969557:GCC:
NC_000019.10:g.(?_41968775)_(41970552_?)del	ATP1A3		Dystonia 12	Uncertain significance(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000831696	19	42472927 - 42474704			831696	821261		
NM_152296.5(ATP1A3):c.410_412del (p.Ser137del)	ATP1A3	S137del, S150del, S148del	Dystonia 12|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	VCV000503717	19	42490327 - 42490329	19	41986175 - 41986177	503717	495867	rs1555865385	NC_000019.10:41986174:AGGAG:AG
NM_152296.5(ATP1A3):c.607-3del	ATP1A3		Dystonia 12	Benign(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV000468606	19	42489578	19	41985426	468606	470277	rs781995257	NC_000019.10:41985425:GGGGG:GGGG
NM_152296.5(ATP1A3):c.2512_2516delinsTC (p.Arg838_Leu839delinsSer)	ATP1A3		Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	VCV000369662	19	42474363 - 42474367	19	41970211 - 41970215	369662	353910	rs1057516032	NC_000019.10:41970210:AGTCT:GA
GRCh38/hg38 16p11.2(chr16:28850210-29019738)x1	ATP2A1|ATP2A1-AS1|CD19|LAT|LOC112340393|MIR4517|NFATC2IP|RABEP2|SH2B1|SPNS1		See cases	Pathogenic(Last reviewed: Feb 14, 2018)	no assertion criteria provided	VCV000032783	16	28861531 - 29031059	16	28850210 - 29019738	32783	41448		
NM_005765.3(ATP6AP2):c.301-11_301-10del	ATP6AP2		Mental retardation, X-linked, syndromic, Hedera type	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000869368	X	40456490 - 40456491	X	40597238 - 40597239	869368	857586		NC_000023.11:40597237:TT:
GRCh37/hg19 1p34.2-34.1(chr1:43336799-44713202)x1	ATP6V0B|CDC20|DPH2|MPL|PTPRF|ST3GAL3|SLC2A1|SLC6A9|TIE1|B4GALT2|ARTN|IPO13|KDM4A|EBNA1BP2|SZT2|DMAP1|ELOVL1|ERI3|HYI|MED8|KLF17|TMEM125|CFAP57|C1orf210|CCDC24|FAM183A		not provided	Pathogenic(Last reviewed: Jan 8, 2018)	no assertion criteria provided	VCV000689310	1	43336799 - 44713202			689310	676902		
GRCh37/hg19 16p13.3(chr16:2527176-2581549)x1	ATP6V0C|AMDHD2|TBC1D24|CEMP1		not provided	Uncertain significance(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000688711	16	2527176 - 2581549			688711	676303		
GRCh38/hg38 10q25.3(chr10:115426223-115612358)x1	ATRNL1		See cases	Uncertain significance(Last reviewed: Jul 11, 2011)	no assertion criteria provided	VCV000149768	10	399687 - 585822	10	115426223 - 115612358	149768	159519		
GRCh37/hg19 9q22.31(chr9:94117511-94122902)x1	AUH		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	no assertion criteria provided	VCV000685654	9	94117511 - 94122902			685654	673246		
GRCh38/hg38 14q13.1-13.3(chr14:33762166-36191750)x1	BAZ1A|BAZ1A-AS1|BRMS1L|CFL2|EAPP|EGLN3|EGLN3-AS1|FAM177A1|INSM2|LINC00609|LOC101927178|LOC106799848|LOC106799849|LOC108281128|LOC110120857|LOC111365217|LOC112268478|LOC112268479|LOC116268458|NFKBIA|NPAS3|PPP2R3C|PRORP|PSMA6|PTCSC3|RALGAPA1|SNORA101B|SNX6|SPTSSA|SRP54|SRP54-AS1		See cases	Uncertain significance(Last reviewed: Jan 5, 2011)	no assertion criteria provided	VCV000154467	14	34231372 - 36660956	14	33762166 - 36191750	154467	164221		
NC_000004.11:g.(?_123663028)_(124235239_?)del	BBS12|FGF2|NUDT6|SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001075381	4	123663028 - 124235239			1075381	1057083		
GRCh37/hg19 2p16.1(chr2:60760776-60789053)x1	BCL11A		Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001220531	2	60760776 - 60789053			1220531	1210507		
GRCh37/hg19 22q11.22-11.23(chr22:22997802-23652512)x1	BCR|GNAZ|IGLC1|RAB36|RSPH14|IGLL5		not provided	Pathogenic(Last reviewed: Jan 31, 2018)	no assertion criteria provided	VCV000687642	22	22997802 - 23652512			687642	675234		
GRCh37/hg19 22q11.22-11.23(chr22:22997802-23652512)x1	BCR|GNAZ|IGLC1|RAB36|RSPH14|IGLL5		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000686625	22	22997802 - 23652512			686625	674217		
GRCh37/hg19 22q11.22-11.23(chr22:22962196-23652512)x1	BCR|GNAZ|IGLC1|RAB36|RSPH14|GGTLC2|IGLL5		not provided	Pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000686040	22	22962196 - 23652512			686040	673632		
GRCh37/hg19 15q26.1(chr15:91229877-93677014)x1	BLM|CHD2|FES|MAN2A2|FURIN|ST8SIA2|PRC1|SV2B|VPS33B|SLCO3A1|UNC45A|RGMA|RCCD1|C15orf32|HDDC3|FAM174B		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000687287	15	91229877 - 93677014			687287	674879		
Single allele	BMERB1|NTAN1|ABCC6|MYH11|NPIPA1|MARF1|PDXDC1|NOMO1|CEP20|NOMO3|NPIPA5|NDE1|MPV17L|ABCC1|RRN3		Epilepsy	Pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV000997820	16	14968859 - 16363239			997820	985538		
GRCh37/hg19 2q32.2-33.1(chr2:190345272-200212289)	BOLL|PCGEM1|NEMP2|STK17B|C2orf66|MYO1B|COQ10B|INPP1|ANKAR|SF3B1|MSTN|RFTN2|HSPE1|GLS|ORMDL1|STAT4|GTF3C3|PGAP1|MFSD6|STAT1|TMEFF2|DNAH7|PLCL1|MOB4|HIBCH|ANKRD44|CAVIN2|ASNSD1|NAB1|C2orf88|PMS1|SLC40A1|OSGEPL1|HSPD1|MARS2|HECW2|SATB2|NABP1|CCDC150|SLC39A10		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jul 28, 2020)	no assertion criteria provided	VCV000977790	2	190345272 - 200212289			977790	965919		
GRCh38/hg38 Yq11.223-11.23(chrY:22727003-25749348)x0	BPY2|BPY2B|BPY2C|CDY1|CDY1B|DAZ1|DAZ2|DAZ3|DAZ4|LOC106144557|LOC106144558|LOC108868753|TTTY17A|TTTY17B|TTTY17C|TTTY3|TTTY3B|TTTY4|TTTY4B|TTTY4C		See cases	Pathogenic(Last reviewed: Sep 4, 2012)	no assertion criteria provided	VCV000149291	Y	24873150 - 27895495	Y	22727003 - 25749348	149291	159042		
GRCh37/hg19 21q22.13-22.2(chr21:37839410..41427526)	BRWD1|CLDN14|ETS2|GET1|HLCS|B3GALT5|DSCAM|DSCR4|DSCR8|DYRK1A|ERG|HMGN1|IGSF5|KCNJ15|KCNJ6|LCA5L|LINC00114|PCP4|PIGP|PSMG1|RIPPLY3|SH3BGR|SIM2|TTC3|VPS26C		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204003	21	37839410 - 41427526			204003	200409		
GRCh37/hg19 2q33.1(chr2:202373645-202375101)x1	C2CD6		not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000604210	2	202373645 - 202375101			604210	595546		
NC_000007.14:g.(?_147395589)_(148847318_?)del	C7orf33|CNTNAP2|EZH2|CUL1		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000833138	7	147092681 - 148544410			833138	819847		
NM_000067.3(CA2):c.681del (p.Lys227fs)	CA2	K227fs, K126fs	Osteopetrosis with renal tubular acidosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000632527	8	86392914	8	85480685	632527	620306	rs779869368	NC_000008.11:85480684:AAA:AA
CA2, 1-BP DEL, 207C	CA2		Osteopetrosis with renal tubular acidosis	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000000920					920	15959		
NM_001127222.2(CACNA1A):c.2812_2813del (p.Gly938fs)	CACNA1A	G938fs, G942fs, G939fs	Epileptic encephalopathy, early infantile, 42	Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000813792	19	13409634 - 13409635	19	13298820 - 13298821	813792	802024		NC_000019.10:13298819:CCCCCC:CCCC
NC_000009.11:g.(?_140622791)_(141016451_?)del	CACNA1B|EHMT1|LOC651337		Kleefstra syndrome 1	Pathogenic(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV001073970	9	140622791 - 141016451			1073970	1057401		
NC_000009.11:g.(?_140513481)_(141016451_?)del	CACNA1B|EHMT1|LOC651337		Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001073969	9	140513481 - 141016451			1073969	1057400		
NM_021098.3(CACNA1H):c.4350+13del	CACNA1H		Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV001130904	16	1261303	16	1211303	1130904	1124874		NC_000016.10:1211302:CCCCC:CCCC
NM_021098.3(CACNA1H):c.4929+7_4929+8delinsTG	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001126906	16	1263938 - 1263939	16	1213938 - 1213939	1126906	1124876		NC_000016.10:1213937:GC:TG
NM_021098.3(CACNA1H):c.5887+10_5887+20del	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Likely benign(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV001125661	16	1268659 - 1268669	16	1218659 - 1218669	1125661	1124885		NC_000016.10:1218658:AGCCAGCAGGAAG:AG
NM_021098.3(CACNA1H):c.3387_3395del (p.Cys1129_Pro1131del)	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001061809	16	1259050 - 1259058	16	1209050 - 1209058	1061809	1049287		NC_000016.10:1209049:CCCTGTGCCCCCTG:CCCTG
NC_000016.9:g.(?_1244962)_(1270994_?)del	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001056315	16	1244962 - 1270994			1056315	1039194		
NM_021098.3(CACNA1H):c.1837_1844del (p.Tyr613fs)	CACNA1H	Y613fs	Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001055793	16	1252285 - 1252292	16	1202285 - 1202292	1055793	1049275		NC_000016.10:1202284:ACTACCCCAC:AC
NM_021098.3(CACNA1H):c.1785_1787del (p.Ala596del)	CACNA1H	A596del	Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001025194	16	1252233 - 1252235	16	1202233 - 1202235	1025194	1011795		NC_000016.10:1202232:GCAGC:GC
NM_021098.3(CACNA1H):c.1785_1796del (p.Thr597_Ala600del)	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001016253	16	1252229 - 1252240	16	1202229 - 1202240	1016253	1011794		NC_000016.10:1202228:TGCCGCAGCCACTGCCGC:TGCCGC
NC_000016.9:g.(?_1251643)_(1255285_?)del	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001011740	16	1251643 - 1255285			1011740	986558		
NM_021098.3(CACNA1H):c.1511_1516del (p.Gln504_Arg505del)	CACNA1H		Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001006869	16	1251957 - 1251962	16	1201957 - 1201962	1006869	996551		NC_000016.10:1201956:CGCCAGCGCC:CGCC
NM_021098.3(CACNA1H):c.1991_1992delinsCT (p.Val664Ala)	CACNA1H	V664A	Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000961897	16	1252441 - 1252442	16	1202441 - 1202442	961897	949141		NC_000016.10:1202440:TC:CT
GRCh37/hg19 16p13.3(chr16:1162715-1236516)x1	CACNA1H		not provided	Uncertain significance(Last reviewed: May 8, 2018)	no assertion criteria provided	VCV000686341	16	1162715 - 1236516			686341	673933		
NM_021098.3(CACNA1H):c.5274_5276del (p.Leu1759del)	CACNA1H	L1759del, L1753del	Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000580583	16	1266959 - 1266961	16	1216959 - 1216961	580583	569511	rs1567552660	NC_000016.10:1216958:CTCCT:CT
NM_021098.3(CACNA1H):c.1778_1789del (p.His593_Thr597delinsPro)	CACNA1H		not provided|Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000573615	16	1252228 - 1252239	16	1202228 - 1202239	573615	569865	rs768475346	NC_000016.10:1202227:ATGCCGCAGCCA:
NM_021098.3(CACNA1H):c.4318_4319delinsGC (p.Phe1440Ala)	CACNA1H	F1440A	Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: May 26, 2018)	criteria provided, single submitter	VCV000573104	16	1261262 - 1261263	16	1211262 - 1211263	573104	567630	rs1567541260	NC_000016.10:1211261:TT:GC
NM_021098.3(CACNA1H):c.1120-3del	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Benign(Last reviewed: Dec 5, 2020)	criteria provided, single submitter	VCV000529657	16	1250707	16	1200707	529657	529289	rs748730819	NC_000016.10:1200706:CCCCCCC:CCCCCC
NM_021098.3(CACNA1H):c.3063+9del	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Likely benign(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000529643	16	1257435	16	1207435	529643	529969	rs757759305	NC_000016.10:1207434:GGGGG:GGGG
NM_021098.3(CACNA1H):c.3143_3145del (p.Leu1048del)	CACNA1H	L1048del	Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Jan 20, 2018)	criteria provided, single submitter	VCV000529595	16	1257848 - 1257850	16	1207848 - 1207850	529595	529972	rs1555514742	NC_000016.10:1207847:CTCC:C
NM_021098.3(CACNA1H):c.6311_6325del (p.Ile2104_Cys2109delinsSer)	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000529561	16	1270243 - 1270257	16	1220243 - 1220257	529561	529738	rs774660673	NC_000016.10:1220242:TCACCAGCTCCGCCT:
NM_021098.3(CACNA1H):c.6955_6957del (p.Glu2319del)	CACNA1H	E2319del, E2313del	Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV000460183	16	1270887 - 1270889	16	1220887 - 1220889	460183	465654	rs755117171	NC_000016.10:1220886:GAG:
NM_021098.3(CACNA1H):c.4780_4781delinsTT (p.Ala1594Phe)	CACNA1H	A1594F, A1588F	not provided|Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000460126	16	1263782 - 1263783	16	1213782 - 1213783	460126	465664	rs1555518356	NC_000016.10:1213781:GC:TT
NM_021098.3(CACNA1H):c.3422_3442del (p.Arg1141_Ser1147del)	CACNA1H		Idiopathic generalized epilepsy|Hyperaldosteronism, familial, type IV	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV000460087	16	1259079 - 1259099	16	1209079 - 1209099	460087	465648	rs746597383	NC_000016.10:1209078:CTGGAGCAGCCGGCGCTCCAGCTGGAGCAGCC:CTGGAGCAGCC
NM_021098.3(CACNA1H):c.2209_2286delinsAGCAGA (p.Gly737_Arg761delinsSer)	CACNA1H		not provided|Epilepsy, childhood absence 6|Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000423060	16	1254216 - 1254293	16	1204216 - 1204293	423060	409441	rs1555513044	
GRCh37/hg19 12p13.33(chr12:1950037-1986237)x1	CACNA2D4		not provided	Uncertain significance(Last reviewed: May 9, 2018)	no assertion criteria provided	VCV000687927	12	1950037 - 1986237			687927	675519		
NC_000002.12:g.(?_151839099)_(151973733_?)del	CACNB4		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000833370	2	152695613 - 152830247			833370	819056		
NM_000726.5(CACNB4):c.610del (p.Gln204fs)	CACNB4	Q170fs, Q18fs, Q157fs, Q186fs, Q204fs	Epilepsy, idiopathic generalized 9	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374311	2	152727364	2	151870850	374311	361167	rs1057518688	NC_000002.12:151870849:G:
NM_000726.5(CACNB4):c.*151del	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331629	2	152695482	2	151838968	331629	282987	rs79470866	NC_000002.12:151838967:TTTTTTTTTTT:TTTTTTTTTT
NM_000726.5(CACNB4):c.*442_*443del	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331625	2	152695190 - 152695191	2	151838676 - 151838677	331625	282985	rs886054966	NC_000002.12:151838675:TC:
NM_000726.5(CACNB4):c.*454del	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331624	2	152695179	2	151838665	331624	282984	rs879114509	NC_000002.12:151838664:TTTTTTTTTTTT:TTTTTTTTTTT
NM_000726.5(CACNB4):c.*624del	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331619	2	152695009	2	151838495	331619	282291	rs11291336	NC_000002.12:151838494:TTTTTTTTTT:TTTTTTTTT
NM_000726.5(CACNB4):c.*787del	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331617	2	152694846	2	151838332	331617	282949	rs560958457	NC_000002.12:151838331:GG:G
NM_000726.5(CACNB4):c.*1501del	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331606	2	152694132	2	151837618	331606	284491	rs886054963	NC_000002.12:151837617:TTTTTTTTTTT:TTTTTTTTTT
NM_000726.5(CACNB4):c.*1520del	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331604	2	152694113	2	151837599	331604	282265	rs374745796	NC_000002.12:151837598:A:
NM_000726.5(CACNB4):c.*1910_*1911del	CACNB4		Juvenile myoclonic epilepsy|Episodic ataxia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331596	2	152693722 - 152693723	2	151837208 - 151837209	331596	284892	rs372743707	NC_000002.12:151837207:AT:
NM_000726.5(CACNB4):c.*2188del	CACNB4		Episodic ataxia|Juvenile myoclonic epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331589	2	152693445	2	151836931	331589	284486	rs75297236	NC_000002.12:151836930:AA:A
NM_014008.5(CCDC22):c.514_515delinsAG (p.Pro172Arg)	CCDC22	P172R	Ritscher-schinzel syndrome 2	Uncertain significance(Last reviewed: Jan 27, 2021)	criteria provided, single submitter	VCV000995994	X	49099629 - 49099630	X	49243163 - 49243164	995994	983695		NC_000023.11:49243162:CC:AG
GRCh37/hg19 17q25.3(chr17:78058431-78074446)x1	CCDC40		not provided	Pathogenic(Last reviewed: Sep 15, 2017)	no assertion criteria provided	VCV000686764	17	78058431 - 78074446			686764	674356		
FAM58A, 40-KB DEL	CCNQ		Syndactyly-telecanthus-anogenital and renal malformations syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000010671					10671	25710		
GRCh37/hg19 7q21.11(chr7:80254791-80276756)x1	CD36		not provided	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000686754	7	80254791 - 80276756			686754	674346		
Single allele	CD36|GNAI1|PTPN12|MAGI2|SEMA3C|PHTF2|TMEM60|RSBN1L|GNAT3		not provided	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000560131	7	77204062 - 80706230			560131	550847		
GRCh37/hg19 5p14.3(chr5:19871350-20575653)x1	CDH18		not provided	Uncertain significance(Last reviewed: Dec 19, 2017)	no assertion criteria provided	VCV000686607	5	19871350 - 20575653			686607	674199		
NC_000023.10:g.(?_18671542)_(18671664_?)del	CDKL5|RS1		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001015176	X	18671542 - 18671664			1015176	1001921		
NM_001323289.2(CDKL5):c.898_899del (p.Gln300fs)	CDKL5	Q300fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000813762	X	18616654 - 18616655	X	18598534 - 18598535	813762	802048	rs1602282699	NC_000023.11:18598533:CA:
NM_001323289.2(CDKL5):c.751delinsTC (p.Ala251fs)	CDKL5	A251fs	Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000523629	X	18613474	X	18595354	523629	514279	rs1555951141	NC_000023.11:18595353:G:TC
NM_003159.2(CDKL5):c.65-?_99+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189596					189596	187447		
NM_001323289.2(CDKL5):c.283-3_290del	CDKL5		Atypical Rett syndrome|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189585	X	18597964 - 18597974	X	18579844 - 18579854	189585	187587	rs786204983	NC_000023.11:18579843:TTAGAATATGCT:T
NM_003159.2(CDKL5):c.(?_-253)_(*85_?)del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189575					189575	187632		
NM_001323289.2(CDKL5):c.2549del (p.Asn850fs)	CDKL5	N850fs	not provided	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000156653	X	18646541	X	18628421	156653	166507	rs587783125	NC_000023.11:18628420:AAA:AA
NM_001323289.2(CDKL5):c.2360_2363del (p.Lys787fs)	CDKL5	K787fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000156651	X	18638068 - 18638071	X	18619948 - 18619951	156651	166505	rs587783123	NC_000023.11:18619947:AAAGAA:AA
NM_001323289.2(CDKL5):c.2323_2326del (p.Glu775fs)	CDKL5	E775fs	not provided	Pathogenic(Last reviewed: Jan 31, 2013)	criteria provided, single submitter	VCV000156650	X	18638032 - 18638035	X	18619912 - 18619915	156650	166504	rs267608654	NC_000023.11:18619911:AGAGA:A
NM_001323289.2(CDKL5):c.1909del (p.Ala637fs)	CDKL5	A637fs	not provided	Pathogenic(Last reviewed: Jul 18, 2013)	criteria provided, single submitter	VCV000156646	X	18622953	X	18604833	156646	166500	rs587783118	NC_000023.11:18604832:G:
NM_001323289.2(CDKL5):c.1345_1363del (p.Glu449fs)	CDKL5	E449fs	not provided	Pathogenic(Last reviewed: Dec 7, 2012)	criteria provided, single submitter	VCV000156641	X	18622388 - 18622406	X	18604268 - 18604286	156641	166495	rs587783113	NC_000023.11:18604267:GGAAAGCTCTCAAAGCAAAG:G
NM_001323289.2(CDKL5):c.549_552del (p.Leu184fs)	CDKL5	L184fs	not provided	Pathogenic(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	VCV000156639	X	18602465 - 18602468	X	18584345 - 18584348	156639	166493	rs587783111	NC_000023.11:18584344:CTTACTT:CTT
NM_001323289.2(CDKL5):c.282+4del	CDKL5		not provided	Pathogenic(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	VCV000156638	X	18593613	X	18575493	156638	166492	rs587783110	NC_000023.11:18575492:AA:A
NM_001323289.2(CDKL5):c.248del (p.Gly83fs)	CDKL5	G83fs	not provided	Pathogenic(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	VCV000156637	X	18593573	X	18575453	156637	166491	rs587783109	NC_000023.11:18575452:GGGG:GGG
NM_001323289.2(CDKL5):c.64+2del	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156093	X	18525282	X	18507162	156093	165889	rs267608419	NC_000023.11:18507161:T:
NM_001323289.2(CDKL5):c.403+49_403+53del	CDKL5		not specified|not provided	Likely benign(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156086	X	18598134 - 18598138	X	18580014 - 18580018	156086	165882	rs267608473	NC_000023.11:18580013:AAGTTAAG:AAG
NM_001323289.2(CDKL5):c.2635_2636del (p.Leu879fs)	CDKL5	L879fs	Early infantile epileptic encephalopathy 2|not provided|Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143809	X	18646629 - 18646630	X	18628509 - 18628510	143809	153541	rs61753251	NC_000023.11:18628508:CT:
NM_001323289.2(CDKL5):c.163_166del (p.Glu55fs)	CDKL5	E55fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|Early infantile epileptic encephalopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143779	X	18593488 - 18593491	X	18575368 - 18575371	143779	153511	rs267608433	NC_000023.11:18575367:AAAGAAA:AAA
NC_000012.12:g.(?_12717002)_(13982130_?)del	CDKN1B|EMP1|GRIN2B|GPRC5A|HEBP1|DDX47|GPRC5D|FAM234B|APOLD1|GSG1		Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000831584	12	12869936 - 14135064			831584	820452		
GRCh37/hg19 16p12.2(chr16:21946438-22441358)x1	CDR2|UQCRC2|EEF2K|POLR3E|VWA3A|PDZD9|MOSMO|SDR42E2		not provided	Pathogenic(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV000988930	16	21946438 - 22441358			988930	976864		
GRCh37/hg19 16p12.2(chr16:21973828-22361172)	CDR2|UQCRC2|EEF2K|POLR3E|VWA3A|PDZD9|MOSMO|SDR42E2		Chromosome 16p12.1 deletion syndrome, 520kb	Likely pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625754	16	21973828 - 22361172			625754	614058		
GRCh37/hg19 16p12.2(chr16:21964083-22386845)	CDR2|UQCRC2|EEF2K|POLR3E|VWA3A|PDZD9|MOSMO|SDR42E2		Chromosome 16p12.1 deletion syndrome, 520kb	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625686	16	21964083 - 22386845			625686	613990		
GRCh37/hg19 16p12.2(chr16:21973828-22361172)	CDR2|UQCRC2|EEF2K|POLR3E|VWA3A|PDZD9|MOSMO|SDR42E2		Chromosome 16p12.1 deletion syndrome, 520kb	Likely pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625677	16	21973828 - 22361172			625677	613981		
GRCh37/hg19 16p12.2(chr16:21976691-22386881)	CDR2|UQCRC2|EEF2K|POLR3E|VWA3A|PDZD9|MOSMO|SDR42E2		Chromosome 16p12.1 deletion syndrome, 520kb	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625599	16	21976691 - 22386881			625599	613903		
GRCh37/hg19 16p12.2(chr16:21943463-22702769)	CDR2|UQCRC2|EEF2K|POLR3E|VWA3A|PDZD9|MOSMO|NPIPB5|SDR42E2		Chromosome 16p12.1 deletion syndrome, 520kb	Likely pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625577	16	21943463 - 22702769			625577	613881		
GRCh37/hg19 15q21.1(chr15:49011048-49079652)x1	CEP152		not provided	Pathogenic(Last reviewed: Dec 29, 2017)	no assertion criteria provided	VCV000688942	15	49011048 - 49079652			688942	676534		
GRCh37/hg19 9q34.11(chr9:130412438-131423964)x1	CFAP157|MIR199B|BBLN|DYNC2I2|AK1|GOLGA2|TTC16|GLE1|SWI5|CDK9|URM1|TRUB2|CIZ1|SLC27A4|ENG|STXBP1|NAIF1|MIR2861|ODF2|DNM1|PTGES2|ST6GALNAC4|COQ4|SPTAN1|TOR2A|DPM2|PIP5KL1|FPGS|SLC25A25|SH2D3C|FAM102A|ST6GALNAC6|CERCAM|PTRH1|LCN2		Infantile epilepsy syndrome	Pathogenic(Last reviewed: Apr 20, 2018)	no assertion criteria provided	VCV000984763	9	130412438 - 131423964			984763	972850		
GRCh37/hg19 7q31.2(chr7:117141921-117159386)x1	CFTR		not provided	Pathogenic(Last reviewed: Jun 7, 2018)	no assertion criteria provided	VCV000686839	7	117141921 - 117159386			686839	674431		
GRCh37/hg19 6q14.3-16.1(chr6:87627836-93698486)x1	CGA|CNR1|GABRR1|GABRR2|HTR1E|MAP3K7|RNGTT|CASP8AP2|SLC35A1|PNRC1|ANKRD6|ZNF292|MDN1|ORC3|UBE2J1|AKIRIN2|RARS2|SMIM8|LYRM2|RRAGD|BACH2|SPACA1|GJA10|PM20D2|SRSF12|CFAP206|C6orf163|GJB7		not provided	Uncertain significance(Last reviewed: Jun 20, 2017)	no assertion criteria provided	VCV000688276	6	87627836 - 93698486			688276	675868		
GRCh37/hg19 10q11.22-11.23(chr10:46966533-51903755)x1	CHAT|ERCC6|GDF2|GDF10|MSMB|NPY4R|MAPK8|RBP3|SLC18A3|NCOA4|PARG|GPRIN2|PTPN20|OGDHL|WDFY4|ARHGAP22|SYT15|C10orf71|ZNF488|FRMPD2|FAM170B|TMEM273|VSTM4|PGBD3|C10orf53|WASHC2A|AGAP6|LRRC18|AGAP9|FAM25C|DRGX|ANXA8|ANXA8L1|AGAP10|FAM25G|TIMM23		not provided	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000686364	10	46966533 - 51903755			686364	673956		
GRCh38/hg38 10q11.22-11.23(chr10:45999930-49937908)x1	CHAT|ERCC6|GDF2|GDF10|MSMB|NPY4R|MAPK8|RBP3|SLC18A3|NCOA4|PARG|GPRIN2|PTPN20|OGDHL|WDFY4|ARHGAP22|SYT15|C10orf71|ZNF488|FRMPD2|FAM170B|TMEM273|ANTXRL|VSTM4|PGBD3|C10orf53|LRRC18|AGAP9|LINC00842|FAM25C|DRGX|ANXA8|ANXA8L1|FAM25G|TIMM23|MIR4294|FAM170B-AS1|C10orf71-AS1|ARHGAP22-IT1|NPY4R2|ERCC6-PGBD3|LOC101927699|LINC02637|LOC102724488|LOC102724593|FAM245B|LOC105378292|LOC105378577|LOC107001062|LOC111818966|LOC111818967|LOC111946240|LOC111946243|LOC111946244|LOC113939916|LOC121366052|LOC121366053|LOC121366054|LOC121366055		See cases	Uncertain significance(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000058548	10	49390075 - 52518989	10	45999930 - 49937908	58548	73143		
NM_001271.4(CHD2):c.4233_4236del (p.Glu1412fs)	CHD2	E1412fs	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000218392	15	93545500 - 93545503	15	93002270 - 93002273	218392	215119	rs864309543	NC_000015.10:93002269:AAAGAA:AA
NC_000008.10:g.(?_27326832)_(27328595_?)del	CHRNA2		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV001064034	8	27326832 - 27328595			1064034	1039118		
NM_000742.4(CHRNA2):c.1563_1564delinsCT (p.Pro522Ser)	CHRNA2	P324S, P363S, P507S, P522S	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001057502	8	27319172 - 27319173	8	27461655 - 27461656	1057502	1045445		NC_000008.11:27461654:GC:AG
NM_000742.4(CHRNA2):c.784del (p.Arg262fs)	CHRNA2	R103fs, R247fs, R262fs, R64fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: May 7, 2020)	criteria provided, single submitter	VCV001026732	8	27321176	8	27463659	1026732	1007958		NC_000008.11:27463658:GG:G
NM_000742.4(CHRNA2):c.607_629delinsATAAGTCCAG (p.Ser203fs)	CHRNA2	S203fs, S188fs, S44fs, S5fs	Seizures|Autosomal dominant nocturnal frontal lobe epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2020)	criteria provided, conflicting interpretations	VCV000969097	8	27321331 - 27321353	8	27463814 - 27463836	969097	955387		NC_000008.11:27463813:TTGGCCTTGTCATAAGTCCAGGA:CTGGACTTAT
NM_000742.4(CHRNA2):c.1152del (p.Pro385fs)	CHRNA2	P226fs, P187fs, P370fs, P385fs	Epilepsy, nocturnal frontal lobe, type 4	Uncertain significance(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000931227	8	27320808	8	27463291	931227	919149		NC_000008.11:27463290:T:
NM_000742.4(CHRNA2):c.987_990del (p.Glu330fs)	CHRNA2	E171fs, E330fs, E315fs, E132fs	Epilepsy, nocturnal frontal lobe, type 4	Uncertain significance(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000931191	8	27320970 - 27320973	8	27463453 - 27463456	931191	919150		NC_000008.11:27463452:CTCGC:C
NM_000742.4(CHRNA2):c.1240del (p.Glu414fs)	CHRNA2	E216fs, E414fs, E255fs, E399fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000858490	8	27320720	8	27463203	858490	834571		NC_000008.11:27463202:CCC:CC
NM_000742.4(CHRNA2):c.485_491del (p.Lys162fs)	CHRNA2	K162fs, K147fs, K3fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000573499	8	27321469 - 27321475	8	27463952 - 27463958	573499	562281	rs1563319139	NC_000008.11:27463951:TGGGCCTTGG:TGG
NM_000742.4(CHRNA2):c.1393del (p.His465fs)	CHRNA2	H465fs, H267fs, H306fs, H450fs	Autosomal dominant nocturnal frontal lobe epilepsy|not provided	Uncertain significance(Last reviewed: Jan 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545945	8	27320567	8	27463050	545945	536335	rs1394301488	NC_000008.11:27463049:GGGG:GGG
NM_000742.4(CHRNA2):c.1464+7_1464+8del	CHRNA2		Autosomal dominant nocturnal frontal lobe epilepsy	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000476989	8	27320488 - 27320489	8	27462971 - 27462972	476989	458366	rs763426344	NC_000008.11:27462970:CA:
NC_000008.11:g.(?_27469335)_(27471194_?)del	CHRNA2		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000417539	8	27326852 - 27328711	8	27469335 - 27471194	417539	396508		
NM_000742.3(CHRNA2):c.-578_-575delATGT	CHRNA2		Nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362719	8	27336779 - 27336782	8	27479262 - 27479265	362719	305052	rs1554517018	NC_000008.11:27479261:ACATACA:ACA
NM_000742.3(CHRNA2):c.-578_-573delATGTGT	CHRNA2		not provided|Nocturnal frontal lobe epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2019)	criteria provided, conflicting interpretations	VCV000362718	8	27336777 - 27336782	8	27479260 - 27479265	362718	314028	rs1554517016	NC_000008.11:27479259:ACACATACACA:ACACA
NM_000742.4(CHRNA2):c.*1024_*1026del	CHRNA2		Nocturnal frontal lobe epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362675	8	27318120 - 27318122	8	27460603 - 27460605	362675	313970	rs151214233	NC_000008.11:27460602:TCTTC:TC
NM_000742.4(CHRNA2):c.*1286del	CHRNA2		Nocturnal frontal lobe epilepsy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000362672	8	27317860	8	27460343	362672	313900	rs199764226	NC_000008.11:27460342:GGG:GG
NM_000742.4(CHRNA2):c.121del (p.Leu41fs)	CHRNA2	L41fs	not specified|not provided	Uncertain significance(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204987	8	27327451	8	27469934	204987	202270	rs796052310	NC_000008.11:27469933:G:
NM_000742.4(CHRNA2):c.1498_1500del (p.Ile500del)	CHRNA2	I500del, I302del, I341del, I485del	not specified	Uncertain significance(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	VCV000204986	8	27319236 - 27319238	8	27461719 - 27461721	204986	202223	rs760166123	NC_000008.11:27461718:GATGA:GA
NM_000742.4(CHRNA2):c.557_558delinsCG (p.Asp186Ala)	CHRNA2	D186A, D27A, D171A	not specified	Uncertain significance(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	VCV000204984	8	27321402 - 27321403	8	27463885 - 27463886	204984	202246	rs796052308	NC_000008.11:27463884:GT:CG
NM_000742.4(CHRNA2):c.339+12_339+13del	CHRNA2		Nocturnal frontal lobe epilepsy|not provided	Benign(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000204944	8	27326839 - 27326840	8	27469322 - 27469323	204944	202254	rs139680977	NC_000008.11:27469321:GGGGGG:GGGG
NC_000020.10:g.(?_61987307)_(61993206_?)del	CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001022502	20	61987307 - 61993206			1022502	1001879		
NM_000744.7(CHRNA4):c.1208_1209delinsT (p.Pro403fs)	CHRNA4	P403fs, P227fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000969516	20	61981554 - 61981555	20	63350202 - 63350203	969516	958861		NC_000020.11:63350201:CG:A
NM_000744.7(CHRNA4):c.1136_1158del (p.Ala379fs)	CHRNA4	A203fs, A379fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000940830	20	61981605 - 61981627	20	63350253 - 63350275	940830	939017		NC_000020.11:63350252:GGGCCAGAAGCGCGGGGCACTGG:
NM_000744.7(CHRNA4):c.431del (p.Phe144fs)	CHRNA4	F144fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Dec 8, 2019)	criteria provided, single submitter	VCV000855758	20	61982332	20	63350980	855758	848501		NC_000020.11:63350979:AA:A
NC_000020.10:g.(?_61977556)_(62046499_?)del	CHRNA4|KCNQ2		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000833387	20	61977556 - 62046499			833387	821307		
NC_000020.10:g.(?_61977556)_(62103836_?)del	CHRNA4|KCNQ2		Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000832463	20	61977556 - 62103836			832463	821308		
NC_000020.11:g.(?_63355955)_(63356104_?)del	CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000832018	20	61987307 - 61987456			832018	821338		
NC_000020.10:g.(?_61992422)_(62038748_?)del	CHRNA4|KCNQ2		Autosomal dominant nocturnal frontal lobe epilepsy|Early infantile epileptic encephalopathy with suppression bursts	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2019)	criteria provided, conflicting interpretations	VCV000831940	20	61992422 - 62038748			831940	821313		
NC_000020.10:g.(?_61977556)_(62044954_?)del	CHRNA4|KCNQ2		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000831309	20	61977556 - 62044954			831309	821306		
NC_000020.10:g.(?_61977556)_(62129136_?)del	CHRNA4|EEF1A2|KCNQ2		Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000831044	20	61977556 - 62129136			831044	821309		
NC_000020.10:g.(?_61977556)_(62562941_?)del	CHRNA4|EEF1A2|KCNQ2|PTK6|SRMS|TPD52L2|TNFRSF6B|ARFRP1|GMEB2|STMN3|RTEL1|LIME1|SLC2A4RG|FNDC11|PPDPF|DNAJC5|ZGPAT|HELZ2|ZBTB46|ABHD16B		Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000830535	20	61977556 - 62562941			830535	821311		
NC_000020.10:g.(?_61977556)_(62065276_?)del	CHRNA4|KCNQ2		Early infantile epileptic encephalopathy with suppression bursts|Autosomal dominant nocturnal frontal lobe epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2020)	criteria provided, conflicting interpretations	VCV000584310	20	61977556 - 62065276			584310	573454		
NM_000744.7(CHRNA4):c.77-5del	CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy|not specified	Likely benign(Last reviewed: Jul 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000515582	20	61991056	20	63359704	515582	507395	rs1209439525	NC_000020.11:63359703:GGGG:GGG
NM_000744.7(CHRNA4):c.1158_1160delinsGGG (p.Glu387Gly)	CHRNA4	E387G, E211G	not specified	Uncertain significance(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	VCV000205048	20	61981603 - 61981605	20	63350251 - 63350253	205048	203659	rs796052320	NC_000020.11:63350250:TCG:CCC
NM_000748.3(CHRNB2):c.648del (p.Asp217fs)	CHRNB2	D217fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV001054597	1	154543944	1	154571468	1054597	1039460		NC_000001.11:154571467:CCCC:CCC
NM_000748.3(CHRNB2):c.297del (p.Phe99fs)	CHRNB2	F99fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001005287	1	154542773	1	154570297	1005287	986915		NC_000001.11:154570296:TTT:TT
NM_000748.3(CHRNB2):c.930del (p.Ser311fs)	CHRNB2	S311fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000964307	1	154544229	1	154571753	964307	941467		NC_000001.11:154571752:C:
NM_000748.3(CHRNB2):c.65-2del	CHRNB2		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000941995	1	154541936	1	154569460	941995	939772		NC_000001.11:154569459:A:
NM_000748.3(CHRNB2):c.1035_1036delinsTT (p.Ala345_Leu346=)	CHRNB2		Autosomal dominant nocturnal frontal lobe epilepsy	Likely benign(Last reviewed: Jun 27, 2020)	criteria provided, single submitter	VCV000762054	1	154544334 - 154544335	1	154571858 - 154571859	762054	761232	rs1571022654	NC_000001.11:154571857:GC:TT
NM_000748.3(CHRNB2):c.734del (p.Cys245fs)	CHRNB2	C245fs	Autosomal dominant nocturnal frontal lobe epilepsy|not provided|Seizures|Epilepsy, nocturnal frontal lobe, type 3	Uncertain significance(Last reviewed: Dec 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000543531	1	154544033	1	154571557	543531	515095	rs780184576	NC_000001.11:154571556:G:
NM_000748.3(CHRNB2):c.1407_1410del (p.Cys470fs)	CHRNB2	C470fs	not specified|Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Apr 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000205080	1	154548303 - 154548306	1	154575827 - 154575830	205080	201046	rs796052332	NC_000001.11:154575826:TGTCTGT:TGT
NM_004366.6(CLCN2):c.668_672del (p.Leu223fs)	CLCN2	L179fs, L223fs	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 16, 2021)	criteria provided, single submitter	VCV001279936	3	184075588 - 184075592	3	184357800 - 184357804	1279936	1269801		NC_000003.12:184357799:GGAGAGGA:GGA
NM_004366.6(CLCN2):c.985_986del (p.Ile329fs)	CLCN2	I329fs, I285fs	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV001032901	3	184074880 - 184074881	3	184357092 - 184357093	1032901	1019793		NC_000003.12:184357091:ATA:A
NM_004366.6(CLCN2):c.1422_1423del (p.Glu475fs)	CLCN2	E475fs, E431fs	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217792	3	184072420 - 184072421	3	184354632 - 184354633	217792	214432	rs863225255	NC_000003.12:184354631:CAC:C
NM_004366.6(CLCN2):c.1304del (p.Leu435fs)	CLCN2	L391fs, L435fs	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217789	3	184073184	3	184355396	217789	214435	rs863225253	NC_000003.12:184355395:A:
NM_004366.6(CLCN2):c.1143del (p.Gly382fs)	CLCN2	G382fs, G338fs	not provided|Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000217788	3	184073509	3	184355721	217788	214436	rs863225252	NC_000003.12:184355720:A:
NM_004366.6(CLCN2):c.1113delinsACTGCTCAT (p.Ser375fs)	CLCN2	S331fs, S375fs	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217787	3	184073539	3	184355751	217787	214437	rs863225251	NC_000003.12:184355750:G:ATGAGCAGT
NM_004366.6(CLCN2):c.64-1107_639del	CLCN2		Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217783	3	184075621 - 184078026	3	184357833 - 184360238	217783	214440		
NM_004366.6(CLCN2):c.430_435del (p.Leu144_Ile145del)	CLCN2		Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000100630	3	184076016 - 184076021	3	184358228 - 184358233	100630	106502	rs587777110	NC_000003.12:184358227:GATGAGGA:GA
NM_004366.6(CLCN2):c.221-14_221-4del	CLCN2		Leukoencephalopathy with ataxia|Epilepsy, idiopathic generalized, susceptibility to, 11	Uncertain significance(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000009036	3	184076605 - 184076615	3	184358817 - 184358827	9036	24075	rs515726132	NC_000003.12:184358816:GGTGCAGGGAAGG:GG
GRCh37/hg19 2p16.1(chr2:55373228-55449759)x1	CLHC1		not provided	Uncertain significance(Last reviewed: Mar 5, 2018)	no assertion criteria provided	VCV000686368	2	55373228 - 55449759			686368	673960		
NM_001042432.2(CLN3):c.791-6del	CLN3		Neuronal ceroid lipofuscinosis	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001123042	16	28493999	16	28482678	1123042	1125153		NC_000016.10:28482677:GGGG:GGG
NM_001042432.2(CLN3):c.992_993del (p.Phe331fs)	CLN3	F307fs, F331fs, F231fs, F253fs, F277fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001075948	16	28493489 - 28493490	16	28482168 - 28482169	1075948	1063619		NC_000016.10:28482167:AAA:A
NC_000016.9:g.(?_28502803)_(28503080_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Apr 18, 2020)	criteria provided, single submitter	VCV001073959	16	28502803 - 28503080			1073959	1057770		
NC_000016.9:g.(?_28493426)_(28493993_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001073958	16	28493426 - 28493993			1073958	1057769		
NC_000016.9:g.(?_28484798_28497560del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV001073957					1073957	1057767		
NC_000016.9:g.(?_28488827)_(28950294_?)del	CLN3|ATP2A1|SULT1A1|SULT1A2|IL27|SH2B1|RABEP2|ATXN2L|EIF3C|NUPR1|TUFM|SGF29|CD19|APOBR		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001073956	16	28488827 - 28950294			1073956	1057768		
NM_001042432.2(CLN3):c.592del (p.Ser198fs)	CLN3	S120fs, S144fs, S174fs, S198fs, S98fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 24, 2020)	criteria provided, single submitter	VCV001072910	16	28497753	16	28486432	1072910	1063620		NC_000016.10:28486431:A:
NM_001042432.2(CLN3):c.392del (p.Ser131fs)	CLN3	S107fs, S131fs, S31fs, S53fs, S77fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV001070933	16	28498845	16	28487524	1070933	1063621		NC_000016.10:28487523:C:
NM_001042432.2(CLN3):c.443_445del (p.Val148del)	CLN3	V124del, V148del, V48del, V70del, V94del	Neuronal ceroid lipofuscinosis|Intellectual disability	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV000975365	16	28498792 - 28498794	16	28487471 - 28487473	975365	963800		NC_000016.10:28487470:CCAC:C
NM_001042432.2(CLN3):c.1075del (p.Leu359fs)	CLN3	L259fs, L281fs, L305fs, L335fs, L359fs	Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000975016	16	28489180	16	28477859	975016	963298		NC_000016.10:28477858:GG:G
NM_001042432.2(CLN3):c.837+3del	CLN3		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000940155	16	28493944	16	28482623	940155	940357		NC_000016.10:28482622:AA:A
NM_001042432.2(CLN3):c.214_216del (p.Gln72del)	CLN3	Q18del, Q72del	Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000858102	16	28500617 - 28500619	16	28489296 - 28489298	858102	843703		NC_000016.10:28489295:CTG:
NC_000016.10:g.(?_28475343)_(28484138_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000833507	16	28486664 - 28495459			833507	820816		
NC_000016.10:g.(?_28475343)_(28486650_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000833481	16	28486664 - 28497971			833481	820817		
NC_000016.10:g.(?_28477496)_(28491779_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000832292	16	28488817 - 28503100			832292	820818		
NC_000016.10:g.(?_28483996)_(28484128_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 17, 2019)	criteria provided, single submitter	VCV000831057	16	28495317 - 28495449			831057	820819		
NM_001042432.2(CLN3):c.373del (p.Ser125fs)	CLN3	S71fs, S101fs, S47fs, S125fs	Neuronal ceroid lipofuscinosis	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803246	16	28498984	16	28487663	803246	791579	rs1596563048	NC_000016.10:28487662:T:
NC_000016.10:g.(?_28485965)_(28486930_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000657904	16	28497286 - 28498251	16	28485965 - 28486930	657904	652837		
NM_001042432.2(CLN3):c.1057-9del	CLN3		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000641439	16	28489207	16	28477886	641439	653255	rs1288269632	NC_000016.10:28477885:A:
NC_000016.10:g.(?_28486347)_(28486650_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000584138	16	28497668 - 28497971	16	28486347 - 28486650	584138	567488		
NM_001042432.2(CLN3):c.790+1del	CLN3		Neuronal ceroid lipofuscinosis 3|Neuronal ceroid lipofuscinosis	Likely pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552706	16	28495326	16	28484005	552706	547744	rs1555468374	NC_000016.10:28484004:CC:C
NC_000016.10:g.(?_28487436)_(28491779_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000527787	16	28498757 - 28503100	16	28487436 - 28491779	527787	529847		
NC_000016.10:g.(?_28486327)_(28486670_?)del	CLN3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000457935			16	28486327 - 28486670	457935	464820		
NM_001042432.2(CLN3):c.734_736del (p.Ala245del)	CLN3	A245del, A167del, A145del, A221del, A191del	Neuronal ceroid lipofuscinosis|not provided	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000205115	16	28495381 - 28495383	16	28484060 - 28484062	205115	203272	rs776966610	NC_000016.10:28484059:CTGCT:CT
NM_001042432.2(CLN3):c.954_962+18del	CLN3		Neuronal ceroid lipofuscinosis 3|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV000056293	16	28493630 - 28493656	16	28482309 - 28482335	56293	70932	rs386833741	NC_000016.10:28482308:TGCCCTCGCTCCTCTTACCAGCGGTATTGC:TGC
NM_001042432.2(CLN3):c.424del (p.Val142fs)	CLN3	V88fs, V118fs, V142fs, V42fs, V64fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 3	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056269	16	28498813	16	28487492	56269	70908	rs386833720	NC_000016.10:28487491:CC:C
NM_001042432.2(CLN3):c.379del (p.Arg127fs)	CLN3	R127fs, R73fs, R49fs, R103fs, R27fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 3|Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV000056267	16	28498858	16	28487537	56267	70906	rs386833717	NC_000016.10:28487536:GGGGG:GGGG
NM_001042432.2(CLN3):c.461-280_677+382del	CLN3		not provided|Neuronal ceroid lipofuscinosis 3	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000003552	16	28497286 - 28498251	16	28485965 - 28486930	3552	18591	rs1555468634	
NM_006493.4(CLN5):c.174-3del	CLN5|FBXL3		Neuronal ceroid lipofuscinosis	Likely benign(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001160368	13	77569194	13	76995059	1160368	1144299		NC_000013.11:76995058:TT:T
NM_006493.4(CLN5):c.955_956delinsCG (p.Lys319Arg)	CLN5|FBXL3	K319R	not provided|Neuronal ceroid lipofuscinosis	Benign/Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV001093126	13	77574982 - 77574983	13	77000847 - 77000848	1093126	1080185		NC_000013.11:77000846:AA:CG
NC_000013.10:g.(?_77566087)_(78492734_?)del	CLN5|SCEL|SLAIN1|FBXL3|EDNRB|MYCBP2		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001074432	13	77566087 - 78492734			1074432	1057638		
NM_006493.4(CLN5):c.812del (p.Asn271fs)	CLN5|FBXL3	N271fs	Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001073281	13	77574837	13	77000702	1073281	1063039		NC_000013.11:77000701:AAA:AA
NC_000013.10:g.(?_77574632_77577161del	CLN5		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001070489					1070489	1057639		
NM_006493.4(CLN5):c.112del (p.Val38fs)	CLN5	V38fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 5	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000946204	13	77566344	13	76992209	946204	926950		NC_000013.11:76992208:GG:G
NM_006493.4(CLN5):c.965_968del (p.Tyr322fs)	CLN5|FBXL3	Y322fs	Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000858697	13	77574991 - 77574994	13	77000856 - 77000859	858697	841012		NC_000013.11:77000855:TATTT:T
NC_000013.11:g.(?_76995053)_(76996137_?)del	CLN5		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000833329	13	77569188 - 77570272			833329	820591		
NC_000013.10:g.77566134del	CLN5		not provided|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 5	Conflicting interpretations of pathogenicity(Last reviewed: May 5, 2020)	criteria provided, conflicting interpretations	VCV000813489	13	77566134	13	76991999	813489	801722	rs765323914	NC_000013.11:76991998:GGGG:GGG
NC_000013.11:g.(?_76991932)_(77000989_?)del	CLN5|FBXL3		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000649631	13	77566067 - 77575124	13	76991932 - 77000989	649631	652518		
NM_006493.4(CLN5):c.566_*1548del (p.Gly189fs)	CLN5|FBXL3	G189fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000577654	13	77574593 - 77576652	13	77000458 - 77002517	577654	567746		
NM_006493.4(CLN5):c.438del (p.His148fs)	CLN5|FBXL3	H148fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 5	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558089	13	77570133	13	76995998	558089	547772	rs1555273992	NC_000013.11:76995997:TTT:TT
NM_006493.4(CLN5):c.187del (p.Arg63fs)	CLN5|FBXL3	R63fs	Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000527740	13	77569210	13	76995075	527740	528326	rs1555273881	NC_000013.11:76995074:CC:C
NM_006493.4(CLN5):c.371del (p.Ser124fs)	CLN5|FBXL3	S124fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 5	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000202192	13	77570068	13	76995933	202192	198634	rs794729218	NC_000013.11:76995932:G:
NM_006493.4(CLN5):c.525del (p.His174_Trp175insTer)	CLN5|FBXL3		Seizures|not provided|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 5	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128784	13	77570221	13	76996086	128784	134233	rs587780315	NC_000013.11:76996085:GG:G
NM_006493.4(CLN5):c.808_823del (p.Gly270fs)	CLN5|FBXL3	G270fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 5|not provided	Pathogenic(Last reviewed: Jul 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056547	13	77574830 - 77574845	13	77000695 - 77000710	56547	71186	rs386833983	NC_000013.11:77000694:ATCTGGGAAATGAAACATCTG:ATCTG
NM_006493.4(CLN5):c.956_959del (p.Lys319fs)	CLN5|FBXL3	K319fs	not provided|Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056529	13	77574980 - 77574983	13	77000845 - 77000848	56529	71168	rs386833967	NC_000013.11:77000844:ACAAACA:ACA
NM_006493.4(CLN5):c.936del (p.Phe312fs)	CLN5|FBXL3	F312fs	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 5	Pathogenic(Last reviewed: Aug 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056528	13	77574959	13	77000824	56528	71167	rs386833966	NC_000013.11:77000823:TTTTT:TTTT
NM_017882.3(CLN6):c.712_713delinsAC (p.Phe238Thr)	CLN6	F238T	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV001072428	15	68500701 - 68500702	15	68208363 - 68208364	1072428	1063399		NC_000015.10:68208362:AA:GT
NM_017882.3(CLN6):c.121del (p.Ala41fs)	CLN6	A41fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001071216	15	68510951	15	68218613	1071216	1063402		NC_000015.10:68218612:CC:C
NM_017882.3(CLN6):c.583_596del (p.Gly195fs)	CLN6	G195fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV001068527	15	68502044 - 68502057	15	68209706 - 68209719	1068527	1063400		NC_000015.10:68209705:GCAGTAAAGCAGCCGC:GC
NC_000015.9:g.(?_68500458)_(68504221_?)del	CLN6		Neuronal ceroid lipofuscinosis	Likely pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV001067841	15	68500458 - 68504221			1067841	1054566		
NM_017882.3(CLN6):c.66del (p.Ser23fs)	CLN6	S23fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000967030	15	68521857	15	68229519	967030	957482		NC_000015.10:68229518:GG:G
NC_000015.10:g.(?_68208120)_(68229604_?)del	CLN6		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000833141	15	68500458 - 68521942			833141	820731		
NM_017882.3(CLN6):c.829_832del (p.Val277fs)	CLN6	V277fs	Neuronal ceroid lipofuscinosis	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2020)	criteria provided, conflicting interpretations	VCV000803105	15	68500582 - 68500585	15	68208244 - 68208247	803105	791482	rs1595816474	NC_000015.10:68208243:CGACC:C
NM_017882.3(CLN6):c.837del (p.Trp279fs)	CLN6	W279fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803104	15	68500577	15	68208239	803104	791481	rs1595816465	NC_000015.10:68208238:CC:C
NC_000015.10:g.(?_68229492)_(68229594_?)del	CLN6		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000665626	15	68521830 - 68521932	15	68229492 - 68229594	665626	652537		
NC_000015.10:g.(?_68229482)_(68229604_?)del	CLN6		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000651807	15	68521820 - 68521942	15	68229482 - 68229604	651807	652535		
NM_017882.3(CLN6):c.297+19del	CLN6		not specified|Neuronal ceroid lipofuscinosis	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000205156	15	68506609	15	68214271	205156	202881	rs61224699	NC_000015.10:68214270:GGGGG:GGGG
NM_018941.4(CLN8):c.827del (p.Gly276fs)	CLN8	G276fs	Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001011113	8	1728698	8	1780532	1011113	992717		NC_000008.11:1780531:GG:G
NM_018941.4(CLN8):c.429_432del (p.Phe143fs)	CLN8	F143fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000962311	8	1719646 - 1719649	8	1771480 - 1771483	962311	945998		NC_000008.11:1771479:CTTTCTT:CTT
NC_000008.11:g.(?_1771045)_(1780577_?)del	CLN8		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000647473	8	1719211 - 1728743	8	1771045 - 1780577	647473	651761		
NM_018941.4(CLN8):c.204del (p.Thr69fs)	CLN8	T69fs	Neuronal ceroid lipofuscinosis 8	Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000556933	8	1719423	8	1771257	556933	544692	rs1554449028	NC_000008.11:1771256:CC:C
NM_018941.4(CLN8):c.50del (p.Asp17fs)	CLN8	D17fs	Neuronal ceroid lipofuscinosis 8	Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000555573	8	1719270	8	1771104	555573	544745	rs1554448924	NC_000008.11:1771103:A:
NM_018941.4(CLN8):c.594del (p.His199fs)	CLN8	H199fs	Neuronal ceroid lipofuscinosis 8	Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000555267	8	1728465	8	1780299	555267	544401	rs1554451504	NC_000008.11:1780298:TT:T
NM_018941.4(CLN8):c.-131_-124+13del	CLN8|CLN8-AS1		Neuronal ceroid lipofuscinosis 8	Uncertain significance(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000553068	8	1712042 - 1712062	8	1763876 - 1763896	553068	544689	rs1554446821	NC_000008.11:1763875:GGCAGCCCAGGTGAGCGCTCAGG:GG
NM_018941.4(CLN8):c.703del (p.Val236fs)	CLN8	V236fs	Inborn genetic diseases|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457979	8	1728574	8	1780408	457979	458651	rs761621368	NC_000008.11:1780407:CC:C
NC_000008.11:g.(?_1771035)_(1780587_?)del	CLN8		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000457933	8	1719201 - 1728753	8	1771035 - 1780587	457933	457688		
NM_018941.4(CLN8):c.47del (p.Leu16fs)	CLN8	L16fs	Neuronal ceroid lipofuscinosis 8	Likely pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000370918	8	1719267	8	1771101	370918	357629	rs1057516867	NC_000008.11:1771100:T:
NM_018941.4(CLN8):c.263del (p.Asp88fs)	CLN8	D88fs	Neuronal ceroid lipofuscinosis 8	Likely pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000370553	8	1719483	8	1771317	370553	357630	rs1057516582	NC_000008.11:1771316:A:
NM_018941.4(CLN8):c.88del (p.Ala30fs)	CLN8	A30fs	Neuronal ceroid lipofuscinosis 8	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000056720	8	1719308	8	1771142	56720	71359	rs386834139	NC_000008.11:1771141:G:
NM_018941.4(CLN8):c.66del (p.Ile23fs)	CLN8	I23fs	Neuronal ceroid lipofuscinosis 8	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000056718	8	1719282	8	1771116	56718	71357	rs34238807	NC_000008.11:1771115:GGGGG:GGGG
NM_018941.4(CLN8):c.181_183del (p.Lys61del)	CLN8	K61del	Neuronal ceroid lipofuscinosis 8	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000056703	8	1719399 - 1719401	8	1771233 - 1771235	56703	71342	rs386834123	NC_000008.11:1771232:AGAAG:AG
NM_001258392.3(CLPB):c.776-10_776-8del	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Likely benign(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001103777	11	72040856 - 72040858	11	72329812 - 72329814	1103777	1100535		NC_000011.10:72329811:GAG:
NC_000011.9:g.(?_72083949)_(72084078_?)del	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001011851	11	72083949 - 72084078			1011851	986479		
NM_001258392.3(CLPB):c.449_451delinsAATAT (p.Val150fs)	CLPB	S69fs, V150fs	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000972600	11	72141360 - 72141362	11	72430316 - 72430318	972600	956663		NC_000011.10:72430315:TGA:ATATT
NC_000011.10:g.(?_72372905)_(72380404_?)del	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000830973	11	72083949 - 72091448			830973	820416		
NM_001258392.3(CLPB):c.403+7_403+8del	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000757985	11	72145108 - 72145109	11	72434064 - 72434065	757985	775948	rs754849241	NC_000011.10:72434063:ATA:A
NC_000011.10:g.(?_72293347)_(72434494_?)del	CLPB		3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000642638	11	72004391 - 72145538	11	72293347 - 72434494	642638	652395		
NM_001258392.3(CLPB):c.1474_1475delinsTG (p.Ala492Cys)	CLPB	A477C, A522C, A463C, A492C	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia|not provided	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000542782	11	72006547 - 72006548	11	72295503 - 72295504	542782	526524	rs1555085159	NC_000011.10:72295502:GC:CA
NM_001258392.3(CLPB):c.1595del (p.Ile532fs)	CLPB	I503fs, I532fs, I562fs, I517fs	3-methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia	Pathogenic(Last reviewed: Sep 14, 2016)	no assertion criteria provided	VCV000192392	11	72005454	11	72294410	192392	190178	rs876657402	NC_000011.10:72294409:A:
NC_000001.10:g.(?_205034083_205035624del	CNTN2		Epilepsy, familial adult myoclonic, 5	Likely pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, single submitter	VCV001067253					1067253	1054251		
NM_005076.5(CNTN2):c.2273_2274delinsAT (p.Trp758Tyr)	CNTN2	W758Y	Epilepsy, familial adult myoclonic, 5|not provided	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000423039	1	205039031 - 205039032	1	205069903 - 205069904	423039	405020	rs1064796187	NC_000001.11:205069902:GG:AT
NM_005076.5(CNTN2):c.504del (p.Trp168fs)	CNTN2	W168fs	Epilepsy, familial adult myoclonic, 5	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000064618	1	205028227	1	205059099	64618	75582	rs398122387	NC_000001.11:205059098:GG:G
GRCh37/hg19 11q22.1(chr11:99631820-99742147)x1	CNTN5		not provided	Uncertain significance(Last reviewed: Nov 21, 2017)	no assertion criteria provided	VCV000686677	11	99631820 - 99742147			686677	674269		
GRCh37/hg19 3p26.3(chr3:1347566-1372108)x1	CNTN6		not provided	Uncertain significance(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000686304	3	1347566 - 1372108			686304	673896		
NC_000007.13:g.(?_146471353)_(146537006_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001075740	7	146471353 - 146537006			1075740	1057266		
NC_000007.13:g.(?_146740989)_(146741156_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001075739	7	146740989 - 146741156			1075739	1057267		
NM_014141.6(CNTNAP2):c.3983_*2del (p.Glu1328fs)	CNTNAP2	E1328fs	Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV001008000	7	148112692 - 148112707	7	148415600 - 148415615	1008000	992185		NC_000007.14:148415599:AGGAATGGCTCATTTGAGG:AGG
NM_014141.6(CNTNAP2):c.3397_3399del (p.Ser1133del)	CNTNAP2	S1133del	Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000965078	7	147964138 - 147964140	7	148267046 - 148267048	965078	955086		NC_000007.14:148267045:CTTCT:CT
NM_014141.6(CNTNAP2):c.1361_1362del (p.Asn454fs)	CNTNAP2	N454fs	Pitt-Hopkins-like syndrome 1	Likely pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000930571	7	146997245 - 146997246	7	147300153 - 147300154	930571	919086		NC_000007.14:147300152:AT:
GRCh37/hg19 7q35(chr7:146997280-146997587)	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Apr 16, 2020)	no assertion criteria provided	VCV000915982	7	146997280 - 146997587			915982	904207		
NM_014141.6(CNTNAP2):c.3588_3591del (p.Asn1198fs)	CNTNAP2	N1198fs	Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000858321	7	148080851 - 148080854	7	148383759 - 148383762	858321	833303		NC_000007.14:148383758:CAGACA:CA
NC_000007.14:g.(?_147300121)_(147395800_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832857	7	146997213 - 147092892			832857	819846		
NC_000007.14:g.(?_147043887)_(147300310_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Feb 10, 2019)	criteria provided, single submitter	VCV000832710	7	146740979 - 146997402			832710	819845		
NC_000007.14:g.(?_146774251)_(146839924_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000831327	7	146471343 - 146537016			831327	819844		
NM_014141.6(CNTNAP2):c.2773+76del	CNTNAP2		Pitt-Hopkins-like syndrome 1|not provided	Benign(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802381	7	147844863	7	148147771	802381	790709	rs5888307	NC_000007.14:148147770:AAAAAAAAAAAAAAA:AAAAAAAAAAAAAA
NM_014141.6(CNTNAP2):c.2217_2227del (p.Pro739_Lys740insTer)	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802380	7	147600775 - 147600785	7	147903683 - 147903693	802380	790708	rs1585020100	NC_000007.14:147903682:CAAGTACTACT:
GRCh37/hg19 7q35(chr7:146444082-146478549)x1	CNTNAP2		not provided	Uncertain significance(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000685768	7	146444082 - 146478549			685768	673360		
NM_014141.6(CNTNAP2):c.636del (p.Ile212fs)	CNTNAP2	I212fs	Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000650946	7	146805323	7	147108231	650946	635852	rs1584848275	NC_000007.14:147108230:TT:T
NC_000007.14:g.(?_147132225)_(147132529_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000648528	7	146829317 - 146829621	7	147132225 - 147132529	648528	651587		
NC_000007.14:g.(?_146774251)_(146774401_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000640453	7	146471343 - 146471493	7	146774251 - 146774401	640453	651647		
NC_000007.14:g.(?_147300141)_(147395780_?)del	CNTNAP2|MIR548F4		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000583989	7	146997233 - 147092872	7	147300141 - 147395780	583989	561035		
NC_000007.14:g.(?_148409371)_(148409491_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000536342	7	148106463 - 148106583	7	148409371 - 148409491	536342	522286		
NM_014141.6(CNTNAP2):c.2497del (p.Trp833fs)	CNTNAP2	W833fs	not provided|Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000536312	7	147815323	7	148118231	536312	522746	rs1391540245	NC_000007.14:148118230:T:
NM_014141.6(CNTNAP2):c.3480_3481del (p.Gly1161fs)	CNTNAP2	G1161fs	Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Sep 9, 2017)	criteria provided, single submitter	VCV000468428	7	148080745 - 148080746	7	148383653 - 148383654	468428	457486	rs771827120	NC_000007.14:148383652:AG:
NC_000007.14:g.(?_147043887)_(147044074_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000468414	7	146740979 - 146741166	7	147043887 - 147044074	468414	455860		
NC_000007.14:g.(?_146116001)_(146116993_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000468413	7	145813093 - 145814085	7	146116001 - 146116993	468413	456458		
NM_014141.6(CNTNAP2):c.2964del (p.Cys989fs)	CNTNAP2	C989fs	Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Sep 7, 2017)	no assertion criteria provided	VCV000438344	7	147869523	7	148172431	438344	431972	rs1554400338	NC_000007.14:148172430:CC:C
NC_000007.13:g.144520633_145949971del	CNTNAP2|TPK1		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Sep 7, 2017)	no assertion criteria provided	VCV000438341	7	144520633 - 145949971			438341	431969		
NC_000007.14:g.(?_146774271)_(146774381_?)del	CNTNAP2		Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000417572	7	146471363 - 146471473	7	146774271 - 146774381	417572	395607		
NM_014141.6(CNTNAP2):c.*5337del	CNTNAP2		Pitt-Hopkins-like syndrome|Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359277	7	148118044	7	148420952	359277	305357	rs886062079	NC_000007.14:148420951:CC:C
NM_014141.6(CNTNAP2):c.*3999del	CNTNAP2		Pitt-Hopkins-like syndrome|Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359262	7	148116693	7	148419601	359262	305343	rs35835723	NC_000007.14:148419600:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_014141.6(CNTNAP2):c.*3419del	CNTNAP2		Pitt-Hopkins-like syndrome|Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359246	7	148116126	7	148419034	359246	310122	rs144252697	NC_000007.14:148419033:AA:A
NM_014141.6(CNTNAP2):c.*2935_*2936del	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359241	7	148115639 - 148115640	7	148418547 - 148418548	359241	305319	rs544152145	NC_000007.14:148418546:AAAAAA:AAAA
NM_014141.6(CNTNAP2):c.*1606del	CNTNAP2		Pitt-Hopkins-like syndrome|Pitt-Hopkins-like syndrome 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359223	7	148114311	7	148417219	359223	305313	rs769986162	NC_000007.14:148417218:AAAA:AAA
NM_014141.6(CNTNAP2):c.*923del	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359209	7	148113631	7	148416539	359209	310076	rs753739211	NC_000007.14:148416538:G:
NM_014141.5(CNTNAP2):c.-331delT	CNTNAP2		Pitt-Hopkins-like syndrome 1|Pitt-Hopkins-like syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 20, 2019)	criteria provided, conflicting interpretations	VCV000359164	7	145813628	7	146116536	359164	310111	rs886062041	NC_000007.14:146116535:TTTTTTTTTTT:TTTTTTTTTT
NM_014141.5(CNTNAP2):c.(?_550)+15275_(1349_?)-61303del	CNTNAP2|CNTNAP2-AS1		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005496	7	146756421 - 146935930	7	147059329 - 147238838	5496	20535		
NM_014141.5(CNTNAP2):c.(?_97)+117643_(1670_?)+6605del	CNTNAP2|CNTNAP2-AS1|MIR548F4		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005494	7	145931708 - 147099477	7	146234616 - 147402385	5494	20533		
NM_014141.6(CNTNAP2):c.3709del (p.Asp1237fs)	CNTNAP2	D1237fs	Pitt-Hopkins-like syndrome 1|not provided	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005490	7	148080973	7	148383881	5490	20529	rs730880275	NC_000007.14:148383880:GG:G
NM_001379500.1(COL18A1):c.3523_3524del (p.Leu1175fs)	COL18A1|SLC19A1	L1352fs, L1587fs, L1175fs	not provided|Glaucoma, primary closed-angle|Macular dystrophy|Knobloch syndrome 1|Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000065410	21	46930005 - 46930006	21	45510091 - 45510092	65410	76340	rs398122391	NC_000021.9:45510090:CT:
Single allele	COL9A3|NTSR1|TCFL5|OGFR|MRGBP		Epilepsy	Uncertain significance(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635913	20	61347565 - 61502268			635913	623726		
NM_020361.5(CPA6):c.-160del	CPA6		Familial temporal lobe epilepsy 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363618	8	68658524	8	67746289	363618	315034	rs796925267	NC_000008.11:67746288:AAAAAAAAA:AAAAAAAA
NM_020361.5(CPA6):c.-11_-10del	CPA6		Familial temporal lobe epilepsy 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000363615	8	68658374 - 68658375	8	67746139 - 67746140	363615	309798	rs531326049	NC_000008.11:67746138:AA:
GRCh38/hg38 8q13.2(chr8:67609185-68060879)x1	CPA6|PREX2		See cases	Likely benign(Last reviewed: Aug 5, 2011)	no assertion criteria provided	VCV000154495	8	68521420 - 68973114	8	67609185 - 68060879	154495	164249		
GRCh37/hg19 17q21.31(chr17:43706886-44210822)x1	CRHR1|KANSL1|MAPT|SPPL2C|STH		Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000666442	17	43706886 - 44210822			666442	654001		
GRCh38/hg38 Xp22.33(chrX:1000807-1223133)x1	CRLF2		See cases	Likely benign(Last reviewed: Apr 21, 2011)	no assertion criteria provided	VCV000148362	X	961542 - 1342026	X	1000807 - 1223133	148362	158113		
GRCh37/hg19 8p21.3(chr8:19514867-19643313)x1	CSGALNACT1		not provided	Uncertain significance(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000687463	8	19514867 - 19643313			687463	675055		
Single allele	CSPG4|MAN2C1|PTPN9|SNUPN|SIN3A|COMMD4|IMP3|NEIL1|ODF3L1|SNX33		Epilepsy|Intellectual disability	Pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV000997817	15	75596353 - 76103430			997817	985535		
NC_000002.11:g.(?_165946660)_(167168266_?)del	CSRNP3|GALNT3|SCN1A|SCN2A|SCN3A|SCN9A|TTC21B		Early infantile epileptic encephalopathy with suppression bursts|not provided|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)	criteria provided, conflicting interpretations	VCV001054402	2	165946660 - 167168266			1054402	1039026		
NC_000021.8:g.(?_45194083)_(45196150_?)del	CSTB		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001074795	21	45194083 - 45196150			1074795	1058106		
NC_000021.8:g.(?_44838120)_(45629566_?)del	CSTB|PWP2|TRAPPC10|GATD3A|PDXK|RRP1|HSF2BP|RRP1B|AGPAT3|SIK1		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000830406	21	44838120 - 45629566			830406	821356		
NM_000100.3(CSTB):c.-36_-24del	CSTB		not specified	Benign(Last reviewed: Jul 23, 2014)	criteria provided, single submitter	VCV000208407	21	45196174 - 45196186	21	43776293 - 43776305	208407	204636	rs577227536	NC_000021.9:43776292:GGCGAGGGGACTCGGCGAGGGGAC:GGCGAGGGGAC
NM_000100.4(CSTB):c.168+2_168+21delinsAA	CSTB		Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000161421	21	45194518 - 45194537	21	43774637 - 43774656	161421	171260	rs864309482	NC_000021.9:43774636:CTCCTGAGGCCCACACTCTA:TT
NM_000100.4(CSTB):c.168+2_168+19del	CSTB		Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000161420	21	45194520 - 45194537	21	43774639 - 43774656	161420	171261	rs312262707	NC_000021.9:43774638:CCTGAGGCCCACACTCTACCT:CCT
CSTB, 2-BP DEL, 2404TC	CSTB		Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000008399					8399	23438		
NM_001909.5(CTSD):c.464_465delinsGC (p.Thr155Ser)	CTSD	T155S	Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000855671	11	1780205 - 1780206	11	1758975 - 1758976	855671	838152		NC_000011.10:1758974:AG:GC
NM_001909.5(CTSD):c.828-14_828-13del	CTSD		not specified	Benign(Last reviewed: Apr 5, 2013)	criteria provided, single submitter	VCV000205331	11	1775381 - 1775382	11	1754151 - 1754152	205331	202535	rs796052395	NC_000011.10:1754150:AG:
NC_000007.14:g.(?_146116001)_(148847318_?)del	CUL1|EZH2|CNTNAP2|C7orf33		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000833114	7	145813093 - 148544410			833114	819842		
Single allele	CYFIP1|GOLGA6L1|NIPA1|NIPA2|TUBGCP5		Epilepsy|Autism spectrum disorder	Uncertain significance(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000223121	15	22410242 - 23222284			223121	224847		
GRCh37/hg19 15q21.2-21.3(chr15:50083229-53439931)x1	CYP19A1|GABPB1|HDC|ONECUT1|MYO5A|MAPK6|USP8|BCL2L10|GNB5|ARPP19|SLC27A2|DMXL2|AP4E1|SCG3|TMOD3|TMOD2|TRPM7|MYO5C|FAM214A|ATP8B4|SPPL2A|LEO1|LYSMD2|GLDN|USP50|TNFAIP8L3		not provided	Uncertain significance(Last reviewed: Aug 8, 2018)	no assertion criteria provided	VCV000687424	15	50083229 - 53439931			687424	675016		
NM_018122.5(DARS2):c.1196del (p.Ile399fs)	DARS2	I399fs	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801580	1	173819469	1	173850331	801580	789886	rs1571995707	NC_000001.11:173850330:T:
NM_018122.5(DARS2):c.228-21_228-20delinsC	DARS2		Hypertensive disorder|Clubfoot|Sensorimotor neuropathy|Cerebral cortical atrophy|EMG: axonal abnormality|Gout|Abnormality of the foot|CNS demyelination|Difficulty walking|Impaired vibration sensation in the lower limbs|Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|Gait imbalance|Dysmetria|Gait ataxia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000001057	1	173797450 - 173797451	1	173828312 - 173828313	1057	16096	rs1553201258	NC_000001.11:173828311:TT:C
GRCh37/hg19 Yq11.222-11.23(chrY:21039792-28799937)x0	DAZ1|RBMY1A1|KDM5D|PRY|BPY2|CDY1|EIF1AY|DAZ3|DAZ2|DAZ4|TTTY5|TTTY13|TTTY14|TTTY6|TTTY3|TTTY4|RPS4Y2|RBMY1F|TTTY10|TTTY17A|RBMY1B|RBMY1D|RBMY1E|RBMY1J|TTTY6B|PRY2|BPY2B|BPY2C|TTTY3B|TTTY4B|TTTY4C|TTTY17B|TTTY17C|PRORY		not provided	Pathogenic(Last reviewed: May 18, 2018)	no assertion criteria provided	VCV000686298	Y	21039792 - 28799937			686298	673890		
NM_001242896.3(DEPDC5):c.3191_3195del (p.Gly1064fs)	DEPDC5	G1036fs, G1055fs, G1064fs, G986fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319780	22	32253465 - 32253469	22	31857479 - 31857483	1319780	1310029		NC_000022.11:31857478:GGGAAG:G
NM_001242896.3(DEPDC5):c.1218-5del	DEPDC5		Familial focal epilepsy with variable foci|not provided	Benign(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV001166556	22	32202100	22	31806114	1166556	1159110		NC_000022.11:31806113:TTTT:TTT
NM_001242896.3(DEPDC5):c.3806-10del	DEPDC5		Familial focal epilepsy with variable foci	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV001124593	22	32275501	22	31879515	1124593	1129107		NC_000022.11:31879514:C:
NM_001242896.3(DEPDC5):c.2801+7_2801+20del	DEPDC5		Familial focal epilepsy with variable foci	Likely benign(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV001117069	22	32239803 - 32239816	22	31843817 - 31843830	1117069	1107693		NC_000022.11:31843816:GAGAGTGGGCTTTGGA:GA
NM_001242896.3(DEPDC5):c.1139del (p.Phe380fs)	DEPDC5	F352fs, F380fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001076836	22	32200204	22	31804218	1076836	1065024		NC_000022.11:31804217:TT:T
NM_001242896.3(DEPDC5):c.2489del (p.Leu830fs)	DEPDC5	L752fs, L802fs, L821fs, L830fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001074788	22	32234805	22	31838819	1074788	1065031		NC_000022.11:31838818:T:
NM_001242896.3(DEPDC5):c.2489_2511del (p.Leu830fs)	DEPDC5	L752fs, L802fs, L821fs, L830fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV001074181	22	32234803 - 32234825	22	31838817 - 31838839	1074181	1065030		NC_000022.11:31838816:GCTGAGCAGTAGCCCACTCTATAGC:GC
NC_000022.10:g.(?_32174065)_(32180881_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001073187	22	32174065 - 32180881			1073187	1058150		
NC_000022.10:g.(?_32301960)_(32302483_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001073186	22	32301960 - 32302483			1073186	1058155		
NC_000022.10:g.(?_32150888)_(32164869_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001073185	22	32150888 - 32164869			1073185	1058146		
NC_000022.10:g.(?_32150888)_(32162674_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001073184	22	32150888 - 32162674			1073184	1058145		
NM_001242896.3(DEPDC5):c.3449_3450del (p.Glu1150fs)	DEPDC5	E1050fs, E1072fs, E1119fs, E1122fs, E1128fs, E1141fs, E1150fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001073135	22	32266694 - 32266695	22	31870708 - 31870709	1073135	1065036		NC_000022.11:31870707:AA:
NC_000022.10:g.(?_32150908)_(32154629_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001071276	22	32150908 - 32154629			1071276	1058148		
NC_000022.10:g.(?_32150888)_(32188823_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV001071275	22	32150888 - 32188823			1071275	1058147		
NC_000022.10:g.(?_32205577)_(32206647_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001071274	22	32205577 - 32206647			1071274	1058154		
NC_000022.10:g.(?_32188019)_(32194642_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001071273	22	32188019 - 32194642			1071273	1058153		
NM_001242896.3(DEPDC5):c.862del (p.Glu288fs)	DEPDC5	E260fs, E288fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001071236	22	32193679	22	31797693	1071236	1065023		NC_000022.11:31797692:GG:G
NM_001242896.3(DEPDC5):c.3578del (p.Leu1193fs)	DEPDC5	L1093fs, L1115fs, L1162fs, L1165fs, L1171fs, L1184fs, L1193fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001071232	22	32270273	22	31874287	1071232	1065037		NC_000022.11:31874286:T:
NM_001242896.3(DEPDC5):c.4671_4672del (p.Trp1558fs)	DEPDC5	W1458fs, W1480fs, W1527fs, W1530fs, W1536fs, W1549fs, W1558fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001070712	22	32302342 - 32302343	22	31906356 - 31906357	1070712	1065039		NC_000022.11:31906355:AT:
NM_001242896.3(DEPDC5):c.4290del (p.Tyr1431fs)	DEPDC5	Y1331fs, Y1353fs, Y1400fs, Y1403fs, Y1409fs, Y1422fs, Y1431fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001070245	22	32293554	22	31897568	1070245	1065038		NC_000022.11:31897567:G:
NM_001242896.3(DEPDC5):c.208_209del (p.Asp70fs)	DEPDC5	D70fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001069270	22	32160975 - 32160976	22	31764989 - 31764990	1069270	1065018		NC_000022.11:31764988:GA:
NM_001242896.3(DEPDC5):c.158del (p.Leu53fs)	DEPDC5	L53fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001069249	22	32156650	22	31760664	1069249	1065016		NC_000022.11:31760663:TTTT:TTT
NM_001242896.3(DEPDC5):c.2275_2281del (p.Tyr759fs)	DEPDC5	Y681fs, Y731fs, Y750fs, Y759fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001069222	22	32233061 - 32233067	22	31837075 - 31837081	1069222	1065028		NC_000022.11:31837074:CTACTTCC:C
NC_000022.10:g.(?_32180780)_(32302503_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001069168	22	32180780 - 32302503			1069168	1058152		
NC_000022.10:g.(?_32179873)_(32179991_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001069167	22	32179873 - 32179991			1069167	1058151		
NC_000022.10:g.(?_32160941)_(32161066_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV001069166	22	32160941 - 32161066			1069166	1058149		
NM_001242896.3(DEPDC5):c.2233_2355-686del	DEPDC5		Familial focal epilepsy with variable foci	Likely pathogenic(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV001068319	22	32233015 - 32233980	22	31837029 - 31837994	1068319	1056680		
NC_000022.10:g.(?_32217598_32219454del	DEPDC5		Familial focal epilepsy with variable foci	Likely pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV001067648					1067648	1054681		
NC_000022.10:g.(?_32154522)_(32156698_?)del	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001064081	22	32154522 - 32156698			1064081	1039254		
NM_001242896.3(DEPDC5):c.768-5_768-4del	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV001056564	22	32193579 - 32193580	22	31797593 - 31797594	1056564	1052094		NC_000022.11:31797592:TTTT:TT
NM_001242896.3(DEPDC5):c.4152del (p.Phe1384fs)	DEPDC5	F1284fs, F1306fs, F1353fs, F1356fs, F1362fs, F1375fs, F1384fs	Epilepsy, familial focal, with variable foci 1	Likely pathogenic	criteria provided, single submitter	VCV000983531	22	32289684	22	31893698	983531	971598		NC_000022.11:31893697:TTT:TT
NM_001242896.3(DEPDC5):c.4748_4788delinsC (p.Arg1583fs)	DEPDC5	R1552fs, R1555fs, R1483fs, R1505fs, R1561fs, R1574fs, R1583fs	Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000966400	22	32302419 - 32302459	22	31906433 - 31906473	966400	959084		NC_000022.11:31906432:GTGACAACCGGCTGGTCACGTTCTGGACAAGTTGCCTGGAG:C
NM_001242896.3(DEPDC5):c.590_592del (p.Asn197_Gly198delinsSer)	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000966107	22	32180827 - 32180829	22	31784841 - 31784843	966107	959074		NC_000022.11:31784840:ATG:
NM_001242896.3(DEPDC5):c.832_833del (p.Phe278fs)	DEPDC5	F250fs, F278fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000964326	22	32193650 - 32193651	22	31797664 - 31797665	964326	951438		NC_000022.11:31797663:TT:
NM_001242896.3(DEPDC5):c.4530del (p.Leu1511fs)	DEPDC5	L1480fs, L1483fs, L1511fs, L1411fs, L1489fs, L1433fs, L1502fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000956751	22	32302199	22	31906213	956751	951454		NC_000022.11:31906212:TTT:TT
NM_001242896.3(DEPDC5):c.3095del (p.Pro1032fs)	DEPDC5	P1004fs, P1023fs, P1032fs, P954fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000944570	22	32242889	22	31846903	944570	929477		NC_000022.11:31846902:CCCCC:CCCC
NM_001242896.3(DEPDC5):c.4291_4294del (p.Tyr1431fs)	DEPDC5	Y1331fs, Y1400fs, Y1409fs, Y1353fs, Y1403fs, Y1422fs, Y1431fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000944440	22	32293553 - 32293556	22	31897567 - 31897570	944440	929479		NC_000022.11:31897566:TGTATG:TG
NM_001242896.3(DEPDC5):c.3709del (p.Glu1237fs)	DEPDC5	E1215fs, E1137fs, E1159fs, E1206fs, E1209fs, E1228fs, E1237fs	Autosomal dominant nocturnal frontal lobe epilepsy	Pathogenic	criteria provided, single submitter	VCV000873407	22	32272155	22	31876169	873407	861537		NC_000022.11:31876168:G:
NM_001242896.3(DEPDC5):c.232del (p.Arg78fs)	DEPDC5	R78fs	Seizures|Familial focal epilepsy with variable foci|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000871543	22	32160998	22	31765012	871543	860715		NC_000022.11:31765011:CC:C
NM_001242896.3(DEPDC5):c.4376-7_4376-3del	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000861441	22	32297717 - 32297721	22	31901731 - 31901735	861441	852934		NC_000022.11:31901730:TTTCCTTTC:TTTC
NM_001242896.3(DEPDC5):c.4066del (p.Leu1356fs)	DEPDC5	L1278fs, L1328fs, L1347fs, L1356fs, L1256fs, L1325fs, L1334fs	Epilepsy	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV000834049	22	32289598	22	31893612	834049	822296		NC_000022.11:31893611:CCC:CC
NC_000022.11:g.(?_31754902)_(31815449_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000833512	22	32150888 - 32211435			833512	821451		
NC_000022.11:g.(?_31760636)_(31760722_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000833301	22	32156622 - 32156708			833301	821452		
NC_000022.11:g.(?_31754902)_(31784895_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000831884	22	32150888 - 32180881			831884	821450		
NC_000022.11:g.(?_31901722)_(31901822_?)del	DEPDC5		Familial focal epilepsy with variable foci	Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000831729	22	32297708 - 32297808			831729	821458		
NC_000022.11:g.(?_31893562)_(31897673_?)del	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Oct 13, 2019)	criteria provided, single submitter	VCV000831616	22	32289548 - 32293659			831616	821457		
NC_000022.11:g.(?_31792013)_(31792122_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000831318	22	32187999 - 32188108			831318	821455		
NC_000022.11:g.(?_31778079)_(31792837_?)del	DEPDC5		Familial focal epilepsy with variable foci	Likely pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000831048	22	32174065 - 32188823			831048	821454		
NC_000022.11:g.(?_31798562)_(31798676_?)del	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000830921	22	32194548 - 32194662			830921	821456		
NM_001242896.3(DEPDC5):c.2634-5del	DEPDC5		Familial focal epilepsy with variable foci|not provided	Benign(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000798578	22	32239623	22	31843637	798578	788363	rs1602354182	NC_000022.11:31843636:TTTT:TTT
NM_001242896.3(DEPDC5):c.1234_1235delinsTA (p.Ser412Tyr)	DEPDC5	S412Y, S384Y	Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000654370	22	32202124 - 32202125	22	31806138 - 31806139	654370	649417	rs1602010588	NC_000022.11:31806137:AG:TA
NM_001242896.3(DEPDC5):c.1018del (p.Val340fs)	DEPDC5	V312fs, V340fs	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000654060	22	32198758	22	31802772	654060	649412	rs1601970168	NC_000022.11:31802771:GGGG:GGG
NC_000022.11:g.(?_31764955)_(31766688_?)del	DEPDC5		Epilepsy, familial focal, with variable foci 1|Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000653533	22	32160941 - 32162674	22	31764955 - 31766688	653533	653286		
NC_000022.11:g.(?_31804142)_(31810661_?)del	DEPDC5		Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000650190	22	32200128 - 32206647	22	31804142 - 31810661	650190	653215		
NC_000022.11:g.(?_31754902)_(31906517_?)del	DEPDC5		Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000647951	22	32150888 - 32302503	22	31754902 - 31906517	647951	653209		
NM_001242896.3(DEPDC5):c.1981_2104+678del	DEPDC5		Familial focal epilepsy with variable foci	Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000647448	22	32217594 - 32219450	22	31821608 - 31823464	647448	653335		
NM_001242896.3(DEPDC5):c.1277_1280del (p.Ala426fs)	DEPDC5	A398fs, A426fs	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000598772	22	32202165 - 32202168	22	31806179 - 31806182	598772	589846	rs1568963062	NC_000022.11:31806178:GGCAGG:GG
NC_000022.11:g.(?_31758526)_(31758653_?)del	DEPDC5		Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000584322	22	32154512 - 32154639	22	31758526 - 31758653	584322	573228		
NM_001242896.3(DEPDC5):c.4692_4693delinsTTT (p.Asp1565fs)	DEPDC5	D1565fs, D1534fs, D1556fs, D1537fs, D1543fs, D1465fs, D1487fs	Epilepsy, familial focal, with variable foci 1	Uncertain significance(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000576543	22	32302363 - 32302364	22	31906377 - 31906378	576543	571975	rs1569255986	NC_000022.11:31906376:GG:TTT
NM_001242896.3(DEPDC5):c.1133del (p.Pro378fs)	DEPDC5	P350fs, P378fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000573709	22	32200197	22	31804211	573709	573377	rs1568955379	NC_000022.11:31804210:CCC:CC
NM_001242896.3(DEPDC5):c.3547del (p.Ala1183fs)	DEPDC5	A1083fs, A1105fs, A1174fs, A1152fs, A1155fs, A1161fs, A1183fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000572795	22	32269302	22	31873316	572795	571963	rs1569166925	NC_000022.11:31873315:G:
NM_001242896.3(DEPDC5):c.4630del (p.Val1544fs)	DEPDC5	V1513fs, V1522fs, V1544fs, V1444fs, V1535fs, V1466fs, V1516fs	Epilepsy, familial focal, with variable foci 1	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000570633	22	32302299	22	31906313	570633	571973	rs1569255443	NC_000022.11:31906312:GGG:GG
NM_001242896.3(DEPDC5):c.2694_2703delinsGGACA (p.Asp898fs)	DEPDC5	D889fs, D820fs, D870fs, D898fs	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: May 28, 2018)	criteria provided, single submitter	VCV000560710	22	32239691 - 32239700	22	31843705 - 31843714	560710	551798	rs1569083500	NC_000022.11:31843704:CTCAGAGTTC:GGACA
NC_000022.11:g.(?_31809591)_(31815232_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000534830	22	32205577 - 32211218	22	31809591 - 31815232	534830	534014		
NC_000022.11:g.(?_31754902)_(31815232_?)del	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000534829	22	32150888 - 32211218	22	31754902 - 31815232	534829	534563		
NC_000022.11:g.(?_32200123)_(32200234_?)del	DEPDC5|RFPL2		Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495291			22	32200123 - 32200234	495291	486776		
NM_001242896.3(DEPDC5):c.694+3_694+6del	DEPDC5		Familial focal epilepsy with variable foci	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000466495	22	32188089 - 32188092	22	31792103 - 31792106	466495	471090	rs1351154360	NC_000022.11:31792102:GTGAGT:GT
NM_001242896.3(DEPDC5):c.363+6_363+7del	DEPDC5		not provided|Familial focal epilepsy with variable foci	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000466484	22	32162660 - 32162661	22	31766674 - 31766675	466484	471526	rs748242785	NC_000022.11:31766673:AT:
NM_001242896.3(DEPDC5):c.2894_2919del (p.His965fs)	DEPDC5	H887fs, H956fs, H937fs, H965fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000466477	22	32241090 - 32241115	22	31845104 - 31845129	466477	471543	rs1555900914	NC_000022.11:31845103:AGGCCCACTGCGACATCTATGGGGACAGGCCC:AGGCCC
NM_001242896.3(DEPDC5):c.1385_1386del (p.Ala461_Tyr462insTer)	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000466450	22	32206566 - 32206567	22	31810580 - 31810581	466450	471094	rs1555882921	NC_000022.11:31810579:TAT:T
NC_000022.10:g.(?_32154512)_(32174174_?)del	DEPDC5		Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000466446	22	32154512 - 32174174			466446	470889		
NC_000022.11:g.(?_31754902)_(31754999_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000466445	22	32150888 - 32150985	22	31754902 - 31754999	466445	470887		
NM_001242896.3(DEPDC5):c.1845del (p.Arg615fs)	DEPDC5	R587fs, R615fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: May 8, 2016)	criteria provided, single submitter	VCV000407342	22	32215185	22	31819199	407342	404380	rs1060501487	NC_000022.11:31819198:GG:G
NM_001242896.3(DEPDC5):c.4261del (p.Glu1421fs)	DEPDC5	E1393fs, E1421fs, E1321fs, E1343fs, E1399fs, E1390fs, E1412fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264745	22	32293524	22	31897538	264745	259377	rs886039272	NC_000022.11:31897537:GG:G
NM_001242896.3(DEPDC5):c.4187del (p.Ala1396fs)	DEPDC5	A1387fs, A1368fs, A1374fs, A1396fs, A1296fs, A1318fs, A1365fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264744	22	32289721	22	31893735	264744	259376	rs886039271	NC_000022.11:31893734:C:
NM_001242896.3(DEPDC5):c.3444del (p.Ile1148fs)	DEPDC5	I1120fs, I1048fs, I1117fs, I1148fs, I1070fs, I1126fs, I1139fs	Epilepsy, familial focal, with variable foci 1|Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000264739	22	32266689	22	31870703	264739	259368	rs886039266	NC_000022.11:31870702:A:
NM_001242896.3(DEPDC5):c.2390del (p.Gln797fs)	DEPDC5	Q769fs, Q797fs, Q719fs, Q788fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264736	22	32234706	22	31838720	264736	259362	rs886039264	NC_000022.11:31838719:A:
NM_001242896.3(DEPDC5):c.1750_1756del (p.Leu584fs)	DEPDC5	L556fs, L584fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264733	22	32215087 - 32215093	22	31819101 - 31819107	264733	259359	rs886039262	NC_000022.11:31819100:CATGCTGCATG:CATG
NM_001242896.3(DEPDC5):c.985del (p.Thr329fs)	DEPDC5	T329fs, T301fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264727	22	32198727	22	31802741	264727	259348	rs886039257	NC_000022.11:31802740:AA:A
NM_001242896.3(DEPDC5):c.783_786del (p.Asn261fs)	DEPDC5	N233fs, N261fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264724	22	32193601 - 32193604	22	31797615 - 31797618	264724	259343	rs886039254	NC_000022.11:31797614:TGAG:
NM_001242896.3(DEPDC5):c.492_496del (p.Arg165fs)	DEPDC5	R137fs, R165fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264719	22	32179898 - 32179902	22	31783912 - 31783916	264719	259337	rs886039250	NC_000022.11:31783911:GTTTCGTT:GTT
NM_001242896.3(DEPDC5):c.454_455del (p.Met152fs)	DEPDC5	M124fs, M152fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264717	22	32174125 - 32174126	22	31778139 - 31778140	264717	259335	rs886039248	NC_000022.11:31778138:AT:
NM_001242896.3(DEPDC5):c.3331-10del	DEPDC5		Familial focal epilepsy with variable foci|not provided	Benign/Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000238681	22	32266566	22	31870580	238681	243713	rs377356885	NC_000022.11:31870579:T:
NM_001242896.3(DEPDC5):c.1122del (p.Leu374fs)	DEPDC5	L374fs, L346fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000050823	22	32200188	22	31804202	50823	59813	rs879255234	NC_000022.11:31804201:A:
NM_001242896.3(DEPDC5):c.489_491del (p.Phe164del)	DEPDC5	F164del, F136del	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000050821	22	32179897 - 32179899	22	31783911 - 31783913	50821	59811	rs587776974	NC_000022.11:31783910:TGTT:T
NM_002439.5(MSH3):c.162_179del (p.Ala57_Ala62del)	DHFR|MSH3		not provided|Megaloblastic anemia due to dihydrofolate reductase deficiency|Familial adenomatous polyposis 4	Benign/Likely benign(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000769652	5	79950700 - 79950717	5	80654881 - 80654898	769652	699196	rs201874762	NC_000005.10:80654880:GCAGCGGCTGCAGCGGCCGCAGCGGC:GCAGCGGC
GRCh38/hg38 10p14(chr10:11738467-12180308)x1	DHTKD1|ECHDC3|LOC121366040|LOC121366041|MIR548AK|NUDT5|PROSER2|PROSER2-AS1|SEC61A2|UPF2		See cases	Uncertain significance(Last reviewed: Apr 16, 2012)	no assertion criteria provided	VCV000149272	10	11780466 - 12222307	10	11738467 - 12180308	149272	159023		
GRCh37/hg19 4p15.31-15.2(chr4:19186845-24548281)	DHX15|SLIT2|PPARGC1A|GBA3|KCNIP4|PACRGL|ADGRA3		4p partial monosomy syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625782	4	19186845 - 24548281			625782	614086		
GRCh37/hg19 18p11.31(chr18:4117583-4193497)x1	DLGAP1		not provided	Uncertain significance(Last reviewed: Jan 24, 2018)	no assertion criteria provided	VCV000685938	18	4117583 - 4193497			685938	673530		
GRCh37/hg19 18p11.31(chr18:3633721-3901635)x1	DLGAP1		not provided	Uncertain significance(Last reviewed: Mar 12, 2018)	no assertion criteria provided	VCV000685823	18	3633721 - 3901635			685823	673415		
NC_000020.11:g.(?_63928326)_(63931588_?)del	DNAJC5		Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Nov 24, 2019)	criteria provided, single submitter	VCV000831459	20	62559679 - 62562941			831459	821346		
NM_020812.4(DOCK6):c.4650+1_4650+3del	DOCK6|LOC105372273		Inborn genetic diseases	Likely pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000522049	19	11322666 - 11322668	19	11211990 - 11211992	522049	512376	rs1280482569	NC_000019.10:11211989:CACC:C
GRCh37/hg19 9p24.3(chr9:209753-246900)x1	DOCK8|DOCK8-AS1		not provided	Uncertain significance(Last reviewed: Apr 19, 2018)	no assertion criteria provided	VCV000686347	9	209753 - 246900			686347	673939		
GRCh37/hg19 16q24.3(chr16:89662327-89927634)x1	DPEP1|FANCA|CHMP1A|CDK10|VPS9D1|CPNE7|SPIRE2|ZNF276|SPATA2L|SPATA33		not provided	Uncertain significance(Last reviewed: May 13, 2017)	no assertion criteria provided	VCV000689215	16	89662327 - 89927634			689215	676807		
GRCh37/hg19 1p21.3(chr1:97874956-98098498)x1	DPYD		not provided	Uncertain significance(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000685851	1	97874956 - 98098498			685851	673443		
GRCh37/hg19 21q22.13-22.2(chr21:38741104..40274106)	DSCR4|ERG|ETS2|KCNJ15|KCNJ6|LINC00114|DSCR8|DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204002	21	38741104 - 40274106			204002	200408		
NM_001347721.2(DYRK1A):c.433_439del (p.Lys145fs)	DYRK1A	K116fs, K145fs, K154fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, single submitter	VCV001299504	21	38853071 - 38853077	21	37480769 - 37480775	1299504	1289559		NC_000021.9:37480768:AAAGTGGA:A
NC_000021.8:g.(?_38844966)_(38884854_?)del	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001073605	21	38844966 - 38884854			1073605	1058102		
NC_000021.8:g.(?_38844966)_(38845202_?)del	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001073604	21	38844966 - 38845202			1073604	1058101		
NM_001347721.2(DYRK1A):c.931_932del (p.Gln311fs)	DYRK1A	Q282fs, Q311fs, Q320fs	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Apr 7, 2021)	criteria provided, single submitter	VCV001065145	21	38865325 - 38865326	21	37493023 - 37493024	1065145	1053483		NC_000021.9:37493022:CA:
NM_001347721.2(DYRK1A):c.490-9_490-5del	DYRK1A		Mental retardation, autosomal dominant 7	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV000999758	21	38858756 - 38858760	21	37486454 - 37486458	999758	999216		NC_000021.9:37486453:TCTTCTCTT:TCTT
NM_001347721.2(DYRK1A):c.687del (p.Phe229fs)	DYRK1A	F200fs, F229fs, F238fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV000984713	21	38862522	21	37490220	984713	972801		NC_000021.9:37490219:TTTTT:TTTT
NC_000021.9:g.37347863_37423682del	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic	criteria provided, single submitter	VCV000981631	21	38720165 - 38795984			981631	969712		
NM_001347721.2(DYRK1A):c.1354_1357del (p.Asp452fs)	DYRK1A	D423fs, D452fs, D461fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000976301	21	38877725 - 38877728	21	37505422 - 37505425	976301	964548		NC_000021.9:37505421:TTGATT:TT
NM_001347721.2(DYRK1A):c.471del (p.Gly159fs)	DYRK1A	G130fs, G159fs, G168fs	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000976047	21	38853110	21	37480808	976047	964546		NC_000021.9:37480807:C:
NM_001347721.2(DYRK1A):c.1289del (p.Ala430fs)	DYRK1A	A439fs, A401fs, A430fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000931464	21	38877662	21	37505359	931464	919935		NC_000021.9:37505358:C:
NM_001347721.2(DYRK1A):c.536_538del (p.Lys179del)	DYRK1A	K150del, K179del, K188del	Mental retardation, autosomal dominant 7	Likely pathogenic	criteria provided, single submitter	VCV000916033	21	38858814 - 38858816	21	37486512 - 37486514	916033	904257		NC_000021.9:37486511:AAAA:A
NM_001347721.2(DYRK1A):c.1812_1829del (p.His605_His610del)	DYRK1A		Mental retardation, autosomal dominant 7	Likely benign(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000833733	21	38884364 - 38884381	21	37512061 - 37512078	833733	822183		NC_000021.9:37512060:CACCATCACCACCACCACCACCATCACCACCACCA:CACCATCACCACCACCA
NC_000021.9:g.(?_37492997)_(37493183_?)del	DYRK1A		Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000831145	21	38865299 - 38865485			831145	821373		
NM_001347721.2(DYRK1A):c.1583del (p.His528fs)	DYRK1A	H537fs, H528fs, H499fs	Mental retardation, autosomal dominant 7	Uncertain significance(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000641967	21	38878465	21	37506162	641967	648997	rs1601319086	NC_000021.9:37506161:A:
NC_000021.8:g.(?_38792657)_(38884854_?)del	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000584409	21	38792657 - 38884854			584409	573716		
NM_001347721.2(DYRK1A):c.658_659del (p.Met220fs)	DYRK1A	M220fs, M229fs, M191fs	Complex neurodevelopmental disorder|Inborn genetic diseases|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000520853	21	38862496 - 38862497	21	37490194 - 37490195	520853	512486	rs1555984102	NC_000021.9:37490193:TAT:T
NM_001347721.2(DYRK1A):c.638-9_638-5del	DYRK1A		not provided|Mental retardation, autosomal dominant 7|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487250	21	38862466 - 38862470	21	37490164 - 37490168	487250	471646	rs1555984064	NC_000021.9:37490163:TTCTCTT:TT
NC_000021.8:g.(?_38868400)_(38884854_?)del	DYRK1A		Mental retardation, autosomal dominant 7	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000472239	21	38868400 - 38884854			472239	470570		
NM_001347721.2(DYRK1A):c.1378del (p.Gln460fs)	DYRK1A	Q431fs, Q460fs, Q469fs	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000435013	21	38877751	21	37505448	435013	430430	rs1555990958	NC_000021.9:37505447:C:
NM_001347721.2(DYRK1A):c.924+4_924+7del	DYRK1A		not provided|Mental retardation, autosomal dominant 7|Complex neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000435011	21	38862764 - 38862767	21	37490462 - 37490465	435011	430428	rs1555984461	NC_000021.9:37490461:GTAAGTA:GTA
NM_001347721.2(DYRK1A):c.545_548del (p.Lys182fs)	DYRK1A	K153fs, K191fs, K182fs	not provided|Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 7	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423335	21	38858822 - 38858825	21	37486520 - 37486523	423335	410861	rs1064796367	NC_000021.9:37486519:AAAGAA:AA
NM_001347721.2(DYRK1A):c.263_264del (p.Ser88fs)	DYRK1A	S59fs, S88fs, S97fs	Intellectual disability|not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Feb 26, 2021)	criteria provided, single submitter	VCV000418949	21	38850564 - 38850565	21	37478262 - 37478263	418949	410857	rs1064793546	NC_000021.9:37478261:TCT:T
NM_001347721.2(DYRK1A):c.1464del (p.Ala489fs)	DYRK1A	A460fs, A498fs, A489fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	VCV000375629	21	38877834	21	37505531	375629	362451	rs1057519628	NC_000021.9:37505530:CCCC:CCC
NM_001347721.2(DYRK1A):c.270_274del (p.Leu91fs)	DYRK1A	L100fs, L62fs, L91fs	Mental retardation, autosomal dominant 7	Pathogenic	no assertion criteria provided	VCV000375618	21	38850568 - 38850572	21	37478266 - 37478270	375618	362432	rs1057519402	NC_000021.9:37478265:TTGACTTGA:TTGA
NM_001347721.2(DYRK1A):c.1074_1077del (p.Asp359fs)	DYRK1A	D368fs, D359fs, D330fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204007	21	38868421 - 38868424	21	37496119 - 37496122	204007	200406	rs797044522	NC_000021.9:37496118:TAGAT:T
NM_001347721.2(DYRK1A):c.434del (p.Lys145fs)	DYRK1A	K145fs, K154fs, K116fs	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204006	21	38853070	21	37480768	204006	200402	rs797044521	NC_000021.9:37480767:AAAA:AAA
NM_001347721.2(DYRK1A):c.143_144del (p.Ile48fs)	DYRK1A	I48fs, I19fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039622	21	38845117 - 38845118	21	37472815 - 37472816	39622	48221	rs587776929	NC_000021.9:37472814:ATA:A
NC_000021.7:g.37796500_37849000del	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030131	21	38874630 - 38927130			30131	39087		
GRCh37/hg19 6p23-22.3(chr6:13910125-22000204)x1	E2F3|GMPR|ID4|JARID2|ATXN1|SOX4|TPMT|DEK|CD83|NUP153|CAP2|MYLIP|FAM8A1|CDKAL1|KIF13A|DTNBP1|MBOAT1|KDM1B|RBM24|RNF182|RNF144B|NHLRC1|STMND1		not provided	Pathogenic(Last reviewed: Feb 28, 2018)	no assertion criteria provided	VCV000688193	6	13910125 - 22000204			688193	675785		
NM_004425.4(ECM1):c.142del (p.Ser48fs)	ECM1	S48fs	Lipid proteinosis	Likely pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000930258	1	150482157	1	150509681	930258	918554		NC_000001.11:150509680:T:
NM_004425.4(ECM1):c.93_94delinsTT (p.Arg31_Gln32delinsSerTer)	ECM1		Lipid proteinosis	Pathogenic(Last reviewed: Nov 19, 2015)	no assertion criteria provided	VCV000222949	1	150482029 - 150482030	1	150509553 - 150509554	222949	224664	rs869025567	NC_000001.11:150509552:GC:TT
NM_004425.4(ECM1):c.507del (p.Arg171fs)	ECM1	R171fs, R198fs	Lipid proteinosis	Pathogenic(Last reviewed: Jul 19, 2021)	no assertion criteria provided	VCV000222947	1	150483473	1	150510997	222947	224660	rs869025565	NC_000001.11:150510996:T:
ECM1, 1163-BP DEL	ECM1		Lipid proteinosis	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000007473					7473	22512		
NM_004425.4(ECM1):c.1019del (p.Gln340fs)	ECM1	Q340fs, Q367fs	Lipid proteinosis	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000007471	1	150484243	1	150511767	7471	22510	rs778473713	NC_000001.11:150511766:A:
NC_000020.11:g.(?_63406624)_(63528152_?)del	EEF1A2|KCNQ2|PPDPF		Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000833079	20	62037977 - 62159505			833079	821339		
GRCh37/hg19 2p16.1(chr2:56141398-56152467)x1	EFEMP1		not provided	Uncertain significance(Last reviewed: Sep 4, 2018)	no assertion criteria provided	VCV000687478	2	56141398 - 56152467			687478	675070		
NM_018100.4(EFHC1):c.723+66del	EFHC1		Juvenile myoclonic epilepsy|Typical absence seizures	Benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV001169203	6	52317698	6	52452900	1169203	1155425		NC_000006.12:52452899:AAAA:AAA
NC_000006.11:g.(?_52329683)_(52334281_?)del	EFHC1		Typical absence seizures|Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001000342	6	52329683 - 52334281			1000342	986320		
NM_018100.4(EFHC1):c.364_369del (p.Ile122_Tyr123del)	EFHC1		Typical absence seizures|Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000953266	6	52303178 - 52303183	6	52438380 - 52438385	953266	945066		NC_000006.12:52438379:ACATTTAC:AC
NC_000006.12:g.(?_52479017)_(52492432_?)del	EFHC1		Juvenile myoclonic epilepsy|Typical absence seizures	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000833385	6	52343815 - 52357230			833385	819700		
NC_000006.12:g.(?_52423789)_(52492432_?)del	EFHC1		Juvenile myoclonic epilepsy|Typical absence seizures	Uncertain significance(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000832614	6	52288587 - 52357230			832614	819699		
NM_018100.4(EFHC1):c.1171del (p.Glu391fs)	EFHC1	E391fs, E372fs	Epilepsy, juvenile absence, susceptibility to, 1|Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000666108	6	52334163	6	52469365	666108	634995	rs1218368055	NC_000006.12:52469364:GG:G
NM_018100.4(EFHC1):c.666_674delinsAAG (p.Tyr223_Thr225delinsSer)	EFHC1		Juvenile myoclonic epilepsy|Epilepsy, juvenile absence, susceptibility to, 1	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000534109	6	52317578 - 52317586	6	52452780 - 52452788	534109	522396	rs1554259746	NC_000006.12:52452779:GTATGTCAC:AAG
NM_018100.4(EFHC1):c.1549_1559delinsTTTTGAAATACA (p.Glu517_Ala520delinsPheTer)	EFHC1		Juvenile myoclonic epilepsy|Typical absence seizures	Uncertain significance(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000534105	6	52344494 - 52344504	6	52479696 - 52479706	534105	522073	rs1554261668	NC_000006.12:52479695:GAGAGCAACGC:TTTTGAAATACA
NM_018100.4(EFHC1):c.682_692del (p.Asp228fs)	EFHC1	D209fs, D228fs	none provided|Juvenile myoclonic epilepsy|Typical absence seizures	Uncertain significance(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000411574	6	52317590 - 52317600	6	52452792 - 52452802	411574	395421	rs775980459	NC_000006.12:52452791:ATCAGACTTTGATCA:ATCA
NM_018100.4(EFHC1):c.*1045delinsATATATATATATATATATATATATATATATATA	EFHC1		Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000357510	6	52358184	6	52493386	357510	308233	rs886061633	NC_000006.12:52493385:T:ATATATATATATATATATATATATATATATATA
NM_018100.4(EFHC1):c.*1045delinsATATATATATATA	EFHC1		Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000357509	6	52358184	6	52493386	357509	303671	rs886061633	NC_000006.12:52493385:T:ATATATATATATA
NM_018100.4(EFHC1):c.666_671del (p.Lys222_Val224delinsAsn)	EFHC1		Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000357481	6	52317578 - 52317583	6	52452780 - 52452785	357481	308180	rs886061628	NC_000006.12:52452779:GTATGT:
NM_018100.4(EFHC1):c.1182del (p.Gln395fs)	EFHC1	Q376fs, Q395fs	Juvenile myoclonic epilepsy|Typical absence seizures|not provided	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000286732	6	52334175	6	52469377	286732	270969	rs753549012	NC_000006.12:52469376:T:
NM_018100.4(EFHC1):c.1314del (p.Phe438fs)	EFHC1	F419fs, F438fs	not provided	Pathogenic(Last reviewed: Sep 21, 2012)	criteria provided, single submitter	VCV000205420	6	52343868	6	52479070	205420	202002	rs796052421	NC_000006.12:52479069:TTT:TT
NM_004247.4:c.(350+1_351-1)_(492+1_493-1)del	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Likely pathogenic(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV001285438					1285438	1275281		
NM_004247.4(EFTUD2):c.378del (p.Glu127fs)	EFTUD2	E127fs, E92fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV001029805	17	42961065	17	44883697	1029805	1018302		NC_000017.11:44883696:T:
NM_004247.4(EFTUD2):c.1331del (p.Gly444fs)	EFTUD2	G409fs, G434fs, G444fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV001029804	17	42941105	17	44863737	1029804	1018301		NC_000017.11:44863736:CCC:CC
NM_004247.4(EFTUD2):c.2562-2_2562-1del	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000984919	17	42929931 - 42929932	17	44852563 - 44852564	984919	973043		NC_000017.11:44852562:CT:
NM_004247.4(EFTUD2):c.1332del (p.Ala445fs)	EFTUD2	A410fs, A435fs, A445fs	Mandibulofacial dysostosis-microcephaly syndrome	Likely pathogenic	no assertion criteria provided	VCV000977825	17	42941104	17	44863736	977825	966002		NC_000017.11:44863735:G:
NM_004247.4(EFTUD2):c.2600del (p.Pro867fs)	EFTUD2	P832fs, P867fs, P857fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000931795	17	42929892	17	44852524	931795	919733		NC_000017.11:44852523:GGGG:GGG
NM_004247.4(EFTUD2):c.1861-9_1861-7del	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Uncertain significance(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV000930897	17	42936556 - 42936558	17	44859188 - 44859190	930897	920373		NC_000017.11:44859187:CAC:
NM_004247.4(EFTUD2):c.1742del (p.Lys581fs)	EFTUD2	K546fs, K571fs, K581fs	Mandibulofacial dysostosis-microcephaly syndrome	Likely pathogenic	no assertion criteria provided	VCV000812586	17	42937391	17	44860023	812586	800835	rs1597795170	NC_000017.11:44860022:TT:T
NM_004247.4(EFTUD2):c.882del (p.Asp295fs)	EFTUD2	D260fs, D285fs, D295fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803428	17	42949926	17	44872558	803428	791782	rs1597807512	NC_000017.11:44872557:A:
NM_004247.4(EFTUD2):c.1567del (p.Gln523fs)	EFTUD2	Q488fs, Q523fs, Q513fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000522863	17	42940121	17	44862753	522863	513468	rs1555565774	NC_000017.11:44862752:GGG:GG
NM_004247.4(EFTUD2):c.2551del (p.Ala851fs)	EFTUD2	A816fs, A841fs, A851fs	Mandibulofacial dysostosis-microcephaly syndrome	Likely pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000488388	17	42930674	17	44853306	488388	481240	rs1555564126	NC_000017.11:44853305:CC:C
NM_004247.4(EFTUD2):c.1775_1779del (p.Val592fs)	EFTUD2	V557fs, V582fs, V592fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431142	17	42937354 - 42937358	17	44859986 - 44859990	431142	424666	rs1135401812	NC_000017.11:44859985:CTCCAC:C
NM_004247.4(EFTUD2):c.1297_1298del (p.Met433fs)	EFTUD2	M433fs, M398fs, M423fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000210915	17	42941138 - 42941139	17	44863770 - 44863771	210915	208399	rs797045551	NC_000017.11:44863769:AT:
NM_004247.4(EFTUD2):c.2823+1del	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000040048	17	42929077	17	44851709	40048	48562	rs879253728	NC_000017.11:44851708:CC:C
NM_004247.4(EFTUD2):c.1759_1760del (p.Val587fs)	EFTUD2	V552fs, V587fs, V577fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030402	17	42937373 - 42937374	17	44860005 - 44860006	30402	39359	rs879253725	NC_000017.11:44860004:ACA:A
NM_024757.5(EHMT1):c.1501+1del	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001285594	9	140652463	9	137758011	1285594	1275436		NC_000009.12:137758010:GG:G
NM_024757.5(EHMT1):c.575_581del (p.Pro192fs)	EHMT1	P161fs, P192fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Jan 19, 2021)	criteria provided, single submitter	VCV001285498	9	140611565 - 140611571	9	137717113 - 137717119	1285498	1275341		NC_000009.12:137717112:CCCGGCCCC:CC
NM_024757.5(EHMT1):c.3012_3016del (p.Pro1005fs)	EHMT1	P1005fs, P998fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Nov 5, 2020)	criteria provided, single submitter	VCV001285440	9	140707601 - 140707605	9	137813149 - 137813153	1285440	1275283		NC_000009.12:137813148:GCCCCG:G
NM_024757.5(EHMT1):c.2161del (p.Glu721fs)	EHMT1	E690fs, E714fs, E721fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001076531	9	140672475	9	137778023	1076531	1061655		NC_000009.12:137778022:GG:G
NM_024757.5(EHMT1):c.50_85+60del	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, single submitter	VCV001068268	9	140605445 - 140605540	9	137710993 - 137711088	1068268	1055810		
NM_024757.5(EHMT1):c.1321_1322delinsAA (p.Ala441Asn)	EHMT1	A410N, A441N, A434N	Kleefstra syndrome 1	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001035027	9	140648695 - 140648696	9	137754243 - 137754244	1035027	1029111		NC_000009.12:137754242:GC:AA
NM_024757.5(EHMT1):c.3000del (p.Asp1001fs)	EHMT1	D1001fs, D994fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV001031404	9	140707586	9	137813134	1031404	1020615		NC_000009.12:137813133:CCCCC:CCCC
NM_024757.5(EHMT1):c.1597del (p.Thr533fs)	EHMT1	T502fs, T526fs, T533fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Jun 17, 2020)	no assertion criteria provided	VCV000992396	9	140657222	9	137762770	992396	980334		NC_000009.12:137762769:A:
NM_024757.5(EHMT1):c.824-2del	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000992223	9	140637821	9	137743369	992223	980169		NC_000009.12:137743368:A:
NM_024757.5(EHMT1):c.508del (p.Gln170fs)	EHMT1	Q139fs, Q170fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000976695	9	140611497	9	137717045	976695	964838		NC_000009.12:137717044:CCCC:CCC
NM_024757.5(EHMT1):c.21+1_21+5del	EHMT1		Kleefstra syndrome 1	Likely pathogenic	criteria provided, single submitter	VCV000974820	9	140513499 - 140513503	9	137619047 - 137619051	974820	963153		NC_000009.12:137619046:GAGGTGAG:GAG
NM_024757.5(EHMT1):c.3174_3175delinsCG (p.Leu1059Val)	EHMT1	L1052V, L1059V	Kleefstra syndrome 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000934083	9	140707976 - 140707977	9	137813524 - 137813525	934083	934703		NC_000009.12:137813523:TC:CG
NC_000009.12:g.(?_137790828)_(137818158_?)del	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000831008	9	140685280 - 140712610			831008	820109		
NC_000009.12:g.(?_137790828)_(137790990_?)del	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000830651	9	140685280 - 140685442			830651	820108		
NM_024757.5(EHMT1):c.2976del (p.Ser992fs)	EHMT1	S992fs, S985fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802552	9	140707566	9	137813114	802552	790879	rs1588854011	NC_000009.12:137813113:C:
NM_024757.5(EHMT1):c.389_397del (p.Pro130_Leu132del)	EHMT1		Kleefstra syndrome 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802549	9	140611380 - 140611388	9	137716928 - 137716936	802549	790876	rs1588328189	NC_000009.12:137716927:CCGGCCCTAC:C
NM_024757.5(EHMT1):c.3443del (p.Pro1148fs)	EHMT1	P1141fs, P1148fs	Kleefstra syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694702	9	140711958	9	137817506	694702	682812	rs1588875719	NC_000009.12:137817505:CC:C
NM_024757.5(EHMT1):c.1495del (p.Ala499fs)	EHMT1	A492fs, A499fs, A468fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000620057	9	140652457	9	137758005	620057	611400		NC_000009.12:137758004:G:
NM_024757.5(EHMT1):c.13_21+153del	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000573983	9	140513484 - 140513645	9	137619032 - 137619193	573983	563101	rs1564509503	
NM_024757.5(EHMT1):c.1456_1457delinsAA (p.Ser486Asn)	EHMT1	S455N, S486N, S479N	Kleefstra syndrome 1	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000569906	9	140652418 - 140652419	9	137757966 - 137757967	569906	563140	rs1564704339	NC_000009.12:137757965:TC:AA
NM_024757.5(EHMT1):c.2224del (p.Leu742fs)	EHMT1	L711fs, L735fs, L742fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560999	9	140674118	9	137779666	560999	552139	rs1564744631	NC_000009.12:137779665:C:
NM_024757.5(EHMT1):c.396_397delinsTG (p.Gln133Glu)	EHMT1	Q133E, Q102E	Kleefstra syndrome 1	Uncertain significance(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000462999	9	140611388 - 140611389	9	137716936 - 137716937	462999	459060	rs1554846569	NC_000009.12:137716935:AC:TG
NM_024757.5(EHMT1):c.128_129delinsGT (p.Ala43Gly)	EHMT1	A12G, A43G	Kleefstra syndrome 1	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV000462976	9	140611120 - 140611121	9	137716668 - 137716669	462976	459369	rs386739686	NC_000009.12:137716667:CA:GT
NM_024757.5(EHMT1):c.3583_3594del (p.Val1195_Phe1198del)	EHMT1		Kleefstra syndrome 1	Likely pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000435046	9	140728842 - 140728853	9	137834390 - 137834401	435046	428984	rs1554908290	NC_000009.12:137834389:CGTCAGCCGGTTC:C
NM_024757.5(EHMT1):c.1434_1435del (p.Tyr479fs)	EHMT1	Y479fs, Y448fs, Y472fs	Kleefstra syndrome 1	Pathogenic	criteria provided, single submitter	VCV000431703	9	140652396 - 140652397	9	137757944 - 137757945	431703	425215	rs1554867189	NC_000009.12:137757943:GT:
NM_024757.5(EHMT1):c.3072_3073del (p.Val1026fs)	EHMT1	V1019fs, V1026fs	not provided|Kleefstra syndrome 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000426664	9	140707874 - 140707875	9	137813422 - 137813423	426664	415187	rs1085307734	NC_000009.12:137813421:CT:
NM_024757.5(EHMT1):c.391del (p.Ala131fs)	EHMT1	A100fs, A131fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Feb 20, 2014)	criteria provided, single submitter	VCV000209152	9	140611382	9	137716930	209152	205761	rs797045043	NC_000009.12:137716929:GG:G
NM_024757.5(EHMT1):c.298_299delinsAT (p.Asp100Ile)	EHMT1	D69I, D100I	not provided|Kleefstra syndrome 1	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000196521	9	140611290 - 140611291	9	137716838 - 137716839	196521	193682	rs797044709	NC_000009.12:137716837:GA:AT
NM_024757.5(EHMT1):c.3181-80_3233del	EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000041267	9	140708803 - 140708935	9	137814351 - 137814483	41267	49691	rs1554896943	
NM_024757.5(EHMT1):c.1413_1425del (p.Pro473fs)	EHMT1	P442fs, P473fs, P466fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000003606	9	140652371 - 140652383	9	137757919 - 137757931	3606	18645	rs137852715	NC_000009.12:137757918:AGACGGCACCAGGAGAC:AGAC
GRCh37/hg19 5q22.2(chr5:111627858-111683659)x1	EPB41L4A		not provided	Uncertain significance(Last reviewed: Jun 18, 2018)	no assertion criteria provided	VCV000686937	5	111627858 - 111683659			686937	674529		
NM_005670.4(EPM2A):c.159_160delinsGT (p.Ala53_Leu54=)	EPM2A|FBXO30-DT		Progressive myoclonic epilepsy	Likely benign(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV001133175	6	146056475 - 146056476	6	145735339 - 145735340	1133175	1116460		NC_000006.12:145735338:GG:AC
NM_005670.4(EPM2A):c.118del (p.Arg39_Leu40insTer)	EPM2A|FBXO30-DT		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV000956069	6	146056517	6	145735381	956069	944913		NC_000006.12:145735380:GG:G
NC_000006.12:g.(?_145625675)_(145635506_?)del	EPM2A		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000830902	6	145946811 - 145956642			830902	819669		
NM_005670.4(EPM2A):c.206_207delinsGC (p.Glu69Gly)	EPM2A|FBXO30-DT	E69G	Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000665213	6	146056428 - 146056429	6	145735292 - 145735293	665213	634672	rs1583156284	NC_000006.12:145735291:CT:GC
NC_000006.12:g.(?_145625675)_(145735518_?)del	EPM2A|FBXO30-DT		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000654665	6	145946811 - 146056654	6	145625675 - 145735518	654665	651526		
NM_005670.4(EPM2A):c.4_39del (p.Arg2_Val13del)	EPM2A|FBXO30-DT		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000653916	6	146056596 - 146056631	6	145735460 - 145735495	653916	634673	rs1583157261	NC_000006.12:145735459:CACGGCGGGTGGCACCACCACCCCAAAGCGGAAGCGCA:CA
NC_000006.12:g.(?_145686102)_(145686316_?)del	EPM2A		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000462911			6	145686102 - 145686316	462911	455759		
NM_005670.4(EPM2A):c.157_159delinsACG (p.Ala53Thr)	EPM2A|FBXO30-DT	A53T	not specified	Uncertain significance(Last reviewed: May 16, 2014)	criteria provided, single submitter	VCV000205450	6	146056476 - 146056478	6	145735340 - 145735342	205450	201939	rs796052439	NC_000006.12:145735339:GGC:CGT
NM_005670.4(EPM2A):c.639_640delinsAA (p.Pro214Thr)	EPM2A	P76T, P60T, P214T	Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000205445	6	145956459 - 145956460	6	145635323 - 145635324	205445	201928	rs796052435	NC_000006.12:145635322:GA:TT
GRCh37/hg19 5q12.1(chr5:60222511-60334925)x1	ERCC8|NDUFAF2		not provided	Uncertain significance(Last reviewed: May 4, 2018)	no assertion criteria provided	VCV000685846	5	60222511 - 60334925			685846	673438		
GRCh37/hg19 15q25.1(chr15:80472308-80484049)x1	FAH		not provided	Uncertain significance(Last reviewed: Mar 19, 2018)	no assertion criteria provided	VCV000688473	15	80472308 - 80484049			688473	676065		
NM_006493.4(CLN5):c.207_213del (p.Pro68_Tyr69insTer)	FBXL3|CLN5		Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001075843	13	77569230 - 77569236	13	76995095 - 76995101	1075843	1063037		NC_000013.11:76995094:ATTGTCAA:A
NM_006493.4(CLN5):c.827_828del (p.Phe276fs)	FBXL3|CLN5	F276fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001071340	13	77574851 - 77574852	13	77000716 - 77000717	1071340	1063040		NC_000013.11:77000715:TTTTT:TTT
NM_005670.4(EPM2A):c.108_139del (p.Ala37fs)	FBXO30-DT|EPM2A	A37fs	Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001075527	6	146056496 - 146056527	6	145735360 - 145735391	1075527	1060626		NC_000006.12:145735359:CCGCGGTGCCGGCCGGCCTCAGGCGGACGGCACCGCG:CCGCG
NM_000142.5(FGFR3):c.1921_1922delinsAT (p.Asp641Ile)	FGFR3	D529I, D641I, D642I, D643I	Hypochondroplasia	Uncertain significance(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000976408	4	1807862 - 1807863	4	1806135 - 1806136	976408	964231		NC_000004.12:1806134:GA:AT
GRCh37/hg19 4p16.3(chr4:1305802-2460571)	FGFR3|LETM1|NSD2|NELFA|SLBP|MAEA|TACC3|MXD4|NKX1-1|UVSSA|ZFYVE28|HAUS3|TMEM129|FAM53A|CRIPAK|NAT8L|POLN|C4orf48		4p partial monosomy syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625700	4	1305802 - 2460571			625700	614004		
NM_014845.6(FIG4):c.831_838del (p.Lys278fs)	FIG4	K278fs	Yunis-Varon syndrome|not provided|Polymicrogyria, bilateral temporooccipital|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000050995	6	110062701 - 110062708	6	109741498 - 109741505	50995	65666	rs786200937	NC_000006.12:109741497:GTAAATTTG:G
GRCh37/hg19 14q12(chr14:28836918-29955663)x1	FOXG1		not provided	Pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000988919	14	28836918 - 29955663			988919	976855		
NM_005249.5(FOXG1):c.946del (p.Leu316fs)	FOXG1	L316fs	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000538818	14	29237429	14	28768223	538818	528486	rs1555321380	NC_000014.9:28768222:CCC:CC
NM_005249.5(FOXG1):c.506del (p.Gly169fs)	FOXG1	G169fs	Inborn genetic diseases|Rett syndrome, congenital variant|not provided	Pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000471470	14	29236986	14	28767780	471470	463729	rs1452295073	NC_000014.9:28767779:GGGGGG:GGGGG
NM_005249.5(FOXG1):c.225_226delinsACCG (p.Pro77fs)	FOXG1	P77fs	not provided	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000205511	14	29236710 - 29236711	14	28767504 - 28767505	205511	202807	rs796052485	NC_000014.9:28767503:GC:ACCG
NM_005249.5(FOXG1):c.183_206del (p.Ala62_Pro69del)	FOXG1		Rett syndrome, congenital variant|not specified	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158590	14	29236657 - 29236680	14	28767451 - 28767474	158590	169049	rs587783632	NC_000014.9:28767450:CCGCCGCCGCCCGCCCCGCAACCGCCGCCGCCGCC:CCGCCGCCGCC
GRCh38/hg38 17q25.3(chr17:82586979-83257441)x1	FOXK2|TBCD|RAB40B|WDR45B|FN3K|FN3KRP|ZNF750|B3GNTL1|METRNL|MIR4525|LOC101929552|LOC108178995|LOC108348028|LOC112533687		See cases	Uncertain significance(Last reviewed: May 14, 2021)	criteria provided, single submitter	VCV001098564			17	82586979 - 83257441	1098564	1087268		
GRCh37/hg19 17q25.3(chr17:80488965-81041938)x1	FOXK2|TBCD|RAB40B|WDR45B|FN3K|FN3KRP|ZNF750|B3GNTL1|METRNL		not provided	Uncertain significance(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000688507	17	80488965 - 81041938			688507	676099		
GRCh37/hg19 2p16.3(chr2:49158272-49209034)x1	FSHR		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000686634	2	49158272 - 49209034			686634	674226		
NM_000147.5(FUCA1):c.170del (p.Lys57fs)	FUCA1	K57fs	Fucosidosis	Pathogenic	no assertion criteria provided	VCV000979025	1	24194607	1	23868117	979025	967104		NC_000001.11:23868116:TT:T
NC_000005.9:g.(?_161128494)_(161580374_?)del	GABRA1|GABRA6|GABRG2		Idiopathic generalized epilepsy|Epilepsy, juvenile myoclonic 5|Epilepsy, childhood absence 4	Pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001069674	5	161128494 - 161580374			1069674	1057150		
NM_001127644.2(GABRA1):c.1321_1324delinsC (p.Thr441_Tyr442delinsHis)	GABRA1		Idiopathic generalized epilepsy|Epilepsy, juvenile myoclonic 5|Epilepsy, childhood absence 4	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000970934	5	161324378 - 161324381	5	161897372 - 161897375	970934	954105		NC_000005.10:161897371:ACGT:C
NM_001127644.2(GABRA1):c.74+3_74+4delinsAT	GABRA1		Idiopathic generalized epilepsy|Epilepsy, childhood absence 4|Epilepsy, juvenile myoclonic 5	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000969559	5	161277893 - 161277894	5	161850887 - 161850888	969559	960559		NC_000005.10:161850886:GG:AT
NC_000005.9:g.(?_160721068)_(161528343_?)del	GABRA1|GABRA6|GABRB2|GABRG2		Epilepsy, juvenile myoclonic 5|Idiopathic generalized epilepsy|Epilepsy, childhood absence 4	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000833049	5	160721068 - 161528343			833049	819641		
NM_001127644.2(GABRA1):c.1060-10del	GABRA1		not provided|Epilepsy, childhood absence 4|Epilepsy, juvenile myoclonic 5|Idiopathic generalized epilepsy	Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000743271	5	161324107	5	161897101	743271	759390	rs1581221506	NC_000005.10:161897100:C:
NM_001127644.2(GABRA1):c.869_888del (p.Val290fs)	GABRA1	V290fs	Epilepsy, juvenile myoclonic 5|Epilepsy, childhood absence 4|Idiopathic generalized epilepsy	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000568345	5	161322682 - 161322701	5	161895676 - 161895695	568345	563015	rs1561587715	NC_000005.10:161895675:TGTGCTCACCATGACAACATTG:TG
NM_001127644.2(GABRA1):c.*304del	GABRA1		not provided|Juvenile myoclonic epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2018)	criteria provided, conflicting interpretations	VCV000352603	5	161324724	5	161897718	352603	303064	rs547262225	NC_000005.10:161897717:AAAAAAAAA:AAAAAAAA
NM_000806.5(GABRA1):c.-438del	GABRA1		Juvenile myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000352584	5	161274224	5	161847218	352584	303045	rs112361424	NC_000005.10:161847217:AAAA:AAA
NM_001127644.2(GABRA1):c.1200del (p.Lys401fs)	GABRA1	K401fs	Epileptic encephalopathy, early infantile, 19	Pathogenic(Last reviewed: Jul 3, 2016)	criteria provided, single submitter	VCV000242830	5	161324257	5	161897251	242830	243934	rs879253748	NC_000005.10:161897250:C:
NM_001127644.2(GABRA1):c.975del (p.Ser326fs)	GABRA1	S326fs	Epilepsy, childhood absence 4	risk factor(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000016215	5	161322790	5	161895784	16215	31254	rs1581220270	NC_000005.10:161895783:C:
NC_000015.10:g.(?_25862297)_(26937328_?)del	GABRA5|GABRB3|ATP10A		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000833345	15	26107444 - 27182475			833345	820670		
NM_000814.6(GABRB3):c.683-9_683-8del	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Likely benign(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001144040	15	26812888 - 26812889	15	26567741 - 26567742	1144040	1145025		NC_000015.10:26567740:AAA:A
NC_000015.9:g.(?_26792940)_(27020442_?)del	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001069675	15	26792940 - 27020442			1069675	1057671		
NM_000814.6(GABRB3):c.782_783delinsTA (p.Ser261Leu)	GABRB3	S190L, S176L, S261L	Epilepsy, childhood absence 1|Epilepsy, childhood absence 5	Uncertain significance(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV000969775	15	26812780 - 26812781	15	26567633 - 26567634	969775	957368		NC_000015.10:26567632:CG:TA
NM_000814.6(GABRB3):c.172+1del	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000969517	15	27017827	15	26772680	969517	960817		NC_000015.10:26772679:CCCCC:CCCC
NM_000814.6(GABRB3):c.1054del (p.Asp352fs)	GABRB3	D281fs, D267fs, D352fs	Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000943697	15	26806105	15	26560958	943697	936833		NC_000015.10:26560957:C:
NM_000814.6(GABRB3):c.405del (p.Thr135_Val136insTer)	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV000942245	15	26866517	15	26621370	942245	936836		NC_000015.10:26621369:T:
NC_000015.10:g.(?_26547773)_(26583434_?)del	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000833422	15	26792920 - 26828581			833422	820671		
NC_000015.10:g.(?_26567561)_(26629023_?)del	GABRB3		Epilepsy, childhood absence 1|Epilepsy, childhood absence 5	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000537298	15	26812708 - 26874170	15	26567561 - 26629023	537298	528596		
NC_000015.10:g.(?_26547773)_(26775295_?)del	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000469568			15	26547773 - 26775295	469568	464507		
NM_000814.5(GABRB3):c.-114_*4247del	GABRB3		Epilepsy, childhood absence 1|Epilepsy, childhood absence 5	Uncertain significance(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000238187	15	26788693 - 27018223	15	26543546 - 26773076	238187	242024		
NM_000815.5(GABRD):c.1194_1195del (p.Glu400fs)	GABRD	E400fs	Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000846992	1	1961556 - 1961557	1	2030117 - 2030118	846992	823249		NC_000001.11:2030116:AG:
NC_000001.11:g.(?_2019404)_(2030302_?)del	GABRD		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000832884	1	1950843 - 1961741			832884	818895		
NC_000001.10:g.(?_1249188)_(1961741_?)del	GABRD|GNB1|NADK|CDK11A|SLC35E2B|CDK11B|DVL1|ANKRD65|TMEM88B|FNDC10|MMP23B|SLC35E2A|MXRA8|INTS11|AURKAIP1|MRPL20|ATAD3A|VWA1|SSU72|CPTP|CCNL2|TAS1R3|ATAD3B|CFAP74|MIB2|CALML6|ATAD3C|TMEM240|TMEM52		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000583548	1	1249188 - 1961741			583548	556491		
NM_198904.4(GABRG2):c.1277del (p.Phe426fs)	GABRG2	F278fs, F286fs, F323fs, F396fs, F397fs, F404fs, F417fs, F418fs, F423fs, F425fs, F426fs, F439fs, F458fs, F466fs	Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV001073528	5	161580218	5	162153212	1073528	1060340		NC_000005.10:162153211:TTTTTT:TTTTT
NC_000005.9:g.(?_161381199_161531016del	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001071857					1071857	1057151		
NC_000005.9:g.(?_161495006)_(161580374_?)del	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001069676	5	161495006 - 161580374			1069676	1057152		
NM_198904.4(GABRG2):c.697del (p.Arg233fs)	GABRG2	R138fs, R230fs, R211fs, R204fs, R233fs, R273fs, R93fs	Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000953695	5	161530959	5	162103953	953695	944526		NC_000005.10:162103952:AA:A
NM_198904.4(GABRG2):c.1087del (p.Arg363fs)	GABRG2	R268fs, R360fs, R334fs, R376fs, R341fs, R363fs, R223fs, R362fs, R403fs	Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000944808	5	161576277	5	162149271	944808	923985		NC_000005.10:162149270:CC:C
NC_000005.10:g.(?_162066642)_(162156539_?)del	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000833050	5	161493648 - 161583545			833050	819569		
NC_000005.10:g.(?_162101215)_(162104046_?)del	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000831885	5	161528221 - 161531052			831885	819571		
NC_000005.10:g.(?_162067980)_(162068126_?)del	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000831562	5	161494986 - 161495132			831562	819570		
NC_000005.10:g.(?_162101225)_(162153368_?)del	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000830557	5	161528231 - 161580374			830557	819572		
NM_198904.4(GABRG2):c.1035del (p.Phe345fs)	GABRG2	F385fs, F345fs, F250fs, F344fs, F316fs, F323fs, F205fs, F342fs, F358fs	Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000652738	5	161576224	5	162149218	652738	633708	rs1581453822	NC_000005.10:162149217:TTT:TT
NM_198904.4(GABRG2):c.677_681del (p.Ser225_Ser226insTer)	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000536744	5	161530937 - 161530941	5	162103931 - 162103935	536744	521493	rs1554098222	NC_000005.10:162103930:GTTCTGTT:GTT
NC_000005.10:g.(?_162142144)_(162153388_?)del	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Likely pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000468864			5	162142144 - 162153388	468864	453622		
NM_198904.4(GABRG2):c.1025del (p.Cys342fs)	GABRG2	C382fs, C342fs, C202fs, C247fs, C313fs, C320fs, C339fs, C341fs, C355fs	Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000408213	5	161576216	5	162149210	408213	395098	rs1060501889	NC_000005.10:162149209:G:
NM_198904.4(GABRG2):c.*2120_*2121del	GABRG2		Generalized epilepsy with febrile seizures plus	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000352671	5	161582494 - 161582495	5	162155488 - 162155489	352671	296799	rs34705786	NC_000005.10:162155487:AT:
NM_198904.4(GABRG2):c.-4del	GABRG2		Seizures|not provided|Generalized epilepsy with febrile seizures plus|Severe myoclonic epilepsy in infancy	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2020)	criteria provided, conflicting interpretations	VCV000352637	5	161494991	5	162067985	352637	298652	rs771282908	NC_000005.10:162067984:AAAAAAAAAAAA:AAAAAAAAAAA
NM_198904.4(GABRG2):c.530del (p.Arg177fs)	GABRG2	R177fs, R148fs, R155fs, R174fs, R37fs, R82fs	Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000238189	5	161524846	5	162097840	238189	239783	rs878854144	NC_000005.10:162097839:G:
NM_198904.4(GABRG2):c.1113_1115del (p.Lys374del)	GABRG2	K414del, K374del, K234del, K279del, K345del, K352del, K371del, K373del, K387del	Epilepsy, childhood absence 2|Familial febrile seizures 8|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2020)	criteria provided, conflicting interpretations	VCV000167117	5	161576302 - 161576304	5	162149296 - 162149298	167117	177736	rs727503941	NC_000005.10:162149295:AAAAA:AA
NM_015973.5(GAL):c.73_81+37del	GAL		Epilepsy, familial temporal lobe, 8	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000956705	11	68452463 - 68452508	11	68684995 - 68685040	956705	960011		NC_000011.10:68684994:CTGGTCGCCGGTAAGTGCGGGGCGCGTCTCCTCCGAGCGAAGGGGAC:C
NM_015973.3:c.82del	GAL		Epilepsy, familial temporal lobe, 8	Uncertain significance(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000642760	11	68453061	11	68685593	642760	650389	rs1594273885	NC_000011.10:68685592:GG:G
NM_000153.4:c.(1161+1_1162-1)_(*1718_?)del	GALC		Intellectual disability	Pathogenic(Last reviewed: Feb 25, 2021)	criteria provided, single submitter	VCV000997812					997812	985530		
Single allele	GALNT3|SCN2A|SCN3A|CSRNP3		Epilepsy	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635920	2	166050817 - 166679227			635920	623733		
GRCh37/hg19 16q23.2(chr16:81380493-81433070)x1	GAN		not provided	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000686489	16	81380493 - 81433070			686489	674081		
GRCh37/hg19 6p12.1(chr6:53113873-53385343)x1	GCLC|ELOVL5		not provided	Uncertain significance(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000685537	6	53113873 - 53385343			685537	673129		
NC_000016.9:g.(?_81121196)_(81129883_?)del	GCSH		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001023159	16	81121196 - 81129883			1023159	1001799		
NM_004483.5(GCSH):c.338_342del (p.Tyr113fs)	GCSH	Y113fs	Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001000783	16	81118150 - 81118154	16	81084545 - 81084549	1000783	997179		NC_000016.10:81084544:AGAATAGA:AGA
NC_000016.10:g.(?_81082846)_(81096298_?)del	GCSH		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000832058	16	81116451 - 81129903			832058	820886		
NM_021267.5(CERS1):c.71_72delinsCC (p.Gln24Pro)	GDF1|CERS1	Q24P	Epilepsy, progressive myoclonic 8	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001053870	19	19006810 - 19006811	19	18896001 - 18896002	1053870	1051177		NC_000019.10:18896000:CT:GG
NM_021267.5(CERS1):c.*331_*342del	GDF1|CERS1		Epilepsy, progressive myoclonic 8	Uncertain significance(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV001053494	19	18981044 - 18981055	19	18870235 - 18870246	1053494	1051174		NC_000019.10:18870234:GCAGCGAGGGCAGCAGC:GCAGC
NM_001492.6(GDF1):c.289del (p.Val97fs)	GDF1|CERS1	V97fs	Epilepsy, progressive myoclonic 8	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000850258	19	18980828	19	18870019	850258	847453		NC_000019.10:18870018:CCCCC:CCCC
NM_001492.6(GDF1):c.1047_1050del (p.Phe349fs)	GDF1|CERS1	F349fs	Epilepsy, progressive myoclonic 8|Heterotaxia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000410641	19	18979475 - 18979478	19	18868666 - 18868669	410641	403256	rs768027510	NC_000019.10:18868665:AAAGAA:AA
NC_000022.11:g.(?_21213348)_(21242174_?)del	GGT2|SNAP29		CEDNIK syndrome	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495289			22	21213348 - 21242174	495289	486775		
GRCh37/hg19 13q12.11(chr13:20788295-20827928)x1	GJB6		not provided	Uncertain significance(Last reviewed: Oct 5, 2017)	no assertion criteria provided	VCV000688734	13	20788295 - 20827928			688734	676326		
GRCh37/hg19 13q12.11(chr13:20796981-21104487)x1	GJB6|CRYL1		not provided	Uncertain significance(Last reviewed: Mar 6, 2018)	no assertion criteria provided	VCV000685839	13	20796981 - 21104487			685839	673431		
GRCh37/hg19 13q12.11(chr13:20796981-21104487)x1	GJB6|CRYL1		not provided	Uncertain significance(Last reviewed: Jun 7, 2018)	no assertion criteria provided	VCV000685295	13	20796981 - 21104487			685295	672887		
NM_000170.3(GLDC):c.2665+9del	GLDC		Non-ketotic hyperglycinemia	Likely benign(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001151537	9	6540042	9	6540042	1151537	1140621		NC_000009.12:6540041:G:
NM_000170.3(GLDC):c.122del (p.Gly41fs)	GLDC	G41fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV001075996	9	6645378	9	6645378	1075996	1061722		NC_000009.12:6645377:CC:C
NM_000170.3(GLDC):c.251del (p.Leu84fs)	GLDC	L84fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001075706	9	6645249	9	6645249	1075706	1061720		NC_000009.12:6645248:A:
NM_000170.3(GLDC):c.613del (p.Glu205fs)	GLDC	E205fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001075327	9	6610214	9	6610214	1075327	1061718		NC_000009.12:6610213:C:
NC_000009.11:g.(?_6610182)_(6620329_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV001074248	9	6610182 - 6620329			1074248	1057430		
NC_000009.11:g.(?_6550793)_(6620329_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001074247	9	6550793 - 6620329			1074247	1057423		
NC_000009.11:g.(?_6533007)_(6565439_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001074246	9	6533007 - 6565439			1074246	1057420		
NC_000009.11:g.(?_6604578)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Apr 12, 2020)	criteria provided, single submitter	VCV001074245	9	6604578 - 6645509			1074245	1057428		
NC_000009.11:g.(?_6550783)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001074244	9	6550783 - 6645519			1074244	1057422		
NM_000170.3(GLDC):c.2176del (p.Tyr725_Leu726insTer)	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001073876	9	6556179	9	6556179	1073876	1061711		NC_000009.12:6556178:GG:G
NC_000009.11:g.(?_6587131)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001072390	9	6587131 - 6645509			1072390	1057426		
NC_000009.11:g.(?_6610182)_(6610366_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001072389	9	6610182 - 6610366			1072389	1057429		
NC_000009.11:g.(?_6533007)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001072388	9	6533007 - 6645509			1072388	1057421		
NM_000170.3(GLDC):c.862-5_883del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001071673	9	6604763 - 6604789	9	6604763 - 6604789	1071673	1061715		NC_000009.12:6604762:CAGTAGCACAGCAGGCCAGGCTCTAGA:
NM_000170.3(GLDC):c.586del (p.Leu196fs)	GLDC	L196fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001071227	9	6610241	9	6610241	1071227	1061719		NC_000009.12:6610240:GGG:GG
NC_000009.11:g.(?_6587131)_(6595129_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001070377	9	6587131 - 6595129			1070377	1057424		
NC_000009.11:g.(?_6587131)_(6610366_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001070376	9	6587131 - 6610366			1070376	1057425		
NC_000009.11:g.(?_6602089)_(6620339_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 7, 2020)	criteria provided, single submitter	VCV001070375	9	6602089 - 6620339			1070375	1057427		
NC_000009.11:g.(?_6602089)_(6604804_?)del	GLDC		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV001066622	9	6602089 - 6604804			1066622	1054473		
NM_000170.3(GLDC):c.1636del (p.Ile546fs)	GLDC	I546fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Aug 3, 2019)	criteria provided, single submitter	VCV000959946	9	6588647	9	6588647	959946	946659		NC_000009.12:6588646:T:
NM_000170.3(GLDC):c.2225_2232del (p.Asp742fs)	GLDC	D742fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000946338	9	6554752 - 6554759	9	6554752 - 6554759	946338	925623		NC_000009.12:6554751:CCCGAAGTC:C
NM_000170.3(GLDC):c.1862del (p.Gly621fs)	GLDC	G621fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000936006	9	6565418	9	6565418	936006	934807		NC_000009.12:6565417:CCC:CC
NM_000170.3(GLDC):c.2380_2399del (p.Ala794fs)	GLDC	A794fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000930882	9	6553426 - 6553445	9	6553426 - 6553445	930882	919237		NC_000009.12:6553425:ACGGTTCCCACAGGACAGGCA:A
NC_000009.12:g.(?_6595004)_(6620329_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000833466	9	6595004 - 6620329			833466	820157		
NC_000009.12:g.(?_6587131)_(6606679_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000833360	9	6587131 - 6606679			833360	820155		
NC_000009.12:g.(?_6558539)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000832957	9	6558539 - 6645519			832957	820151		
NC_000009.12:g.(?_6558549)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000832697	9	6558549 - 6645509			832697	820152		
NC_000009.12:g.(?_6620174)_(6620329_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000832605	9	6620174 - 6620329			832605	820162		
NC_000009.12:g.(?_6592841)_(6620329_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000832448	9	6592841 - 6620329			832448	820156		
NC_000009.12:g.(?_6533007)_(6610366_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000832281	9	6533007 - 6610366			832281	820149		
NC_000009.12:g.(?_6606582)_(6606679_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000832249	9	6606582 - 6606679			832249	820160		
NC_000009.12:g.(?_6606572)_(6606689_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000831868	9	6606572 - 6606689			831868	820159		
NC_000009.12:g.(?_6620174)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000831793	9	6620174 - 6645509			831793	820163		
NC_000009.12:g.(?_6587121)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831447	9	6587121 - 6645519			831447	820154		
NC_000009.12:g.(?_6604568)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000830920	9	6604568 - 6645519			830920	820158		
NC_000009.12:g.(?_6558539)_(6558704_?)del	GLDC		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000830742	9	6558539 - 6558704			830742	820150		
NC_000009.12:g.(?_6620164)_(6620339_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000830523	9	6620164 - 6620339			830523	820161		
NC_000009.12:g.(?_6587121)_(6606689_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000830434	9	6587121 - 6606689			830434	820153		
NC_000009.12:g.(?_6533007)_(6550924_?)del	GLDC		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000830426	9	6533007 - 6550924			830426	820148		
GRCh37/hg19 9p24.1(chr9:6548392-6620059)x1	GLDC		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	no assertion criteria provided	VCV000689250	9	6548392 - 6620059			689250	676842		
NC_000009.12:g.(?_6610172)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000662293	9	6610172 - 6645519	9	6610172 - 6645519	662293	651867		
NC_000009.12:g.(?_6565334)_(6610376_?)del	GLDC|LOC113839554		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000660682	9	6565334 - 6610376	9	6565334 - 6610376	660682	652080		
NC_000009.12:g.(?_6644604)_(6645509_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000659612	9	6644604 - 6645509	9	6644604 - 6645509	659612	651850		
NM_000170.3(GLDC):c.1629del (p.Asn543fs)	GLDC	N543fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000657819	9	6588654	9	6588654	657819	638378	rs1345599468	NC_000009.12:6588653:A:
NC_000009.12:g.(?_6644594)_(6645519_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000643709	9	6644594 - 6645519	9	6644594 - 6645519	643709	651957		
NC_000009.12:g.(?_6550793)_(6610366_?)del	GLDC|LOC113839554		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000640451	9	6550793 - 6610366	9	6550793 - 6610366	640451	651863		
NM_000170.3(GLDC):c.1337del (p.Val446fs)	GLDC	V446fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635297	9	6592915	9	6592915	635297	623150	rs1587951033	NC_000009.12:6592914:A:
NM_000170.3(GLDC):c.2033_2035del (p.Ala678del)	GLDC	A678del	Non-ketotic hyperglycinemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2020)	criteria provided, conflicting interpretations	VCV000558242	9	6558576 - 6558578	9	6558576 - 6558578	558242	545218	rs769625871	NC_000009.12:6558575:CTGC:C
NM_000170.3(GLDC):c.2481_2484del (p.Gln828fs)	GLDC	Q828fs	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557789	9	6550888 - 6550891	9	6550888 - 6550891	557789	544938	rs766762760	NC_000009.12:6550887:TTGTTT:TT
NM_000170.3(GLDC):c.156_167del (p.Glu54_Leu57del)	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000557011	9	6645333 - 6645344	9	6645333 - 6645344	557011	545262	rs1554652793	NC_000009.12:6645332:AGGCGCTCCAGGAGGCGC:AGGCGC
NM_000170.3(GLDC):c.2081_2088del (p.Ala694fs)	GLDC	A694fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000553839	9	6556267 - 6556274	9	6556267 - 6556274	553839	545569	rs1196401015	NC_000009.12:6556266:CATGATAGC:C
NM_000170.3(GLDC):c.160_171del (p.Glu54_Leu57del)	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000553644	9	6645329 - 6645340	9	6645329 - 6645340	553644	545617	rs1554652791	NC_000009.12:6645328:CAGAAGGCGCTCCAG:CAG
NM_000170.3(GLDC):c.128del (p.Asp43fs)	GLDC	D43fs	not provided|Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552137	9	6645372	9	6645372	552137	545621	rs1251443902	NC_000009.12:6645371:T:
NM_000170.2(GLDC):c.1484_1489del6	GLDC		Non-ketotic hyperglycinemia|not provided	Uncertain significance(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550535	9	6589286 - 6589291	9	6589286 - 6589291	550535	545341	rs778109389	NC_000009.12:6589285:CCAGTTCC:CC
NM_000170.3(GLDC):c.2631_2639del (p.Glu877_Val879del)	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000550039	9	6540077 - 6540085	9	6540077 - 6540085	550039	545199	rs1554642294	NC_000009.12:6540076:TCCACAGCCTC:TC
NC_000009.12:g.(?_6594994)_(6620339_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000531793	9	6594994 - 6620339	9	6594994 - 6620339	531793	524412		
NC_000009.12:g.(?_6550783)_(6620339_?)del	GLDC|LOC113839554		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000531792	9	6550783 - 6620339	9	6550783 - 6620339	531792	524110		
NC_000009.12:g.(?_6558539)_(6565449_?)del	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000531791	9	6558539 - 6565449	9	6558539 - 6565449	531791	523837		
NM_000170.3(GLDC):c.1850+1del	GLDC		Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000531765	9	6587140	9	6587140	531765	525004	rs1399754800	NC_000009.12:6587139:CC:C
NM_000170.3(GLDC):c.2316-6del	GLDC		Non-ketotic hyperglycinemia	Benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV000462870	9	6553515	9	6553515	462870	459253	rs3215923	NC_000009.12:6553514:TTTTTTTT:TTTTTTT
NM_000170.3(GLDC):c.197_198delinsAA (p.Arg66Lys)	GLDC	R66K	Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000462864	9	6645302 - 6645303	9	6645302 - 6645303	462864	459665	rs1554652780	NC_000009.12:6645301:CC:TT
NM_000170.3(GLDC):c.-186del	GLDC		Non-ketotic hyperglycinemia|not provided	Benign/Likely benign(Last reviewed: Jul 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000367212	9	6645685	9	6645685	367212	308647	rs140030144	NC_000009.12:6645684:G:
NM_000170.3(GLDC):c.*505_*506del	GLDC		Non-ketotic hyperglycinemia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000367163	9	6532511 - 6532512	9	6532511 - 6532512	367163	308625	rs3215922	NC_000009.12:6532510:AAAAAAAAAAAAA:AAAAAAAAAAA
NM_000170.3(GLDC):c.793del (p.Gln265fs)	GLDC	Q265fs	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056103	9	6605199	9	6605199	56103	70742	rs386833586	NC_000009.12:6605198:GG:G
NM_000170.3(GLDC):c.28del (p.Leu10fs)	GLDC	L10fs	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000056092	9	6645472	9	6645472	56092	70731	rs386833574	NC_000009.12:6645471:G:
NM_000170.3(GLDC):c.2422del (p.Ser808fs)	GLDC	S808fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056077	9	6553403	9	6553403	56077	70716	rs386833558	NC_000009.12:6553402:T:
NM_000170.3(GLDC):c.2267_2269del (p.Phe756del)	GLDC	F756del	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000056067	9	6554715 - 6554717	9	6554715 - 6554717	56067	70706	rs121964975	NC_000009.12:6554714:AGAAG:AG
NM_000170.3(GLDC):c.2213_2214del (p.Cys738fs)	GLDC	C738fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056065	9	6554770 - 6554771	9	6554770 - 6554771	56065	70704	rs386833546	NC_000009.12:6554769:ACA:A
NM_000170.3(GLDC):c.2186del (p.Ala729fs)	GLDC	A729fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056062	9	6556169	9	6556169	56062	70701	rs386833543	NC_000009.12:6556168:G:
NM_000170.3(GLDC):c.2153_2155delinsTCCTGGTTTA (p.His718_Gln719delinsLeuLeuValTer)	GLDC		Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056060	9	6556200 - 6556202	9	6556200 - 6556202	56060	70699	rs386833541	NC_000009.12:6556199:GAT:TAAACCAGGA
NM_000170.3(GLDC):c.1822_1832del (p.Tyr608fs)	GLDC	Y608fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056051	9	6587159 - 6587169	9	6587159 - 6587169	56051	70690	rs386833532	NC_000009.12:6587158:ACCTGGTCATAACCTG:ACCTG
NM_000170.3(GLDC):c.1175del (p.Ala392fs)	GLDC	A392fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056039	9	6595100	9	6595100	56039	70678	rs386833520	NC_000009.12:6595099:G:
NM_000170.3(GLDC):c.1054del (p.Thr352fs)	GLDC	T352fs	not provided|Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000056037	9	6604592	9	6604592	56037	70676	rs386833518	NC_000009.12:6604591:TT:T
GLDC, 30-KB DEL	GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000011984					11984	27023		
NM_000824.5(GLRB):c.298-6del	GLRB		Hyperekplexia 2	Uncertain significance(Last reviewed: Feb 23, 2020)	criteria provided, single submitter	VCV001018374	4	158057615	4	157136463	1018374	1005147		NC_000004.12:157136462:C:
NC_000004.12:g.(?_157170412)_(157170748_?)del	GLRB		Hyperekplexia 2	Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000663950	4	158091564 - 158091900	4	157170412 - 157170748	663950	651253		
NM_000824.5(GLRB):c.24del (p.Phe9_Leu10insTer)	GLRB		Hyperekplexia 2	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000653331	4	157999199	4	157078047	653331	632061	rs1380139789	NC_000004.12:157078046:CC:C
NM_000824.5(GLRB):c.472del (p.Gln158fs)	GLRB	Q158fs	Hyperekplexia 2	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000582806	4	158057793	4	157136641	582806	563550	rs1560962636	NC_000004.12:157136640:CCC:CC
NM_000824.5(GLRB):c.798_800delinsGATGATGGGGGT (p.Gly267delinsMetMetGlyVal)	GLRB		Hyperekplexia 2	Uncertain significance(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000540367	4	158065005 - 158065007	4	157143853 - 157143855	540367	519795	rs1553998291	NC_000004.12:157143852:CGG:GATGATGGGGGT
NM_000824.5(GLRB):c.*996del	GLRB		Hyperekplexia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000347945	4	158092870	4	157171718	347945	292670	rs556022501	NC_000004.12:157171717:TTTTTTT:TTTTTT
NM_004287.5(GOSR2):c.262del (p.Gln88fs)	GOSR2|LRRC37A2	Q87fs, Q70fs, Q88fs	Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000859319	17	45009490	17	46932124	859319	850658		NC_000017.11:46932123:CC:C
NC_000017.11:g.(?_46923173)_(46940633_?)del	GOSR2		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000831185	17	45000539 - 45017999			831185	821100		
NM_004287.5(GOSR2):c.199_200delinsCA (p.Arg67Gln)	GOSR2|LRRC37A2	R49Q, R67Q, R66Q	not provided|Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jan 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000498891	17	45008569 - 45008570	17	46931203 - 46931204	498891	490315	rs1555709548	NC_000017.11:46931202:AG:CA
NM_003801.4(GPAA1):c.1477_1478del (p.Arg493fs)	GPAA1	R493fs	Glycosylphosphatidylinositol biosynthesis defect 15	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802447	8	145140501 - 145140502	8	144085598 - 144085599	802447	790787	rs782339984	NC_000008.11:144085597:AG:
NM_003801.4(GPAA1):c.160_161delinsAA (p.Ala54Asn)	GPAA1	A54N	Glycosylphosphatidylinositol biosynthesis defect 15	Uncertain significance(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000453252	8	145138112 - 145138113	8	144083209 - 144083210	453252	446834	rs1554763777	NC_000008.11:144083208:GC:AA
NM_003801.4(GPAA1):c.920del (p.Gly307fs)	GPAA1	G307fs	Glycosylphosphatidylinositol biosynthesis defect 15	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453249	8	145139421	8	144084518	453249	446831	rs1554764067	NC_000008.11:144084517:GG:G
NM_003801.4(GPAA1):c.981_993del (p.Gln327fs)	GPAA1	Q327fs	Glycosylphosphatidylinositol biosynthesis defect 15	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453248	8	145139483 - 145139495	8	144084580 - 144084592	453248	446830	rs1554764080	NC_000008.11:144084579:GTACAAGTATGAC:
GRCh37/hg19 14q23.3(chr14:67135019-67197722)x1	GPHN		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000686024	14	67135019 - 67197722			686024	673616		
NC_000014.9:g.(?_66776464)_(66776521_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495287	14	67243182 - 67243239	14	66776464 - 66776521	495287	486754		
NC_000014.9:g.(?_66824474)_(66824566_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495286	14	67291192 - 67291284	14	66824474 - 66824566	495286	486755		
NC_000014.8:g.(?_67243157)_(67647704_?)del	GPHN		Molybdenum cofactor deficiency, complementation group C	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495285	14	67243157 - 67647704			495285	486753		
NM_001080.3(ALDH5A1):c.104_127del (p.Ser35_Gln43delinsTer)	GPLD1|ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000582120	6	24495328 - 24495351	6	24495100 - 24495123	582120	560670	rs1561865665	NC_000006.12:24495099:CCGGGCCTGCGCCCGGCCCGGCCC:
GRCh37/hg19 10p12.1(chr10:25573964-25798996)x1	GPR158		not provided	Uncertain significance(Last reviewed: May 7, 2018)	no assertion criteria provided	VCV000685790	10	25573964 - 25798996			685790	673382		
NM_007327.4(GRIN1):c.1632+17_1632+23del	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|not provided	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV001170188	9	140056553 - 140056559	9	137162101 - 137162107	1170188	1156164		NC_000009.12:137162100:CGGGTGGCGGG:CGGG
NM_007327.4(GRIN1):c.1467+7_1467+14del	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely benign(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV001126707	9	140055872 - 140055879	9	137161420 - 137161427	1126707	1119554		NC_000009.12:137161419:GGCTGGACGGC:GGC
NM_007327.4(GRIN1):c.41_43del (p.Ser14del)	GRIN1	S14del	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001004101	9	140033977 - 140033979	9	137139525 - 137139527	1004101	993364		NC_000009.12:137139524:CTCCT:CT
NM_007327.4(GRIN1):c.2414del (p.Pro805fs)	GRIN1	P805fs, P826fs	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely benign(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000833895	9	140058088	9	137163636	833895	822001		NC_000009.12:137163635:CCCC:CCC
NM_007327.4(GRIN1):c.1342del (p.Arg448fs)	GRIN1	R448fs, R469fs	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000807609	9	140055648	9	137161196	807609	798618	rs1588727276	NC_000009.12:137161195:CC:C
NM_007327.4(GRIN1):c.1198-3del	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Sep 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589355	9	140055499	9	137161047	589355	579664	rs762423431	NC_000009.12:137161046:CCCCCCC:CCCCCC
NM_007327.4(GRIN1):c.1198-2del	GRIN1		Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000472571	9	140055506	9	137161054	472571	459908	rs1212517874	NC_000009.12:137161053:A:
NC_000016.9:g.(?_9984833)_(9984967_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001075612	16	9984833 - 9984967			1075612	1057850		
NC_000016.9:g.(?_9857006)_(9862956_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001073743	16	9857006 - 9862956			1073743	1057847		
NC_000016.9:g.(?_10273845)_(10274268_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001071859	16	10273845 - 10274268			1071859	1057722		
NC_000016.9:g.(?_9916111)_(9916291_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV001071858	16	9916111 - 9916291			1071858	1057849		
NM_001134407.3(GRIN2A):c.67_81del (p.Pro23_Ala27del)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV001031668	16	10274188 - 10274202	16	10180331 - 10180345	1031668	1021394		NC_000016.10:10180330:CGCCGCCGCGCTCGGCGCCG:CGCCG
NM_000833.3:c.(?_-310-1)_(414+1_415-1)del	GRIN2A		Epilepsy	Likely pathogenic(Last reviewed: Mar 4, 2021)	no assertion criteria provided	VCV000998168					998168	985896		
NM_001134407.3(GRIN2A):c.452_463del (p.Ile151_Ala155delinsThr)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV000983445	16	10032360 - 10032371	16	9938503 - 9938514	983445	971512		NC_000016.10:9938502:CTTGCTGCTGGA:
NM_001134407.3(GRIN2A):c.2335_2336delinsAG (p.Leu779Arg)	GRIN2A	L779R	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000976247	16	9892154 - 9892155	16	9798297 - 9798298	976247	964464		NC_000016.10:9798296:AA:CT
NM_001134407.3(GRIN2A):c.4320_4324del (p.Thr1441fs)	GRIN2A	T1441fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000952450	16	9857077 - 9857081	16	9763220 - 9763224	952450	928036		NC_000016.10:9763219:GGGTAG:G
NM_001134407.3(GRIN2A):c.1204del (p.Asp402fs)	GRIN2A	D402fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000948855	16	9943737	16	9849880	948855	928045		NC_000016.10:9849879:CC:C
NM_001134407.3(GRIN2A):c.1054del (p.Glu352fs)	GRIN2A	E352fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic	criteria provided, single submitter	VCV000917870	16	9984911	16	9891054	917870	906190		NC_000016.10:9891053:C:
NM_001134407.3(GRIN2A):c.3887del (p.Val1296fs)	GRIN2A	V1296fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV000863189	16	9857514	16	9763657	863189	844648		NC_000016.10:9763656:A:
NC_000016.10:g.(?_9890966)_(10180431_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000831099	16	9984823 - 10274288			831099	820966		
NC_000016.10:g.(?_9829403)_(9829672_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000831053	16	9923260 - 9923529			831053	820965		
NC_000016.10:g.(?_9798257)_(9849981_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000830906	16	9892114 - 9943838			830906	820964		
NM_001134407.3(GRIN2A):c.1362del (p.Lys454fs)	GRIN2A	K454fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000813772	16	9934928	16	9841071	813772	802018		NC_000016.10:9841070:TTT:TT
NM_001134407.3(GRIN2A):c.1946_1947delinsCT (p.Leu649Pro)	GRIN2A	L649P	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000813733	16	9923340 - 9923341	16	9829483 - 9829484	813733	802015		NC_000016.10:9829482:CA:AG
NM_001134407.3(GRIN2A):c.3339_3342del (p.Arg1114fs)	GRIN2A	R1114fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803213	16	9858059 - 9858062	16	9764202 - 9764205	803213	791666	rs1379582796	NC_000016.10:9764201:TCTA:
NM_001134407.3(GRIN2A):c.3345_3347del (p.Asp1115_Lys1116delinsGlu)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803212	16	9858054 - 9858056	16	9764197 - 9764199	803212	791665	rs1440127051	NC_000016.10:9764196:TTGT:T
NM_001134407.3(GRIN2A):c.2007+1del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800809	16	9923279	16	9829422	800809	789383	rs1596471698	NC_000016.10:9829421:CC:C
NM_001134407.3(GRIN2A):c.2793del (p.Met932fs)	GRIN2A	M932fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000664368	16	9858608	16	9764751	664368	645253	rs1596377439	NC_000016.10:9764750:G:
NM_001134407.3(GRIN2A):c.2776del (p.Gln926fs)	GRIN2A	Q926fs	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000652989	16	9858625	16	9764768	652989	645254	rs1596377481	NC_000016.10:9764767:GG:G
NM_001134407.3(GRIN2A):c.1648del (p.Phe549_Leu550insTer)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000641340	16	9934507	16	9840650	641340	645259	rs1596483044	NC_000016.10:9840649:G:
NM_001134407.3(GRIN2A):c.1264_1308delinsGTCAAAGTTCCGTGGAAA (p.Ile422_Cys436delinsValLysValProTrpLys)	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000639911	16	9943633 - 9943677	16	9849776 - 9849820	639911	645263	rs1596494678	NC_000016.10:9849775:ACATGGCACGGTGTTCCTCACACACGTCTCGGTCAGGGGGTCTAT:TTTCCACGGAACTTTGAC
NC_000016.10:g.(?_9890966)_(9891120_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000532726	16	9984823 - 9984977	16	9890966 - 9891120	532726	529287		
NC_000016.10:g.(?_9849736)_(9849981_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000532725	16	9943593 - 9943838	16	9849736 - 9849981	532725	529861		
NC_000016.9:g.(?_10273835)_(10274288_?)del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000464050	16	10273835 - 10274288			464050	465388		
NM_001134407.3(GRIN2A):c.1639_1641del (p.Ser547del)	GRIN2A	S547del	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433126	16	9934514 - 9934516	16	9840657 - 9840659	433126	426692	rs1555494676	NC_000016.10:9840656:AGAAG:AG
NM_001134407.3(GRIN2A):c.2346_2356+8del	GRIN2A		not provided|Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421444	16	9892126 - 9892144	16	9798269 - 9798287	421444	409818	rs1064795143	NC_000016.10:9798268:GGTCTTACCATCACCCACA:
NM_001134407.3(GRIN2A):c.1498-14_1498-13del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321613	16	9934670 - 9934671	16	9840813 - 9840814	321613	336953	rs1491547779	NC_000016.10:9840812:CA:
NM_001134407.3(GRIN2A):c.*542_*544del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321592	16	9856462 - 9856464	16	9762605 - 9762607	321592	336930	rs760275969	NC_000016.10:9762604:AAGAA:AA
NM_001134407.3(GRIN2A):c.*1432del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321581	16	9855574	16	9761717	321581	344802	rs569463295	NC_000016.10:9761716:AAAAAAAAAA:AAAAAAAAA
NM_001134407.3(GRIN2A):c.*5790del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321521	16	9851216	16	9757359	321521	343132	rs74985384	NC_000016.10:9757358:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_001134407.3(GRIN2A):c.*6897del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321496	16	9850109	16	9756252	321496	336850	rs886052527	NC_000016.10:9756251:A:
NM_001134407.3(GRIN2A):c.*7293del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321486	16	9849713	16	9755856	321486	336844	rs58903398	NC_000016.10:9755855:AAAAAAAAAAA:AAAAAAAAAA
NM_001134407.3(GRIN2A):c.*7650_*7654del	GRIN2A		Epilepsy, focal, with speech disorder and with or without mental retardation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000321481	16	9849352 - 9849356	16	9755495 - 9755499	321481	326935	rs537062402	NC_000016.10:9755494:ACTTAACTT:ACTT
NM_000834.5(GRIN2B):c.3400_3416del (p.Leu1134fs)	GRIN2B	L1134fs	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000940412	12	13716756 - 13716772	12	13563822 - 13563838	940412	936039		NC_000012.12:13563821:GTTCGGAACTGGTCCAGGT:GT
NM_000834.5(GRIN2B):c.2011-18_2011-3del	GRIN2B		Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000931755	12	13724901 - 13724916	12	13571967 - 13571982	931755	920314		NC_000012.12:13571966:GGAGAGAGAAAGACAG:
NM_000834.5(GRIN2B):c.3295del (p.Arg1099fs)	GRIN2B	R1099fs	Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000916605	12	13716877	12	13563943	916605	904916		NC_000012.12:13563942:GGG:GG
NM_000834.5(GRIN2B):c.1088del (p.Val363fs)	GRIN2B	V363fs	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000916597	12	13828716	12	13675782	916597	904937		NC_000012.12:13675781:A:
NM_000834.5(GRIN2B):c.1439_1446del (p.Leu480fs)	GRIN2B	L480fs	Muscular hypotonia|Sleep disturbance|Behavioral abnormality|Self-injurious behavior|Microcephaly|Intellectual disability|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000916029	12	13768481 - 13768488	12	13615547 - 13615554	916029	904254		NC_000012.12:13615546:GGTAACCAGGTAA:GGTAA
NM_000834.5(GRIN2B):c.4437del (p.Ser1479fs)	GRIN2B	S1479fs	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Uncertain significance(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000856799	12	13715735	12	13562801	856799	839694		NC_000012.12:13562800:A:
NM_000834.5(GRIN2B):c.4309_4310delinsAT (p.Ala1437Ile)	GRIN2B	A1437I	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely benign(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000765967	12	13715862 - 13715863	12	13562928 - 13562929	765967	769021	rs1591604894	NC_000012.12:13562927:GC:AT
NM_000834.5(GRIN2B):c.412-5del	GRIN2B		not provided|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely benign(Last reviewed: Mar 30, 2020)	criteria provided, single submitter	VCV000763040	12	13906854	12	13753920	763040	775849	rs1591712751	NC_000012.12:13753919:AAAAA:AAAA
NM_000834.5(GRIN2B):c.1126-7del	GRIN2B		not provided|Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely benign(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000701147	12	13769598	12	13616664	701147	690030	rs774388082	NC_000012.12:13616663:AA:A
NM_000834.5(GRIN2B):c.2560del (p.Cys854fs)	GRIN2B	C854fs	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000619997	12	13719997	12	13567063	619997	611410		NC_000012.12:13567062:A:
NM_000834.5(GRIN2B):c.4015_4016del (p.Met1339fs)	GRIN2B	M1339fs	History of neurodevelopmental disorder|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2019)	criteria provided, conflicting interpretations	VCV000588039	12	13716156 - 13716157	12	13563222 - 13563223	588039	579767	rs1565453023	NC_000012.12:13563221:AT:
NM_000834.5(GRIN2B):c.2273_2281del (p.Ala758_Thr760del)	GRIN2B		Epileptic encephalopathy, early infantile, 27	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561026	12	13722842 - 13722850	12	13569908 - 13569916	561026	552156	rs1565457062	NC_000012.12:13569907:CAGTGGAAGCA:CA
NM_000834.5(GRIN2B):c.2172-10del	GRIN2B		not specified|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Benign/Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516106	12	13722961	12	13570027	516106	504011	rs761900678	NC_000012.12:13570026:AAAAAA:AAAAA
NM_000834.5(GRIN2B):c.2926_2928del (p.Lys976del)	GRIN2B	K976del	Mental retardation, autosomal dominant 6|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2017)	criteria provided, conflicting interpretations	VCV000234587	12	13717244 - 13717246	12	13564310 - 13564312	234587	231833	rs876661102	NC_000012.12:13564309:CTTC:C
NM_000834.5(GRIN2B):c.2589del (p.Ile864fs)	GRIN2B	I864fs	not provided|Mental retardation, autosomal dominant 6	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2017)	criteria provided, conflicting interpretations	VCV000205721	12	13719968	12	13567034	205721	202666	rs796052578	NC_000012.12:13567033:GG:G
NM_001077350.3(NPRL3):c.1287del (p.Phe430fs)	HBA-LCR|NPRL3	F251fs, F352fs, F405fs, F430fs	Epilepsy, familial focal, with variable foci 3	Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001285410	16	139775	16	89777	1285410	1275253		NC_000016.10:89776:GGGG:GGG
NM_001077350.3(NPRL3):c.15del (p.Ser6fs)	HBA-LCR|NPRL3	S6fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001073416	16	188252	16	138253	1073416	1063504		NC_000016.10:138252:GG:G
NM_001077350.3(NPRL3):c.258del (p.Lys87fs)	HBA-LCR|NPRL3	K87fs, K9fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV001072921	16	169185	16	119186	1072921	1063495		NC_000016.10:119185:C:
NC_000016.9:g.142723del	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001069552	16	142723	16	92725	1069552	1063832		NC_000016.10:92724:CC:C
NM_001077350.3(NPRL3):c.1492_1512del (p.Ile498_Ala504del)	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001059077	16	138729 - 138749	16	88730 - 88750	1059077	1049956		NC_000016.10:88729:GGCTGCGGGTACACTGAGGATGGCTGCG:GGCTGCG
NM_001077350.3(NPRL3):c.691_717del (p.Leu231_Ala239del)	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001052456	16	150420 - 150446	16	100422 - 100448	1052456	1049251		NC_000016.10:100421:GGCCGCATAGTGGATCTTGTGGGGCAGG:G
NM_001077350.3(NPRL3):c.1230_1231del (p.Cys411fs)	HBA-LCR|NPRL3	C232fs, C333fs, C386fs, C411fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000979191	16	139831 - 139832	16	89833 - 89834	979191	967282		NC_000016.10:89832:AGA:A
NM_001077350.3(NPRL3):c.44del (p.Ser15fs)	HBA-LCR|NPRL3	S15fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000949866	16	188223	16	138224	949866	927556		NC_000016.10:138223:G:
NM_001077350.3(NPRL3):c.644del (p.Gly215fs)	HBA-LCR|NPRL3	G137fs, G215fs, G190fs, G36fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000946477	16	150493	16	100495	946477	927516		NC_000016.10:100494:CCC:CC
NM_001077350.3(NPRL3):c.349del (p.Glu117fs)	HBA-LCR|NPRL3	E117fs, E39fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000861113	16	167344	16	117345	861113	842983		NC_000016.10:117344:CCC:CC
NM_001077350.3(NPRL3):c.1211_1245del (p.Ile404fs)	HBA-LCR|NPRL3	I404fs, I326fs, I379fs, I225fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000850891	16	139817 - 139851	16	89819 - 89853	850891	844604		NC_000016.10:89818:TGAGGCCATCAGGCAGACATAGGTGTGCAGCTGGATGAG:TGAG
NM_001077350.3(NPRL3):c.591_629+634del	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000845406	16	159889 - 160561	16	109891 - 110563	845406	852612		
NM_001077350.3(NPRL3):c.1280_1283delinsTCCC (p.Asp427_Val428delinsValPro)	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000666209	16	139779 - 139782	16	89781 - 89784	666209	645188	rs1596496451	NC_000016.10:89780:ACGT:GGGA
NC_000016.10:g.(?_98125)_(100529_?)del	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000654677	16	148123 - 150527	16	98125 - 100529	654677	652914		
NM_001077350.3(NPRL3):c.341del (p.Pro114fs)	HBA-LCR|NPRL3	P36fs, P114fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000648035	16	167352	16	117353	648035	643822	rs1596526976	NC_000016.10:117352:GGGG:GGG
NM_001077350.3(NPRL3):c.423_426del (p.Leu142fs)	HBA-LCR|NPRL3	L117fs, L64fs, L142fs	Intellectual disability|Epilepsy, familial focal, with variable foci 3	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000577957	16	162742 - 162745	16	112743 - 112746	577957	569461	rs1567139896	NC_000016.10:112742:CAGACAG:CAG
NC_000016.10:g.(?_130502)_(138287_?)del	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000542815	16	180501 - 188286	16	130502 - 138287	542815	529833		
NC_000016.10:g.(?_100352)_(100529_?)del	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000542814	16	150350 - 150527	16	100352 - 100529	542814	529831		
NM_001077350.3(NPRL3):c.1514_1518delinsTTCTGGGGCT (p.Gln505fs)	HBA-LCR|NPRL3	Q505fs, Q480fs, Q326fs, Q427fs	Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000542797	16	138723 - 138727	16	88724 - 88728	542797	530919	rs1555439541	NC_000016.10:88723:GTTCT:AGCCCCAGAA
NM_001077350.3(NPRL3):c.1070del (p.Pro357fs)	HBA-LCR|NPRL3	P279fs, P357fs, P178fs, P332fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV000254361	16	142685	16	92687	254361	248901	rs886037962	NC_000016.10:92686:GGG:GG
NM_001077350.3(NPRL3):c.1352-4_1352-1delinsTGACCCATCC	HBA-LCR|NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000254358	16	138889 - 138892	16	88891 - 88894	254358	248898	rs886037959	NC_000016.10:88890:CTGT:GGATGGGTCA
GRCh37/hg19 6p12.1(chr6:55053759-55499082)x1	HCRTR2|HMGCLL1|GFRAL		not provided	Uncertain significance(Last reviewed: Nov 29, 2017)	no assertion criteria provided	VCV000686721	6	55053759 - 55499082			686721	674313		
NM_018486.2(HDAC8):c.911delG (p.Gly304Glufs)	HDAC8		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, single submitter	VCV000521181	X	71681948	X	72462098	521181	512749	rs1555991965	NC_000023.11:72462097:CC:C
NM_152722.5(HEPACAM):c.*456_*460del	HEPACAM		Megalencephalic leukoencephalopathy with subcortical cysts	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303305	11	124790574 - 124790578	11	124920678 - 124920682	303305	313088	rs886047924	NC_000011.10:124920677:CAAAA:
NM_152722.5(HEPACAM):c.*457_*460del	HEPACAM		Megalencephalic leukoencephalopathy with subcortical cysts	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303304	11	124790574 - 124790577	11	124920678 - 124920681	303304	313086	rs72505890	NC_000011.10:124920677:CAAA:
NM_152722.5(HEPACAM):c.*1451del	HEPACAM|HEPN1		Megalencephalic leukoencephalopathy with subcortical cysts	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303293	11	124789583	11	124919687	303293	313076	rs886047919	NC_000011.10:124919686:GGGGG:GGGG
GRCh37/hg19 22q11.21(chr22:18875956-21466715)x1	HIRA|UFD1|ZNF74|DGCR6|LZTR1|CLTCL1|ESS2|CDC45|P2RX6|SNAP29|DGCR2|TXNRD2|TSSK2|TRMT2A|ZDHHC8|MED15|DGCR8|GNB1L|MRPL40|RTN4R|RTL10|THAP7|KLHL22|DGCR6L|RIMBP3|SCARF2|C22orf39|TANGO2|AIFM3|USP41|FAM230A|GGTLC3|TMEM191B|ARVCF|COMT|CRKL|GP1BB|GSC2|SERPIND1|PI4KA|SEPTIN5|PRODH|RANBP1|SLC7A4|SLC25A1|TBX1|CLDN5		not provided	Pathogenic(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000605098	22	18875956 - 21466715			605098	596434		
GRCh37/hg19 22q12.3(chr22:35645948-35697504)x1	HMGXB4|TOM1		not provided	Uncertain significance(Last reviewed: Dec 11, 2017)	no assertion criteria provided	VCV000686466	22	35645948 - 35697504			686466	674058		
NM_031844.3(HNRNPU):c.149_156del (p.Arg50fs)	HNRNPU	R50fs	Seizures|Intellectual disability	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561030	1	245027454 - 245027461	1	244864152 - 244864159	561030	552042	rs1558190846	NC_000001.11:244864151:GGCGGGGCGGC:GGC
NM_031844.3(HNRNPU):c.401_402del (p.Asp134fs)	HNRNPU	D134fs	Epileptic encephalopathy, early infantile, 54	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495241	1	245027208 - 245027209	1	244863906 - 244863907	495241	486731	rs1553283916	NC_000001.11:244863905:GT:
NM_031844.3(HNRNPU):c.16delinsATT (p.Val6fs)	HNRNPU	V6fs	Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431120	1	245027594	1	244864292	431120	424638	rs1135401794	NC_000001.11:244864291:C:AAT
GRCh37/hg19 19q13.11-13.12(chr19:35111811-37744992)	HPN|HSPB6|OVOL3|POLR2I|PRODH2|PSENEN|RBM42|SBSN|IGFLR1|KIRREL2|PROSER3|MAG|NFKBID|NPHS1|ALKBH6|APLP1|ARHGAP33|ATP4A|CAPNS1|CD22|CLIP3|COX6B1|COX7A1|DMKN|ETV2|FAM187B|FFAR1|FFAR2|FFAR3|FXYD1|FXYD3|FXYD5|FXYD7|GAPDHS|GPR42|GRAMD1A|HAMP|HAUS5|HCST|KMT2B|KRTDAP|LGI4|LIN37|LRFN3|LSR|SCN1B|SDHAF1|SYNE4|TBCB|THAP8|TMEM147|TYROBP|U2AF1L4|UPK1A|USF2|WDR62|ZBTB32|ZFP14|ZFP82|ZNF146|ZNF181|ZNF260|ZNF30|ZNF302|ZNF345|ZNF382|ZNF383|ZNF420|ZNF461|ZNF529|ZNF565|ZNF566|ZNF567|ZNF568|ZNF585A|ZNF585B|ZNF599|ZNF790|ZNF792|ZNF829|ZNF850		Generalized epilepsy with febrile seizures plus, type 1	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625760	19	35111811 - 37744992			625760	614064		
NM_016097.5(IER3IP1):c.66del (p.His23fs)	IER3IP1	H23fs	Microcephaly, epilepsy, and diabetes syndrome	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV000862753	18	44702583	18	47176212	862753	846899		NC_000018.10:47176211:C:
NM_016097.5(IER3IP1):c.80del (p.Phe27fs)	IER3IP1	F27fs	Microcephaly, epilepsy, and diabetes syndrome	Uncertain significance(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000208459	18	44702569	18	47176198	208459	204984	rs863223399	NC_000018.10:47176197:AA:A
GRCh37/hg19 13q12.11(chr13:21201901-21217306)x1	IFT88		not provided	Uncertain significance(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000685233	13	21201901 - 21217306			685233	672825		
GRCh37/hg19 16p12.2(chr16:21618158-21741439)x1	IGSF6|METTL9|OTOA		not provided	Pathogenic(Last reviewed: May 24, 2017)	no assertion criteria provided	VCV000689334	16	21618158 - 21741439			689334	676926		
GRCh37/hg19 16p12.2(chr16:21573708-21741439)x1	IGSF6|METTL9|OTOA		not provided	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000685072	16	21573708 - 21741439			685072	672664		
GRCh37/hg19 16p12.2(chr16:21597346-21741439)x1	IGSF6|METTL9|OTOA		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000684885	16	21597346 - 21741439			684885	672477		
GRCh38/hg38 Xq28(chrX:155800088-156003242)x1	IL9R|VAMP7		See cases	Benign(Last reviewed: Nov 16, 2011)	no assertion criteria provided	VCV000148905	X	155029751 - 155232907	X	155800088 - 156003242	148905	158656		
GRCh37/hg19 6p22.3(chr6:15396791-15408790)x1	JARID2		not provided	Uncertain significance(Last reviewed: Sep 5, 2018)	no assertion criteria provided	VCV000686164	6	15396791 - 15408790			686164	673756		
GRCh37/hg19 Xq13.2(chrX:73138086-73169576)x0	JPX		not provided	Benign(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000616964	X	73138086 - 73169576			616964	608300		
GRCh37/hg19 9p24.3(chr9:488090-516638)x1	KANK1		not provided	Uncertain significance(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000686977	9	488090 - 516638			686977	674569		
GRCh37/hg19 9p24.3(chr9:608682-705931)x1	KANK1		not provided	Uncertain significance(Last reviewed: Sep 4, 2018)	no assertion criteria provided	VCV000685657	9	608682 - 705931			685657	673249		
NM_015443.4(KANSL1):c.1849-26_1871del	KANSL1		Koolen-de Vries syndrome	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001299570	17	44128048 - 44128096	17	46050682 - 46050730	1299570	1289625		NC_000017.11:46050681:CGGATTGTGCTGTTCCGGTGAACCTGTGAAAAAAGCCAAACAAAACTGAC:C
NC_000017.10:g.(?_43972176)_(44159918_?)del	KANSL1|MAPT|STH		Koolen-de Vries syndrome	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001071166	17	43972176 - 44159918			1071166	1057970		
NM_015443.4(KANSL1):c.494del (p.Ser164_Ser165insTer)	KANSL1		Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001045528	17	44249016	17	46171650	1045528	1033362		NC_000017.11:46171649:G:
NM_015443.4(KANSL1):c.517_518delinsAT (p.Ser173Ile)	KANSL1	S173I	Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001016363	17	44248992 - 44248993	17	46171626 - 46171627	1016363	1012826		NC_000017.11:46171625:GA:AT
NM_015443.4(KANSL1):c.1849-4661_1895del	KANSL1		Koolen-de Vries syndrome	Pathogenic	criteria provided, single submitter	VCV000981466	17	44128024 - 44132731	17	46050658 - 46055365	981466	969550		
NM_015443.4(KANSL1):c.2591del (p.Asn864fs)	KANSL1	N863fs, N864fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jun 17, 2019)	no assertion criteria provided	VCV000976453	17	44111602	17	46034236	976453	964720		NC_000017.11:46034235:TT:T
NM_015443.4(KANSL1):c.1768_1769delinsAG (p.Ala590Arg)	KANSL1	A590R	Koolen-de Vries syndrome	Likely pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000936637	17	44143982 - 44143983	17	46066616 - 46066617	936637	937996		NC_000017.11:46066615:GC:CT
NM_015443.4(KANSL1):c.540del (p.Lys180fs)	KANSL1	K180fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689767	17	44248970	17	46171604	689767	677455	rs1597874008	NC_000017.11:46171603:TTTT:TTT
NM_015443.4(KANSL1):c.876del (p.Asp293fs)	KANSL1	D293fs	Koolen-de Vries syndrome	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666307	17	44248634	17	46171268	666307	653893	rs1597872089	NC_000017.11:46171267:A:
NM_015443.4(KANSL1):c.1289+3_1289+5del	KANSL1		Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Sep 15, 2018)	criteria provided, single submitter	VCV000647791	17	44248216 - 44248218	17	46170850 - 46170852	647791	653462	rs1597870189	NC_000017.11:46170849:CTC:
NM_015443.4(KANSL1):c.449del (p.Pro150fs)	KANSL1	P150fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000620068	17	44249061	17	46171695	620068	611427	rs1567764119	NC_000017.11:46171694:GG:G
NM_015443.4(KANSL1):c.2938_2939del (p.Leu980fs)	KANSL1	L979fs, L980fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000620029	17	44109564 - 44109565	17	46032198 - 46032199	620029	611426	rs1568366050	NC_000017.11:46032197:AAA:A
NC_000017.11:g.(?_46031456)_(46082562_?)del	KANSL1		Koolen-de Vries syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000584056	17	44108822 - 44159928	17	46031456 - 46082562	584056	574273		
NM_015443.4(KANSL1):c.1046del (p.Lys349fs)	KANSL1	K349fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000571768	17	44248464	17	46171098	571768	571552	rs1567761585	NC_000017.11:46171097:TTT:TT
NM_015443.4(KANSL1):c.531_540del (p.Gly179fs)	KANSL1	G179fs	Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561035	17	44248970 - 44248979	17	46171604 - 46171613	561035	552205	rs1567763809	NC_000017.11:46171603:TTTTCCCCCATT:TT
NM_015443.4(KANSL1):c.878del (p.Asp293fs)	KANSL1	D293fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000545439	17	44248632	17	46171266	545439	535708	rs1555575405	NC_000017.11:46171265:T:
NM_015443.4(KANSL1):c.572del (p.Gly191fs)	KANSL1	G191fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	no assertion criteria provided	VCV000487349	17	44248938	17	46171572	487349	480418	rs1555575816	NC_000017.11:46171571:CCCCC:CCCC
NM_015443.4(KANSL1):c.808_809del (p.Leu270fs)	KANSL1	L270fs	not provided|Koolen-de Vries syndrome|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jul 8, 2020)	criteria provided, conflicting interpretations	VCV000468412	17	44248701 - 44248702	17	46171335 - 46171336	468412	468132	rs551541795	NC_000017.11:46171334:AG:
NM_015443.4(KANSL1):c.985_995del (p.Leu329fs)	KANSL1	L329fs	Koolen-de Vries syndrome	Likely pathogenic(Last reviewed: Sep 16, 2014)	no assertion criteria provided	VCV000374269	17	44248515 - 44248525	17	46171149 - 46171159	374269	361228	rs1057518659	NC_000017.11:46171148:AGTTTGCTCAAAGT:AGT
NM_015443.4(KANSL1):c.3125del (p.Leu1042fs)	KANSL1	L1041fs, L1042fs	Koolen-de Vries syndrome	Likely pathogenic(Last reviewed: Apr 25, 2014)	criteria provided, single submitter	VCV000209164	17	44109035	17	46031669	209164	205784	rs797045049	NC_000017.11:46031668:A:
NM_015443.4(KANSL1):c.985_986del (p.Leu329fs)	KANSL1	L329fs	Koolen-de Vries syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000038930	17	44248524 - 44248525	17	46171158 - 46171159	38930	47533	rs281865473	NC_000017.11:46171157:AAA:A
NM_015443.4(KANSL1):c.1867_1870del (p.Ile623fs)	KANSL1	I623fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Nov 20, 2012)	no assertion criteria provided	VCV000038929	17	44128049 - 44128052	17	46050683 - 46050686	38929	47532	rs281865472	NC_000017.11:46050682:GGAT:
GRCh37/hg19 16p12.1(chr16:27599138-27681983)x1	KATNIP		not provided	Uncertain significance(Last reviewed: Jun 16, 2017)	no assertion criteria provided	VCV000685531	16	27599138 - 27681983			685531	673123		
NM_000217.3(KCNA1):c.868_872delinsTC (p.Ile290_Leu291delinsSer)	KCNA1		Episodic ataxia type 1	Uncertain significance(Last reviewed: Jun 24, 2017)	criteria provided, single submitter	VCV000463866	12	5021412 - 5021416	12	4912246 - 4912250	463866	462258	rs1555085756	NC_000012.12:4912245:ATCCT:TC
NM_001112741.2(KCNC1):c.1370del (p.Lys457fs)	KCNC1	K457fs	Epilepsy, progressive myoclonic 7	Likely pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000692088	11	17794004	11	17772457	692088	679776	rs1590106815	NC_000011.10:17772456:AAAAAAAA:AAAAAAA
NM_001112741.2(KCNC1):c.108del (p.Trp36fs)	KCNC1	W36fs	Epilepsy, progressive myoclonic 7	Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000658535	11	17757656	11	17736109	658535	639845	rs1590088831	NC_000011.10:17736108:GG:G
NM_000238.4(KCNH2):c.2769_2771delinsAGC (p.Gly924Ala)	KCNH2	G924A, G584A	Arrhythmia	Uncertain significance(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000920801	7	150644888 - 150644890	7	150947800 - 150947802	920801	910710		NC_000007.14:150947799:CCC:GCT
NM_002241.5(KCNJ10):c.321_322del (p.Val109fs)	KCNJ10	V109fs	EAST syndrome	Pathogenic(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV000841424	1	160012001 - 160012002	1	160042211 - 160042212	841424	822885		NC_000001.11:160042210:AG:
NM_002241.5(KCNJ10):c.934_935delinsTT (p.Thr312Leu)	KCNJ10	T312L	EAST syndrome	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000663852	1	160011388 - 160011389	1	160041598 - 160041599	663852	626984	rs1571265205	NC_000001.11:160041597:GT:AA
NM_002241.5(KCNJ10):c.775del (p.Val258_Val259insTer)	KCNJ10		EAST syndrome	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030253	1	160011548	1	160041758	30253	39209	rs1557967748	NC_000001.11:160041757:CC:C
NM_001161352.2(KCNMA1):c.603-9_603-6del	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001089387	10	78944680 - 78944683	10	77184922 - 77184925	1089387	1077522		NC_000010.11:77184921:AGACAG:AG
NM_001161352.2(KCNMA1):c.34_39del (p.Ser12_Gly13del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001023565	10	79397362 - 79397367	10	77637604 - 77637609	1023565	1009212		NC_000010.11:77637603:GCCGCTGC:GC
NM_001161352.2(KCNMA1):c.168_179del (p.Ser57_Ser60del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Feb 9, 2020)	criteria provided, single submitter	VCV000969377	10	79397222 - 79397233	10	77637464 - 77637475	969377	956214		NC_000010.11:77637463:GAGGACGAGGAGGA:GA
NM_001161352.2(KCNMA1):c.27_56del (p.Gly13_Ser22del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000955396	10	79397345 - 79397374	10	77637587 - 77637616	955396	947078		NC_000010.11:77637586:CCGCCGCCGCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGCCGCC:CCGCCGCCGCCGCC
NM_001161352.2(KCNMA1):c.36_65del (p.Gly13_Ser22del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000942877	10	79397336 - 79397365	10	77637578 - 77637607	942877	935187		NC_000010.11:77637577:CTGCTGCCTCCGCCGCCGCCGCCGCCGCCGCTGCTGCC:CTGCTGCC
NM_001161352.2(KCNMA1):c.2786del (p.Asn929fs)	KCNMA1|KCNMA1-AS1	N821fs, N871fs, N878fs, N929fs, N720fs, N912fs, N874fs, N875fs	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000859287	10	78704647	10	76944889	859287	837318		NC_000010.11:76944888:TT:T
NM_001161352.2(KCNMA1):c.298_309del (p.Gly100_Phe103del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000845122	10	79397092 - 79397103	10	77637334 - 77637345	845122	837327		NC_000010.11:77637333:GAAGAGGCCCCCGAAGA:GAAGA
NM_001161352.2(KCNMA1):c.16_33del (p.Gly6_Ser11del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000838390	10	79397368 - 79397385	10	77637610 - 77637627	838390	837332		NC_000010.11:77637609:GCTGCCGCCGCCGCCGCCGC:GC
NM_001161352.2(KCNMA1):c.30_56del (p.Ser11_Gly19del)	KCNMA1		not provided|Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000655940	10	79397345 - 79397371	10	77637587 - 77637613	655940	639178	rs1163075445	NC_000010.11:77637586:CCGCCGCCGCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGCCGCC:CCGCCGCCGCCGCCGCC
NM_001161352.2(KCNMA1):c.31_48del (p.Ser11_Gly16del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000567863	10	79397353 - 79397370	10	77637595 - 77637612	567863	563955	rs759136661	NC_000010.11:77637594:GCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGC:GCCGCCGCCGCCGC
NM_001161352.2(KCNMA1):c.31_51del (p.Ser11_Gly17del)	KCNMA1		Cerebellar atrophy, developmental delay, and seizures|Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2021)	criteria provided, conflicting interpretations	VCV000464298	10	79397350 - 79397370	10	77637592 - 77637612	464298	460169	rs1484259264	NC_000010.11:77637591:GCCGCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGCCGC:GCCGCCGCCGCCGCCGC
NM_001161352.2(KCNMA1):c.31_34delinsG (p.Ser11_Ser12delinsGly)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy|not provided	Uncertain significance(Last reviewed: May 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000464297	10	79397367 - 79397370	10	77637609 - 77637612	464297	460171	rs1555528807	NC_000010.11:77637608:TGCT:C
NM_001161352.2(KCNMA1):c.162_173del (p.Ser57_Ser60del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)	criteria provided, conflicting interpretations	VCV000193230	10	79397228 - 79397239	10	77637470 - 77637481	193230	190395	rs754606765	NC_000010.11:77637469:GAGGAGGAAGAGGAGGAGGAAGA:GAGGAGGAAGA
NM_001161352.2(KCNMA1):c.31_54del (p.Ser11_Gly18del)	KCNMA1		Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy|not provided	Uncertain significance(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000129327	10	79397347 - 79397370	10	77637589 - 77637612	129327	134773	rs587780364	NC_000010.11:77637588:GCCGCCGCCGCCGCCGCCGCTGCTGCCGCCGCCGCCGCCGCC:GCCGCCGCCGCCGCCGCC
NC_000020.10:g.(?_62046246)_(62055569_?)del	KCNQ2		Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001073750	20	62046246 - 62055569			1073750	1058084		
NC_000020.10:g.(?_61987717)_(62038734_?)del	KCNQ2|CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000999129	20	61987717 - 62038734			999129	986673		
NM_172107.4(KCNQ2):c.2315del (p.Pro772fs)	KCNQ2	P741fs, P744fs, P754fs, P772fs, P790fs	Benign familial neonatal seizures 1	Pathogenic	criteria provided, single submitter	VCV000995954	20	62038301	20	63406948	995954	983655		NC_000020.11:63406947:GGGG:GGG
NM_172107.4(KCNQ2):c.507_514+10del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic	criteria provided, single submitter	VCV000977314	20	62076581 - 62076598	20	63445228 - 63445245	977314	965444		NC_000020.11:63445227:CAGGCCTCACCAATCACACAG:CAG
NM_172107.4(KCNQ2):c.2272_2286del (p.Gly758_Ser762del)	KCNQ2		Early infantile epileptic encephalopathy 7	Uncertain significance(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000930306	20	62038330 - 62038344	20	63406977 - 63406991	930306	919924		NC_000020.11:63406976:GCTGGCGCGGTTGCC:
NM_172107.4(KCNQ2):c.197del (p.Lys66fs)	KCNQ2	K66fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000929427	20	62103620	20	63472267	929427	917741		NC_000020.11:63472266:TT:T
NM_172107.4(KCNQ2):c.2048_2049del (p.His683fs)	KCNQ2	H665fs, H683fs, H652fs, H655fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000813777	20	62038567 - 62038568	20	63407214 - 63407215	813777	802032		NC_000020.11:63407213:GTG:G
NC_000020.11:g.(?_63406624)_(63472483_?)del	KCNQ2|KCNQ2-AS1		Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000641559	20	62037977 - 62103836	20	63406624 - 63472483	641559	653536		
NM_172107.4(KCNQ2):c.2378_2391del (p.Val793fs)	KCNQ2	V793fs, V765fs, V775fs, V762fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000520409	20	62038225 - 62038238	20	63406872 - 63406885	520409	511018	rs1555850403	NC_000020.11:63406871:CTCCTCGTGGTCCAC:C
NM_172107.4(KCNQ2):c.1610_1615del (p.Lys537_Val538del)	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000433180	20	62045457 - 62045462	20	63414104 - 63414109	433180	426752	rs1555853977	NC_000020.11:63414103:TGACTTTGA:TGA
NM_172107.4(KCNQ2):c.1569_1581del (p.Cys523fs)	KCNQ2	C495fs, C523fs, C492fs, C505fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000374999	20	62045491 - 62045503	20	63414138 - 63414150	374999	361690	rs1555854036	NC_000020.11:63414137:AAACTCGCAGGGG:
NM_172107.4(KCNQ2):c.2296del (p.Leu766fs)	KCNQ2	L748fs, L735fs, L738fs, L766fs	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374390	20	62038320	20	63406967	374390	361236	rs1057518668	NC_000020.11:63406966:GG:G
NM_172107.4(KCNQ2):c.2425del (p.Gln809fs)	KCNQ2	Q791fs, Q781fs, Q778fs, Q809fs	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374272	20	62038191	20	63406838	374272	361235	rs1057518662	NC_000020.11:63406837:GGG:GG
NM_172107.4(KCNQ2):c.1856_1886del (p.Met619fs)	KCNQ2	M591fs, M619fs, M588fs, M601fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369812	20	62039767 - 62039797	20	63408414 - 63408444	369812	353972	rs1555851445	NC_000020.11:63408413:TGCTTCTCCACCTTCCCGAGCCGTCCCATCATGCT:TGCT
NM_172107.3(KCNQ2):c.1764-?_*(455_?)del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369809	20	62037542 - 62039889	20	63406189 - 63408536	369809	353967		
NC_000020.11:g.(?_63413450)_(63415126_?)del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369796			20	63413450 - 63415126	369796	354040		
NM_172107.4(KCNQ2):c.1418_1419del (p.Leu473fs)	KCNQ2	L455fs, L445fs, L443fs, L473fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369795	20	62046362 - 62046363	20	63415009 - 63415010	369795	353985	rs1057516117	NC_000020.11:63415008:GAG:G
NM_172107.3(KCNQ2):c.1248-?_*(455_?)del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369792	20	62037542 - 62051025	20	63406189 - 63419672	369792	353968		
NM_172107.2(KCNQ2):c.1119-?_*382del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369787					369787	354037		
NM_172107.4(KCNQ2):c.1126del (p.Thr376fs)	KCNQ2	T376fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369786	20	62062715	20	63431362	369786	353990	rs1057516113	NC_000020.11:63431361:TTT:TT
NM_172107.4(KCNQ2):c.592_594delinsA (p.Arg198fs)	KCNQ2	R198fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369752	20	62076108 - 62076110	20	63444755 - 63444757	369752	354024	rs1057516084	NC_000020.11:63444754:CCG:T
NM_172107.2(KCNQ2):c.388-?_1301+?del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369750					369750	354036		
NM_172107.2(KCNQ2):c.388-682_1118+?del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369749					369749	354035		
NM_172107.2(KCNQ2):c.297-?_1247+?del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369745					369745	354034		
NM_172107.2:c.1-?c.993+?del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369740					369740	354033		
NM_172107.3(KCNQ2):c.(?_-177)_690+?del	KCNQ2|KCNQ2-AS1		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369739	20	62076012 - 62103993	20	63444659 - 63472640	369739	353969		
NM_172107.4(KCNQ2):c.1229del (p.Pro410fs)	KCNQ2	P410fs, P400fs	Benign familial neonatal seizures 1|not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280043	20	62055548	20	63424195	280043	264761	rs886041339	NC_000020.11:63424194:GGGGGG:GGGGG
NM_172107.4(KCNQ2):c.2126_2127del (p.Pro709fs)	KCNQ2	P678fs, P691fs, P709fs, P681fs	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, multiple submitters, no conflicts	VCV000205945	20	62038489 - 62038490	20	63407136 - 63407137	205945	203702	rs796052667	NC_000020.11:63407135:AG:
NM_172107.4(KCNQ2):c.2102_2104del (p.Phe701del)	KCNQ2	F701del, F673del, F670del, F683del	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7|not specified|Early infantile epileptic encephalopathy with suppression bursts	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000205944	20	62038512 - 62038514	20	63407159 - 63407161	205944	203703	rs758334927	NC_000020.11:63407158:AGAAG:AG
NM_172107.4(KCNQ2):c.1734_1735delinsAA (p.Met578_Leu579delinsIleMet)	KCNQ2		Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Jul 30, 2014)	criteria provided, single submitter	VCV000205942	20	62044831 - 62044832	20	63413478 - 63413479	205942	203721	rs796052665	NC_000020.11:63413477:GC:TT
NM_172107.4(KCNQ2):c.1160del (p.Pro387fs)	KCNQ2	P387fs, P377fs	Epileptic encephalopathy, early infantile, 1|not provided|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000205929	20	62059777	20	63428424	205929	203754	rs796052657	NC_000020.11:63428423:GGGGGG:GGGGG
NM_172107.4(KCNQ2):c.1197del (p.Ser399fs)	KCNQ2	S389fs, S399fs	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000129331	20	62059740	20	63428387	129331	134777	rs587780365	NC_000020.11:63428386:A:
nsv1197577	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000042118	20	62015806 - 62064474	20	63384457 - 63433124	42118	51284		
NM_172107.2:c.(1228_1230)del12	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000039096					39096	47702		
NM_172107.4(KCNQ2):c.65_68del (p.Val22fs)	KCNQ2	V22fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021796	20	62103749 - 62103752	20	63472396 - 63472399	21796	34648	rs118192187	NC_000020.11:63472395:CCCACC:CC
NM_172107.4(KCNQ2):c.388-1_389del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021789	20	62076716 - 62076718	20	63445363 - 63445365	21789	34641	rs118192196	NC_000020.11:63445362:TCCT:T
NM_172107.4(KCNQ2):c.346_348del (p.Lys116del)	KCNQ2	K116del	Benign familial neonatal seizures	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021785	20	62078139 - 62078141	20	63446786 - 63446788	21785	34637	rs118192192	NC_000020.11:63446785:CTT:
NM_172107.4(KCNQ2):c.314_316del (p.Ser105del)	KCNQ2	S105del	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021784	20	62078171 - 62078173	20	63446818 - 63446820	21784	34636	rs118192191	NC_000020.11:63446817:AGGAG:AG
NM_172107.4(KCNQ2):c.2597del (p.Gly866fs)	KCNQ2	G838fs, G835fs, G848fs, G866fs	not provided|Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000021781	20	62038019	20	63406666	21781	34633	rs118192245	NC_000020.11:63406665:CCC:CC
NM_172107.4(KCNQ2):c.232del (p.Gln78fs)	KCNQ2	Q78fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021778	20	62103585	20	63472232	21778	34630	rs118192189	NC_000020.11:63472231:G:
NM_172107.4(KCNQ2):c.2015del (p.Ser672fs)	KCNQ2	S641fs, S654fs, S644fs, S672fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021775	20	62038601	20	63407248	21775	34627	rs118192243	NC_000020.11:63407247:C:
NM_172107.4(KCNQ2):c.1956del (p.Thr653fs)	KCNQ2	T635fs, T653fs, T622fs, T625fs	Early infantile epileptic encephalopathy with suppression bursts|Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Apr 19, 2020)	criteria provided, single submitter	VCV000021773	20	62038660	20	63407307	21773	34625	rs118192242	NC_000020.11:63407306:C:
NM_172107.4(KCNQ2):c.1930del (p.Tyr644fs)	KCNQ2	Y644fs, Y613fs, Y626fs, Y616fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021772	20	62038686	20	63407333	21772	34624	rs118192241	NC_000020.11:63407332:A:
NM_172107.4(KCNQ2):c.1192_1193del (p.Lys398fs)	KCNQ2	K398fs, K388fs	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000021759	20	62059744 - 62059745	20	63428391 - 63428392	21759	34611	rs118192222	NC_000020.11:63428390:TT:
NM_172107.4(KCNQ2):c.2127del (p.Val710fs)	KCNQ2	V710fs, V679fs, V682fs, V692fs	Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|not provided|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007390	20	62038489	20	63407136	7390	22429	rs118192244	NC_000020.11:63407135:A:
KCNQ2, 10-BP DEL/1-BP INS, NT761	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000007387					7387	22426		
KCNQ2, 1-BP DEL, 1846T	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000007384					7384	22423		
NM_004519.4(KCNQ3):c.1141-5del	KCNQ3		Benign familial neonatal seizures	Likely benign(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001151993	8	133182680	8	132170433	1151993	1139103		NC_000008.11:132170432:GGGG:GGG
NC_000008.10:g.(?_133141509)_(133492779_?)del	KCNQ3		Benign familial neonatal seizures	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001071385	8	133141509 - 133492779			1071385	1057342		
NC_000008.10:g.(?_133141509)_(134296554_?)del	KCNQ3|SLA|TG|CCN4|NDRG1|DNAAF11|PHF20L1|TMEM71		Benign familial neonatal seizures	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001071384	8	133141509 - 134296554			1071384	1057343		
NC_000008.10:g.(?_133141509)_(133198438_?)del	KCNQ3		Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001064175	8	133141509 - 133198438			1064175	1039114		
NM_004519.4(KCNQ3):c.63_71del (p.Gly22_Gly24del)	KCNQ3		Benign familial neonatal seizures	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001043756	8	133492709 - 133492717	8	132480462 - 132480470	1043756	1028297		NC_000008.11:132480461:CCGCCGCCTCCGCCGCC:CCGCCGCC
NM_004519.4(KCNQ3):c.104_105del (p.Ala35fs)	KCNQ3	A35fs	Benign familial neonatal seizures 2	Likely pathogenic(Last reviewed: Feb 12, 2021)	no assertion criteria provided	VCV000998162	8	133492675 - 133492676	8	132480428 - 132480429	998162	985890		NC_000008.11:132480427:CGC:C
NM_004519.4(KCNQ3):c.61_77del (p.Gly20_Gly21insTer)	KCNQ3		Benign familial neonatal seizures	Pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV000842150	8	133492703 - 133492719	8	132480456 - 132480472	842150	834139		NC_000008.11:132480455:GCCGCCCCGCCGCCTCCGCCGCCCC:GCCGCCCC
NM_004519.4(KCNQ3):c.1722del (p.Gly575fs)	KCNQ3	G575fs, G455fs	Benign familial neonatal seizures	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000841488	8	133146614	8	132134367	841488	834123		NC_000008.11:132134366:A:
NM_004519.4(KCNQ3):c.50_67del (p.Asp17_Gly22del)	KCNQ3		Benign familial neonatal seizures	Uncertain significance(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000569719	8	133492713 - 133492730	8	132480466 - 132480483	569719	564641	rs1376853632	NC_000008.11:132480465:CGCCTCCGCCGCCCCCGTCGCC:CGCC
NM_004519.4(KCNQ3):c.2139del (p.Phe713fs)	KCNQ3	F593fs, F713fs	Benign familial neonatal seizures	Uncertain significance(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000471222	8	133141989	8	132129742	471222	457796	rs1554621412	NC_000008.11:132129741:AAAAAA:AAAAA
NM_004519.4(KCNQ3):c.1249_1250delinsAT (p.Glu417Met)	KCNQ3	E417M, E297M	Benign familial neonatal seizures 2|not specified	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000450849	8	133175727 - 133175728	8	132163480 - 132163481	450849	444213	rs1554625699	NC_000008.11:132163479:TC:AT
NM_004519.4(KCNQ3):c.-138del	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361891	8	133492917	8	132480670	361891	313010	rs886062696	NC_000008.11:132480669:A:
NM_004519.4(KCNQ3):c.*755_*758del	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361860	8	133140751 - 133140754	8	132128504 - 132128507	361860	312956	rs886062684	NC_000008.11:132128503:TGTATGT:TGT
NM_004519.4(KCNQ3):c.*755_*760del	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361859	8	133140749 - 133140754	8	132128502 - 132128507	361859	312953	rs886062683	NC_000008.11:132128501:TGTGTATGTGT:TGTGT
NM_004519.4(KCNQ3):c.*2266_*2269del	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361841	8	133139240 - 133139243	8	132126993 - 132126996	361841	307873	rs886062678	NC_000008.11:132126992:AAAGAA:AA
NM_004519.4(KCNQ3):c.*2385_*2388del	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361839	8	133139121 - 133139124	8	132126874 - 132126877	361839	304232	rs763323782	NC_000008.11:132126873:TACTTA:TA
NM_004519.4(KCNQ3):c.*4316del	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361807	8	133137193	8	132124946	361807	312916	rs61438560	NC_000008.11:132124945:G:
NM_004519.4(KCNQ3):c.*4982del	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361797	8	133136527	8	132124280	361797	307860	rs35772668	NC_000008.11:132124279:TTTTTTT:TTTTTT
NM_004519.4(KCNQ3):c.*6446del	KCNQ3		Benign Neonatal Epilepsy|Benign familial neonatal seizures	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000361774	8	133135063	8	132122816	361774	307801	rs35153843	NC_000008.11:132122815:T:
NM_004519.4(KCNQ3):c.56_73del (p.Gly19_Gly24del)	KCNQ3		not specified|Benign familial neonatal seizures|Seizures	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2020)	criteria provided, conflicting interpretations	VCV000206000	8	133492707 - 133492724	8	132480460 - 132480477	206000	202189	rs774616642	NC_000008.11:132480459:CCCCGCCGCCTCCGCCGCCCCCG:CCCCG
NM_020822.3(KCNT1):c.3177+12del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001169386	9	138677185	9	135785339	1169386	1156161		NC_000009.12:135785338:CCCC:CCC
NM_020822.3(KCNT1):c.1769+11del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001160061	9	138662302	9	135770456	1160061	1140303		NC_000009.12:135770455:GGG:GG
NM_020822.3(KCNT1):c.1036-8del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001157640	9	138656869	9	135765023	1157640	1140297		NC_000009.12:135765022:A:
NC_000009.11:g.(?_138606505_138607415del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Likely benign(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001139591					1139591	1109170		
NM_020822.3(KCNT1):c.2349+8del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Likely benign(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV001138804	9	138667269	9	135775423	1138804	1119468		NC_000009.12:135775422:T:
NC_000009.11:g.(?_138606413)_(138606576_?)del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001105896	9	138606413 - 138606576			1105896	1087676		
NM_020822.3(KCNT1):c.704del (p.Phe235fs)	KCNT1	F187fs, F235fs	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001035125	9	138649171	9	135757325	1035125	1029011		NC_000009.12:135757324:TT:T
NM_020822.3(KCNT1):c.3460_3461delinsGT (p.Lys1154Val)	KCNT1	K1109V, K1154V	not provided|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV001010946	9	138678325 - 138678326	9	135786479 - 135786480	1010946	993316		NC_000009.12:135786478:AA:GT
NM_020822.3(KCNT1):c.3145_3147del (p.Ser1049del)	KCNT1	S1049del, S1004del	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000965168	9	138676723 - 138676725	9	135784877 - 135784879	965168	955753		NC_000009.12:135784876:CTCC:C
NM_020822.3(KCNT1):c.2204_2206del (p.Glu735del)	KCNT1	E690del, E735del	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000960038	9	138664755 - 138664757	9	135772909 - 135772911	960038	946491		NC_000009.12:135772908:GAGG:G
NM_020822.3(KCNT1):c.2206_2211del (p.Val736_Thr737del)	KCNT1		Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000953691	9	138664757 - 138664762	9	135772911 - 135772916	953691	946492		NC_000009.12:135772910:GGTGACG:G
NM_020822.3(KCNT1):c.1833del (p.Arg613fs)	KCNT1	R568fs, R613fs	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000953236	9	138662763	9	135770917	953236	946489		NC_000009.12:135770916:GGGG:GGG
NM_020822.3(KCNT1):c.2166_2170del (p.Pro724fs)	KCNT1	P679fs, P724fs	Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000930468	9	138664718 - 138664722	9	135772872 - 135772876	930468	919205		NC_000009.12:135772871:GCTGC:
NM_020822.3(KCNT1):c.195_254+851del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000845198	9	138606504 - 138607414	9	135714658 - 135715568	845198	852172		
NM_020822.3(KCNT1):c.1975del (p.Arg659fs)	KCNT1	R614fs, R659fs	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000840541	9	138662906	9	135771060	840541	835812		NC_000009.12:135771059:CCC:CC
NM_020822.3(KCNT1):c.793_796del (p.Ser265fs)	KCNT1	S265fs, S217fs	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000835741	9	138650290 - 138650293	9	135758444 - 135758447	835741	835802		NC_000009.12:135758443:CAGTCAG:CAG
NC_000009.12:g.(?_135786177)_(135792181_?)del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000833297	9	138678023 - 138684027			833297	820097		
NM_020822.3(KCNT1):c.3156+15_3156+37del	KCNT1		not provided|Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Likely benign(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000696383	9	138676743 - 138676765	9	135784897 - 135784919	696383	685250	rs777726660	NC_000009.12:135784896:GGCAGCCTGGGGGCTGGGACTGTGGCAGCC:GGCAGCC
NC_000009.12:g.(?_135775290)_(135788182_?)del	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000583754	9	138667136 - 138680028	9	135775290 - 135788182	583754	563236		
NM_020822.3(KCNT1):c.1326_1327delinsAT (p.Met443Leu)	KCNT1	M398L, M443L	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000540588	9	138657595 - 138657596	9	135765749 - 135765750	540588	524763	rs1554773537	NC_000009.12:135765748:CA:AT
NM_020822.3(KCNT1):c.82_85delinsC (p.Glu28_Phe29delinsLeu)	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000540574	9	138594186 - 138594189	9	135702340 - 135702343	540574	524597	rs1554760875	NC_000009.12:135702339:GAGT:C
NM_020822.3(KCNT1):c.1698_1699delinsTA (p.Met566_Gly567delinsIleSer)	KCNT1		Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000540567	9	138662222 - 138662223	9	135770376 - 135770377	540567	524610	rs1554774874	NC_000009.12:135770375:GG:TA
NM_020822.3(KCNT1):c.2061_2066del (p.Gly691_Gly692del)	KCNT1		not provided|Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000473368	9	138664611 - 138664616	9	135772765 - 135772770	473368	459238	rs754629346	NC_000009.12:135772764:GGCGGTGG:GG
NM_020822.3(KCNT1):c.909_910delinsGA (p.Ser304Thr)	KCNT1	S304T, S259T	Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000412317	9	138651579 - 138651580	9	135759733 - 135759734	412317	396722	rs1060503697	NC_000009.12:135759732:CT:GA
NM_020822.3(KCNT1):c.1077_1078del (p.Gly361fs)	KCNT1	G361fs, G316fs	not provided|Epilepsy, nocturnal frontal lobe, 5|Early infantile epileptic encephalopathy 14	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2020)	criteria provided, conflicting interpretations	VCV000289274	9	138656918 - 138656919	9	135765072 - 135765073	289274	273511	rs796214553	NC_000009.12:135765071:AG:
NM_153033.5(KCTD7):c.144+9del	KCTD7		Epilepsy, progressive myoclonic 3	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001117186	7	66094202	7	66629215	1117186	1096468		NC_000007.14:66629214:GGG:GG
NC_000007.13:g.(?_66094052)_(66104219_?)del	KCTD7		Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001075621	7	66094052 - 66104219			1075621	1057296		
NM_153033.5(KCTD7):c.339_340del (p.Asp115fs)	KCTD7	D115fs	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV001069708	7	66103264 - 66103265	7	66638277 - 66638278	1069708	1061118		NC_000007.14:66638276:AG:
NM_153033.5(KCTD7):c.331del (p.Leu111fs)	KCTD7	L111fs	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000860762	7	66103255	7	66638268	860762	833812		NC_000007.14:66638267:CC:C
NC_000007.14:g.(?_66629045)_(66640414_?)del	KCTD7		Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000831752	7	66094032 - 66105401			831752	819912		
NC_000007.14:g.(?_66638233)_(66639252_?)del	KCTD7		Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000583587	7	66103220 - 66104239	7	66638233 - 66639252	583587	561099		
NM_153033.5(KCTD7):c.104_115del (p.Ala35_Ala38del)	KCTD7		Epilepsy, progressive myoclonic 3	Uncertain significance(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000566683	7	66094152 - 66094163	7	66629165 - 66629176	566683	564397	rs778647590	NC_000007.14:66629164:CGGCCACGCAGGCGG:CGG
NM_153033.5(KCTD7):c.594del (p.Ile199fs)	KCTD7	I199fs	not provided|Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000037009	7	66103941	7	66638954	37009	45675	rs727502785	NC_000007.14:66638953:CCC:CC
GRCh37/hg19 7p22.1(chr7:6465815-6601692)x1	KDELR2|DAGLB|GRID2IP		not provided	Uncertain significance(Last reviewed: Aug 17, 2017)	no assertion criteria provided	VCV000684887	7	6465815 - 6601692			684887	672479		
NM_012310.5(KIF4A):c.1489-8_1490delinsATAATGAAAG	KIF4A		Mental retardation, X-linked 100	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000140729	X	69573464 - 69573473	X	70353614 - 70353623	140729	150443	rs1555949612	NC_000023.11:70353613:TTTTCCAGCA:ATAATGAAAG
NM_199180.4(KIRREL2):c.1275del (p.Ala426fs)	KIRREL2	A376fs, A426fs	Neurodevelopmental delay|Epilepsy	Uncertain significance(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000975906	19	36352526	19	35861624	975906	964522		NC_000019.10:35861623:CCC:CC
NM_170606.3(KMT2C):c.8543del (p.Asn2848fs)	KMT2C	N2848fs	Kleefstra syndrome 1	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV001033181	7	151873995	7	152176910	1033181	1020346		NC_000007.14:152176909:TT:T
NM_182931.3(KMT2E):c.1603del (p.Leu535fs)	KMT2E	L535fs	See cases	Uncertain significance(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000805902	7	104730700	7	105090253	805902	794233	rs1584783327	NC_000007.14:105090252:C:
NM_182931.3(KMT2E):c.1239del (p.Asn414fs)	KMT2E	N414fs	See cases	Uncertain significance(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000805901	7	104719399	7	105078952	805901	794232	rs1584768283	NC_000007.14:105078951:CCC:CC
NM_182931.3(KMT2E):c.1776_1780del (p.Lys593fs)	KMT2E	K593fs	See cases|O'Donnell-Luria-Rodan syndrome|Epilepsy|intellectual deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000617565	7	104741923 - 104741927	7	105101476 - 105101480	617565	608933	rs1562927768	NC_000007.14:105101475:GAAAAGA:GA
NM_002296.4(LBR):c.32_35del (p.Val11fs)	LBR	V11fs	Pelger-Hut anomaly|Greenberg dysplasia	Pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000100902	1	225611743 - 225611746	1	225424041 - 225424044	100902	106764	rs863223326	NC_000001.11:225424040:ACCA:
NM_002296.4(LBR):c.1599_1605delinsCTAGAAG (p.Leu534_Leu535delinsTer)	LBR		Pelger-Hut anomaly|Greenberg dysplasia	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000009529	1	225592188 - 225592194	1	225404486 - 225404492	9529	24568	rs387906416	NC_000001.11:225404485:TAGAAGA:CTTCTAG
NC_000017.11:g.(?_27647231)_(27748498_?)del	LGALS9		Epilepsy|Autism spectrum disorder	Uncertain significance(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000223125	17	25974257 - 26075524	17	27647231 - 27748498	223125	224851		
NM_005097.4(LGI1):c.108del (p.Lys36fs)	LGI1	K36fs	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001076005	10	95518007	10	93758250	1076005	1062043		NC_000010.11:93758249:AAA:AA
NC_000010.10:g.(?_95517882)_(95537394_?)del	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001071970	10	95517882 - 95537394			1071970	1057484		
NM_005097.4(LGI1):c.446_449del (p.Asn149fs)	LGI1	N101fs, N149fs	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001069952	10	95549869 - 95549872	10	93790112 - 93790115	1069952	1062044		NC_000010.11:93790111:AACAA:A
NM_005097.4(LGI1):c.504-9_505del	LGI1		Familial temporal lobe epilepsy 1	Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001067401	10	95552491 - 95552501	10	93792734 - 93792744	1067401	1055952		NC_000010.11:93792733:GTCTTTCAGGG:
NM_005097.4(LGI1):c.1465del (p.Tyr489fs)	LGI1	Y441fs, Y489fs	Familial temporal lobe epilepsy 1	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000648214	10	95557351	10	93797594	648214	639317	rs1589776148	NC_000010.11:93797593:T:
NM_005097.4(LGI1):c.1580_1581del (p.His527fs)	LGI1	H479fs, H527fs	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000641538	10	95557466 - 95557467	10	93797709 - 93797710	641538	639318	rs1364913665	NC_000010.11:93797708:AT:
NM_005097.4(LGI1):c.1439_1442del (p.Gln480fs)	LGI1	Q480fs, Q432fs	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000464746	10	95557323 - 95557326	10	93797566 - 93797569	464746	460338	rs1554907835	NC_000010.11:93797565:CCAGCC:CC
NC_000010.11:g.(93704377_?)_(?_93785620)del	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000208479	10	95464133 - 95545376	10	93704377 - 93785620	208479	205006		
NM_005097.4(LGI1):c.758del (p.Ala253fs)	LGI1	A205fs, A253fs	Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000208477	10	95553027	10	93793270	208477	205003	rs797044997	NC_000010.11:93793269:C:
LGI1, 81-KB DEL	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Apr 24, 2012)	no assertion criteria provided	VCV000040218					40218	48703		
LGI1, 1-BP DEL, 835C	LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: Jun 15, 2005)	no assertion criteria provided	VCV000005431					5431	20470		
NM_006859.4(LIAS):c.217del (p.Arg73fs)	LIAS	R73fs	not provided	Pathogenic(Last reviewed: Jul 30, 2014)	criteria provided, single submitter	VCV000206046	4	39462579	4	39460959	206046	201768	rs796052703	NC_000004.12:39460958:AAA:AA
GRCh37/hg19 9p21.1(chr9:28586142-28766228)x1	LINGO2		not provided	Uncertain significance(Last reviewed: Jan 12, 2018)	no assertion criteria provided	VCV000689152	9	28586142 - 28766228			689152	676744		
NM_032737.4(LMNB2):c.402-18_402-3del	LMNB2		Lipodystrophy, partial, acquired, susceptibility to|Epilepsy, progressive myoclonic, 9	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001044284	19	2438532 - 2438547	19	2438534 - 2438549	1044284	1034193		NC_000019.10:2438533:GAAAGTCAAGAGGGCA:
NM_032737.4(LMNB2):c.1618del (p.His540fs)	LMNB2	H540fs	Lipodystrophy, partial, acquired, susceptibility to|Epilepsy, progressive myoclonic, 9	Uncertain significance(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001040528	19	2431873	19	2431875	1040528	1034185		NC_000019.10:2431874:GGG:GG
NM_032737.4(LMNB2):c.757_759del (p.Asp253del)	LMNB2	D253del	Epilepsy, progressive myoclonic, 9|Lipodystrophy, partial, acquired, susceptibility to	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000837379	19	2435095 - 2435097	19	2435097 - 2435099	837379	847477		NC_000019.10:2435096:GTCGT:GT
GRCh37/hg19 9q33.3(chr9:129414011-129460757)	LMX1B		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625639	9	129414011 - 129460757			625639	613943		
NM_030650.3(LNPK):c.726del (p.Pro243fs)	LNPK	P120fs, P243fs, P309fs, P245fs, P274fs	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559606	2	176804366	2	175939638	559606	550327	rs1553498948	NC_000002.12:175939637:T:
NM_000744.7(CHRNA4):c.14del (p.Gly5fs)	LOC100130587|CHRNA4	G5fs	Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000944850	20	61992504	20	63361152	944850	929236		NC_000020.11:63361151:CCCCC:CCCC
GRCh38/hg38 16p13.11(chr16:14816348-16100721)x1	LOC100505915|MIR1972-1|LOC112340377|LOC112340378|LOC112340379|CEP20|LOC100288162|LOC112340380|LOC112340381|LOC112340382|LOC113939949|MARF1|MIR3179-1|MIR3180-1|MIR3180-4|MIR6511A1|MIR6511B2|MIR6770-1|MIR3670-1|MIR484|MIR6506|MPV17L|ABCC1|BMERB1|MYH11|NDE1|NOMO1|NPIPA1|NPIPA5|NTAN1|PDXDC1|RRN3		See cases	Pathogenic(Last reviewed: Feb 14, 2018)	no assertion criteria provided	VCV000032353	16	14910205 - 16194578	16	14816348 - 16100721	32353	41018		
NC_000002.12:g.(?_165090130)_(166286643_?)del	LOC100506124|LOC102724058|LOC120977013|SCN1A|CSRNP3|GALNT3|SCN1A-AS1|SCN2A|SCN3A|SCN9A|TTC21B|TTC21B-AS1		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000652948	2	165946640 - 167143153	2	165090130 - 166286643	652948	650777		
NM_001165963.4(SCN1A):c.4999del (p.Leu1667fs)	LOC102724058|SCN1A	L1638fs, L1639fs, L1655fs, L1656fs, L1667fs, L853fs	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV001210335	2	166848786	2	165992276	1210335	1200335		NC_000002.12:165992275:GGG:GG
NM_001165963.4(SCN1A):c.5343del (p.Met1780_Tyr1781insTer)	LOC102724058|SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000976242	2	166848442	2	165991932	976242	964176		NC_000002.12:165991931:G:
NM_001165963.4(SCN1A):c.5114_5115delinsGT (p.Phe1705Cys)	LOC102724058|SCN1A	F1676C, F1677C, F1693C, F1694C, F1705C, F891C	Early infantile epileptic encephalopathy with suppression bursts	Likely pathogenic(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV000939736	2	166848670 - 166848671	2	165992160 - 165992161	939736	930919		NC_000002.12:165992159:GA:AC
NM_001165963.4(SCN1A):c.5087del (p.Lys1696fs)	LOC102724058|SCN1A	K1667fs, K882fs, K1668fs, K1696fs, K1684fs, K1685fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870155	2	166848698	2	165992188	870155	858335		NC_000002.12:165992187:TT:T
NM_001165963.4(SCN1A):c.4146del (p.Asp1383fs)	LOC102724058|SCN1A	D1383fs, D569fs, D1372fs, D1354fs, D1355fs, D1371fs	Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801796	2	166859120	2	166002610	801796	790093	rs1574005699	NC_000002.12:166002609:A:
NM_001165963.4(SCN1A):c.5217del (p.Asp1740fs)	LOC102724058|SCN1A	D1712fs, D1728fs, D926fs, D1740fs, D1711fs, D1729fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801790	2	166848568	2	165992058	801790	790087	rs1573949198	NC_000002.12:165992057:GGG:GG
NM_001165963.4(SCN1A):c.2616_3206delinsAAGTTGGCAAAA (p.Trp873_Ile1069delinsSerTrpGlnAsn)	LOC102724058|SCN1A		Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000690430	2	166892781 - 166894616	2	166036271 - 166038106	690430	678116		
NM_001165963.4(SCN1A):c.4467del (p.Lys1491fs)	LOC102724058|SCN1A	K1479fs, K677fs, K1462fs, K1463fs, K1480fs, K1491fs	Autosomal dominant epilepsy	Likely pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000632977	2	166854557	2	165998047	632977	621100	rs1559118914	NC_000002.12:165998046:C:
NM_001165963.4(SCN1A):c.3195_3196del (p.Thr1066fs)	LOC102724058|SCN1A	T1054fs, T252fs, T1055fs, T1066fs, T1037fs, T1038fs	not provided	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000449376	2	166892791 - 166892792	2	166036281 - 166036282	449376	443028	rs1553540282	NC_000002.12:166036280:TAT:T
NM_001165963.4(SCN1A):c.*672_*675del	LOC102724058|SCN1A		Epilepsy|Familial hemiplegic migraine	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331874	2	166847080 - 166847083	2	165990570 - 165990573	331874	285247	rs886055038	NC_000002.12:165990569:AAGCA:A
NM_001165963.4(SCN1A):c.*1872del	LOC102724058|SCN1A		Familial hemiplegic migraine|Epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331859	2	166845883	2	165989373	331859	282516	rs878898132	NC_000002.12:165989372:AAAAAAAAA:AAAAAAAA
NM_001165963.4(SCN1A):c.3704del (p.Leu1235fs)	LOC102724058|SCN1A	L1206fs, L1223fs, L1235fs, L421fs, L1207fs, L1224fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	VCV000224087	2	166870255	2	166013745	224087	225817	rs869312670	NC_000002.12:166013744:A:
NM_001165963.4(SCN1A):c.3852del (p.Trp1284fs)	LOC102724058|SCN1A	W1273fs, W470fs, W1255fs, W1256fs, W1272fs, W1284fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Aug 16, 2012)	criteria provided, single submitter	VCV000217245	2	166868646	2	166012136	217245	213799	rs863225034	NC_000002.12:166012135:CC:C
NM_001165963.4(SCN1A):c.4548del (p.Lys1518fs)	LOC102724058|SCN1A	K1507fs, K1518fs, K1490fs, K1506fs, K704fs, K1489fs	not provided	Pathogenic(Last reviewed: Jul 23, 2014)	criteria provided, single submitter	VCV000206919	2	166852556	2	165996046	206919	201480	rs796053081	NC_000002.12:165996045:C:
NM_001165963.4(SCN1A):c.3705+10del	LOC102724058|SCN1A		not specified|Early infantile epileptic encephalopathy with suppression bursts	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2020)	criteria provided, conflicting interpretations	VCV000206728	2	166870244	2	166013734	206728	201520	rs570862962	NC_000002.12:166013733:T:
NM_001165963.4(SCN1A):c.5297_5298del (p.Phe1766fs)	LOC102724058|SCN1A	F1766fs, F1737fs, F1738fs, F1754fs, F1755fs, F952fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190003	2	166848487 - 166848488	2	165991977 - 165991978	190003	187712	rs794726832	NC_000002.12:165991976:AAAAAA:AAAA
NM_001165963.4(SCN1A):c.4554del (p.Lys1518fs)	LOC102724058|SCN1A	K1489fs, K1506fs, K704fs, K1490fs, K1507fs, K1518fs	Early infantile epileptic encephalopathy with suppression bursts|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189994	2	166852550	2	165996040	189994	187739	rs794726825	NC_000002.12:165996039:TTTTTT:TTTTT
NM_001165963.4(SCN1A):c.4823del (p.Asp1608fs)	LOC102724058|SCN1A	D1579fs, D1580fs, D1608fs, D794fs, D1597fs, D1596fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189948	2	166850685	2	165994175	189948	187734	rs794726785	NC_000002.12:165994174:T:
NM_001165963.4(SCN1A):c.5334del (p.Asn1779fs)	LOC102724058|SCN1A	N965fs, N1750fs, N1767fs, N1779fs, N1751fs, N1768fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189946	2	166848451	2	165991941	189946	187711	rs794726783	NC_000002.12:165991940:C:
NM_001165963.4(SCN1A):c.3487del (p.Pro1162_Val1163insTer)	LOC102724058|SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189937	2	166872180	2	166015670	189937	187775	rs794726774	NC_000002.12:166015669:C:
NM_001165963.4(SCN1A):c.5003del (p.Pro1668fs)	LOC102724058|SCN1A	P854fs, P1639fs, P1656fs, P1668fs, P1640fs, P1657fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189919	2	166848782	2	165992272	189919	187725	rs794726758	NC_000002.12:165992271:GG:G
NM_001165963.4(SCN1A):c.5010_5013del (p.Phe1671fs)	LOC102724058|SCN1A	F857fs, F1659fs, F1671fs, F1642fs, F1643fs, F1660fs	Epileptic encephalopathy|Early infantile epileptic encephalopathy with suppression bursts|not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Aug 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189914	2	166848772 - 166848775	2	165992262 - 165992265	189914	187723	rs794726754	NC_000002.12:165992261:AAACAA:AA
NM_001165963.4(SCN1A):c.3477del (p.Ile1159fs)	LOC102724058|SCN1A	I1148fs, I1159fs, I345fs, I1130fs, I1131fs, I1147fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189885	2	166872190	2	166015680	189885	187776	rs794726729	NC_000002.12:166015679:G:
NM_001165963.4(SCN1A):c.3802_3812del (p.Leu1268fs)	LOC102724058|SCN1A	L1240fs, L1239fs, L1256fs, L1257fs, L1268fs, L454fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189860	2	166868686 - 166868696	2	166012176 - 166012186	189860	187763	rs794726709	NC_000002.12:166012175:CATTTTAGAAGCATTT:CATTT
NM_001165963.4(SCN1A):c.4244_4245del (p.Asn1414_Phe1415insTer)	LOC102724058|SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189854	2	166859021 - 166859022	2	166002511 - 166002512	189854	187746	rs794726705	NC_000002.12:166002510:AAA:A
NM_001165963.4(SCN1A):c.5250_5252del (p.Ser1750_Ser1751delinsArg)	LOC102724058|SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189851	2	166848533 - 166848535	2	165992023 - 165992025	189851	187715	rs794726703	NC_000002.12:165992022:GAG:
GRCh38/hg38 2q24.3(chr2:165986097-166443535)x1	LOC102724058|SCN1A|SCN1A-AS1|SCN7A|SCN9A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000154605	2	166842607 - 167300045	2	165986097 - 166443535	154605	164359		
NM_001165963.4(SCN1A):c.5797del (p.Arg1933fs)	LOC102724058|SCN1A	R1905fs, R1933fs, R1922fs, R1119fs, R1904fs, R1921fs	Generalized epilepsy with febrile seizures plus, type 2|Early infantile epileptic encephalopathy with suppression bursts|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2017)	criteria provided, conflicting interpretations	VCV000130208	2	166847988	2	165991478	130208	135655	rs587780446	NC_000002.12:165991477:G:
NM_001165963.4(SCN1A):c.3609del (p.Gln1203fs)	LOC102724058|SCN1A	Q1203fs, Q1175fs, Q1174fs, Q1191fs, Q1192fs, Q389fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Sep 15, 2008)	no assertion criteria provided	VCV000012901	2	166870350	2	166013840	12901	27940	rs1574061044	NC_000002.12:166013839:TT:T
GRCh38/hg38 8q23.3(chr8:115401331-115502029)x1	LOC110120802|TRPS1		See cases	Pathogenic(Last reviewed: May 7, 2012)	no assertion criteria provided	VCV000150636	8	116413559 - 116514256	8	115401331 - 115502029	150636	160387		
NC_000016.10:g.(?_78386840)_(78432772_?)del	LOC112486209|WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Likely pathogenic(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	VCV000584296	16	78420737 - 78466669	16	78386840 - 78432772	584296	567547		
NC_000009.12:g.(?_6532997)_(6645519_?)del	LOC113839554|GLDC		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000462848	9	6532997 - 6645519	9	6532997 - 6645519	462848	458654		
NM_001040142.2(SCN2A):c.-51-1736_-51-1735del	LOC120977013|SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|not provided|Seizures, benign familial infantile, 3	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2021)	criteria provided, conflicting interpretations	VCV000331709	2	166150521 - 166150522	2	165294011 - 165294012	331709	282352	rs67417831	NC_000002.12:165294010:AAAAAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAAAA
NM_001040142.2(SCN2A):c.-51-1735del	LOC120977013|SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|not provided|Seizures, benign familial infantile, 3	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2019)	criteria provided, conflicting interpretations	VCV000331708	2	166150521	2	165294011	331708	283031	rs67417831	NC_000002.12:165294010:AAAAAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAAAAA
GRCh38/hg38 6q27(chr6:170210927-170714507)x1	LOC154449|DLL1|FAM120B|LINC01624|LOC101929692|LOC108663996|LOC110121051|LOC285804|MIR4644|PDCD2|PSMB1|TBP		See cases	Likely pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000148324	6	170526161 - 171023595	6	170210927 - 170714507	148324	158075		
NC_000009.11:g.(?_140646763)_(140729425_?)del	LOC651337|EHMT1		Kleefstra syndrome 1	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001073971	9	140646763 - 140729425			1073971	1057402		
GRCh37/hg19 4q31.3(chr4:151428984-151807861)x1	LRBA|MAB21L2		not provided	Uncertain significance(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000687200	4	151428984 - 151807861			687200	674792		
GRCh38/hg38 2q22.1-22.2(chr2:141241948-142692191)x1	LRP1B		See cases	Uncertain significance(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000154604	2	141999517 - 143449760	2	141241948 - 142692191	154604	164358		
NM_004287.5(GOSR2):c.557_584del (p.Ala186fs)	LRRC37A2|GOSR2	A139fs, A138fs, A168fs, A185fs, A186fs, A121fs	Progressive myoclonic epilepsy|not provided	Uncertain significance(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000205635	17	45016042 - 45016069	17	46938676 - 46938703	205635	203467	rs796052541	NC_000017.11:46938675:GGCTTTCCAGGACAAGTACTTTATGATAGG:GG
NC_000023.10:g.(113050826_113097589)_(114931342_114941807)del	LUZP4|LRCH2|RBMXL3|MIR448|HTR2C|IL13RA2|PLS3		Bone mineral density quantitative trait locus 18	Pathogenic(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	VCV000209215	X	113050826 - 114941807			209215	205806		
NM_016373.4(WWOX):c.1110_1119del (p.Leu371fs)	MAF|WWOX	L258fs, L371fs	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000958916	16	79245552 - 79245561	16	79211655 - 79211664	958916	949586		NC_000016.10:79211654:GGAGGGTCTGGGAGGG:GGAGGG
NM_016373.4(WWOX):c.1132_1133delinsTG (p.Asn378Cys)	MAF|WWOX	N265C, N378C	Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000839154	16	79245580 - 79245581	16	79211683 - 79211684	839154	844355		NC_000016.10:79211682:AA:TG
NM_016373.4(WWOX):c.1240_*36del (p.Gly414_Ter415del)	MAF|WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000834653	16	79245686 - 79245727	16	79211789 - 79211830	834653	844359		NC_000016.10:79211788:CCGGCTAAGTGGAGCTCAGAGCGGATGGGCACACACACCCGCCC:CC
NM_016373.4(WWOX):c.1179_1210del (p.Ala394fs)	MAF|WWOX	A281fs, A394fs	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000410090	16	79245626 - 79245657	16	79211729 - 79211760	410090	401349	rs1064792969	NC_000016.10:79211728:CGGCCCGGACCCTGTGGGCGCTCAGCGAGAGGC:C
NM_016373.4(WWOX):c.1231_1233del (p.Ser411del)	MAF|WWOX	S411del, S298del	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000374383	16	79245677 - 79245679	16	79211780 - 79211782	374383	361223	rs770788315	NC_000016.10:79211779:GCAGC:GC
MAPK10, EX10-14DEL	MAPK10		Epileptic encephalopathy Lennox-Gastaut type	Uncertain significance(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000006746					6746	21785		
GRCh37/hg19 16p13.11(chr16:15425965-16199736)	MARF1|ABCC1|MYH11|NDE1|BMERB1|CEP20|MPV17L|NPIPA5		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625835	16	15425965 - 16199736			625835	614139		
NM_001378120.1(MBD5):c.1470_1478del (p.490PRS[1])	MBD5		not provided	Uncertain significance(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000546443	2	149226978 - 149226986	2	148469409 - 148469417	546443	536607	rs1553518587	NC_000002.12:148469408:CACCCAGGTCACC:CACC
NM_001378120.1(MBD5):c.5154del (p.Lys1719fs)	MBD5	K1486fs, K1719fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000406452	2	149270475	2	148512906	406452	391608	rs1060501151	NC_000002.12:148512905:CCCCCC:CCCCC
GRCh37/hg19 14q13.2-13.3(chr14:36216962-36783249)x1	MBIP|BRMS1L|RALGAPA1|PTCSC3		not provided	Uncertain significance(Last reviewed: May 11, 2017)	no assertion criteria provided	VCV000687146	14	36216962 - 36783249			687146	674738		
NM_005918.4(MDH2):c.596del (p.Gly199fs)	MDH2	G92fs, G199fs, G157fs	Epileptic encephalopathy, early infantile, 51|Infantile encephalopathy	Pathogenic	criteria provided, single submitter	VCV000266121	7	75692872	7	76063554	266121	260945	rs1057519567	NC_000007.14:76063553:GG:G
NM_001110792.2(MECP2):c.63-5800_1271del	MECP2		Epilepsy|Intellectual disability	Likely pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV000997823	X	153296044 - 153303808	X	154030593 - 154038357	997823	985541		
NM_001110792.2(MECP2):c.1089_*2300del (p.Pro363_Ter499delinsXaa)	MECP2		Rett syndrome	Pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000813730	X	153293518 - 153296226	X	154028067 - 154030775	813730	802045		
NM_001110792.2(MECP2):c.1194_*261del (p.Pro399fs)	MECP2	P294fs, P399fs, P387fs, P164fs	Rett syndrome	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000393488	X	153295557 - 153296121	X	154030106 - 154030670	393488	380327	rs1557134621	
NM_001110792.2(MECP2):c.1165_1234del (p.Lys389fs)	MECP2	K389fs, K284fs, K377fs, K154fs	not provided|Rett syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2013)	criteria provided, conflicting interpretations	VCV000156615	X	153296081 - 153296150	X	154030630 - 154030699	156615	166469	rs1557135353	
NM_001110792.2(MECP2):c.1121_1222delinsAAGAAGGAGCACCACCACCATCACCACCACTCAGAGTCCCCAAAGGCCCCCGTGCCACTGCTCCCACCCCTGC (p.Pro374fs)	MECP2	P374fs, P269fs, P362fs, P139fs	not provided	Pathogenic(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	VCV000156613	X	153296093 - 153296194	X	154030642 - 154030743	156613	166467	rs1557135516	
NM_001110792.2(MECP2):c.1043_1133delinsCTGTAAGTGCAC (p.Leu348fs)	MECP2	L243fs, L348fs, L113fs, L336fs	not provided	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000156611	X	153296182 - 153296272	X	154030731 - 154030821	156611	166465	rs1557135901	
NC_000005.9:g.(?_88027526)_(88027738_?)del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001072396	5	88027526 - 88027738			1072396	1057179		
NC_000005.9:g.(?_87776690)_(88119605_?)del	MEF2C|MIR9-2		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV001070269	5	87776690 - 88119605			1070269	1057178		
NC_000005.9:g.(?_87976333_88057095del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Uncertain significance(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV001040234					1040234	1022263		
NM_002397.4:c.(?_-1)_(*1_?)del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000974582					974582	962879		
NM_002397.5(MEF2C):c.988del (p.Leu330fs)	MEF2C	L180fs, L322fs, L340fs, L274fs, L282fs, L204fs, L320fs, L330fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000854734	5	88024422	5	88728605	854734	831249		NC_000005.10:88728604:GG:G
NC_000005.10:g.(?_88722584)_(88823808_?)del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000832792	5	88018401 - 88119625			832792	819631		
NC_000005.10:g.(?_88804588)_(88884466_?)del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000831579	5	88100405 - 88180283			831579	819632		
NM_002397.5(MEF2C):c.411del (p.Pro138fs)	MEF2C	P12fs, P136fs, P156fs, P138fs, P90fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	not provided	no assertion provided	VCV000684451	5	88047852	5	88752035	684451	672064	rs1581753788	NC_000005.10:88752034:T:
NM_002397.5(MEF2C):c.413del (p.Pro138fs)	MEF2C	P138fs, P12fs, P136fs, P156fs, P90fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	not provided	no assertion provided	VCV000684450	5	88047850	5	88752033	684450	672063	rs1581753587	NC_000005.10:88752032:GG:G
NC_000005.9:g.88142510_88347193del204684insG	MEF2C|MEF2C-AS1		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000598760	5	88142510 - 88347193	5	88846693 - 89051376	598760	589802		
NM_002397.5(MEF2C):c.614_626delinsGTCTCCAC (p.Thr205fs)	MEF2C	T203fs, T205fs, T223fs, T157fs, T63fs, T79fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000487207	5	88044898 - 88044910	5	88749081 - 88749093	487207	455995	rs1554110298	NC_000005.10:88749080:CCTGCACCAGACG:GTGGAGAC
NC_000005.10:g.(?_88823715)_(88823808_?)del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000478619	5	88119532 - 88119625	5	88823715 - 88823808	478619	454426		
NM_001131005.2(MEF2C):c.-143+4248del	MEF2C		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354600	5	88179071	5	88883254	354600	305065	rs144197632	NC_000005.10:88883253:GGGGGGGGG:GGGGGGGG
NM_002397.5(MEF2C):c.-208del	MEF2C		Frontotemporal dementia|Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations|not specified	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000354593	5	88178837	5	88883020	354593	300690	rs886060864	NC_000005.10:88883019:AAAAAAAAAA:AAAAAAAAA
NM_002397.5(MEF2C):c.-91_-89del	MEF2C		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354589	5	88119694 - 88119696	5	88823877 - 88823879	354589	298378	rs747852567	NC_000005.10:88823876:CTCCT:CT
NM_002397.5(MEF2C):c.*31_*32del	MEF2C|MEF2C-AS2		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354583	5	88018389 - 88018390	5	88722572 - 88722573	354583	305020	rs56660854	NC_000005.10:88722571:AAAAAAAAAAAAA:AAAAAAAAAAA
NM_002397.5(MEF2C):c.*51_*55del	MEF2C|MEF2C-AS2		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354582	5	88018366 - 88018370	5	88722549 - 88722553	354582	305016	rs886060862	NC_000005.10:88722548:ATAGCA:A
NM_002397.5(MEF2C):c.*115del	MEF2C|MEF2C-AS2		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354581	5	88018306	5	88722489	354581	298377	rs553216678	NC_000005.10:88722488:TTTTTTTTTTT:TTTTTTTTTT
NM_002397.5(MEF2C):c.*2267del	MEF2C|MEF2C-AS2		Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354576	5	88016154	5	88720337	354576	305015	rs3841444	NC_000005.10:88720336:TTTTTTTTTTTT:TTTTTTTTTTT
NM_001131005.2(MEF2C):c.-143+4180_-143+4193del	MEF2C		Frontotemporal dementia	Likely pathogenic(Last reviewed: Aug 1, 2015)	criteria provided, single submitter	VCV000219247	5	88179126 - 88179139	5	88883309 - 88883322	219247	217270	rs1085307051	NC_000005.10:88883308:GAGGAGGAGGAAGA:
NM_002397.5(MEF2C):c.833del (p.Leu277_Leu278insTer)	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations|not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158888	5	88026029	5	88730212	158888	168541	rs587783749	NC_000005.10:88730211:AAAA:AAA
NM_002397.5(MEF2C):c.458del (p.Asn153fs)	MEF2C	N105fs, N151fs, N153fs, N27fs, N11fs, N171fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000040217	5	88047805	5	88751988	40217	48702	rs730882192	NC_000005.10:88751987:TT:T
NM_001371596.2(MFSD8):c.63-4del	MFSD8		Late-infantile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 7|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 23, 2021)	criteria provided, conflicting interpretations	VCV000196582	4	128878751	4	127957596	196582	193743	rs755011754	NC_000004.12:127957595:GG:G
GRCh37/hg19 7q34(chr7:141760798-141795506)x0	MGAM		not provided	Benign(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000610441	7	141760798 - 141795506			610441	601777		
GRCh37/hg19 12q21.31(chr12:86438504-86522229)x1	MGAT4C		not provided	Uncertain significance(Last reviewed: Aug 10, 2017)	no assertion criteria provided	VCV000688409	12	86438504 - 86522229			688409	676001		
GRCh37/hg19 13q12.12(chr13:23506404-24925728)x1	MIPEP|SGCG|SACS|TNFRSF19|SPATA13|C1QTNF9|C1QTNF9B|PCOTH		not provided	Uncertain significance(Last reviewed: Nov 22, 2017)	no assertion criteria provided	VCV000685610	13	23506404 - 24925728			685610	673202		
GRCh37/hg19 14q21.1(chr14:37964229-37996852)x1	MIPOL1		not provided	Uncertain significance(Last reviewed: Sep 13, 2017)	no assertion criteria provided	VCV000687263	14	37964229 - 37996852			687263	674855		
NG_007092.2:g.1180537_1293253del	MIR548F4|CNTNAP2		Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Sep 7, 2017)	no assertion criteria provided	VCV000438343	7	146988989 - 147101705	7	147291897 - 147404613	438343	431971		
NM_002693.3(POLG):c.1586-33_1586-31del	MIR6766|POLG		Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619459	15	89870000 - 89870002	15	89326769 - 89326771	619459	610870	rs1567190938	NC_000015.10:89326768:AGGAG:AG
NM_002693.3(POLG):c.1586-5del	MIR6766|POLG		Progressive sclerosing poliodystrophy|not specified|Seizures|none provided	Benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000199081	15	89869974	15	89326743	199081	196240	rs2307434	NC_000015.10:89326742:G:
GRCh37/hg19 22q13.33(chr22:50464963-50668571)x1	MLC1|MOV10L1|PANX2|TRABD|SELENOO|TUBGCP6|TTLL8		not provided	Uncertain significance(Last reviewed: Feb 23, 2018)	no assertion criteria provided	VCV000686392	22	50464963 - 50668571			686392	673984		
NM_015166.4(MLC1):c.1076del (p.Leu359fs)	MLC1	L359fs, L280fs, L307fs, L325fs, L329fs, L340fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000558299	22	50500070	22	50061641	558299	549437	rs1372842345	NC_000022.11:50061640:A:
NM_015166.4(MLC1):c.448del (p.Leu150fs)	MLC1	L150fs, L116fs, L120fs, L71fs, L98fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000556409	22	50515907	22	50077478	556409	549442	rs1555967227	NC_000022.11:50077477:G:
NM_015166.4(MLC1):c.1065del (p.Arg356fs)	MLC1	R356fs, R277fs, R304fs, R322fs, R326fs, R337fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Uncertain significance(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000552297	22	50500081	22	50061652	552297	549296	rs1555962643	NC_000022.11:50061651:GG:G
NM_015166.4(MLC1):c.42del (p.Met15fs)	MLC1	M15fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552049	22	50523290	22	50084861	552049	549169	rs1555968785	NC_000022.11:50084860:CC:C
NM_015166.4(MLC1):c.624_625del (p.Ala209fs)	MLC1	A209fs, A130fs, A157fs, A175fs, A179fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000371571	22	50512734 - 50512735	22	50074305 - 50074306	371571	358666	rs1057517375	NC_000022.11:50074304:CA:
NM_015166.4(MLC1):c.449_455del (p.Leu150fs)	MLC1	L150fs, L116fs, L120fs, L71fs, L98fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000371207	22	50515900 - 50515906	22	50077471 - 50077477	371207	358668	rs1057517090	NC_000022.11:50077470:AGCAGGA:
NM_015166.4(MLC1):c.136del (p.Cys46fs)	MLC1	C46fs	Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370785	22	50523196	22	50084767	370785	358670	rs1057516766	NC_000022.11:50084766:A:
NM_015166.4(MLC1):c.271_272del (p.Ile91fs)	MLC1	I91fs, I12fs, I61fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000370234	22	50518822 - 50518823	22	50080393 - 50080394	370234	358669	rs1057516336	NC_000022.11:50080392:AT:
NM_015166.4(MLC1):c.223del (p.Val75fs)	MLC1	V75fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 3, 2014)	no assertion criteria provided	VCV000202208	22	50521557	22	50083128	202208	198646	rs794729233	NC_000022.11:50083127:C:
NM_015166.4(MLC1):c.324del (p.Asn110fs)	MLC1	N110fs, N31fs, N80fs	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189169	22	50518446	22	50080017	189169	187068	rs786204747	NC_000022.11:50080016:AA:A
NM_015166.4(MLC1):c.298_423+108del	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000021523	22	50518239 - 50518796	22	50079810 - 50080367	21523	34375	rs1555967644	
MLC1, 17-BP DEL, G INS	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004723					4723	19762		
NM_015166.4(MLC1):c.594_597del (p.Ser197_Tyr198insTer)	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Pathogenic(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV000004720	22	50515270 - 50515273	22	50076841 - 50076844	4720	19759	rs267607236	NC_000022.11:50076840:TGAGT:T
MLC1, 7-BP DEL, NT564	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004715					4715	19754		
GRCh37/hg19 14q23.1(chr14:61253791-61387865)x1	MNAT1		not provided	Uncertain significance(Last reviewed: Mar 16, 2018)	no assertion criteria provided	VCV000688747	14	61253791 - 61387865			688747	676339		
NM_000791.4(DHFR):c.-442_-434del	MSH3|DHFR		not provided|Megaloblastic anemia due to dihydrofolate reductase deficiency|not specified	Benign(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000402590	5	79950742 - 79950750	5	80654923 - 80654931	402590	389689	rs3045983	NC_000005.10:80654922:CCCCCAGCTCCC:CCC
NM_002449.5(MSX2):c.548_555del (p.Glu183fs)	MSX2	E183fs	Parietal foramina 1	Pathogenic(Last reviewed: Nov 15, 2005)	no assertion criteria provided	VCV000016968	5	174156327 - 174156334	5	174729324 - 174729331	16968	32007	rs1561643060	NC_000005.10:174729323:CAGAGACCCAG:CAG
NM_002449.5(MSX2):c.345del (p.Ala114_Trp115insTer)	MSX2		Parietal foramina 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000016966	5	174152006	5	174725003	16966	32005	rs121912972	NC_000005.10:174725002:GG:G
NM_002449.5(MSX2):c.265_266delinsTA (p.Ala89Ter)	MSX2	A89*	Parietal foramina 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000016965	5	174151927 - 174151928	5	174724924 - 174724925	16965	32004	rs121912971	NC_000005.10:174724923:GC:TA
nsv513767	MSX2		Parietal foramina 1	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000016964					16964	32003		
MSX2, 6-BP DEL, NT475	MSX2		Parietal foramina 1	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000016962					16962	32001		
m.5132_5133delAA	MT-ND2	N222fs	Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Aug 22, 2002)	no assertion criteria provided	VCV000009719	MT	5132 - 5133	MT	5132 - 5133	9719	24758	rs199476116	NC_012920.1:5131:AAA:A
Single allele	MTMR10|CHRNA7|FAN1|KLF13|MIR211|OTUD7A|TRPM1		Epilepsy|Autism spectrum disorder	Likely pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000223109	15	30941572 - 32509926			223109	224835		
NM_000431.4(MVK):c.677+7del	MVK		Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type	Likely benign(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001100184	12	110024611	12	109586806	1100184	1100825		NC_000012.12:109586805:T:
NC_000012.11:g.(?_110032813)_(110034402_?)del	MVK		Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001075609	12	110032813 - 110034402			1075609	1057581		
NC_000012.11:g.(?_110012646_110013970del	MVK		Mevalonic aciduria|Porokeratosis 3, disseminated superficial actinic type|Hyperimmunoglobulin D with periodic fever	Likely pathogenic(Last reviewed: Apr 29, 2020)	criteria provided, single submitter	VCV001067488					1067488	1054531		
NM_000431.4(MVK):c.503_508del (p.Leu168_Asp170delinsHis)	MVK		Hyperimmunoglobulin D with periodic fever	Uncertain significance(Last reviewed: May 21, 2020)	no assertion criteria provided	VCV000973651	12	110019331 - 110019336	12	109581526 - 109581531	973651	961963		NC_000012.12:109581525:TGAAGG:
NM_000431.4(MVK):c.632-3del	MVK		Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever	Uncertain significance(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000935308	12	110024554	12	109586749	935308	940241		NC_000012.12:109586748:TTT:TT
NM_000431.4(MVK):c.78+7_78+10del	MVK		Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not specified	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000246309	12	110012712 - 110012715	12	109574907 - 109574910	246309	244709	rs771523264	NC_000012.12:109574906:AGCC:
NM_000431.4(MVK):c.86del (p.Leu29fs)	MVK	L29fs	Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097635	12	110013810	12	109576005	97635	103527	rs104895381	NC_000012.12:109576004:T:
NM_000431.4(MVK):c.79_226del (p.Val27Serfs)	MVK		Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097628					97628	103520	rs104895327	
NM_000431.4(MVK):c.78+2del	MVK		Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097623	12	110012707	12	109574902	97623	103515	rs104895378	NC_000012.12:109574901:T:
NM_000431.4(MVK):c.571del (p.Gln191fs)	MVK	Q191fs, Q139fs	Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097598	12	110023869	12	109586064	97598	103490	rs104895371	NC_000012.12:109586063:CC:C
NM_000431.4(MVK):c.503_512delinsAC (p.Leu168fs)	MVK	L168fs	Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097594	12	110019331 - 110019340	12	109581526 - 109581535	97594	103486	rs104895375	NC_000012.12:109581525:TGAAGGACGG:AC
NM_000431.4(MVK):c.421del (p.Ala141fs)	MVK	A141fs	Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097589	12	110019246	12	109581441	97589	103481	rs104895323	NC_000012.12:109581440:GGGG:GGG
NM_000431.4(MVK):c.372_527del (p.Ala125_Arg176del)	MVK		Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097584					97584	103476	rs104895310	
NM_000431.4(MVK):c.340_344del (p.Tyr114fs)	MVK	Y114fs	Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097580	12	110017717 - 110017721	12	109579912 - 109579916	97580	103472	rs104895370	NC_000012.12:109579911:CTTTACTT:CTT
NM_000431.4(MVK):c.277_283del (p.Glu93fs)	MVK	E93fs	Hyperimmunoglobulin D with periodic fever|MVK-Related Disorders	Uncertain significance(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000097579	12	110017656 - 110017662	12	109579851 - 109579857	97579	103471	rs104895369	NC_000012.12:109579850:GGAGGTTG:G
NM_000431.4(MVK):c.129_130del (p.His44fs)	MVK	H44fs	Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000097574	12	110013851 - 110013852	12	109576046 - 109576047	97574	103466	rs104895368	NC_000012.12:109576045:CCCC:CC
NM_000431.4(MVK):c.1097_1100del (p.Asp366fs)	MVK	D314fs, D366fs	Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097565	12	110034286 - 110034289	12	109596481 - 109596484	97565	103457	rs104895372	NC_000012.12:109596480:TGACTG:TG
NM_000431.4(MVK):c.-13_78+1del	MVK		Hyperimmunoglobulin D with periodic fever	not provided	no assertion provided	VCV000097559	12	110012612 - 110012703	12	109574807 - 109574898	97559	103451	rs104895309	
NM_000431.4(MVK):c.16_34del (p.Leu6fs)	MVK	L6fs	Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000011935	12	110012643 - 110012661	12	109574838 - 109574856	11935	26974	rs104895334	NC_000012.12:109574837:CTACTGGTGTCTGCTCCGG:
GRCh37/hg19 17p13.1(chr17:10233434-10305820)x1	MYH8|MYH13		not provided	Uncertain significance(Last reviewed: May 9, 2018)	no assertion criteria provided	VCV000685728	17	10233434 - 10305820			685728	673320		
GRCh37/hg19 2p24.3(chr2:15133366-15730846)x1	NBAS		not provided	Uncertain significance(Last reviewed: Nov 14, 2017)	no assertion criteria provided	VCV000687033	2	15133366 - 15730846			687033	674625		
NM_004544.4(NDUFA10):c.*1894_*1914delinsGGG	NDUFA10		Mitochondrial complex I deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000335177	2	240898621 - 240898641	2	239959204 - 239959224	335177	285476	rs886055819	NC_000002.12:239959203:AGGGGATGATCAGAGCACCCG:CCC
NM_004544.4(NDUFA10):c.1000-5del	NDUFA10		Mitochondrial complex I deficiency|not provided|Leigh syndrome	Benign/Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000214702	2	240900608	2	239961191	214702	210797	rs138479490	NC_000002.12:239961190:GGGGG:GGGG
NM_014165.4(NDUFAF4):c.-32del	NDUFAF4		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000358276	6	97345709	6	96897833	358276	304443	rs886061831	NC_000006.12:96897832:CC:C
NM_005006.7(NDUFS1):c.154-10_154-9del	NDUFS1		Leigh syndrome|not provided|Mitochondrial complex I deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Aug 9, 2019)	criteria provided, conflicting interpretations	VCV000333789	2	207014658 - 207014659	2	206149934 - 206149935	333789	284922	rs568965659	NC_000002.12:206149933:AAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAA
NM_005006.7(NDUFS1):c.262-15del	NDUFS1		Leigh syndrome|Mitochondrial complex I deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)	criteria provided, conflicting interpretations	VCV000333788	2	207013835	2	206149111	333788	287257	rs34184317	NC_000002.12:206149110:AAAAAAAAAAA:AAAAAAAAAA
NM_005006.7(NDUFS1):c.1393-7del	NDUFS1		Leigh syndrome|Mitochondrial complex I deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)	criteria provided, conflicting interpretations	VCV000333782	2	206997836	2	206133112	333782	287238	rs760292289	NC_000002.12:206133111:AAAAAAAAAAA:AAAAAAAAAA
NM_005006.7(NDUFS1):c.*846del	NDUFS1		Leigh syndrome|Mitochondrial complex I deficiency	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333765	2	206988063	2	206123339	333765	284147	rs58253838	NC_000002.12:206123338:AAAAAAAAAAAA:AAAAAAAAAAA
NM_001377299.1(NDUFS2):c.495_496del (p.Arg166fs)	NDUFS2	R166fs	Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000632085	1	161179083 - 161179084	1	161209293 - 161209294	632085	619957	rs1558084765	NC_000001.11:161209292:CTC:C
NM_001377299.1(NDUFS2):c.*71_*76delinsTGCGTCTGTGTGTG	NDUFS2		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293283	1	161184054 - 161184059	1	161214264 - 161214269	293283	276897	rs886045465	NC_000001.11:161214263:GGCCTC:TGCGTCTGTGTGTG
NM_001377299.1(NDUFS2):c.1213-9del	NDUFS2		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293280	1	161183429	1	161213639	293280	277989	rs750838845	NC_000001.11:161213638:CC:C
NM_002495.4(NDUFS4):c.351-11_351-8del	NDUFS4		Mitochondrial complex I deficiency|Leigh syndrome|Leigh syndrome|not provided|Mitochondrial complex I deficiency	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2021)	criteria provided, conflicting interpretations	VCV000353890	5	52954367 - 52954370	5	53658537 - 53658540	353890	297817	rs375549253	NC_000005.10:53658536:TTTGTTT:TTT
GRCh37/hg19 18q21.31(chr18:55929965-55937109)x1	NEDD4L		not provided	Benign(Last reviewed: Feb 22, 2011)	no assertion criteria provided	VCV000603196	18	55929965 - 55937109			603196	594532		
GRCh38/hg38 1p31.1(chr1:71633132-72092337)x1	NEGR1|NEGR1-IT1		See cases	Uncertain significance(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000148439	1	72098815 - 72558020	1	71633132 - 72092337	148439	158190		
NM_198586.3(NHLRC1):c.583del (p.Asp195fs)	NHLRC1	D195fs	Lafora disease	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001299569	6	18122255	6	18122024	1299569	1289624		NC_000006.12:18122023:C:
NM_198586.3(NHLRC1):c.670_673del (p.Thr224fs)	NHLRC1	T224fs	Lafora disease	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001071786	6	18122165 - 18122168	6	18121934 - 18121937	1071786	1060643		NC_000006.12:18121933:GGGTGG:GG
NM_198586.3(NHLRC1):c.799del (p.Val267fs)	NHLRC1	V267fs	Lafora disease	Pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001069688	6	18122039	6	18121808	1069688	1060642		NC_000006.12:18121807:CCCC:CCC
NM_198586.3(NHLRC1):c.423_425del (p.Val144del)	NHLRC1	V144del	Lafora disease	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001047716	6	18122413 - 18122415	6	18122182 - 18122184	1047716	1027090		NC_000006.12:18122181:ACGAC:AC
NM_198586.3(NHLRC1):c.612del (p.Phe204fs)	NHLRC1	F204fs	Lafora disease	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000943845	6	18122226	6	18121995	943845	933249		NC_000006.12:18121994:AAAAAAA:AAAAAA
NM_198586.3(NHLRC1):c.*358_*361del	NHLRC1		Lafora disease	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356067	6	18121289 - 18121292	6	18121058 - 18121061	356067	299623	rs550375620	NC_000006.12:18121057:TACTT:T
NM_198586.3(NHLRC1):c.468del (p.Gly158fs)	NHLRC1	G158fs	Lafora disease|not provided	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280034	6	18122370	6	18122139	280034	264259	rs757954108	NC_000006.12:18122138:T:
NM_198586.3(NHLRC1):c.4_5delinsAA (p.Ala2Lys)	NHLRC1	A2K	Lafora disease|not specified	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206193	6	18122833 - 18122834	6	18122602 - 18122603	206193	201968	rs796052757	NC_000006.12:18122601:GC:TT
NM_198586.3(NHLRC1):c.992del (p.Gly331fs)	NHLRC1	G331fs	Epilepsy, progressive myoclonic 2b	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000002589	6	18121846	6	18121615	2589	17628	rs587776543	NC_000006.12:18121614:CCC:CC
NM_198586.3(NHLRC1):c.468_469del (p.Gly158fs)	NHLRC1	G158fs	Lafora disease|Epilepsy, progressive myoclonic 2b|not provided	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002588	6	18122369 - 18122370	6	18122138 - 18122139	2588	17627	rs587776542	NC_000006.12:18122137:CT:
GRCh37/hg19 Xp22.13(chrX:17637495-17638015)x0	NHS		not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000616762	X	17637495 - 17638015			616762	608098		
NM_000481.4(AMT):c.63del (p.Leu22fs)	NICN1|AMT	L22fs	Non-ketotic hyperglycinemia	Likely pathogenic	no assertion criteria provided	VCV000056237	3	49459821	3	49422388	56237	70876	rs386833688	NC_000003.12:49422387:GG:G
GRCh37/hg19 15q11.2(chr15:24892074-24975056)x1	NPAP1		not provided	Uncertain significance(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000689262	15	24892074 - 24975056			689262	676854		
NC_000015.9:g.(?_23730704)_(28530182_?)del	NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|SNORD115-1|SNORD116-1|SNRPN|PWRN1|PWRN2|ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|MAGEL2|MKRN3|NDN|SNURF|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Aug 21, 2013)	criteria provided, single submitter	VCV000209214	15	23730704 - 28530182			209214	205805		
GRCh37/hg19 2q13(chr2:110871508-110980919)x1	NPHP1|MALL		not provided	Pathogenic(Last reviewed: May 9, 2018)	no assertion criteria provided	VCV000686286	2	110871508 - 110980919			686286	673878		
NM_006545.5(NPRL2):c.865_871del (p.Ser289fs)	NPRL2	S289fs	Epilepsy, familial focal, with variable foci 2	Likely pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, single submitter	VCV001297009	3	50385616 - 50385622	3	50348185 - 50348191	1297009	1286799		NC_000003.12:50348184:CAGGGCTCAGG:CAGG
NM_006545.5(NPRL2):c.445_448+3del	NPRL2		Epilepsy, familial focal, with variable foci 2	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000692035	3	50386814 - 50386820	3	50349383 - 50349389	692035	679824	rs1575562076	NC_000003.12:50349382:TACCAAT:
NM_006545.5(NPRL2):c.68_69del (p.Ile23fs)	NPRL2	I23fs	Epilepsy, familial focal, with variable foci 2	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000254365	3	50388015 - 50388016	3	50350584 - 50350585	254365	248905	rs886037966	NC_000003.12:50350583:GA:
NC_000016.9:g.(?_136684)_(169274_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001076141	16	136684 - 169274			1076141	1057724		
NC_000016.9:g.(?_160513)_(180600_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV001076140	16	160513 - 180600			1076140	1057732		
NC_000016.9:g.(?_167290)_(180600_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001076139	16	167290 - 180600			1076139	1057737		
NC_000016.9:g.(?_148133)_(188266_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001076138	16	148133 - 188266			1076138	1057730		
NC_000016.9:g.(?_167290)_(188266_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: May 24, 2020)	criteria provided, single submitter	VCV001076137	16	167290 - 188266			1076137	1057738		
NC_000016.9:g.(?_138677)_(188286_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV001076136	16	138677 - 188286			1076136	1057726		
NC_000016.9:g.(?_142584)_(188266_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001076135	16	142584 - 188266			1076135	1057729		
NC_000016.9:g.(?_150360)_(150517_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001072233	16	150360 - 150517			1072233	1057731		
NC_000016.9:g.(?_169115)_(169264_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001072232	16	169115 - 169264			1072232	1057739		
NC_000016.9:g.(?_180511)_(180600_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001072231	16	180511 - 180600			1072231	1057741		
NC_000016.9:g.(?_136704)_(188266_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001072230	16	136704 - 188266			1072230	1057725		
NM_001077350.3(NPRL3):c.622del (p.Tyr208fs)	NPRL3|HBA-LCR	Y130fs, Y183fs, Y208fs, Y29fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV001069081	16	160530	16	110532	1069081	1063493		NC_000016.10:110531:AA:A
NC_000016.9:g.(?_159889_160561del	NPRL3		Epilepsy, familial focal, with variable foci 3	Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV001066857					1066857	1054579		
NM_001077350.3(NPRL3):c.1544+1del	NPRL3|HBA-LCR		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001002237	16	138696	16	88697	1002237	997230		NC_000016.10:88696:CC:C
NM_001077350.3(NPRL3):c.768-2del	NPRL3|HBA-LCR		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000983137	16	148301	16	98303	983137	971063		NC_000016.10:98302:T:
NM_001077350.3(NPRL3):c.1372del (p.Leu458fs)	NPRL3|HBA-LCR	L380fs, L458fs, L279fs, L433fs	Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jul 28, 2019)	criteria provided, single submitter	VCV000944018	16	138868	16	88870	944018	928003		NC_000016.10:88869:GGG:GG
NM_001077350.3(NPRL3):c.1544+3_1544+5del	NPRL3|HBA-LCR		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000863785	16	138692 - 138694	16	88693 - 88695	863785	851687		NC_000016.10:88692:CCC:
NC_000016.10:g.(?_89693)_(100529_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832843	16	139691 - 150527			832843	820916		
NC_000016.10:g.(?_138130)_(138287_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832358	16	188129 - 188286			832358	820764		
NC_000016.9:g.(?_148123)_(188286_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000832174	16	148123 - 188286			832174	820972		
NC_000016.10:g.(?_86685)_(86890_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000831622	16	136684 - 136889			831622	820889		
NC_000016.9:g.(?_136684)_(162794_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000830471	16	136684 - 162794			830471	820970		
NM_001077350.3(NPRL3):c.377del (p.Val126fs)	NPRL3|HBA-LCR	V126fs, V48fs	Epilepsy, familial focal, with variable foci 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817393	16	167316	16	117317	817393	805857	rs1596526915	NC_000016.10:117316:A:
NM_001077350.3(NPRL3):c.1561del (p.Arg521fs)	NPRL3	R521fs, R496fs, R342fs, R443fs	Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000651702	16	136853	16	86854	651702	645083	rs1596492194	NC_000016.10:86853:GG:G
NC_000016.9:g.(?_136684)_(188286_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000583997	16	136684 - 188286			583997	570737		
NC_000016.9:g.(?_160503)_(162794_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000542816	16	160503 - 162794			542816	530819		
NM_001077350.3(NPRL3):c.1707_1708del (p.Ter570SerextTer?)	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000542795	16	136706 - 136707	16	86707 - 86708	542795	530881	rs756232589	NC_000016.10:86706:AG:
NC_000016.10:g.(?_130502)_(130611_?)del	NPRL3|HBA-LCR		Epilepsy, familial focal, with variable foci 3	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000476212	16	180501 - 180610	16	130502 - 130611	476212	465659		
NC_000016.9:g.(?_136684)_(143343_?)del	NPRL3		Epilepsy, familial focal, with variable foci 3	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000476211	16	136684 - 143343			476211	467314		
NM_001330078.2(NRXN1):c.773-304_790+128del	NRXN1		not provided	Likely pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000560109	2	51152948 - 51153397	2	50925810 - 50926259	560109	550825	rs1553368900	
NRXN1, 287-KB DEL	NRXN1		Pitt-Hopkins-like syndrome 2	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000030097					30097	39052		
NRXN1, 79-KB DEL	NRXN1		Pitt-Hopkins-like syndrome 2	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000030096					30096	39051		
Single allele	NUBPL|ARHGAP5-AS1|LOC112267854|HECTD1|STRN3|ARHGAP5|MIR624|AP4S1|NUBPL-DT|DTD2|HEATR5A|GPR33|LINC02313|HEATR5A-DT		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000560123	14	31481456 - 32662912	14	31012250 - 32193706	560123	550839		
NM_025152.3(NUBPL):c.*1148del	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313059	14	32329534	14	31860328	313059	335819	rs886050465	NC_000014.9:31860327:G:
NM_025152.3(NUBPL):c.*1146_*1148del	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313058	14	32329532 - 32329534	14	31860326 - 31860328	313058	335814	rs886050464	NC_000014.9:31860325:AAG:
NM_025152.3(NUBPL):c.*1145_*1148del	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313057	14	32329531 - 32329534	14	31860325 - 31860328	313057	329202	rs886050463	NC_000014.9:31860324:AAAG:
NM_025152.3(NUBPL):c.*1144_*1147del	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313056	14	32329509 - 32329512	14	31860303 - 31860306	313056	329201	rs34847511	NC_000014.9:31860302:AAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAA
NM_025152.3(NUBPL):c.*1122_*1124del	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313054	14	32329508 - 32329510	14	31860302 - 31860304	313054	329191	rs886050460	NC_000014.9:31860301:CAA:
NM_025152.3(NUBPL):c.*1121_*1123del	NUBPL		Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000313052	14	32329507 - 32329509	14	31860301 - 31860303	313052	337682	rs886050458	NC_000014.9:31860300:TCA:
NC_000006.11:g.(117971549_117971550)_(118218719_118218720)del	NUS1|LOC101927919		Tremor|generalized epilepsy with atypical absence and tonic/myoclonic seizures|Intellectual disability	Pathogenic	no assertion criteria provided	VCV000180226	6	117971549 - 118218720	6	117650386 - 117897557	180226	178414		
NC_000006.11:g.(117961791_117961792)_(118280043_118280044)del	NUS1|SLC35F1|LOC101927919		Tremor|generalized epilepsy with atypical absence seizures|Intellectual disability	Pathogenic	no assertion criteria provided	VCV000180225	6	117961791 - 118280044	6	117640628 - 117958881	180225	178413		
NM_003611.3(OFD1):c.1840del (p.Ala614fs)	OFD1	A614fs, A474fs, A574fs	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000503662	X	13778419	X	13760300	503662	495796	rs1555906894	NC_000023.11:13760299:G:
Single allele	OMP|OSBP|OVOL1|P2RX3|P2RY2|P2RY6|PAFAH1B2|PAK1|PAX6|PC|PDE2A|PDE3B|PGA5|PGR|PIK3C2A|PLCB3|POLR2G|POU2AF1|PPP1CA|PPP2R1B|PPP2R5B|PRCP|PRG2|THAP12|PSMA1|PSMC3|PTH|PTPRCAP|PTPRJ|PTS|PYGM|RAB3IL1|RAB6A|MAP4K2|RAD9A|RAG1|RAG2|RAPSN|PLAAT4|RBM4|RCN1|RDX|RELA|DPF2|SNORD15A|ROM1|RPS3|RPS6KB2|TRIM64B|TRIM49C|UBTFL1|BTBD18|MS4A4E|PGA3|PGA4|CLDN25|RASSF10|TRIM64C|MIR610|LOC728196|MS4A18|TRIM49D2|CSKMT|UQCC3|LOC100128088|C11orf91|ZNF705E|LOC100132686|ARHGEF17-AS1|BACE1-AS|CCDC179|NDUFV1-DT|ARAP1-AS2|CASP12|TPBGL|RBM14-RBM4|SAA2-SAA4|NDUFC2-KCTD14|FXYD6-FXYD2|MADD-AS1|RPS13|SAA1|SAA2|SAA4|SCN2B|SCN4B|SDHD|SIPA1|SLC1A2|SLC3A2|SLN|SPI1|SPTBN2|SSRP1|STX3|STX5|ABCC8|TAGLN|TCN1|TEAD1|THRSP|TM7SF2|TPH1|TRAF6|TRPC6|TSG101|TYR|UCP2|UCP3|SCGB1A1|UVRAG|VEGFB|BEST1|WNT11|WT1|SF1|ZFPL1|ZBTB16|CSRP3|PDHX|FOSL1|CUL5|PICALM|FZD4|BBOX1|PPFIA1|SLC43A1|DGKZ|CHST1|API5|MADD|JRKL|CTSF|EED|FADD|BANF1|ZPR1|MTMR2|RPS6KA4|AIP|SYT7|SART1|SLC6A5|FIBP|PCSK7|HTR3B|ZW10|MTA2|UBE2L6|SNORD29|SNORD31|SNORD30|SNORD28|SNORD27|SNORD26|SNORD25|SNORD22|MMP20|UBE4A|SLC22A6|SLC22A8|NRXN2|LPXN|PEX16|FADS2|MED17|MAPK8IP1|TP53I11|PITPNM1|RIN1|TESMIN|MICAL2|CEP57|ATG13|SPCS2|CKAP5|ARHGEF17|GAB2|FCHSD2|FGF19|CCS|RCE1|NAALAD2|NAALADL1|KCNE3|NR1H3|IL18BP|DPP3|USH1C|KCNK7|HIPK3|RBM7|PRMT3|MPZL2|RASGRP2|GLYAT|CDK2AP2|TCIRG1|RTN3|PRG3|YAP1|SPON1|RBM14|CDC42EP2|EIF3M|NXF1|KAT5|ZNRD2|HTATIP2|DRAP1|TAF6L|ATP5MG|SCGB1D2|SCGB1D1|CELF1|POLD3|OR5I1|STARD10|NEU3|ME3|GPR83|YIF1A|SRSF8|EHD1|C11orf58|STIP1|CLP1|SF3B2|CCDC85B|B4GAT1|PRSS23|PLAAT3|HPS5|PTGDR2|SLCO2B1|RRAS2|CEP164|ZP1|SHANK2|KDM2A|ENDOD1|EXPH5|ATG2A|GANAB|FAM168A|DTX4|SIK2|NUP160|FNBP4|SIK3|CLCF1|BACE1|FAM89B|SNHG1|POLA2|RAB38|CADM1|FLRT1|MTCH2|PANX1|FJX1|KIAA1549L|PRDX5|ABTB2|BRMS1|CATSPERZ|CHRDL2|PAMR1|ANAPC15|ZDHHC5|ATL3|TSKU|REXO2|C2CD3|TKFC|TENM4|B3GAT3|FBXO3|SERGEF|EHF|OR5L2|PPP1R14B|TIMM10|TIMM8B|MYEOV|BSCL2|ELP4|CHORDC1|DKK3|RAB30|PRPF19|C11orf54|AAMDC|MACROD1|SLC43A3|COMMD9|PACSIN3|SAC3D1|SNX15|RHOD|EFEMP2|NOX4|KCNK4|UBXN1|APIP|TMX2|GAL|SIDT2|KMT5B|HSD17B12|TMEM216|COA4|SLC15A3|PHF21A|MS4A4A|WT1-AS|PPME1|CABP2|HIKESHI|CWC15|TRMT112|TMEM138|PCF11|MRPL48|RSF1|FXYD6|C11orf24|CNTN5|C11orf71|ZDHHC13|WDR74|SLC35F2|RAB39A|TRIM44|BTG4|NXPE4|SYTL2|ANKRD49|MS4A12|MRPL16|SDHAF2|SSH3|TTC12|TMEM132A|PLAAT2|LAMTOR1|USP47|VPS37C|ANO1|NADSYN1|FAM86C1P|NKAPD1|NAT10|CCDC87|PPP6R3|UEVLD|RNF121|LIN7C|ACER3|SLC35C1|TCP11L1|LGR4|ELMOD1|SOX6|CDC42BPG|OTUB1|AMBRA1|PACS1|KDM4D|KBTBD4|PARVA|TTC17|TMEM126B|SLC22A11|TEX12|TMPRSS4|GPR137|SMCO4|EMSY|PRDM11|CABP4|SLC17A6|TRIM49|CD248|CORO1B|SCYL1|DSCAML1|USP35|CEP126|ARHGAP20|CARNS1|SYT13|USP28|LRRC4C|POLD4|KRTAP5-8|PLEKHB1|MS4A7|CREBZF|CARD18|CCDC90B|CCDC81|AASDHPPT|ALX4|FAM111A|ANO3|MMP27|MS4A6A|MS4A5|C11orf1|KLC2|TUT1|MRPL11|TMEM135|KCTD14|ZFTA|LRFN4|AHNAK|ALG8|PRRG4|TMEM223|TMEM109|CCDC86|LBHD1|C11orf49|TRIM48|TAF1D|DYNC2H1|C11orf80|NARS2|E2F8|CCDC82|ALG9|ZNF408|NAA40|QSER1|AGBL2|ZBTB3|CPSF7|PRR5L|ASRGL1|MOGAT2|TMEM134|MUS81|PAAF1|PDGFD|INTS5|ZFP91|TMPRSS5|OR8J3|OR4P4|OR4C15|OR4A5|OR4A16|OR4A15|OR10W1|GDPD5|CLPB|UNC93B1|RAB1B|KIF18A|C11orf68|MS4A8|FERMT3|TRPT1|RBM4B|FRMD8|BCO2|TMEM133|TMPRSS13|RNASEH2C|FAR1|TMEM126A|DCUN1D5|BTBD10|EIF1AD|NUDT22|ARFGAP2|MSANTD4|MAML2|SYVN1|DGAT2|ACCS|MS4A14|TRIM51|BUD13|PTPN5|MICALCL|RELT|CFAP300|LGALS12|TNKS1BP1|DIXDC1|CEP295|ZC3H12C|GAL3ST3|NAV2|ATG16L2|TSPAN18|CREB3L1|AP5B1|CCDC34|SLC39A13|DEPDC7|SYT12|ACY3|ALKBH8|FDXACB1|C11orf52|INTS4|GLYATL1|CDCA5|SAAL1|SLC22A9|CARD16|C1QTNF4|TMEM123|PTPMT1|BATF2|SLC22A12|MRGPRD|APOA5|MRGPRF|ARAP1|CATSPER1|MRGPRX2|MRGPRX3|MRGPRX4|PLAAT5|IFTAP|OR4C46|OR4X2|OR4B1|LARGE2|SLC36A4|FAT3|TRIM64|CYP2R1|DBX1|COLCA2|PIH1D2|NXPE1|NXPE2|JAML|DNAJC24|ARL14EP|OR8I2|LDLRAD3|XRRA1|MUC15|C11orf94|FAM76B|SESN3|PIWIL4|ARHGAP42|KBTBD3|CWF19L2|POGLUT3|LAYN|SPINDOC|PLEKHA7|SPTY2D1|TMEM86A|AMOTL1|SLC5A12|DEUP1|C11orf65|LDHAL6A|GPHA2|B3GNT6|METTL15|MPZL3|IMMP1L|ANO5|OR8U1|OR4C16|OR4C11|OR4S2|OR4C6|OR5D14|OR5L1|OR5D18|OR5AS1|OR8K5|OR5T2|OR8H1|OR8K3|OR8J1|OR8U3|OR5M3|OR5M8|OR5M11|OR5AR1|LRRC55|SMTNL1|YPEL4|MED19|FOLH1B|MRPL21|TPCN2|OR6Q1|OR9I1|OR9Q1|OR9Q2|OR1S2|OR1S1|OR10Q1|OR5B17|OR5B21|GLYATL2|MPEG1|OR5A2|OR5A1|OR4D6|OR4D11|PATL1|OOSP2|MS4A15|VWCE|CYB561A3|PPP1R32|GDPD4|DDIAS|CCDC83|LTO1|LRTOMT|TIGD3|FAM181B|CCDC89|LRRN4CL|HNRNPUL2|ALKBH3|MS4A6E|DEFB108B|PELI3|ANGPTL5|EHBP1L1|SNX32|TSGA10IP|RNF169|CNIH2|ZDHHC24|C11orf86|NUDT8|ACAT1|ACP2|ACTN3|GRK2|ANKK1|OR4C3|OR4S1|EML3|TMEM151A|RNF214|APLNR|ALDH3B1|ALDH3B2|BIRC2|BIRC3|APOA1|SVIP|MRGPRX1|NPAS4|SELENOH|AQP11|OR10AG1|APOA4|APOC3|ARHGAP1|PHOX2A|ARL2|ARNTL|OR5J2|OR4C13|OR4C12|TRIM49B|MAJIN|SLC25A45|ARRB1|ATM|FXYD2|BAD|BBS1|CCND1|NEAT1|OR9G4|P4HA3|PGM2L1|KLHL35|KCTD21|BDNF|SERPING1|CAPN5|VPS51|MRPL49|ZNHIT2|CCDC88B|TTC9C|SLC22A24|RCOR2|HARBI1|LINC00294|MPPED2|MYRF|TMEM258|DAGLA|CALCA|CALCB|IGSF22|LUZP2|OR5F1|OR5AP2|ANKRD13D|ANKRD42|CAPN1|CASP1|CASP4|CASP5|CAT|SERPINH1|CD3D|OTOG|DCDC1|C11orf53|MS4A10|OR2AT4|HEPHL1|CD3E|CD3G|CD5|CD6|MS4A1|MS4A3|TBX10|PLET1|RTN4RL2|NCR3LG1|FAM111B|TMEM179B|CD44|CD59|CFL1|CTSC|CHKA|CHRM1|TBC1D10C|DNAJB13|MALAT1|KRTAP5-10|SLC22A25|INSC|CHRM4|CLNS1A|CNTF|COPB1|COX8A|CPT1A|FIBIN|C11orf96|SLC22A10|SPDYC|LIPT2|VSTM5|CRY2|CRYAB|CST6|CSTF3|CTNND1|CTSW|DDB1|DDB2|DDX10|DHCR7|DLAT|DLG2|DRD2|EEF1G|ELF5|MARK2|CTTN|ESRRA|EXT2|F2|FANCF|FAU|MS4A2|FDX1|FEN1|FGF3|FGF4|FKBP2|FOLH1|FOLR1|FOLR2|FOLR3|FSHB|FTH1|FUT4|LRRC32|GAS2|CBLIF|GNG3|GRIA4|GRM5|GSTP1|GTF2H1|GUCY1A2|SLC29A2|HSPB2|DNAJC4|HTR3A|IGHMBP2|IL10RA|IL18|INCENP|INPPL1|CD82|ACCSL|OR4X1|OR5D13|OR5D16|OR5W2|OR8H2|KCNA4|KCNC1|KCNJ11|KRTAP5-9|LDHA|LDHC|OR8H3|OR5T3|OR5T1|OR8K1|OR5M9|OR5M10|FADS1|FADS3|LMO2|LRP4|LRP5|LTBP3|OR5M1|OR9G1|OR5AK2|OR5B2|OR5B12|OR5AN1|CAPRIN1|MAP6|MDK|MEN1|SCGB2A1|SCGB2A2|OR4D10|OR4D9|OR10V1|LRRC10B|GPR152|TRIM77|MAP3K11|KMT2A|MMP1|MMP3|MMP7|MMP8|IZUMO1R|KDM4E|FAM180B|PCNX3|TRIM49D1|C11orf87|MMP10|MMP12|MMP13|MRE11|MTNR1B|MYBPC3|HOATZ|OR4A47|SCGB1D4|MIR130A|MIR139|MIR192|MYO7A|MYOD1|NCAM1|NDUFC2|NDUFS3|NDUFV1|MIR194-2|MIR34B|MIR34C|DDI1|KRTAP5-7|KRTAP5-11|NDUFS8|NELL1|NNMT|NPAT|NUCB2|NUMA1|CARD17|OR5B3|MIR326|CCDC73|BDNF-AS|MS4A13		Intellectual disability	Pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV000997825	11	11835569 - 118373112			997825	985543		
OPHN1, 17.6-KB DEL	OPHN1		Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000011580					11580	26619		
NM_016023.5(OTUD6B):c.379_383del (p.Leu127fs)	OTUD6B	L127fs, L26fs	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies|Epilepsy|Dysmorphic features|Intellectual disability|not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000375702	8	92090644 - 92090648	8	91078416 - 91078420	375702	362592	rs759317757	NC_000008.11:91078415:AACTTAAC:AAC
NM_001198533.2(OXR1):c.1324del (p.Ser442fs)	OXR1	S435fs, S442fs, S443fs	Intellectual disability|Cerebellar atrophy|Seizures|Congenital cerebellar hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000694387	8	107719072	8	106706844	694387	682314		NC_000008.11:106706843:AA:A
NM_177939.3(P4HTM):c.949del (p.Val317fs)	P4HTM	V317fs	Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities	Pathogenic(Last reviewed: Jul 12, 2019)	no assertion criteria provided	VCV000635798	3	49042355	3	49004922	635798	623630	rs1576608329	NC_000003.12:49004921:G:
NM_002571.4(PAEP):c.311-444_*248del	PAEP		Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000666598	9	138455646 - 138458646	9	135563800 - 135566800	666598	654158		
NC_000017.11:g.(?_2638238)_(2638345_?)del	PAFAH1B1		Lissencephaly due to LIS1 mutation	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495279	17	2541532 - 2541639	17	2638238 - 2638345	495279	486766		
NC_000017.11:g.(?_2680139)_(2681852_?)del	PAFAH1B1		Lissencephaly due to LIS1 mutation	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495278	17	2583433 - 2585146	17	2680139 - 2681852	495278	486767		
GRCh37/hg19 13q32.3(chr13:100934274-101069066)x1	PCCA		not provided	Pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	VCV000686309	13	100934274 - 101069066			686309	673901		
NM_001184880.2(PCDH19):c.498del (p.Thr165_Tyr166insTer)	PCDH19		Early infantile epileptic encephalopathy 9	Likely pathogenic	no assertion criteria provided	VCV001184537	X	99663098	X	100408100	1184537	1174389		NC_000023.11:100408099:G:
NM_001184880.2(PCDH19):c.2502del (p.Asn834fs)	PCDH19	N787fs, N834fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV001074865	X	99657636	X	100402638	1074865	1065080		NC_000023.11:100402637:A:
NM_001184880.2(PCDH19):c.2619del (p.Glu874fs)	PCDH19	E827fs, E874fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV001073896	X	99605700	X	100350702	1073896	1065078		NC_000023.11:100350701:A:
NM_001184880.2(PCDH19):c.833del (p.Tyr278fs)	PCDH19	Y278fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001073149	X	99662763	X	100407765	1073149	1065092		NC_000023.11:100407764:T:
NC_000023.10:g.(?_99654182_99661939del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV001072978					1072978	1058357		
NC_000023.10:g.(?_99596891)_(99663595_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001072977	X	99596891 - 99663595			1072977	1058356		
NC_000023.10:g.(?_99596891)_(99597083_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV001072976	X	99596891 - 99597083			1072976	1058355		
NM_001184880.2(PCDH19):c.714del (p.Phe238fs)	PCDH19	F238fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001072832	X	99662882	X	100407884	1072832	1065095		NC_000023.11:100407883:AAA:AA
NM_001184880.2(PCDH19):c.1416_1420del (p.Leu473fs)	PCDH19	L473fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001071350	X	99662176 - 99662180	X	100407178 - 100407182	1071350	1065088		NC_000023.11:100407177:AGAGCAGA:AGA
NM_001184880.2(PCDH19):c.1985_1995del (p.Leu662fs)	PCDH19	L662fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001069939	X	99661601 - 99661611	X	100406603 - 100406613	1069939	1065083		NC_000023.11:100406602:AGCAGGGGACAAG:AG
NM_001184880.2(PCDH19):c.1671del (p.Asn557fs)	PCDH19	N557fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001069328	X	99661925	X	100406927	1069328	1065085		NC_000023.11:100406926:G:
NC_000023.10:g.(?_99640151_99663517del	PCDH19		Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV001066901					1066901	1054720		
NM_001184880.2(PCDH19):c.1639_1640delinsTT (p.Ala547Phe)	PCDH19	A547F	Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001042374	X	99661956 - 99661957	X	100406958 - 100406959	1042374	1035282		NC_000023.11:100406957:GC:AA
NM_001184880.2(PCDH19):c.85del (p.Ser28_Val29insTer)	PCDH19		Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000974568	X	99663511	X	100408513	974568	962866		NC_000023.11:100408512:CC:C
NM_001184880.2(PCDH19):c.1640delinsTA (p.Ala547fs)	PCDH19	A547fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000971886	X	99661956	X	100406958	971886	959143		NC_000023.11:100406957:G:TA
NM_001184880.2(PCDH19):c.581del (p.Lys194fs)	PCDH19	K194fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000969611	X	99663015	X	100408017	969611	959145		NC_000023.11:100408016:TTTT:TTT
NM_001184880.2(PCDH19):c.659del (p.Gly220fs)	PCDH19	G220fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000961561	X	99662937	X	100407939	961561	951551		NC_000023.11:100407938:CCC:CC
NM_001184880.2(PCDH19):c.1410del (p.Tyr471fs)	PCDH19	Y471fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000951388	X	99662186	X	100407188	951388	929519		NC_000023.11:100407187:GG:G
NM_001184880.2(PCDH19):c.1479_1483del (p.Pro494fs)	PCDH19	P494fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000950366	X	99662113 - 99662117	X	100407115 - 100407119	950366	929518		NC_000023.11:100407114:ACGGCACG:ACG
NM_001184880.2(PCDH19):c.1145del (p.Gly382fs)	PCDH19	G382fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000949455	X	99662451	X	100407453	949455	929520		NC_000023.11:100407452:CC:C
NM_001184880.2(PCDH19):c.476del (p.Gly159fs)	PCDH19	G159fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000949065	X	99663120	X	100408122	949065	929525		NC_000023.11:100408121:CC:C
NM_001184880.2(PCDH19):c.1808_1816del (p.Val603_Tyr605del)	PCDH19		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000938884	X	99661780 - 99661788	X	100406782 - 100406790	938884	939371		NC_000023.11:100406781:CGTAGGTGAC:C
NM_001184880.2(PCDH19):c.564del (p.Glu189fs)	PCDH19	E189fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000935578	X	99663032	X	100408034	935578	939375		NC_000023.11:100408033:GG:G
NM_001184880.2(PCDH19):c.490_513del (p.Gln164_Asn171del)	PCDH19		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000935184	X	99663083 - 99663106	X	100408085 - 100408108	935184	939376		NC_000023.11:100408084:GTTGGGCGTGAGCTCGTAAGTCTG:
NM_001184880.2(PCDH19):c.384_394del (p.Phe129fs)	PCDH19	F129fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000933682	X	99663202 - 99663212	X	100408204 - 100408214	933682	939378		NC_000023.11:100408203:CTGCCGGGAAACTG:CTG
NM_001184880.2(PCDH19):c.615del (p.Phe206fs)	PCDH19	F206fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870187	X	99662981	X	100407983	870187	858365		NC_000023.11:100407982:G:
NM_001184880.2(PCDH19):c.1973delinsGTA (p.Val658fs)	PCDH19	V658fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870166	X	99661623	X	100406625	870166	858361		NC_000023.11:100406624:A:TAC
NM_001184880.2(PCDH19):c.820_847del (p.Val274fs)	PCDH19	V274fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870163	X	99662749 - 99662776	X	100407751 - 100407778	870163	858364		NC_000023.11:100407750:CGTTGACGTAGCCATAGAAGGAGTAGACC:C
NM_001184880.2(PCDH19):c.2556_2559del (p.Phe853fs)	PCDH19	F853fs, F806fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870162	X	99657579 - 99657582	X	100402581 - 100402584	870162	858360		NC_000023.11:100402580:GAAAGA:GA
NM_001184880.2(PCDH19):c.687del (p.Asp230fs)	PCDH19	D230fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000855076	X	99662909	X	100407911	855076	849499		NC_000023.11:100407910:GG:G
NM_001184880.2(PCDH19):c.816_817del (p.Gln272fs)	PCDH19	Q272fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000841308	X	99662779 - 99662780	X	100407781 - 100407782	841308	849496		NC_000023.11:100407780:CC:
NM_001184880.2(PCDH19):c.533del (p.Ile178fs)	PCDH19	I178fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000837774	X	99663063	X	100408065	837774	849500		NC_000023.11:100408064:A:
NC_000023.11:g.(?_100402504)_(100408617_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000832431	X	99657502 - 99663615			832431	821538		
NC_000023.11:g.(?_100402504)_(100402871_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000831979	X	99657502 - 99657869			831979	821537		
NM_001184880.2(PCDH19):c.1206del (p.Ser403fs)	PCDH19	S403fs	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, single submitter	VCV000813757	X	99662390	X	100407392	813757	802040		NC_000023.11:100407391:G:
NM_001184880.2(PCDH19):c.2531_2540del (p.Ser844fs)	PCDH19	S844fs, S797fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000813750	X	99657598 - 99657607	X	100402600 - 100402609	813750	802039		NC_000023.11:100402599:TGGTTAGCACTGGT:TGGT
NM_001184880.2(PCDH19):c.745del (p.Glu249fs)	PCDH19	E249fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000813748	X	99662851	X	100407853	813748	802041		NC_000023.11:100407852:C:
NM_001184880.2(PCDH19):c.134_135del (p.Asp45fs)	PCDH19	D45fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804060	X	99663461 - 99663462	X	100408463 - 100408464	804060	792097	rs1602638456	NC_000023.11:100408462:GT:
NM_001184880.2(PCDH19):c.260_292del (p.Ile87_Pro97del)	PCDH19		Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804059	X	99663304 - 99663336	X	100408306 - 100408338	804059	792096	rs1602638228	NC_000023.11:100408305:TGGGGCTCTGGCGGCACAGCAGATCACGGTCAAT:T
NM_001184880.2(PCDH19):c.1172del (p.Asn391fs)	PCDH19	N391fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804056	X	99662424	X	100407426	804056	792093	rs1602636591	NC_000023.11:100407425:TT:T
NM_001184880.2(PCDH19):c.1623del (p.Ser542fs)	PCDH19	S542fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804054	X	99661973	X	100406975	804054	792091	rs1602635781	NC_000023.11:100406974:GGG:GG
NM_001184880.2(PCDH19):c.2624del (p.Asn875fs)	PCDH19	N828fs, N875fs	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000804050	X	99605695	X	100350697	804050	792087	rs34651888	NC_000023.11:100350696:TTTT:TTT
NM_001184880.2(PCDH19):c.3404_3405del (p.Lys1135fs)	PCDH19	K1088fs, K1087fs, K1135fs	not provided|Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804048	X	99551317 - 99551318	X	100296319 - 100296320	804048	792085	rs999749949	NC_000023.11:100296318:TTT:T
NC_000023.11:g.(?_100296257)_(100342095_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000665028	X	99551255 - 99597093	X	100296257 - 100342095	665028	653734		
NM_001184880.1(PCDH19):c.79_2616+17371del	PCDH19		Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000661243			X	100385153 - 100408519	661243	653485		
NC_000023.11:g.(?_100296257)_(100408617_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000654099	X	99551255 - 99663615	X	100296257 - 100408617	654099	653632		
NM_001184880.2(PCDH19):c.3248del (p.Tyr1083fs)	PCDH19	Y1035fs, Y1083fs, Y1036fs	Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000650979	X	99551474	X	100296476	650979	649565	rs1602566823	NC_000023.11:100296475:T:
NM_001184880.2(PCDH19):c.670del (p.Ser225fs)	PCDH19	S225fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000647772	X	99662926	X	100407928	647772	649581	rs1602637452	NC_000023.11:100407927:GG:G
NM_001184880.2(PCDH19):c.132del (p.Asp45fs)	PCDH19	D45fs	Early infantile epileptic encephalopathy 9|not provided	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000639643	X	99663464	X	100408466	639643	649587	rs1602638463	NC_000023.11:100408465:TTT:TT
NM_001184880.2(PCDH19):c.1682del (p.Pro561fs)	PCDH19	P561fs	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000637972	X	99661914	X	100406916	637972	625826	rs1602635656	NC_000023.11:100406915:GGGG:GGG
NM_001184880.2(PCDH19):c.971del (p.Asn324fs)	PCDH19	N324fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000620031	X	99662625	X	100407627	620031	611437		NC_000023.11:100407626:TT:T
NM_001184880.2(PCDH19):c.1091del (p.Pro364fs)	PCDH19	P364fs	Early infantile epileptic encephalopathy 9|History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589939	X	99662505	X	100407507	589939	580706	rs758946412	NC_000023.11:100407506:GGGGGGG:GGGGGG
NM_001184880.2(PCDH19):c.994del (p.Val332fs)	PCDH19	V332fs	Early infantile epileptic encephalopathy 9|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000589901	X	99662602	X	100407604	589901	580724	rs1569315156	NC_000023.11:100407603:CC:C
NM_001184880.2(PCDH19):c.827_829del (p.Ser276del)	PCDH19	S276del	Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000579744	X	99662767 - 99662769	X	100407769 - 100407771	579744	572148	rs1569315403	NC_000023.11:100407768:AGGAG:AG
NM_001184880.2(PCDH19):c.1121_1122del (p.Val373_Ser374insTer)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000576806	X	99662474 - 99662475	X	100407476 - 100407477	576806	572137	rs1569315042	NC_000023.11:100407475:AGA:A
NM_001184880.2(PCDH19):c.1853_1857delinsCGAAGTCAGAA (p.Asp618_Gln619delinsAlaLysSerGlu)	PCDH19		Early infantile epileptic encephalopathy 9	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000570838	X	99661739 - 99661743	X	100406741 - 100406745	570838	573497	rs1569314297	NC_000023.11:100406740:CTGGT:TTCTGACTTCG
NM_001184880.2(PCDH19):c.1657_2616+3340del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000565718	X	99654182 - 99661939	X	100399184 - 100406941	565718	575309		
NM_001184880.2(PCDH19):c.1676del (p.Asn559fs)	PCDH19	N559fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561073	X	99661920	X	100406922	561073	552236	rs1569314475	NC_000023.11:100406921:TT:T
NM_001184880.2(PCDH19):c.489_490delinsAT (p.Gln164Ter)	PCDH19	Q164*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000548139	X	99663106 - 99663107	X	100408108 - 100408109	548139	538624	rs1555985639	NC_000023.11:100408107:GC:AT
NC_000023.11:g.(?_100296257)_(100296895_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000533859	X	99551255 - 99551893	X	100296257 - 100296895	533859	534371		
NM_001184880.2(PCDH19):c.619del (p.Arg207fs)	PCDH19	R207fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000465307	X	99662977	X	100407979	465307	472038	rs1555985543	NC_000023.11:100407978:GG:G
NM_001184880.2(PCDH19):c.2453del (p.Gln818fs)	PCDH19	Q818fs, Q771fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000465300	X	99657685	X	100402687	465300	471657	rs1555984453	NC_000023.11:100402686:T:
NM_001184880.2(PCDH19):c.1442_1448del (p.Asp481fs)	PCDH19	D481fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000465297	X	99662148 - 99662154	X	100407150 - 100407156	465297	472034	rs1555985163	NC_000023.11:100407149:CCCAGGTC:C
NC_000023.10:g.(?_99551255)_(99926004_?)del	PCDH19|TNMD|TSPAN6|SRPX2		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000465294	X	99551255 - 99926004			465294	470389		
NM_001184880.2(PCDH19):c.138_139delinsTT (p.Arg47Ter)	PCDH19	R47*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000446433	X	99663457 - 99663458	X	100408459 - 100408460	446433	439889	rs1555985820	NC_000023.11:100408458:GC:AA
NM_001184880.2(PCDH19):c.2341del (p.Ile781fs)	PCDH19	I734fs, I781fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000408902	X	99657797	X	100402799	408902	404418	rs1060502175	NC_000023.11:100402798:TTTTTTT:TTTTTT
NM_001184880.2(PCDH19):c.457_458delinsAT (p.Ala153Ile)	PCDH19	A153I	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000216981	X	99663138 - 99663139	X	100408140 - 100408141	216981	213663	rs863224907	NC_000023.11:100408139:GC:AT
NM_001184880.2(PCDH19):c.199_207del (p.Ser67_Pro69del)	PCDH19		not specified	Uncertain significance(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000206365	X	99663389 - 99663397	X	100408391 - 100408399	206365	203952	rs796052840	NC_000023.11:100408390:TGGAGCCGA:
NM_001184880.2(PCDH19):c.2399del (p.Asn800fs)	PCDH19	N753fs, N800fs	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000206360	X	99657739	X	100402741	206360	203887	rs796052836	NC_000023.11:100402740:TT:T
NM_001184880.2(PCDH19):c.1683_1696del (p.Val562fs)	PCDH19	V562fs	not provided	Pathogenic(Last reviewed: Apr 30, 2014)	criteria provided, single submitter	VCV000206356	X	99661900 - 99661913	X	100406902 - 100406915	206356	203903	rs796052832	NC_000023.11:100406901:GGGCTGTGATGACCGGG:GGG
NM_001184880.2(PCDH19):c.1308del (p.Lys437fs)	PCDH19	K437fs	not provided	Pathogenic(Last reviewed: Apr 23, 2012)	criteria provided, single submitter	VCV000206355	X	99662288	X	100407290	206355	203914	rs796052831	NC_000023.11:100407289:GG:G
NM_001184880.2(PCDH19):c.1134del (p.Gly379fs)	PCDH19	G379fs	not provided	Pathogenic(Last reviewed: Oct 31, 2012)	criteria provided, single submitter	VCV000206354	X	99662462	X	100407464	206354	203920	rs796052830	NC_000023.11:100407463:T:
NM_001184880.2(PCDH19):c.1059_1062del (p.Glu354fs)	PCDH19	E354fs	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206351	X	99662534 - 99662537	X	100407536 - 100407539	206351	203923	rs796052828	NC_000023.11:100407535:CTCACT:CT
NM_001184880.2(PCDH19):c.805del (p.Thr269fs)	PCDH19	T269fs	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206350	X	99662791	X	100407793	206350	203928	rs796052827	NC_000023.11:100407792:T:
NM_001184880.2(PCDH19):c.524del (p.Gly175fs)	PCDH19	G175fs	not provided	Pathogenic(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	VCV000206349	X	99663072	X	100408074	206349	203938	rs796052826	NC_000023.11:100408073:CC:C
NM_018938.4(PCDHB4):c.915del (p.Lys305fs)	PCDHB4|PCDHB@	K305fs	not provided|Intellectual disability|Microcephaly|Seizures	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV000183300	5	140502487	5	141122905	183300	181417	rs372292910	NC_000005.10:141122904:AAAAAAAAA:AAAAAAAA
NM_000209.4(PDX1):c.188del (p.Pro63fs)	PDX1	P63fs	Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young type 4|not provided|Pancreatic agenesis 1|Maturity-onset diabetes of the young type 4	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021124	13	28494458	13	27920321	21124	33976	rs193929377	NC_000013.11:27920320:CCCCCC:CCCCC
PDX1, 1-BP DEL, 188C	PDX1		Maturity-onset diabetes of the young type 4|Pancreatic agenesis 1	Pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000008857					8857	23896		
GRCh37/hg19 19q13.11(chr19:33963521-33975799)x1	PEPD		not provided	Pathogenic(Last reviewed: Mar 13, 2018)	no assertion criteria provided	VCV000686349	19	33963521 - 33975799			686349	673941		
GRCh37/hg19 2q32.3-33.1(chr2:197359024-201383462)x1	PGAP1|MAIP1|C2orf66|HSPD1|CCDC150|FTCDNL1|C2orf69|TYW5|SATB2|SF3B1|KCTD18|ANKRD44|BOLL|MOB4|GTF3C3|RFTN2|SPATS2L|PLCL1|HSPE1|COQ10B|HECW2|MARS2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Nov 14, 2019)	no assertion criteria provided	VCV000983310	2	197359024 - 201383462			983310	971378		
NM_001015877.2(PHF6):c.829del (p.Arg277fs)	PHF6	R277fs, R278fs	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000846281	X	133549141	X	134415111	846281	849662		NC_000023.11:134415110:AAAAA:AAAA
NM_001015877.2(PHF6):c.139-11_139-7del	PHF6		Borjeson-Forssman-Lehmann syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000594571	X	133512021 - 133512025	X	134377991 - 134377995	594571	585634	rs781657256	NC_000023.11:134377990:AATGTAAT:AAT
NM_001015877.2(PHF6):c.113del (p.Lys38fs)	PHF6	K38fs	Borjeson-Forssman-Lehmann syndrome	Uncertain significance(Last reviewed: Dec 31, 2016)	criteria provided, single submitter	VCV000375264	X	133511759	X	134377729	375264	361966	rs1057519064	NC_000023.11:134377728:AA:A
NM_004204.5(PIGQ):c.1532-17del	PIGQ		Developmental and epileptic encephalopathy, 77|Epilepsy|not provided	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV001164856	16	632231	16	582231	1164856	1157769		NC_000016.10:582230:G:
NM_004204.5(PIGQ):c.1531+9del	PIGQ		Epilepsy	Likely benign(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV001141662	16	630981	16	580981	1141662	1146384		NC_000016.10:580980:T:
NM_004204.5(PIGQ):c.638_639delinsTT (p.Cys213Phe)	PIGQ	C213F	Epilepsy	Uncertain significance(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000956711	16	624712 - 624713	16	574712 - 574713	956711	949447		NC_000016.10:574711:GC:TT
NM_004204.5(PIGQ):c.618del (p.Arg206fs)	PIGQ	R206fs	Epilepsy	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000644371	16	624691	16	574691	644371	644787	rs1229740428	NC_000016.10:574690:GG:G
NC_000016.10:g.(?_582883)_(648190_?)del	PIGQ|RAB40C|TRG-CCC2-2|METTL26|MCRIP2|WFIKKN1|LOC100287175		Epilepsy	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000583884	16	632883 - 698190	16	582883 - 648190	583884	569392		
NC_000016.10:g.(?_578765)_(579200_?)del	PIGQ		Epilepsy	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000526296	16	628765 - 629200	16	578765 - 579200	526296	529849		
NM_004204.5(PIGQ):c.39_40delinsAG (p.Thr14Ala)	PIGQ	T14A	Epilepsy	Uncertain significance(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000526275	16	624113 - 624114	16	574113 - 574114	526275	530366	rs1555451582	NC_000016.10:574112:GA:AG
NM_004204.5(PIGQ):c.968_969del (p.Leu323fs)	PIGQ	L323fs	Epilepsy|Developmental and epileptic encephalopathy, 77|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000520669	16	628404 - 628405	16	578404 - 578405	520669	512217	rs747661902	NC_000016.10:578403:TG:
NM_004204.5(PIGQ):c.1199_1201del (p.Tyr400del)	PIGQ	Y400del	Developmental and epileptic encephalopathy, 77|Inborn genetic diseases|not provided|Epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000449630	16	628912 - 628914	16	578912 - 578914	449630	445592	rs766667249	NC_000016.10:578911:CTACT:CT
GRCh37/hg19 16q22.2(chr16:72001049-72029303)x1	PKD1L3		not provided	Benign(Last reviewed: Jun 7, 2011)	no assertion criteria provided	VCV000615099	16	72001049 - 72029303			615099	606435		
GRCh37/hg19 6p12.3(chr6:51589088-51673301)x1	PKHD1		not provided	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000686576	6	51589088 - 51673301			686576	674168		
NC_000020.10:g.(?_8113299)_(8352107_?)del	PLCB1		Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001070277	20	8113299 - 8352107			1070277	1058091		
NC_000020.10:g.(?_8113279)_(8352117_?)del	PLCB1		Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000831489	20	8113279 - 8352117			831489	821314		
GRCh37/hg19 5q11.2(chr5:56283070-58079028)x1	PLK2|GPBP1|RAB3C|GAPT|ACTBL2		not provided	Uncertain significance(Last reviewed: Sep 22, 2017)	no assertion criteria provided	VCV000685431	5	56283070 - 58079028			685431	673023		
NM_007198.4(PLPBP):c.773del (p.Pro258fs)	PLPBP	P256fs, P258fs, P268fs, P206fs	Epilepsy, early-onset, vitamin b6-dependent	Uncertain significance(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000816888	8	37635564	8	37778046	816888	805088	rs764045400	NC_000008.11:37778045:CCCC:CCC
NM_007254.4(PNKP):c.1295_1298+6del	PNKP		Early infantile epileptic encephalopathy 12|Early infantile epileptic encephalopathy 10|Ataxia-oculomotor apraxia type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000159788	19	50365023 - 50365032	19	49861766 - 49861775	159788	169587	rs587784366	NC_000019.10:49861765:CGCTACCTGGCGC:CGC
NM_018129.4(PNPO):c.205delinsTTTCCCCT (p.Ala69fs)	PNPO	A69fs	Pyridoxal phosphate-responsive seizures	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000967984	17	46020738	17	47943372	967984	958152		NC_000017.11:47943371:G:TTTCCCCT
NM_018129.3(PNPO):c.*2535_*2539delCAACC	PNPO		Pyridoxal phosphate-responsive seizures	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000369216	17	46026683 - 46026687	17	47949317 - 47949321	369216	353445	rs144540976	NC_000017.11:47949316:CAACCC:C
NM_018129.4(PNPO):c.*731del	PNPO		Pyridoxal phosphate-responsive seizures	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000323921	17	46024870	17	47947504	323921	339049	rs796725211	NC_000017.11:47947503:TTTTTTTTTT:TTTTTTTTT
NM_018129.4(PNPO):c.448_451del (p.Pro150fs)	PNPO	P150fs	Pyridoxal phosphate-responsive seizures|not provided	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	VCV000206460	17	46023254 - 46023257	17	47945888 - 47945891	206460	203481	rs796052872	NC_000017.11:47945887:CTGCCTG:CTG
NC_000015.9:g.(?_89753516)_(89876985_?)del	POLG|RLBP1|FANCI		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001076353	15	89753516 - 89876985			1076353	1057716		
NM_002693.3(POLG):c.2004del (p.Met669fs)	POLG	M669fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001073559	15	89867404	15	89324173	1073559	1063437		NC_000015.10:89324172:C:
NC_000015.9:g.(?_89862162_89864159del	POLG		Progressive sclerosing poliodystrophy	Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV001068175					1068175	1054571		
NM_002693.3(POLG):c.1434-7del	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001014182	15	89870301	15	89327070	1014182	1011681		NC_000015.10:89327069:A:
NM_002693.3(POLG):c.67_88del (p.Gly23fs)	POLG	G23fs	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000984421	15	89876898 - 89876919	15	89333667 - 89333688	984421	972490		NC_000015.10:89333666:CGGAGCTGGAGACCCAGCGCCCCGGAGCTGGA:CGGAGCTGGA
NM_002693.3(POLG):c.2599-5del	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000954670	15	89864496	15	89321265	954670	960124		NC_000015.10:89321264:GGG:GG
NM_002693.3(POLG):c.1022_1023delinsAT (p.Ala341Asp)	POLG	A341D	Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000946586	15	89872174 - 89872175	15	89328943 - 89328944	946586	927448		NC_000015.10:89328942:CG:AT
NM_002693.3(POLG):c.1887del (p.Asp629fs)	POLG	D629fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000942821	15	89868743	15	89325512	942821	937107		NC_000015.10:89325511:G:
NM_002693.3(POLG):c.1818del (p.Trp607fs)	POLG	W607fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000936926	15	89868812	15	89325581	936926	937108		NC_000015.10:89325580:GG:G
NC_000015.10:g.(?_89316731)_(89316847_?)del	POLG|FANCI		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000831259	15	89859962 - 89860078			831259	820741		
NM_002693.3(POLG):c.3282del (p.Ser1095fs)	POLG	S1095fs	Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type	Likely pathogenic	criteria provided, single submitter	VCV000813494	15	89861972	15	89318741	813494	801729	rs1596350117	NC_000015.10:89318740:GG:G
NM_002693.3(POLG):c.2515del (p.Ala839fs)	POLG	A839fs	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000807660	15	89865050	15	89321819	807660	798691	rs1596352895	NC_000015.10:89321818:CCCC:CCC
NM_002693.3(POLG):c.159delinsGCAACAGCAGCCT (p.Pro56_Gln57insGlnProGlnGln)	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000648340	15	89876827	15	89333596	648340	643619	rs1596362608	NC_000015.10:89333595:T:AGGCTGCTGTTGC
NM_002693.3(POLG):c.2157+5_2157+6delinsAG	POLG		Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619500	15	89867040 - 89867041	15	89323809 - 89323810	619500	610897	rs1596354607	NC_000015.10:89323808:GC:CT
NM_002693.3(POLG):c.2266-48del	POLG		Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619468	15	89866181	15	89322950	619468	610849	rs766283304	NC_000015.10:89322949:T:
NM_002693.3(POLG):c.1562del (p.Pro521fs)	POLG	P521fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619448	15	89870166	15	89326935	619448	610774	rs1567191094	NC_000015.10:89326934:GGGG:GGG
NM_002693.3(POLG):c.2038del (p.Leu680fs)	POLG	L680fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619396	15	89867370	15	89324139	619396	610764	rs1567188632	NC_000015.10:89324138:GG:G
NM_002693.3(POLG):c.1950-32_1950-30del	POLG		Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619361	15	89867488 - 89867490	15	89324257 - 89324259	619361	610862	rs1567188748	NC_000015.10:89324256:GCTG:G
NM_002693.3(POLG):c.1251-23del	POLG		Progressive sclerosing poliodystrophy	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619356	15	89870603	15	89327372	619356	610876	rs541579481	NC_000015.10:89327371:T:
NM_002693.3(POLG):c.2845_2847del (p.Phe949del)	POLG	F949del	Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000619330	15	89864131 - 89864133	15	89320900 - 89320902	619330	610735	rs1567186596	NC_000015.10:89320899:GAAGA:GA
NM_002693.3(POLG):c.2391_2393del (p.Met797del)	POLG	M797del	Progressive sclerosing poliodystrophy	Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619325	15	89866006 - 89866008	15	89322775 - 89322777	619325	610757	rs1567187766	NC_000015.10:89322774:ATCAT:AT
NM_002693.3(POLG):c.3483-4_3497del	POLG		Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619313	15	89860753 - 89860771	15	89317522 - 89317540	619313	610813	rs756325504	NC_000015.10:89317521:TAGGCAAACATGCACCTGA:
NM_002693.3(POLG):c.3149del (p.Lys1050fs)	POLG	K1050fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000619309	15	89862286	15	89319055	619309	610724	rs1567185603	NC_000015.10:89319054:TT:T
NM_000326.5(RLBP1):c.504_508del (p.Ser168fs)	POLG|RLBP1	S168fs	not provided|Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000595846	15	89758308 - 89758312	15	89215077 - 89215081	595846	586908	rs1379405913	NC_000015.10:89215076:CTTGACTT:CTT
NM_002693.3(POLG):c.125_139del (p.Arg42_Gln46del)	POLG		not provided|Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Feb 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000581378	15	89876847 - 89876861	15	89333616 - 89333630	581378	569210	rs780010436	NC_000015.10:89333615:GCTGCTGCTGCTGCCGC:GC
NM_002693.3(POLG):c.134_137delinsG (p.Gln45_Gln46delinsArg)	POLG		Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000580549	15	89876849 - 89876852	15	89333618 - 89333621	580549	567336	rs1567194455	NC_000015.10:89333617:TGCT:C
NM_002693.3(POLG):c.646del (p.Ser216fs)	POLG	S216fs	Progressive sclerosing poliodystrophy	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000567927	15	89876340	15	89333109	567927	573580	rs1567193844	NC_000015.10:89333108:A:
NM_002693.3(POLG):c.1615_1623del (p.Phe539_Gln541del)	POLG		Mitochondrial DNA depletion syndrome 4B, MNGIE type|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive sclerosing poliodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000548594	15	89869932 - 89869940	15	89326701 - 89326709	548594	539063	rs754586219	NC_000015.10:89326700:TTGTTGAAA:
NM_002693.3(POLG):c.3716del (p.Pro1239fs)	POLG|FANCI	P1239fs	Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000528384	15	89859986	15	89316755	528384	529106	rs1555452076	NC_000015.10:89316754:GG:G
NM_002693.3(POLG):c.158_166del (p.Gln53_Gln55del)	POLG		Progressive sclerosing poliodystrophy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000501355	15	89876820 - 89876828	15	89333589 - 89333597	501355	492779	rs769735492	NC_000015.10:89333588:GCTGCTGTTGCTGCTG:GCTGCTG
NM_002693.3(POLG):c.1646del (p.Leu549fs)	POLG	L549fs	not provided|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1	Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449949	15	89869909	15	89326678	449949	445459	rs1555453538	NC_000015.10:89326677:AA:A
NM_002693.3(POLG):c.158_159delinsCT (p.Gln53Pro)	POLG	Q53P	not provided|Progressive sclerosing poliodystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 9, 2021)	criteria provided, conflicting interpretations	VCV000422763	15	89876827 - 89876828	15	89333596 - 89333597	422763	409384	rs1064795981	NC_000015.10:89333595:TT:AG
NM_002693.3(POLG):c.380_386del (p.Leu127fs)	POLG	L127fs	not provided|Progressive sclerosing poliodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420842	15	89876600 - 89876606	15	89333369 - 89333375	420842	409382	rs1064794735	NC_000015.10:89333368:GGCGGCAGGCG:GGCG
NM_002693.3(POLG):c.1612_1613delinsTT (p.Glu538Leu)	POLG	E538L	not specified|Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206634	15	89869942 - 89869943	15	89326711 - 89326712	206634	203004	rs796052921	NC_000015.10:89326710:TC:AA
NM_002693.3(POLG):c.2395del (p.Ser799fs)	POLG	S799fs	Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206632	15	89866004	15	89322773	206632	202969	rs796052919	NC_000015.10:89322772:AAA:AA
NM_002693.3(POLG):c.-186_-185delinsCC	POLG		not specified	Likely benign(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000206495	15	89877929 - 89877930	15	89334698 - 89334699	206495	203071	rs796052879	NC_000015.10:89334697:CT:GG
NM_002693.3(POLG):c.3105-16_3105-15del	POLG		Progressive sclerosing poliodystrophy|not specified|not provided	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206472	15	89862345 - 89862346	15	89319114 - 89319115	206472	202936	rs146915033	NC_000015.10:89319113:ACA:A
NC_000020.10:g.(?_61977556)_(62159505_?)del	PPDPF|EEF1A2|KCNQ2|CHRNA4		Autosomal dominant nocturnal frontal lobe epilepsy|Early infantile epileptic encephalopathy with suppression bursts|Epileptic encephalopathy, early infantile, 33	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2020)	criteria provided, conflicting interpretations	VCV000476031	20	61977556 - 62159505			476031	471353		
NM_001099403.2(PRDM8):c.1767_1787del (p.Ala592_Ala598del)	PRDM8		Epilepsy, progressive myoclonic, 10	Uncertain significance(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000956276	4	81124381 - 81124401	4	80203227 - 80203247	956276	944131		NC_000004.12:80203226:GCTGCAGCCGCGGCTGCGGCGGC:GC
NM_001099403.2(PRDM8):c.1279_1284del (p.Ala427_Ala428del)	PRDM8		Epilepsy, progressive myoclonic, 10	Uncertain significance(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000939773	4	81123890 - 81123895	4	80202736 - 80202741	939773	932447		NC_000004.12:80202735:CCGCGGCCGCG:CCGCG
NM_001099403.2(PRDM8):c.1779_1796del (p.Ala594_Gly599del)	PRDM8		Epilepsy, progressive myoclonic, 10	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000719793	4	81124395 - 81124412	4	80203241 - 80203258	719793	721086	rs574748973	NC_000004.12:80203240:TGCGGCGGCGGCCGCGGG:
NM_001099403.2(PRDM8):c.1951_1952delinsAT (p.Glu651Met)	PRDM8	E651M	Epilepsy, progressive myoclonic, 10	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000662898	4	81124567 - 81124568	4	80203413 - 80203414	662898	632472	rs1578268165	NC_000004.12:80203412:GA:AT
NM_001099403.2(PRDM8):c.850_861del (p.Ser284_Ser287del)	PRDM8		Epilepsy, progressive myoclonic, 10	Uncertain significance(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000475685	4	81123465 - 81123476	4	80202311 - 80202322	475685	453787	rs1455395711	NC_000004.12:80202310:CAGCAGCGGTAGC:C
NM_001099403.2(PRDM8):c.1778_1795del (p.Ala593_Ala598del)	PRDM8		Epilepsy, progressive myoclonic, 10	Benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV000475674	4	81124387 - 81124404	4	80203233 - 80203250	475674	453812	rs755316101	NC_000004.12:80203232:GCCGCGGCTGCGGCGGCGGCCGCGG:GCCGCGG
NM_153026.3(PRICKLE1):c.1985_1996delinsG (p.Asn662fs)	PRICKLE1	N662fs	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000970481	12	42854111 - 42854122	12	42460309 - 42460320	970481	956869		NC_000012.12:42460308:TCTCTTCAAAAT:C
NM_153026.3(PRICKLE1):c.473del (p.Cys158fs)	PRICKLE1	C158fs	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000951274	12	42862543	12	42468741	951274	926629		NC_000012.12:42468740:C:
NM_153026.3(PRICKLE1):c.2141_2142delinsTT (p.Gln714Leu)	PRICKLE1	Q714L	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000940233	12	42853965 - 42853966	12	42460163 - 42460164	940233	936116		NC_000012.12:42460162:CT:AA
NM_153026.3(PRICKLE1):c.1088_1089delinsAT (p.Leu363His)	PRICKLE1	L363H	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000856256	12	42858747 - 42858748	12	42464945 - 42464946	856256	839916		NC_000012.12:42464944:GA:AT
NM_153026.3(PRICKLE1):c.133-5del	PRICKLE1		Progressive myoclonus epilepsy with ataxia|not provided	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000761118	12	42864166	12	42470364	761118	776041	rs1009731020	NC_000012.12:42470363:AAAA:AAA
NM_153026.3(PRICKLE1):c.1639+8_1639+20del	PRICKLE1		not provided|Progressive myoclonus epilepsy with ataxia	Likely benign(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000743788	12	42858177 - 42858189	12	42464375 - 42464387	743788	760203	rs1488350369	NC_000012.12:42464374:ATAATCCCTAGAT:
NM_153026.3(PRICKLE1):c.588+10del	PRICKLE1		not specified|Progressive myoclonus epilepsy with ataxia	Likely benign(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000510500	12	42862418	12	42468616	510500	504861	rs766626651	NC_000012.12:42468615:TTTTTTTT:TTTTTTT
NM_153026.3(PRICKLE1):c.139del (p.Leu47fs)	PRICKLE1	L47fs	Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000469503	12	42864155	12	42470353	469503	462459	rs1555230922	NC_000012.12:42470352:G:
NM_153026.3(PRICKLE1):c.775+9_775+18del	PRICKLE1		not specified|Progressive myoclonus epilepsy with ataxia	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000418809	12	42859978 - 42859987	12	42466176 - 42466185	418809	408654	rs769446547	NC_000012.12:42466175:GGCTGGCTGTGG:GG
NM_153026.3(PRICKLE1):c.1413_1414delinsTC (p.Met471_Tyr472delinsIleHis)	PRICKLE1		Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Oct 15, 2016)	criteria provided, single submitter	VCV000410635	12	42858422 - 42858423	12	42464620 - 42464621	410635	399457	rs1060502985	NC_000012.12:42464619:AC:GA
NM_153026.3(PRICKLE1):c.*552del	PRICKLE1		Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308692	12	42853059	12	42459257	308692	324780	rs68074167	NC_000012.12:42459256:TTTTTTTTTTT:TTTTTTTTTT
NM_153026.3(PRICKLE1):c.*594_*595del	PRICKLE1		Progressive myoclonus epilepsy with ataxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308691	12	42853016 - 42853017	12	42459214 - 42459215	308691	317066	rs769616581	NC_000012.12:42459213:TT:
Single allele	PRICKLE1		Progressive myoclonus epilepsy with ataxia	Likely pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000243056	12	42870202 - 42899456	12	42476400 - 42505654	243056	244138		
NM_153026.3(PRICKLE1):c.8del (p.Leu3fs)	PRICKLE1	L3fs	not specified	Uncertain significance(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	VCV000206674	12	42866311	12	42472509	206674	202709	rs754532709	NC_000012.12:42472508:AAA:AA
NM_198859.4(PRICKLE2):c.1286_1287del (p.Ser429fs)	PRICKLE2	S429fs	See cases	Likely pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, single submitter	VCV001064441	3	64132879 - 64132880	3	64147203 - 64147204	1064441	1052628		NC_000003.12:64147202:AC:
NM_198859.4(PRICKLE2):c.*579del	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346468	3	64084148	3	64098472	346468	295967	rs35195442	NC_000003.12:64098471:AAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAA
NM_198859.4(PRICKLE2):c.*580del	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346467	3	64084147	3	64098471	346467	295966	rs370988517	NC_000003.12:64098470:G:
NM_198859.4(PRICKLE2):c.*584del	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346464	3	64084143	3	64098467	346464	292650	rs886058795	NC_000003.12:64098466:T:
NM_198859.4(PRICKLE2):c.*2288_*2296delinsT	PRICKLE2|PRICKLE2-AS1		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000346442	3	64082431 - 64082439	3	64096755 - 64096763	346442	295956	rs386661734	NC_000003.12:64096754:TGAGAAAGG:A
NM_198859.4(PRICKLE2):c.380del (p.Gly127fs)	PRICKLE2	G127fs	Epilepsy, progressive myoclonic 5	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	VCV000209186	3	64145632	3	64159956	209186	205736	rs797045065	NC_000003.12:64159955:CC:C
GRCh37/hg19 17q24.2(chr17:64582010-64733650)x1	PRKCA		not provided	Uncertain significance(Last reviewed: Feb 12, 2018)	no assertion criteria provided	VCV000685353	17	64582010 - 64733650			685353	672945		
GRCh37/hg19 6q26(chr6:162615960-162895692)x1	PRKN		not provided	Uncertain significance(Last reviewed: Jun 28, 2018)	no assertion criteria provided	VCV000687890	6	162615960 - 162895692			687890	675482		
GRCh37/hg19 Xp22.33-22.31(chrX:3185613-6333441)x0	PRKX|MXRA5|NLGN4X		not provided	Uncertain significance(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000688412	X	3185613 - 6333441			688412	676004		
GRCh37/hg19 22q11.21(chr22:18916842-19024659)x1	PRODH|DGCR2		not provided	Uncertain significance(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000685149	22	18916842 - 19024659			685149	672741		
GRCh37/hg19 10p13(chr10:13469262-13747769)x1	PRPF18|FRMD4A|BEND7		not provided	Uncertain significance(Last reviewed: Sep 11, 2018)	no assertion criteria provided	VCV000688300	10	13469262 - 13747769			688300	675892		
NM_145239.3(PRRT2):c.341_342del (p.Val114fs)	PRRT2	V114fs	Seizures, benign familial infantile, 2	Likely pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000976325	16	29824715 - 29824716	16	29813394 - 29813395	976325	964449		NC_000016.10:29813393:GTG:G
NC_000016.10:g.(?_29813054)_(29813955_?)del	PRRT2		Seizures, benign familial infantile, 2	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000813798					813798	802059		
NC_000016.10:g.(?_29813045)_(29814648_?)del	PRRT2		Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000645873	16	29824366 - 29825969	16	29813045 - 29814648	645873	652624		
NM_145239.3(PRRT2):c.304del (p.Glu102fs)	PRRT2	E102fs	Seizures, benign familial infantile, 2|Episodic kinesigenic dyskinesia 1|Infantile convulsions and choreoathetosis	Likely pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000626000	16	29824679	16	29813358	626000	614422	rs1567379016	NC_000016.10:29813357:G:
NM_145239.3(PRRT2):c.799del (p.Asp267fs)	PRRT2	D267fs	Infantile convulsions and choreoathetosis	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623391	16	29825172	16	29813851	623391	612309	rs1567380076	NC_000016.10:29813850:GGG:GG
NM_145239.3(PRRT2):c.972_975del (p.Val325fs)	PRRT2	V325fs	Episodic kinesigenic dyskinesia 1	Likely pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000536484	16	29825746 - 29825749	16	29814425 - 29814428	536484	529993	rs1555502908	NC_000016.10:29814424:AGTC:
NM_145239.3(PRRT2):c.535_538del (p.Gln179fs)	PRRT2	Q179fs	Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Feb 4, 2017)	criteria provided, single submitter	VCV000522556	16	29824907 - 29824910	16	29813586 - 29813589	522556	513169	rs1555502708	NC_000016.10:29813585:AAGCAAG:AAG
NC_000016.10:g.(?_29824300)_(29826034_?)del	PRRT2|MVP		Infantile convulsions and choreoathetosis	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495288			16	29824300 - 29826034	495288	486761		
NC_000016.10:g.(?_29813035)_(29814658_?)del	PRRT2		Paroxysmal kinesigenic dyskinesia	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000468611	16	29824356 - 29825979	16	29813035 - 29814658	468611	464834		
NM_145239.3(PRRT2):c.323_324del (p.Thr108fs)	PRRT2	T108fs	not provided|Paroxysmal kinesigenic dyskinesia	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000280022	16	29824697 - 29824698	16	29813376 - 29813377	280022	264777	rs886041327	NC_000016.10:29813375:ACA:A
NM_145239.3(PRRT2):c.650del (p.Arg217fs)	PRRT2	R217fs	Seizures, benign familial infantile, 2|not provided	Likely pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000183020	16	29825025	16	29813704	183020	181171	rs730882124	NC_000016.10:29813703:G:
NM_145239.3(PRRT2):c.291del (p.Asn98fs)	PRRT2	N98fs	Seizures, benign familial infantile, 2	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039755	16	29824665	16	29813344	39755	48354	rs730882073	NC_000016.10:29813343:CC:C
NM_145239.3(PRRT2):c.629del (p.Pro210fs)	PRRT2	P210fs	Seizures, benign familial infantile, 2	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039754	16	29824998	16	29813677	39754	48353	rs730882067	NC_000016.10:29813676:CCCCCCC:CCCCCC
NM_145239.3(PRRT2):c.649del (p.Arg217fs)	PRRT2	R217fs	Seizures, benign familial infantile, 2|Episodic kinesigenic dyskinesia 1|not provided|Paroxysmal kinesigenic dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039752	16	29825016	16	29813695	39752	48351	rs587778771	NC_000016.10:29813694:CCCCCCCCC:CCCCCCCC
NM_145239.3(PRRT2):c.972del (p.Val325fs)	PRRT2	V325fs	Episodic kinesigenic dyskinesia 1	Pathogenic(Last reviewed: Nov 20, 2011)	no assertion criteria provided	VCV000031170	16	29825746	16	29814425	31170	40127	rs730882066	NC_000016.10:29814424:A:
NM_000314.8(PTEN):c.255_262delinsC (p.Ala86fs)	PTEN	A259fs, A86fs	Hemimegalencephaly	Pathogenic(Last reviewed: Mar 23, 2021)	criteria provided, single submitter	VCV001048543	10	89692771 - 89692778	10	87933014 - 87933021	1048543	1036490		NC_000010.11:87933013:TGCACAAT:C
GRCh37/hg19 9p24.1(chr9:8684982-8788779)x1	PTPRD		not provided	Uncertain significance(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000686629	9	8684982 - 8788779			686629	674221		
GRCh37/hg19 9p24.1(chr9:8509505-8619969)x1	PTPRD		not provided	Uncertain significance(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000685381	9	8509505 - 8619969			685381	672973		
GRCh37/hg19 20q12(chr20:40531441-40723901)x1	PTPRT		not provided	Uncertain significance(Last reviewed: Nov 16, 2017)	no assertion criteria provided	VCV000687416	20	40531441 - 40723901			687416	675008		
RAB18, EX2DEL	RAB18		Warburg micro syndrome 3	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030248					30248	39204		
NM_012233.3(RAB3GAP1):c.2187_2188delinsCT (p.Met729_Lys730delinsIleTer)	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: Jul 7, 2021)	no assertion criteria provided	VCV001177056	2	135911344 - 135911345	2	135153774 - 135153775	1177056	1166548		NC_000002.12:135153773:GA:CT
RAB3GAP1, EX1-25DEL	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: Jun 7, 2021)	no assertion criteria provided	VCV001162291					1162291	1151296		
NM_012233.3(RAB3GAP1):c.9del (p.Asp4fs)	RAB3GAP1	D4fs	MARTSOLF SYNDROME 2|Cataract-intellectual disability-hypogonadism syndrome	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000545408	2	135809885	2	135052315	545408	535673	rs1553437083	NC_000002.12:135052314:CC:C
NM_012233.3(RAB3GAP1):c.264_270delinsTTATTA (p.Lys89fs)	RAB3GAP1	K89fs	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007062	2	135848681 - 135848687	2	135091111 - 135091117	7062	22101	rs730882184	NC_000002.12:135091110:AAAGGAT:TTATTA
NM_012233.3(RAB3GAP1):c.2801del (p.Pro934fs)	RAB3GAP1	P934fs, P941fs	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000007056	2	135926202	2	135168632	7056	22095	rs730882182	NC_000002.12:135168631:CCCCC:CCCC
NM_012414.4(RAB3GAP2):c.1966del (p.Asp656fs)	RAB3GAP2	D656fs	Cataract-intellectual disability-hypogonadism syndrome	Likely pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319795	1	220357410	1	220184068	1319795	1310044		NC_000001.11:220184067:C:
NM_012414.4(RAB3GAP2):c.2981-9_2981-6del	RAB3GAP2		Warburg micro syndrome 2|Cataract-intellectual disability-hypogonadism syndrome	Likely benign(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV001125543	1	220340747 - 220340750	1	220167405 - 220167408	1125543	1110213		NC_000001.11:220167404:AGTCAG:AG
NM_012414.4(RAB3GAP2):c.2366_2370delinsGACTGTGG (p.Gln789_Ser790delinsArgLeuTrp)	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV001030256	1	220346025 - 220346029	1	220172683 - 220172687	1030256	1015658		NC_000001.11:220172682:TGACT:CCACAGTC
NM_012414.4(RAB3GAP2):c.613-14del	RAB3GAP2		Warburg micro syndrome|Cataract-intellectual disability-hypogonadism syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2019)	criteria provided, conflicting interpretations	VCV000295668	1	220379362	1	220206020	295668	279534	rs572027376	NC_000001.11:220206019:AAAAAAAAAAA:AAAAAAAAAA
NM_012414.4(RAB3GAP2):c.812-6del	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|not provided|Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome 2|Warburg micro syndrome	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000295665	1	220369746	1	220196404	295665	280845	rs35396665	NC_000001.11:220196403:AAAAAAAAAAAA:AAAAAAAAAAA
NM_012414.4(RAB3GAP2):c.2416+8_2416+9del	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295650	1	220345970 - 220345971	1	220172628 - 220172629	295650	280923	rs769425345	NC_000001.11:220172627:TTT:T
NM_012414.4(RAB3GAP2):c.*1144del	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295627	1	220323449	1	220150107	295627	280874	rs11316594	NC_000001.11:220150106:TTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTT
NM_012414.4(RAB3GAP2):c.*1145del	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295626	1	220323448	1	220150106	295626	280873	rs886046014	NC_000001.11:220150105:C:
NM_012414.4(RAB3GAP2):c.*2338_*2339del	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295614	1	220322254 - 220322255	1	220148912 - 220148913	295614	279286	rs886046011	NC_000001.11:220148911:ATA:A
NM_012414.4(RAB3GAP2):c.*2512del	RAB3GAP2		Warburg micro syndrome|Cataract-intellectual disability-hypogonadism syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295609	1	220322081	1	220148739	295609	279493	rs143756119	NC_000001.11:220148738:TTTTTTTTT:TTTTTTTT
NM_012414.4(RAB3GAP2):c.*2551_*2552del	RAB3GAP2		Cataract-intellectual disability-hypogonadism syndrome|Warburg micro syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295605	1	220322041 - 220322042	1	220148699 - 220148700	295605	279491	rs886046008	NC_000001.11:220148698:TA:
NM_012414.4(RAB3GAP2):c.499_507del (p.Phe167_Thr169del)	RAB3GAP2		Warburg micro syndrome 2	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000030782	1	220384146 - 220384154	1	220210804 - 220210812	30782	39739	rs1553278569	NC_000001.11:220210803:AGTGTAGAA:
NM_018723.4(RBFOX1):c.468+10_468+11del	RBFOX1		Idiopathic generalized epilepsy	Likely benign(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV001118196	16	7637312 - 7637313	16	7587310 - 7587311	1118196	1104215		NC_000016.10:7587309:TT:
NM_018723.4(RBFOX1):c.594_597del (p.Asn198fs)	RBFOX1	N198fs, N218fs, N241fs	Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV000945276	16	7647402 - 7647405	16	7597400 - 7597403	945276	927944		NC_000016.10:7597399:AAATAAA:AAA
NC_000016.10:g.(?_7653795)_(7664988_?)del	RBFOX1		Idiopathic generalized epilepsy	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000830723	16	7703797 - 7714990			830723	820872		
GRCh37/hg19 16p13.3(chr16:7096122-7196614)x1	RBFOX1		not provided	Uncertain significance(Last reviewed: Mar 21, 2018)	no assertion criteria provided	VCV000686348	16	7096122 - 7196614			686348	673940		
Single allele	RBFOX1		not provided	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000560142	16	6628137 - 6945035	16	6578137 - 6895035	560142	550858		
NC_000016.10:g.(?_6654578)_(6654675_?)del	RBFOX1		Undetermined early-onset epileptic encephalopathy	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495281	16	6704579 - 6704676	16	6654578 - 6654675	495281	486763		
NC_000016.10:g.(?_6316970)_(6317082_?)del	RBFOX1		Undetermined early-onset epileptic encephalopathy	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495280	16	6366971 - 6367083	16	6316970 - 6317082	495280	486762		
NM_018723.4(RBFOX1):c.979_984del (p.Ala327_Ala328del)	RBFOX1		Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433120	16	7726819 - 7726824	16	7676817 - 7676822	433120	426684	rs974157467	NC_000016.10:7676816:CTGCCGCTGCC:CTGCC
NM_018723.4(RBFOX1):c.758-5_758-4delinsTT	RBFOX1		Idiopathic generalized epilepsy	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV000415954	16	7703812 - 7703813	16	7653810 - 7653811	415954	401350	rs1060504699	NC_000016.10:7653809:CG:TT
NM_001082575.3(RBFOX3):c.361-10del	RBFOX3		Idiopathic generalized epilepsy	Likely benign(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001159651	17	77100218	17	79104136	1159651	1147745		NC_000017.11:79104135:C:
NC_000010.11:g.(?_93161309)_(93797823_?)del	RBP4|MYOF|PDE6C|CEP55|FFAR4|FRA10AC1|LGI1		Familial temporal lobe epilepsy 1	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000833253	10	94921066 - 95557580			833253	820283		
NM_005045.4(RELN):c.3711+9_3711+10del	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Likely benign(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV001160889	7	103234758 - 103234759	7	103594311 - 103594312	1160889	1138246		NC_000007.14:103594310:AG:
NM_005045.4(RELN):c.8275-9_8275-6del	RELN|SLC26A5-AS1		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001099641	7	103143683 - 103143686	7	103503236 - 103503239	1099641	1095753		NC_000007.14:103503235:AAACA:A
NM_005045.4(RELN):c.4190del (p.Asn1397fs)	RELN	N1397fs	Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001074751	7	103216108	7	103575661	1074751	1060935		NC_000007.14:103575660:TTTTT:TTTT
NC_000007.13:g.(?_103196019_103206706del	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001067251					1067251	1054413		
NM_005045.4(RELN):c.1763+5_1763+6delinsTT	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001063822	7	103292992 - 103292993	7	103652545 - 103652546	1063822	1044507		NC_000007.14:103652544:TC:AA
NM_005045.4(RELN):c.226+9del	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001035513	7	103629569	7	103989122	1035513	1027571		NC_000007.14:103989121:GG:G
NM_005045.4(RELN):c.3552_3553delinsTA (p.Glu1185Lys)	RELN	E1185K	Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001016544	7	103234926 - 103234927	7	103594479 - 103594480	1016544	1007038		NC_000007.14:103594478:CC:TA
NM_005045.4(RELN):c.5418_5420del (p.Asp1807del)	RELN	D1807del	Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001001260	7	103202088 - 103202090	7	103561641 - 103561643	1001260	991866		NC_000007.14:103561640:TCGTC:TC
NM_005045.4(RELN):c.6314del (p.Phe2105fs)	RELN	F2105fs	Epilepsy, familial temporal lobe, 7	Likely pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000992962	7	103185780	7	103545333	992962	980924		NC_000007.14:103545332:AAA:AA
NM_005045.4(RELN):c.2822_2836del (p.Thr941_Asp945del)	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000972256	7	103252117 - 103252131	7	103611670 - 103611684	972256	954961		NC_000007.14:103611669:TGTCCATGTGTGGGGTGT:TGT
NM_005045.4(RELN):c.6202_6203del (p.Leu2068fs)	RELN	L2068fs	Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000955573	7	103191613 - 103191614	7	103551166 - 103551167	955573	945281		NC_000007.14:103551165:AAA:A
NM_005045.4(RELN):c.3215del (p.Asp1072fs)	RELN	D1072fs	Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000856842	7	103243869	7	103603422	856842	832702		NC_000007.14:103603421:T:
NM_005045.4(RELN):c.9030_9032del (p.Glu3010del)	RELN|SLC26A5-AS1	E3010del	Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Uncertain significance(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000843311	7	103137134 - 103137136	7	103496687 - 103496689	843311	832639		NC_000007.14:103496686:TCTTC:TC
NM_005045.4(RELN):c.10322_10324del (p.Arg3441del)	RELN|SLC26A5-AS1	R3439del, R3441del	Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Uncertain significance(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV000838832	7	103113318 - 103113320	7	103472871 - 103472873	838832	832633		NC_000007.14:103472870:GTCGT:GT
NM_005045.4(RELN):c.9841del (p.Ala3281fs)	RELN|SLC26A5-AS1	A3281fs	Norman-Roberts syndrome	Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800880	7	103126786	7	103486339	800880	788810	rs1586472959	NC_000007.14:103486338:CC:C
NM_005045.4(RELN):c.5211-10_5211-7del	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000789190	7	103202407 - 103202410	7	103561960 - 103561963	789190	779295	rs34125550	NC_000007.14:103561959:AAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAA
NM_005045.4(RELN):c.7668+8_7668+9delinsAG	RELN		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome|not provided	Likely benign(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000763139	7	103162460 - 103162461	7	103522013 - 103522014	763139	775266	rs1584261648	NC_000007.14:103522012:AA:CT
NM_005045.4(RELN):c.2466-7del	RELN		not provided|Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586401	7	103270630	7	103630183	586401	576932	rs571882672	NC_000007.14:103630182:AAAAAAAAAAA:AAAAAAAAAA
NM_005045.4(RELN):c.578-3del	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000581734	7	103389954	7	103749507	581734	563928	rs1047136329	NC_000007.14:103749506:AAAA:AAA
NM_005045.4(RELN):c.1290-3del	RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Benign(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000542592	7	103301977	7	103661530	542592	521944	rs146986040	NC_000007.14:103661529:AAAAAAAAA:AAAAAAAA
NM_005045.4(RELN):c.8667+9_8667+13del	RELN|SLC26A5-AS1		Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000436520	7	103141179 - 103141183	7	103500732 - 103500736	436520	428642	rs755797350	NC_000007.14:103500731:GCTTT:
NM_005045.4(RELN):c.4937-4del	RELN		Norman-Roberts syndrome|Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7|not specified	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000196903	7	103206002	7	103565555	196903	194064	rs35268159	NC_000007.14:103565554:AAAAAAAAAAA:AAAAAAAAAA
NM_005045.4(RELN):c.9370-13_9370-8del	RELN|SLC26A5-AS1		not specified|not provided|Epilepsy, familial temporal lobe, 7|Norman-Roberts syndrome	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095238	7	103132481 - 103132486	7	103492034 - 103492039	95238	101138	rs141397961	NC_000007.14:103492033:AAACATAAACA:AAACA
RELN, 148-BP DEL	RELN		Norman-Roberts syndrome	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000009085					9085	24124		
GRCh37/hg19 9p24.2(chr9:3381819-3419693)x1	RFX3		not provided	Uncertain significance(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000687154	9	3381819 - 3419693			687154	674746		
NM_024589.3(ROGDI):c.329_336+5del	ROGDI		Amelocerebrohypohidrotic syndrome	Likely pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000967389	16	4850494 - 4850506	16	4800493 - 4800505	967389	960845		NC_000016.10:4800492:GTCACCTGCTGCAG:G
NM_024589.3(ROGDI):c.117+6_117+7delinsAT	ROGDI		Amelocerebrohypohidrotic syndrome	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV000958701	16	4852376 - 4852377	16	4802375 - 4802376	958701	960161		NC_000016.10:4802374:TC:AT
NM_024589.3(ROGDI):c.715_718del (p.Leu239fs)	ROGDI	L239fs	Amelocerebrohypohidrotic syndrome	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000946794	16	4847819 - 4847822	16	4797818 - 4797821	946794	927822		NC_000016.10:4797817:CCAG:
NC_000016.10:g.(?_4797440)_(4802591_?)del	ROGDI		Amelocerebrohypohidrotic syndrome	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000583558	16	4847441 - 4852592	16	4797440 - 4802591	583558	567509		
NM_024589.2(ROGDI):c.-198del	ROGDI		Amelocerebrohypohidrotic syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319412	16	4852770	16	4802769	319412	341603	rs569838251	NC_000016.10:4802768:CCCCC:CCCC
NM_024589.3(ROGDI):c.45+9_45+20del	ROGDI		Amelocerebrohypohidrotic syndrome	Likely pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000041467	16	4852508 - 4852519	16	4802507 - 4802518	41467	49903	rs772340154	NC_000016.10:4802506:CGCTGGCCCGCGCGC:CGC
NM_024589.3(ROGDI):c.507del (p.Glu170fs)	ROGDI	E170fs	Amelocerebrohypohidrotic syndrome|not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000041465	16	4848594	16	4798593	41465	49901	rs786205124	NC_000016.10:4798592:GGGG:GGG
NM_134261.3(RORA):c.821-17_827delinsGCTTTCGTGTTTG	RORA|RORA-AS1		Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	Likely pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000636257	15	60797822 - 60797845	15	60505623 - 60505646	636257	624068	rs1595874995	NC_000015.10:60505622:AGGTGTTCTAAGGAGAAAACGGGA:CAAACACGAAAGC
NM_134261.3(RORA):c.1019del (p.Arg340fs)	RORA|RORA-AS1	R340fs, R365fs, R285fs, R373fs	Severe intellectual deficiency|Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2018)	no assertion criteria provided	VCV000374220	15	60795790	15	60503591	374220	361144	rs1057518981	NC_000015.10:60503590:C:
NC_000009.11:g.77261322_77313598del	RORB		Epilepsy, idiopathic generalized, susceptibility to, 15	risk factor(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620654					620654	612040		
NM_006914.4(RORB):c.1249_1251del (p.Thr417del)	RORB	T417del, T428del	Epilepsy, idiopathic generalized, susceptibility to, 15|Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	VCV000225116	9	77300403 - 77300405	9	74685487 - 74685489	225116	226917	rs869312972	NC_000009.12:74685486:ACG:
9q21.13 deletion	RORB|LOC101927358|MIR6130|RORB-AS1		Idiopathic generalized epilepsy|Epilepsy, childhood absence 1	Likely pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000223147					223147	224873		
NC_000023.11:g.(?_18653412)_(18653564_?)del	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000830639	X	18671532 - 18671684			830639	821577		
GRCh37/hg19 3q25.32(chr3:158209613-158255406)x1	RSRC1		not provided	Uncertain significance(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000687669	3	158209613 - 158255406			687669	675261		
GRCh37/hg19 3q25.32(chr3:158209613-158255406)x1	RSRC1		not provided	Uncertain significance(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000687668	3	158209613 - 158255406			687668	675260		
GRCh37/hg19 1q43(chr1:237492296-237781014)x1	RYR2		not provided	Uncertain significance(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000686556	1	237492296 - 237781014			686556	674148		
NC_000009.11:g.(?_139018777)_(141018984_?)del	SAPCD2|TOR4A|C8G|NPDC1|TMEM141|UAP1L1|CYSRT1|SSNA1|RNF208|SLC34A3|NELFB|NRARP|INPP5E|LINC02908|MIR126|DNLZ|TPRN|MRPL41|AGPAT2|EDF1|STPG3|ENTPD2|LCN10|CARD9|PHPT1|RABL6|EGFL7|LCN8|FAM166A|ENTR1|LCN12|NOXA1|MAN1B1|EXD3|ABCA2|CACNA1B|PNPLA7|NSMF|EHMT1|NDOR1|DPH7|ZMYND19|ENTPD8|GPSM1|LHX3|SEC16A|NOTCH1|C9orf163|LCNL1|RNF224|PAXX|ARRDC1|PTGDS|ANAPC2|PMPCA|TMEM203|FBXW5|LCN6|FUT7|DPP7|LOC651337|MAMDC4|GRIN1|TRAF2|TMEM210|SNAPC4|DIPK1B|CLIC3|CCDC183|TUBB4B|SNHG7|LRRC26|LCN15|QSOX2|AJM1		Kleefstra syndrome 1	Pathogenic(Last reviewed: Oct 4, 2020)	criteria provided, single submitter	VCV000986753	9	139018777 - 141018984			986753	974902		
NM_001172509.2(SATB2):c.1153del (p.Val385fs)	SATB2	V385fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, single submitter	VCV001308668	2	200213444	2	199348721	1308668	1298937		NC_000002.12:199348720:C:
NC_000002.11:g.(?_200136914)_(200320780_?)del	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001076235	2	200136914 - 200320780			1076235	1056921		
NM_001172509.2(SATB2):c.721_722del (p.Asn241fs)	SATB2	N241fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000976026	2	200213875 - 200213876	2	199349152 - 199349153	976026	964189		NC_000002.12:199349151:TTTT:TT
NM_001172509.2(SATB2):c.1504del (p.Gln502fs)	SATB2	Q502fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000973264	2	200188564	2	199323841	973264	961594		NC_000002.12:199323840:G:
NM_001172509.2(SATB2):c.1808_1817del (p.Pro603fs)	SATB2	P603fs	Chromosome 2q32-q33 deletion syndrome	Likely pathogenic(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV000930870	2	200137319 - 200137328	2	199272596 - 199272605	930870	918725		NC_000002.12:199272595:GGAGGAGGTGGG:GG
NM_001172509.2(SATB2):c.2002_2021del (p.Tyr668fs)	SATB2	Y668fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Mar 23, 2019)	criteria provided, single submitter	VCV000840533	2	200137115 - 200137134	2	199272392 - 199272411	840533	825541		NC_000002.12:199272391:CCGTGGTGCTTCACGTGGTACCG:CCG
NM_001172509.2(SATB2):c.75del (p.Pro26fs)	SATB2	P26fs	Chromosome 2q32-q33 deletion syndrome	Likely pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000830000	2	200320686	2	199455963	830000	818181	rs1574645416	NC_000002.12:199455962:CCCC:CCC
NM_001172509.2(SATB2):c.1103_1106del (p.Val368fs)	SATB2	V368fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000807482	2	200213491 - 200213494	2	199348768 - 199348771	807482	798492	rs1574532220	NC_000002.12:199348767:CTGACT:CT
NM_001172509.2(SATB2):c.1610del (p.Asn537fs)	SATB2	N537fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000691258	2	200173613	2	199308890	691258	678936	rs1574492395	NC_000002.12:199308889:TTTT:TTT
NM_001172509.2(SATB2):c.1218_1221del (p.Ala407fs)	SATB2	A407fs	Chromosome 2q32-q33 deletion syndrome	Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000666577	2	200193586 - 200193589	2	199328863 - 199328866	666577	654117	rs1574510975	NC_000002.12:199328862:GGCTG:G
NM_001172509.2(SATB2):c.1826del (p.Asp609fs)	SATB2	D609fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666260	2	200137310	2	199272587	666260	653808	rs1574459072	NC_000002.12:199272586:T:
GRCh37/hg19 2q33.1(chr2:200213361-200233633)	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625775	2	200213361 - 200233633			625775	614079		
NM_001172509.2(SATB2):c.598-4del	SATB2		History of neurodevelopmental disorder|Chromosome 2q32-q33 deletion syndrome	Likely benign(Last reviewed: Aug 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589489	2	200233434	2	199368711	589489	579030	rs199978702	NC_000002.12:199368710:AAAAAAAAAA:AAAAAAAAA
NC_000002.12:g.(?_199348681)_(199433534_?)del	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000584397	2	200213404 - 200298257	2	199348681 - 199433534	584397	558074		
NM_001172509.2(SATB2):c.1627del (p.Arg543fs)	SATB2	R543fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431132	2	200173596	2	199308873	431132	424642	rs1135401803	NC_000002.12:199308872:G:
GRCh37/hg19 19p13.3(chr19:1132637-1148812)x1	SBNO2		not provided	Benign(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000603323	19	1132637 - 1148812			603323	594659		
NM_005506.4(SCARB2):c.48del (p.Leu17fs)	SCARB2	L17fs	Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001076714	4	77134649	4	76213496	1076714	1060086		NC_000004.12:76213495:C:
NC_000004.11:g.(?_77082866)_(77102264_?)del	SCARB2		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001047138	4	77082866 - 77102264			1047138	1022250		
NM_005506.4(SCARB2):c.55_75del (p.Thr19_Val25del)	SCARB2		Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001045944	4	77134622 - 77134642	4	76213469 - 76213489	1045944	1026002		NC_000004.12:76213468:CACCAGCAGCGTGACGCTGGTCACCAGCAG:CACCAGCAG
NM_005506.4(SCARB2):c.741_743del (p.Met247del)	SCARB2	M104del, M247del	Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001024661	4	77097025 - 77097027	4	76175872 - 76175874	1024661	1005455		NC_000004.12:76175871:ATCAT:AT
NM_005506.4(SCARB2):c.956del (p.Leu319fs)	SCARB2	L176fs, L319fs	Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000971806	4	77095335	4	76174182	971806	953849		NC_000004.12:76174181:A:
NM_005506.4(SCARB2):c.134del (p.Asn45fs)	SCARB2	N45fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000807488	4	77117001	4	76195848	807488	798547	rs1578733075	NC_000004.12:76195847:TT:T
NM_005506.4(SCARB2):c.1382_1383del (p.Gln461fs)	SCARB2	Q318fs, Q461fs	Progressive myoclonic epilepsy	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000566187	4	77084393 - 77084394	4	76163240 - 76163241	566187	559809	rs1233094134	NC_000004.12:76163239:CT:
NM_005506.4(SCARB2):c.1398+10_1398+22del	SCARB2		not specified|Progressive myoclonic epilepsy	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420325	4	77084356 - 77084368	4	76163203 - 76163215	420325	406460	rs778683141	NC_000004.12:76163202:AGTTCCTTCAGCCAGTTC:AGTTC
NM_005506.4(SCARB2):c.1385_1390delinsATGCATGCACC (p.Gly462fs)	SCARB2	G462fs, G319fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268147	4	77084386 - 77084391	4	76163233 - 76163238	268147	263763	rs886041079	NC_000004.12:76163232:TGGATC:GGTGCATGCAT
NM_005506.4(SCARB2):c.666_670del (p.Tyr222_Asn224delinsTer)	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268138	4	77097624 - 77097628	4	76176471 - 76176475	268138	263773	rs886041075	NC_000004.12:76176470:TAAGGTAA:TAA
NM_005506.4(SCARB2):c.296del (p.Asn99fs)	SCARB2	N99fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268136	4	77102234	4	76181081	268136	263771	rs886041073	NC_000004.12:76181080:TTT:TT
NM_005506.4(SCARB2):c.111del (p.Ile37fs)	SCARB2	I37fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268135	4	77134586	4	76213433	268135	263772	rs886041072	NC_000004.12:76213432:G:
NM_005506.4(SCARB2):c.1258del (p.Glu420fs)	SCARB2	E420fs, E277fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000030258	4	77084518	4	76163365	30258	39214	rs727502782	NC_000004.12:76163364:C:
NM_001165963.1:c.(3429+1_3430-1)_(4002+1_4003-1)del	SCN1A		Generalized epilepsy with febrile seizures plus, type 2	Likely pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001285579					1285579	1275421		
NM_001165963.4(SCN1A):c.1639_1640del (p.Lys547fs)	SCN1A	K546fs, K547fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 7, 2020)	criteria provided, single submitter	VCV001285480	2	166901575 - 166901576	2	166045065 - 166045066	1285480	1275323		NC_000002.12:166045064:TTTT:TT
NM_001165963.4(SCN1A):c.265del (p.Thr89fs)	SCN1A	T89fs	Generalized epilepsy with febrile seizures plus, type 2	Likely pathogenic	criteria provided, single submitter	VCV001180552	2	166915198	2	166058688	1180552	1170094		NC_000002.12:166058687:T:
NM_001165963.4(SCN1A):c.5624_5630del (p.Val1875fs)	SCN1A|LOC102724058	V1061fs, V1846fs, V1847fs, V1863fs, V1864fs, V1875fs	Generalized epilepsy with febrile seizures plus, type 2	Likely pathogenic	criteria provided, single submitter	VCV001174162	2	166848155 - 166848161	2	165991645 - 165991651	1174162	1163370		NC_000002.12:165991644:CCTAGAACC:CC
NM_001165963.4(SCN1A):c.1423_1424delinsCT (p.Ala475Leu)	SCN1A	A474L, A475L	Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy	Conflicting interpretations of pathogenicity	criteria provided, conflicting interpretations	VCV001164075	2	166901791 - 166901792	2	166045281 - 166045282	1164075	1153075		NC_000002.12:166045280:GC:AG
NM_001165963.4(SCN1A):c.2393_2404del (p.Asn798_Val802delinsIle)	SCN1A		Severe myoclonic epilepsy in infancy	Likely pathogenic	criteria provided, single submitter	VCV000977931	2	166897752 - 166897763	2	166041242 - 166041253	977931	966060		NC_000002.12:166041241:CTGTAAGCACAT:
NM_001165963.4(SCN1A):c.1133del (p.Leu378fs)	SCN1A	L378fs	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000977923	2	166904174	2	166047664	977923	966052		NC_000002.12:166047663:A:
NM_001165963.4(SCN1A):c.986del (p.Gly329fs)	SCN1A	G329fs	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000976439	2	166905438	2	166048928	976439	964180		NC_000002.12:166048927:CCC:CC
NM_001165963.4(SCN1A):c.1575_1581del (p.Glu526fs)	SCN1A	E525fs, E526fs	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000929417	2	166901634 - 166901640	2	166045124 - 166045130	929417	917731		NC_000002.12:166045123:GTCCTCAG:G
NM_001165963.4(SCN1A):c.3016del (p.Asp1006fs)	SCN1A	D1006fs, D192fs, D977fs, D978fs, D994fs, D995fs	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Feb 19, 2020)	no assertion criteria provided	VCV000929414	2	166892971	2	166036461	929414	917730		NC_000002.12:166036460:C:
NM_001165963.4(SCN1A):c.36del (p.Asp12fs)	SCN1A	D12fs	Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Apr 2, 2020)	criteria provided, single submitter	VCV000870591	2	166930096	2	166073586	870591	858753		NC_000002.12:166073585:G:
NM_001165963.4(SCN1A):c.1489del (p.Arg497fs)	SCN1A	R497fs, R496fs	Severe myoclonic epilepsy in infancy	Pathogenic	criteria provided, single submitter	VCV000870349	2	166901726	2	166045216	870349	858514		NC_000002.12:166045215:TTT:TT
NM_001165963.4(SCN1A):c.591del (p.Ile198fs)	SCN1A	I198fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870159	2	166911159	2	166054649	870159	858341		NC_000002.12:166054648:G:
NM_001165963.4(SCN1A):c.1164delinsGG (p.Tyr388Ter)	SCN1A	Y388*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870157	2	166904143	2	166047633	870157	858339		NC_000002.12:166047632:A:CC
NM_001165963.4(SCN1A):c.4789_4792del (p.His1597fs)	SCN1A|LOC102724058	H1585fs, H1586fs, H783fs, H1569fs, H1568fs, H1597fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870153	2	166850716 - 166850719	2	165994206 - 165994209	870153	858336		NC_000002.12:165994205:AATG:
NM_001165963.4(SCN1A):c.2295del (p.Met766fs)	SCN1A	M737fs, M754fs, M755fs, M766fs, M738fs	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, single submitter	VCV000813760	2	166897861	2	166041351	813760	801982		NC_000002.12:166041350:C:
GRCh37/hg19 2q24.3(chr2:166767837-167334206)	SCN1A|SCN7A|SCN9A|TTC21B		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000813324	2	166767837 - 167334206			813324	801573		
NM_001165963.4(SCN1A):c.207del (p.Pro70fs)	SCN1A	P70fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801825	2	166929925	2	166073415	801825	790122	rs1574371902	NC_000002.12:166073414:A:
NM_001165963.4(SCN1A):c.262_264+1del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801824	2	166929867 - 166929870	2	166073357 - 166073360	801824	790121	rs1574371141	NC_000002.12:166073356:CTTTCTT:CTT
NM_001165963.4(SCN1A):c.684del (p.Val229fs)	SCN1A	V229fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801819	2	166909372	2	166052862	801819	790116	rs1574271602	NC_000002.12:166052861:T:
NC_000002.12:g.166051989del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801818	2	166908498	2	166051988	801818	790115	rs1574266816	NC_000002.12:166051987:CC:C
NM_001165963.4(SCN1A):c.2147_2150del (p.Ile716fs)	SCN1A	I716fs, I687fs, I704fs, I705fs, I688fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801807	2	166898828 - 166898831	2	166042318 - 166042321	801807	790104	rs1574208760	NC_000002.12:166042317:GCTA:
GRCh37/hg19 2q24.3(chr2:166680709-166947043)x1	SCN1A|TTC21B		not provided	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000685770	2	166680709 - 166947043			685770	673362		
Single allele	SCN1A		Epilepsy	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635922	2	166818453 - 166939516			635922	623735		
NM_001165963.4(SCN1A):c.4450_4453del (p.Asp1484fs)	SCN1A|LOC102724058	D1456fs, D1473fs, D1484fs, D1455fs, D1472fs, D670fs	History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000589001	2	166854571 - 166854574	2	165998061 - 165998064	589001	578938	rs1559118996	NC_000002.12:165998060:TATCTAT:TAT
NM_001165963.4(SCN1A):c.1273del (p.Ala425fs)	SCN1A	A425fs	Autosomal dominant epilepsy	Likely pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000496116	2	166903384	2	166046874	496116	486877	rs1553546836	NC_000002.12:166046873:CC:C
NM_001165963.4(SCN1A):c.126del (p.Asp43fs)	SCN1A	D43fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000496115	2	166930006	2	166073496	496115	486946	rs1553560831	NC_000002.12:166073495:TTTTTT:TTTTT
NM_001165963.4(SCN1A):c.2020_2023del (p.Asp674fs)	SCN1A	D674fs	Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495263	2	166900199 - 166900202	2	166043689 - 166043692	495263	486738	rs1553544470	NC_000002.12:166043688:TATCTAT:TAT
NM_001165963.4(SCN1A):c.2350_2351del (p.Phe784fs)	SCN1A	F772fs, F755fs, F756fs, F773fs, F784fs	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000461250	2	166897805 - 166897806	2	166041295 - 166041296	461250	449127	rs1553543215	NC_000002.12:166041294:AAAA:AA
NM_001165963.4(SCN1A):c.172_183del (p.Gly58_Leu61del)	SCN1A		Early infantile epileptic encephalopathy with suppression bursts	Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000461244	2	166929949 - 166929960	2	166073439 - 166073450	461244	449158	rs1553560760	NC_000002.12:166073438:AAGGTTCTTTCCA:A
NM_001165963.4(SCN1A):c.2044-5del	SCN1A		Early infantile epileptic encephalopathy with suppression bursts|Epilepsy|not provided|Familial hemiplegic migraine|not specified	Benign/Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000331892	2	166898939	2	166042429	331892	282542	rs549232924	NC_000002.12:166042428:AAAAAAAAA:AAAAAAAA
NM_001165963.4(SCN1A):c.5744_5748del (p.Glu1915fs)	SCN1A|LOC102724058	E1101fs, E1886fs, E1904fs, E1887fs, E1903fs, E1915fs	not provided	Pathogenic(Last reviewed: May 15, 2012)	criteria provided, single submitter	VCV000208411	2	166848037 - 166848041	2	165991527 - 165991531	208411	204630	rs797044984	NC_000002.12:165991526:TTCCT:
NM_001165963.4(SCN1A):c.5504_5512del (p.Leu1835_Pro1837del)	SCN1A|LOC102724058		not provided	Pathogenic(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	VCV000208410	2	166848273 - 166848281	2	165991763 - 165991771	208410	204631	rs797044983	NC_000002.12:165991762:GCGGTTCAAGCG:GCG
NM_001165963.4(SCN1A):c.2686_2694del (p.Val896_Ala898del)	SCN1A		not provided	Pathogenic(Last reviewed: Jun 29, 2012)	criteria provided, single submitter	VCV000208408	2	166894538 - 166894546	2	166038028 - 166038036	208408	204634	rs797044981	NC_000002.12:166038027:GGCCAAGACG:G
NM_001165963.4(SCN1A):c.942del (p.Asp313_Trp314insTer)	SCN1A		not provided	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000206950	2	166908251	2	166051741	206950	201605	rs796053105	NC_000002.12:166051740:CC:C
NM_001165963.4(SCN1A):c.5770_5790del (p.Arg1924_Leu1930del)	SCN1A|LOC102724058		not specified	Uncertain significance(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	VCV000206926	2	166847995 - 166848015	2	165991485 - 165991505	206926	201421	rs796053088	NC_000002.12:165991484:AAGGTGGCGTCTGTAAGCACG:
NM_001165963.4(SCN1A):c.4821del (p.Phe1607fs)	SCN1A|LOC102724058	F1607fs, F1596fs, F793fs, F1578fs, F1579fs, F1595fs	not provided	Pathogenic(Last reviewed: Jan 30, 2013)	criteria provided, single submitter	VCV000206921	2	166850687	2	165994177	206921	201464	rs796053083	NC_000002.12:165994176:AAAAA:AAAA
NM_001165963.4(SCN1A):c.4318del (p.Ala1440fs)	SCN1A|LOC102724058	A1412fs, A1428fs, A1429fs, A626fs, A1411fs, A1440fs	not provided	Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	VCV000206917	2	166856253	2	165999743	206917	201493	rs796053079	NC_000002.12:165999742:C:
NM_001165963.4(SCN1A):c.4166del (p.Asp1389fs)	SCN1A|LOC102724058	D1361fs, D1360fs, D1377fs, D1378fs, D1389fs, D575fs	not provided	Pathogenic(Last reviewed: Mar 4, 2014)	criteria provided, single submitter	VCV000206915	2	166859100	2	166002590	206915	201501	rs796053077	NC_000002.12:166002589:T:
NM_001165963.4(SCN1A):c.3409del (p.Asp1137fs)	SCN1A|LOC102724058	D1108fs, D1137fs, D1109fs, D1126fs, D1125fs, D323fs	not provided	Pathogenic(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	VCV000206909	2	166892578	2	166036068	206909	201527	rs796053071	NC_000002.12:166036067:CC:C
NM_001165963.4(SCN1A):c.1850_1851delinsAT (p.Arg617Asn)	SCN1A	R616N, R617N	not specified	Uncertain significance(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	VCV000206901	2	166900371 - 166900372	2	166043861 - 166043862	206901	201562	rs796053063	NC_000002.12:166043860:TC:AT
NM_001165963.4(SCN1A):c.1819del (p.Ser607fs)	SCN1A	S607fs, S606fs	not provided	Pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	VCV000206900	2	166900403	2	166043893	206900	201563	rs796053062	NC_000002.12:166043892:AA:A
NM_001165963.4(SCN1A):c.1518_1522del (p.Lys507fs)	SCN1A	K506fs, K507fs	not provided	Pathogenic(Last reviewed: Jan 2, 2015)	criteria provided, single submitter	VCV000206896	2	166901693 - 166901697	2	166045183 - 166045187	206896	201575	rs796053058	NC_000002.12:166045182:CTTTC:
NM_001165963.4(SCN1A):c.1430del (p.Gly477fs)	SCN1A	G476fs, G477fs	not provided	Pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	VCV000206895	2	166901785	2	166045275	206895	201578	rs796053057	NC_000002.12:166045274:CC:C
NM_001165963.4(SCN1A):c.1192del (p.Thr398fs)	SCN1A	T398fs	not provided	Pathogenic(Last reviewed: May 8, 2012)	criteria provided, single submitter	VCV000206893	2	166903465	2	166046955	206893	201588	rs796053055	NC_000002.12:166046954:TTTT:TTT
NM_001165963.4(SCN1A):c.368del (p.Lys123fs)	SCN1A	K123fs	not provided	Pathogenic(Last reviewed: Oct 21, 2013)	criteria provided, single submitter	VCV000206890	2	166915095	2	166058585	206890	201627	rs796053052	NC_000002.12:166058584:TT:T
NM_001165963.4(SCN1A):c.292del (p.Ala98fs)	SCN1A	A98fs	not provided	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000206888	2	166915171	2	166058661	206888	201631	rs796053050	NC_000002.12:166058660:CC:C
NM_001165963.4(SCN1A):c.1139del (p.Thr380fs)	SCN1A	T380fs	not provided	Pathogenic(Last reviewed: Jul 2, 2013)	criteria provided, single submitter	VCV000206879	2	166904168	2	166047658	206879	201591	rs796053047	NC_000002.12:166047657:G:
NM_006920.4(SCN1A):c.384_473del (p.Leu129_Glu158del)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190030					190030	187871		
NM_001165963.4(SCN1A):c.1663_2176del (p.Ser555Asnfs*21)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190022					190022	187888		
NM_001165963.4(SCN1A):c.4338_6030del (p.Asn1446_Gly2008del)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190015					190015	187887		
NM_001165963.4(SCN1A):c.2980_2981del (p.Ser994fs)	SCN1A	S180fs, S982fs, S965fs, S966fs, S983fs, S994fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190001	2	166893006 - 166893007	2	166036496 - 166036497	190001	187783	rs794726830	NC_000002.12:166036495:GAG:G
NM_001165963.4(SCN1A):c.1442_1445del (p.Asp481fs)	SCN1A	D481fs, D480fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190000	2	166901770 - 166901773	2	166045260 - 166045263	190000	187830	rs794726829	NC_000002.12:166045259:CTGTCTG:CTG
NM_001165963.1(SCN1A):c.4285_4476del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189995					189995	187886		
NM_001165963.4(SCN1A):c.1197_1198del (p.Met400fs)	SCN1A	M400fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189987	2	166903459 - 166903460	2	166046949 - 166046950	189987	187836	rs794726818	NC_000002.12:166046948:TGT:T
NM_001165963.1(SCN1A):c.384_964del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189981					189981	187885		
NM_001165963.4(SCN1A):c.3017del (p.Asp1006fs)	SCN1A	D978fs, D995fs, D1006fs, D192fs, D977fs, D994fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189980	2	166892970	2	166036460	189980	187781	rs794726813	NC_000002.12:166036459:T:
NM_001165963.4(SCN1A):c.1301del (p.Leu434fs)	SCN1A	L434fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189977	2	166903356	2	166046846	189977	187832	rs794726810	NC_000002.12:166046845:AA:A
NM_001165963.4(SCN1A):c.2872_2881del (p.Asp958fs)	SCN1A	D144fs, D929fs, D947fs, D930fs, D946fs, D958fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189974	2	166894351 - 166894360	2	166037841 - 166037850	189974	187791	rs794726808	NC_000002.12:166037840:CCATACAGTCCCA:CCA
NM_001165963.4(SCN1A):c.2100del (p.Met701fs)	SCN1A	M689fs, M701fs, M690fs, M672fs, M673fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189972	2	166898878	2	166042368	189972	187818	rs794726806	NC_000002.12:166042367:GG:G
NM_001165963.4(SCN1A):c.289_292del (p.Lys97fs)	SCN1A	K97fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189959	2	166915171 - 166915174	2	166058661 - 166058664	189959	187879	rs794726796	NC_000002.12:166058660:CCTTCC:CC
NM_001165963.4(SCN1A):c.1096_1115del (p.Asp366fs)	SCN1A	D366fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189955	2	166904192 - 166904211	2	166047682 - 166047701	189955	187844	rs794726792	NC_000002.12:166047681:AAAGCCCAACTGAAGGTATCAAAGC:AAAGC
NM_001165963.4(SCN1A):c.185del (p.Pro62fs)	SCN1A	P62fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189954	2	166929947	2	166073437	189954	187881	rs35595680	NC_000002.12:166073436:GG:G
NM_001165963.4(SCN1A):c.896_905del (p.Asn299fs)	SCN1A	N299fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189951	2	166908288 - 166908297	2	166051778 - 166051787	189951	187857	rs794726788	NC_000002.12:166051777:CCATTATAAT:
NM_001165963.4(SCN1A):c.2603del (p.Lys868fs)	SCN1A	K839fs, K868fs, K857fs, K54fs, K840fs, K856fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189950	2	166894629	2	166038119	189950	187801	rs794726787	NC_000002.12:166038118:TT:T
NM_001165963.4(SCN1A):c.1183_1184del (p.Ala395fs)	SCN1A	A395fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189939	2	166903473 - 166903474	2	166046963 - 166046964	189939	187837	rs794726776	NC_000002.12:166046962:GC:
NM_001165963.4(SCN1A):c.3062_3066del (p.Lys1021fs)	SCN1A	K993fs, K1009fs, K1010fs, K1021fs, K207fs, K992fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189916	2	166892921 - 166892925	2	166036411 - 166036415	189916	187780	rs794726756	NC_000002.12:166036410:TCCTTT:T
NM_001165963.4(SCN1A):c.751del (p.Val250_Met251insTer)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189910	2	166908442	2	166051932	189910	187861	rs794726751	NC_000002.12:166051931:TT:T
NM_001165963.4(SCN1A):c.2523_2524del (p.Thr841_Leu842insTer)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189895	2	166895998 - 166895999	2	166039488 - 166039489	189895	187807	rs794726738	NC_000002.12:166039487:GCG:G
NM_001165963.4(SCN1A):c.659_662del (p.Val220fs)	SCN1A	V220fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189878	2	166909394 - 166909397	2	166052884 - 166052887	189878	187865	rs794726724	NC_000002.12:166052883:AGAA:
NM_001165963.4(SCN1A):c.474_602del (p.Thr160_Tyr202del)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189875	2	166911148 - 166911276	2	166054638 - 166054766	189875	187868	rs1553551314	
NM_001165963.4(SCN1A):c.2947del	SCN1A		not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189866	2	166893040	2	166036530	189866	187786	rs794726715	NC_000002.12:166036529:CC:C
NM_001165963.4(SCN1A):c.2946+1_2946+2del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189865	2	166894284 - 166894285	2	166037774 - 166037775	189865	187784	rs794726714	NC_000002.12:166037773:AC:
NM_001165963.4(SCN1A):c.1667del (p.Leu556fs)	SCN1A	L556fs, L555fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189853	2	166900555	2	166044045	189853	187824	rs794726704	NC_000002.12:166044044:AAA:AA
NM_001165963.4(SCN1A):c.2044_6030del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189852					189852	187884		
NM_001165963.4(SCN1A):c.1118del (p.Leu373fs)	SCN1A	L373fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189842	2	166904189	2	166047679	189842	187843	rs794726695	NC_000002.12:166047678:AAAAAA:AAAAA
NM_001165963.4(SCN1A):c.1171-10_1171-9del	SCN1A		not specified|Epilepsy|Early infantile epileptic encephalopathy with suppression bursts|Familial hemiplegic migraine	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093628	2	166903495 - 166903496	2	166046985 - 166046986	93628	99532	rs372840031	NC_000002.12:166046984:AAAAA:AAA
SCN1A, 6.5-KB DEL	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Sep 26, 2006)	no assertion criteria provided	VCV000012900					12900	27939		
SCN1A, EX21-26DEL	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Sep 26, 2006)	no assertion criteria provided	VCV000012899					12899	27938		
NM_001165963.4(SCN1A):c.2528del (p.Ser843fs)	SCN1A	S29fs, S814fs, S815fs, S831fs, S832fs, S843fs	Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Feb 28, 2006)	no assertion criteria provided	VCV000012898	2	166895994	2	166039484	12898	27937		NC_000002.12:166039483:C:
NM_001365536.1(SCN9A):c.2204del (p.Lys735fs)	SCN1A-AS1|SCN9A	K724fs, K735fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV001068510	2	167137006	2	166280496	1068510	1059082		NC_000002.12:166280495:TTTTT:TTTT
NM_001365536.1(SCN9A):c.3413_3415del (p.Gly1138del)	SCN1A-AS1|SCN9A	G1127del, G1138del	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001051190	2	167108332 - 167108334	2	166251822 - 166251824	1051190	1040765		NC_000002.12:166251821:CTCCT:CT
NM_001365536.1(SCN9A):c.2008_2010del (p.Cys670del)	SCN1A-AS1|SCN9A	C659del, C670del	Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001044788	2	167138283 - 167138285	2	166281773 - 166281775	1044788	1023882		NC_000002.12:166281772:ACAAC:AC
NM_001365536.1(SCN9A):c.4629_4631delinsAGA (p.Met1543_Thr1544delinsIleAsp)	SCN1A-AS1|SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000968165	2	167060608 - 167060610	2	166204098 - 166204100	968165	952769		NC_000002.12:166204097:GTC:TCT
NM_001365536.1(SCN9A):c.4510del (p.Ile1504fs)	SCN1A-AS1|SCN9A	I1493fs, I1504fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000940282	2	167060729	2	166204219	940282	930954		NC_000002.12:166204218:TTTT:TTT
NM_001365536.1(SCN9A):c.2112_2114del (p.Glu705del)	SCN1A-AS1|SCN9A	E694del, E705del	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000861062	2	167137096 - 167137098	2	166280586 - 166280588	861062	825156		NC_000002.12:166280585:TCTTC:TC
NM_001365536.1(SCN9A):c.4444_4446del (p.Tyr1482del)	SCN1A-AS1|SCN9A	Y1471del, Y1482del	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000853573	2	167060927 - 167060929	2	166204417 - 166204419	853573	825128		NC_000002.12:166204416:ATA:
NM_001365536.1(SCN9A):c.2984delinsCC (p.Ile995fs)	SCN1A-AS1|SCN9A	I984fs, I995fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000663011	2	167129276	2	166272766	663011	628923	rs1574844397	NC_000002.12:166272765:A:GG
NM_001365536.1(SCN9A):c.2033del (p.Asp678fs)	SCN1A-AS1|SCN9A	D667fs, D678fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000657338	2	167138260	2	166281750	657338	628938	rs1574859556	NC_000002.12:166281749:T:
NM_001365536.1(SCN9A):c.1129del (p.Thr377fs)	SCN1A-AS1|SCN9A	T377fs	Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000651331	2	167145132	2	166288622	651331	628952	rs1574873149	NC_000002.12:166288621:TTTT:TTT
NM_001365536.1(SCN9A):c.1766_1769del (p.Phe589fs)	SCN1A-AS1|SCN9A	F589fs	Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000650286	2	167141168 - 167141171	2	166284658 - 166284661	650286	628946	rs775868908	NC_000002.12:166284657:ACAAACA:ACA
NM_001365536.1(SCN9A):c.1602+5del	SCN1A-AS1|SCN9A		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: Sep 9, 2017)	criteria provided, single submitter	VCV000578185	2	167142841	2	166286331	578185	558897	rs1488594635	NC_000002.12:166286330:GG:G
NM_001365536.1(SCN9A):c.2875-6_2875-5delinsG	SCN1A-AS1|SCN9A		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000577786	2	167129390 - 167129391	2	166272880 - 166272881	577786	557672	rs1558999342	NC_000002.12:166272879:AT:C
NM_001365536.1(SCN9A):c.2577del (p.Ile859fs)	SCN1A-AS1|SCN9A	I848fs, I859fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000574992	2	167133790	2	166277280	574992	557711	rs753900410	NC_000002.12:166277279:AA:A
NM_001365536.1(SCN9A):c.4869_4870delinsGA (p.Val1624Ile)	SCN1A-AS1|SCN9A	V1613I, V1624I	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV000538449	2	167056279 - 167056280	2	166199769 - 166199770	538449	516693	rs1553473301	NC_000002.12:166199768:CT:TC
NC_000002.12:g.(?_166226547)_(166228992_?)del	SCN1A-AS1|SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000471074			2	166226547 - 166228992	471074	448472		
NM_001365536.1(SCN9A):c.2875-5del	SCN1A-AS1|SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Familial febrile seizures|Severe myoclonic epilepsy in infancy|Small fiber neuropathy|Congenital Indifference to Pain|Inherited Erythromelalgia|Paroxysmal extreme pain disorder	Benign/Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331976	2	167129390	2	166272880	331976	283322	rs774840081	NC_000002.12:166272879:A:
NM_001365536.1(SCN9A):c.*491del	SCN1A-AS1|SCN9A		Congenital Indifference to Pain|Severe myoclonic epilepsy in infancy|Paroxysmal extreme pain disorder|Small fiber neuropathy|Familial febrile seizures|Inherited Erythromelalgia|Generalized epilepsy with febrile seizures plus	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331947	2	167054691	2	166198181	331947	283267	rs886055047	NC_000002.12:166198180:AA:A
NM_001365536.1(SCN9A):c.*1605_*1606del	SCN1A-AS1|SCN9A		Familial febrile seizures|Severe myoclonic epilepsy in infancy|Congenital Indifference to Pain|Inherited Erythromelalgia|Paroxysmal extreme pain disorder|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331929	2	167053576 - 167053577	2	166197066 - 166197067	331929	283227	rs200091138	NC_000002.12:166197065:TAT:T
NM_001365536.1(SCN9A):c.*2616_*2626del	SCN1A-AS1|SCN9A		Paroxysmal extreme pain disorder|Small fiber neuropathy|Familial febrile seizures|Severe myoclonic epilepsy in infancy|Congenital Indifference to Pain|Inherited Erythromelalgia|Generalized epilepsy with febrile seizures plus	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331908	2	167052556 - 167052566	2	166196046 - 166196056	331908	282565	rs145255931	NC_000002.12:166196045:TTAAAAAAGTTTT:TT
NM_001365536.1(SCN9A):c.*2744del	SCN1A-AS1|SCN9A		Paroxysmal extreme pain disorder|Small fiber neuropathy|Familial febrile seizures|Severe myoclonic epilepsy in infancy|Congenital Indifference to Pain|Inherited Erythromelalgia|Generalized epilepsy with febrile seizures plus	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331904	2	167052438	2	166195928	331904	284810	rs763459885	NC_000002.12:166195927:G:
NM_001365536.1(SCN9A):c.1975-3del	SCN1A-AS1|SCN9A		Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|Congenital Indifference to Pain|Familial febrile seizures|Inherited Erythromelalgia|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA|not specified|Paroxysmal extreme pain disorder	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194207	2	167138321	2	166281811	194207	191370	rs35888674	NC_000002.12:166281810:AAAAAAAAAA:AAAAAAAAA
NM_001037.5(SCN1B):c.448+205del	SCN1B	S218fs	Brugada syndrome 5|not provided	Uncertain significance(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000942863	19	35524848	19	35033944	942863	938649		NC_000019.10:35033943:G:
NM_001040142.2(SCN2A):c.606-6_606-4del	SCN2A		Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001118573	2	166165854 - 166165856	2	165309344 - 165309346	1118573	1089939		NC_000002.12:165309343:TATTA:TA
NM_001040142.2(SCN2A):c.1497del (p.Glu500fs)	SCN2A	E500fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001071677	2	166172090	2	165315580	1071677	1059008		NC_000002.12:165315579:AAAAA:AAAA
NM_001040142.2(SCN2A):c.718del (p.Ala240fs)	SCN2A	A240fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001071664	2	166166849	2	165310339	1071664	1059005		NC_000002.12:165310338:GGGGG:GGGG
NM_001040142.2(SCN2A):c.1912del (p.Leu638fs)	SCN2A	L638fs	Episodic ataxia type 9|Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Likely pathogenic(Last reviewed: Jun 3, 2020)	no assertion criteria provided	VCV000988714	2	166179905	2	165323395	988714	976644		NC_000002.12:165323394:CC:C
NM_001040142.2(SCN2A):c.605+4_605+7del	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000962112	2	166165305 - 166165308	2	165308795 - 165308798	962112	959586		NC_000002.12:165308794:GTAAGTA:GTA
NM_001040142.2(SCN2A):c.4447-7_4447-3del	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000862293	2	166237594 - 166237598	2	165381084 - 165381088	862293	851089		NC_000002.12:165381083:TTTCTTT:TT
NM_001040142.2(SCN2A):c.3793_3795del (p.Gly1265del)	SCN2A	G1265del	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000848481	2	166226752 - 166226754	2	165370242 - 165370244	848481	825080		NC_000002.12:165370241:TGGT:T
NM_001040142.2(SCN2A):c.1530_1531del (p.Lys511fs)	SCN2A	K511fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000848365	2	166172126 - 166172127	2	165315616 - 165315617	848365	825059		NC_000002.12:165315615:AGA:A
NM_001040142.2(SCN2A):c.5836_5838del (p.Lys1946del)	SCN2A	K1946del	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000839505	2	166246152 - 166246154	2	165389642 - 165389644	839505	825098		NC_000002.12:165389641:AAA:
NC_000002.12:g.(?_165342276)_(165389844_?)del	SCN2A		Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Likely pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000831895	2	166198786 - 166246354			831895	819063		
NC_000002.12:g.(?_165090130)_(165344931_?)del	SCN2A|SCN3A		not provided|Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Conflicting interpretations of pathogenicity(Last reviewed: Jul 17, 2019)	criteria provided, conflicting interpretations	VCV000831369	2	165946640 - 166201441			831369	819057		
NM_001040142.2(SCN2A):c.507del (p.Glu169fs)	SCN2A	E169fs	Seizures, benign familial infantile, 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801775	2	166165205	2	165308695	801775	790072	rs1574554892	NC_000002.12:165308694:AA:A
NM_001040142.2(SCN2A):c.3666_3668del (p.Ser1222_Gly1223delinsArg)	SCN2A		Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000654990	2	166223871 - 166223873	2	165367361 - 165367363	654990	628782	rs1574697784	NC_000002.12:165367360:GTGG:G
NM_001040142.2(SCN2A):c.4844_4845del (p.Ile1615fs)	SCN2A	I1615fs	Complex neurodevelopmental disorder|Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000650150	2	166245159 - 166245160	2	165388649 - 165388650	650150	628785	rs1574751309	NC_000002.12:165388648:ATA:A
NC_000002.12:g.(?_165365123)_(165389844_?)del	SCN2A		Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000583829	2	166221633 - 166246354	2	165365123 - 165389844	583829	557420		
NM_001040142.2(SCN2A):c.962_970+1del	SCN2A		Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000579666	2	166167096 - 166167105	2	165310586 - 165310595	579666	558821	rs1559353540	NC_000002.12:165310585:GAGGATAAAAG:G
NM_001040142.2(SCN2A):c.5316del (p.Ile1772fs)	SCN2A	I1772fs	Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000575820	2	166245632	2	165389122	575820	557643	rs1558886168	NC_000002.12:165389121:C:
NM_001040142.2(SCN2A):c.709_711delinsTTG (p.Ile237Leu)	SCN2A	I237L	Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000562197	2	166166844 - 166166846	2	165310334 - 165310336	562197	553374	rs1559353139	NC_000002.12:165310333:ATT:TTG
NM_001040142.2(SCN2A):c.3036del (p.Gly1013fs)	SCN2A	G1013fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000533484	2	166210816	2	165354306	533484	516592	rs1553583659	NC_000002.12:165354305:AAA:AA
NM_001040142.2(SCN2A):c.1402_1404del (p.Ser468del)	SCN2A	S468del	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2020)	criteria provided, conflicting interpretations	VCV000514940	2	166171999 - 166172001	2	165315489 - 165315491	514940	499046	rs780584405	NC_000002.12:165315488:TCT:
NM_001040142.2(SCN2A):c.5125del (p.Gln1709fs)	SCN2A	Q1709fs	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11	Likely pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000464914	2	166245440	2	165388930	464914	448807	rs1553463516	NC_000002.12:165388929:CC:C
NM_001040142.2(SCN2A):c.4160_4161del (p.Lys1387fs)	SCN2A	K1387fs	Autism Spectrum Disorder with Intellectual Disability	Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431141	2	166231381 - 166231382	2	165374871 - 165374872	431141	424641	rs1135401811	NC_000002.12:165374870:AAA:A
NM_001040142.2(SCN2A):c.-51-1734del	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331712	2	166150549	2	165294039	331712	284606	rs886054994	NC_000002.12:165294038:G:
NM_001040142.2(SCN2A):c.-51-1734_-51-1733del	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331711	2	166150548 - 166150549	2	165294038 - 165294039	331711	283039	rs1553563943	NC_000002.12:165294037:AGA:A
NM_001040142.2(SCN2A):c.-51-1735_-51-1733del	SCN2A		Early Infantile Epileptic Encephalopathy, Autosomal Dominant|Seizures, benign familial infantile, 3	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331710	2	166150547 - 166150549	2	165294037 - 165294039	331710	284604	rs886054992	NC_000002.12:165294036:AAGA:A
NM_001040142.2(SCN2A):c.3401del (p.Lys1134fs)	SCN2A	K1134fs	not provided	Pathogenic(Last reviewed: Jun 18, 2014)	criteria provided, single submitter	VCV000207075	2	166221653	2	165365143	207075	201354	rs796053192	NC_000002.12:165365142:AA:A
NM_001040142.2(SCN2A):c.3374del (p.Glu1125fs)	SCN2A	E1125fs	Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Dec 10, 2013)	criteria provided, single submitter	VCV000130220	2	166211156	2	165354646	130220	135667	rs587780450	NC_000002.12:165354645:A:
NM_004588.5(SCN2B):c.625_626delinsCC (p.Asn209Pro)	SCN2B	N209P	not specified|Atrial fibrillation, familial, 14	Uncertain significance(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422854	11	118037624 - 118037625	11	118166909 - 118166910	422854	408276	rs1064796044	NC_000011.10:118166908:TT:GG
NM_001330260.2(SCN8A):c.2706del (p.Glu903fs)	SCN8A	E903fs	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001299336	12	52159614	12	51765830	1299336	1289195		NC_000012.12:51765829:AAA:AA
NM_001330260.2(SCN8A):c.4443_4444delinsTG (p.Met1481_Thr1482delinsIleAla)	SCN8A		Early infantile epileptic encephalopathy 13	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000870200	12	52184205 - 52184206	12	51790421 - 51790422	870200	858352		NC_000012.12:51790420:GA:TG
NM_001330260.2(SCN8A):c.5156_5157del (p.Pro1719fs)	SCN8A	P1678fs, P1719fs	Cognitive impairment with or without cerebellar ataxia	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000008912	12	52200426 - 52200427	12	51806642 - 51806643	8912	23951	rs587776703	NC_000012.12:51806641:CT:
NM_001365536.1(SCN9A):c.4399-6_4399-3del	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001099314	2	167060977 - 167060980	2	166204467 - 166204470	1099314	1089990		NC_000002.12:166204466:AAAGAAA:AAA
NM_001365536.1(SCN9A):c.116del (p.Lys39fs)	SCN9A	K39fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV001075008	2	167168151	2	166311641	1075008	1059083		NC_000002.12:166311640:TTTT:TTT
NC_000002.11:g.(?_167055172)_(167060984_?)del	SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001074563	2	167055172 - 167060984			1074563	1056916		
NM_001365536.1(SCN9A):c.1026_1027delinsTT (p.Ser343Cys)	SCN9A|SCN1A-AS1	S343C	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001018572	2	167149821 - 167149822	2	166293311 - 166293312	1018572	1003430		NC_000002.12:166293310:TC:AA
NM_001365536.1(SCN9A):c.5568_5569delinsTT (p.Met1856_Asp1857delinsIleTyr)	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000968581	2	167055580 - 167055581	2	166199070 - 166199071	968581	952765		NC_000002.12:166199069:CC:AA
NM_001365536.1(SCN9A):c.4819del (p.Thr1607fs)	SCN9A|SCN1A-AS1	T1596fs, T1607fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000966709	2	167056330	2	166199820	966709	952768		NC_000002.12:166199819:T:
NM_001365536.1(SCN9A):c.5082del (p.Thr1695fs)	SCN9A|SCN1A-AS1	T1684fs, T1695fs	Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV000962274	2	167056067	2	166199557	962274	942371		NC_000002.12:166199556:AA:A
NM_001365536.1(SCN9A):c.2709del (p.Asp902_Cys903insTer)	SCN9A|SCN1A-AS1		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Aug 11, 2019)	criteria provided, single submitter	VCV000948229	2	167133658	2	166277148	948229	922389		NC_000002.12:166277147:A:
NM_001365536.1(SCN9A):c.363del (p.Ile122fs)	SCN9A	I122fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000852438	2	167163480	2	166306970	852438	825179		NC_000002.12:166306969:C:
NM_001365536.1(SCN9A):c.3024_3026del (p.Glu1008_Phe1009delinsAsp)	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000850481	2	167129234 - 167129236	2	166272724 - 166272726	850481	825143		NC_000002.12:166272723:AAT:
NM_001365536.1(SCN9A):c.5735_5739del (p.Ile1912fs)	SCN9A|SCN1A-AS1	I1901fs, I1912fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000849194	2	167055410 - 167055414	2	166198900 - 166198904	849194	825111		NC_000002.12:166198899:TGATAT:T
NM_001365536.1(SCN9A):c.468-15_468-8del	SCN9A		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV000841012	2	167162438 - 167162445	2	166305928 - 166305935	841012	850850		NC_000002.12:166305927:CAAGATTCCA:CA
NM_001365536.1(SCN9A):c.4503+9del	SCN9A|SCN1A-AS1		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA|not provided	Likely benign(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000702420	2	167060861	2	166204351	702420	695100	rs759871579	NC_000002.12:166204350:TTTTTTT:TTTTTT
NM_001365536.1(SCN9A):c.596+4_596+7del	SCN9A		Generalized epilepsy with febrile seizures plus, type 7|Hereditary sensory and autonomic neuropathy type IIA	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000650799	2	167162295 - 167162298	2	166305785 - 166305788	650799	650863	rs1574905327	NC_000002.12:166305784:TACTTAC:TAC
NC_000002.12:g.(?_165090130)_(166228992_?)del	SCN9A|SCN1A-AS1|CSRNP3|GALNT3|SCN1A|LOC100506124|TTC21B|LOC120977013|TTC21B-AS1|SCN3A|LOC102724058|SCN2A		Early infantile epileptic encephalopathy with suppression bursts|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000530654	2	165946640 - 167085502	2	165090130 - 166228992	530654	516160		
NM_001365536.1(SCN9A):c.690_691delinsAT (p.Gly230_Leu231=)	SCN9A		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Likely benign(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000471162	2	167159810 - 167159811	2	166303300 - 166303301	471162	449211	rs1553495271	NC_000002.12:166303299:GG:AT
NM_001365536.1(SCN9A):c.5746_5749delinsAACT (p.Tyr1916_Ile1917delinsAsnLeu)	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000471150	2	167055400 - 167055403	2	166198890 - 166198893	471150	449149	rs1553472800	NC_000002.12:166198889:TGTA:AGTT
NM_001365536.1(SCN9A):c.5351del (p.Glu1784fs)	SCN9A|SCN1A-AS1	E1773fs, E1784fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Pathogenic(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV000471143	2	167055798	2	166199288	471143	449057	rs1553473041	NC_000002.12:166199287:T:
NM_001365536.1(SCN9A):c.2454_2458del (p.Leu818fs)	SCN9A|SCN1A-AS1	L818fs	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|Indifference to pain, congenital, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000471099	2	167134709 - 167134713	2	166278199 - 166278203	471099	449209	rs766212849	NC_000002.12:166278198:AACTTAA:AA
NC_000002.12:g.(?_166227650)_(166227743_?)del	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Jul 29, 2017)	criteria provided, single submitter	VCV000471075			2	166227650 - 166227743	471075	448550		
NC_000002.12:g.(?_166195185)_(166204464_?)del	SCN9A|SCN1A-AS1		Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7	Uncertain significance(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000417445	2	167051695 - 167060974	2	166195185 - 166204464	417445	391452		
Single allele	SDCCAG8|LOC110120698|ZBTB18|LOC111828504|LINC02774|PLD5|LOC112577566|AKT3|LINC01347|CEP170|MIR4677|C1orf100		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	Pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	VCV000243062	1	242263612 - 244559673	1	242100310 - 244396371	243062	244143		
NM_004168.4(SDHA):c.667del (p.Asp223fs)	SDHA	D175fs, D223fs	Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141876	5	228344	5	228229	141876	151590	rs587782077	NC_000005.10:228228:GG:G
NM_032108.4(SEMA6B):c.1991del (p.Gly664fs)	SEMA6B	G664fs	Epilepsy, progressive myoclonic, 11	Pathogenic(Last reviewed: May 12, 2020)	no assertion criteria provided	VCV000872934					872934	861069		
NM_015559.3(SETBP1):c.632del (p.Gln211fs)	SETBP1	Q211fs	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001302004	18	42529937	18	44949972	1302004	1292286		NC_000018.10:44949971:A:
NC_000018.9:g.(?_42281312)_(45423127_?)del	SETBP1|ST8SIA5|IER3IP1|ELOA2|EPG5|KATNAL2|HDHD2|HAUS1|LOXHD1|C18orf25|SIGLEC15|SLC14A1|SLC14A2|PSTPIP2|PIAS2|RNF165|SKOR2|ATP5F1A|SMAD2		Microcephaly, epilepsy, and diabetes syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001004278	18	42281312 - 45423127			1004278	986632		
NM_015559.3(SETBP1):c.1414_1417del (p.Glu472fs)	SETBP1	E472fs	Schinzel-Giedion syndrome|Mental retardation, autosomal dominant 29	Likely pathogenic(Last reviewed: Oct 8, 2020)	no assertion criteria provided	VCV000988755	18	42530718 - 42530721	18	44950753 - 44950756	988755	976671		NC_000018.10:44950752:AGAGA:A
NM_015559.3(SETBP1):c.4790_*9del (p.Ter1597TrpextTer?)	SETBP1		Mental retardation, autosomal dominant 29	Likely pathogenic(Last reviewed: Mar 2, 2018)	no assertion criteria provided	VCV000984901	18	42643660 - 42643670	18	45063695 - 45063705	984901	972993		NC_000018.10:45063694:CTAGGGCGGGTCT:CT
NM_015559.3(SETBP1):c.1408del (p.Lys469_Met470insTer)	SETBP1		Inborn genetic diseases|Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	VCV000520830	18	42530710	18	44950745	520830	512352	rs1555706391	NC_000018.10:44950744:AAAA:AAA
NM_015559.3(SETBP1):c.1568del (p.His523fs)	SETBP1	H523fs	SETBP1-Related Disorder|not provided|Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000280223	18	42530873	18	44950908	280223	264907	rs886041469	NC_000018.10:44950907:A:
NM_015559.3(SETBP1):c.1821del (p.Ser608fs)	SETBP1	S608fs	Mental retardation, autosomal dominant 29|Schinzel-Giedion syndrome	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000212152	18	42531125	18	44951160	212152	208453	rs797045952	NC_000018.10:44951159:CC:C
NM_015559.3(SETBP1):c.427del (p.Arg143fs)	SETBP1	R143fs	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157558	18	42281738	18	44701771	157558	167421	rs606231271	NC_000018.10:44701770:CCC:CC
NM_015559.3(SETBP1):c.2464del (p.Ile822fs)	SETBP1	I822fs	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157555	18	42531769	18	44951803	157555	167418	rs606231269	NC_000018.10:44951802:AA:A
NM_001353345.2(SETD1B):c.1526_1527del (p.Glu509fs)	SETD1B	E509fs	Epilepsy	Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000692025	12	122248376 - 122248377	12	121810470 - 121810471	692025	679784	rs1592977444	NC_000012.12:121810469:GAG:G
GRCh37/hg19 3p26.1(chr3:4060387-4417997)x1	SETMAR|SUMF1		not provided	Uncertain significance(Last reviewed: Jul 23, 2018)	no assertion criteria provided	VCV000687775	3	4060387 - 4417997			687775	675367		
NM_000193.4(SHH):c.143del (p.Ile48fs)	SHH	I48fs	Holoprosencephaly 3	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495245	7	155604674	7	155811980	495245	486746	rs1554495331	NC_000007.14:155811979:A:
NM_020708.5(SLC12A5):c.2910+9del	SLC12A5		Early infantile epileptic encephalopathy 34	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001161384	20	44684920	20	46056281	1161384	1149505		NC_000020.11:46056280:C:
NM_020708.5(SLC12A5):c.3173_3175del (p.Glu1058del)	SLC12A5	E1081del, E1058del	Early infantile epileptic encephalopathy 34	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001047286	20	44685855 - 44685857	20	46057216 - 46057218	1047286	1034736		NC_000020.11:46057215:GAGG:G
NM_020708.5(SLC12A5):c.266del (p.Lys89fs)	SLC12A5	K89fs, K112fs	Early infantile epileptic encephalopathy 34	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV000856637	20	44664156	20	46035517	856637	848433		NC_000020.11:46035516:AAAAAA:AAAAA
NC_000020.11:g.(?_46045858)_(46046456_?)del	SLC12A5		Early infantile epileptic encephalopathy 34	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000833486	20	44674497 - 44675095			833486	821331		
NC_000020.11:g.(?_46021746)_(46057625_?)del	SLC12A5|LOC100128028		Early infantile epileptic encephalopathy 34	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000833121	20	44650385 - 44686264			833121	821330		
NM_020708.5(SLC12A5):c.2548-5_2548-4delinsCT	SLC12A5		Early infantile epileptic encephalopathy 34	Likely benign(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000747421	20	44682212 - 44682213	20	46053573 - 46053574	747421	760960	rs1600604943	NC_000020.11:46053572:TG:CT
NM_005045.4(RELN):c.8120-9del	SLC26A5-AS1|RELN		Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001081698	7	103151461	7	103511014	1081698	1074172		NC_000007.14:103511013:AAAAAAA:AAAAAA
NM_005045.4(RELN):c.9764-10del	SLC26A5-AS1|RELN		not provided|Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV000796089	7	103126873	7	103486426	796089	787490	rs777831069	NC_000007.14:103486425:AA:A
NM_006516.4(SLC2A1):c.275+1del	SLC2A1		GLUT1 deficiency syndrome 1	Pathogenic	no assertion criteria provided	VCV001048756	1	43396716	1	42931045	1048756	1036843		NC_000001.11:42931044:CC:C
NM_006516.4(SLC2A1):c.293del (p.Met98fs)	SLC2A1	M98fs	GLUT1 deficiency syndrome 2	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000977496	1	43396520	1	42930849	977496	965620		NC_000001.11:42930848:A:
NM_006516.4(SLC2A1):c.339del (p.Lys114fs)	SLC2A1	K114fs	Intellectual disability|GLUT1 deficiency syndrome 1	Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV000975958	1	43396474	1	42930803	975958	964157		NC_000001.11:42930802:C:
NM_006516.4(SLC2A1):c.274del (p.Arg92fs)	SLC2A1	R92fs	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801470	1	43396718	1	42931047	801470	789968	rs1570593820	NC_000001.11:42931046:GG:G
NM_006516.4(SLC2A1):c.624del (p.Glu209fs)	SLC2A1	E209fs	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801469	1	43395599	1	42929928	801469	789967	rs1570592844	NC_000001.11:42929927:GGGG:GGG
NM_006516.4(SLC2A1):c.621_629del (p.Glu209_Pro211del)	SLC2A1		GLUT1 deficiency syndrome 1	Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000635052	1	43395594 - 43395602	1	42929923 - 42929931	635052	622863	rs1557646075	NC_000001.11:42929922:CTCTCGGGGC:C
NM_006516.4(SLC2A1):c.1033_1042del (p.Ala345fs)	SLC2A1	A345fs	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000495062	1	43394635 - 43394644	1	42928964 - 42928973	495062	486609	rs1553155973	NC_000001.11:42928963:CACAACCCGCCA:CA
NM_006516.4(SLC2A1):c.732del (p.Met244fs)	SLC2A1	M244fs	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000488600	1	43395399	1	42929728	488600	481468	rs1553156069	NC_000001.11:42929727:C:
NM_006516.4(SLC2A1):c.844_855del (p.Gln282_Ser285del)	SLC2A1		GLUT1 deficiency syndrome 2	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000433186	1	43395276 - 43395287	1	42929605 - 42929616	433186	426739	rs1553156047	NC_000001.11:42929604:AGACAGCTGCTG:
NM_006516.2(SLC2A1):c.-390delA	SLC2A1		GLUT1 deficiency syndrome|not provided|Dystonia	Benign(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000297392	1	43424712	1	42959041	297392	282349	rs28365848	NC_000001.11:42959040:T:
NM_006516.4(SLC2A1):c.574_575del (p.Ile192fs)	SLC2A1	I192fs	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000235888	1	43395648 - 43395649	1	42929977 - 42929978	235888	237523	rs878853161	NC_000001.11:42929976:AT:
NM_006516.4(SLC2A1):c.828_841del (p.Val277fs)	SLC2A1	V277fs	not provided	Pathogenic(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	VCV000207221	1	43395290 - 43395303	1	42929619 - 42929632	207221	201153	rs796053268	NC_000001.11:42929618:ACAGCTGCAGCACCACAGC:ACAGC
NM_006516.4(SLC2A1):c.972+7del	SLC2A1		GLUT1 deficiency syndrome 1, autosomal recessive|GLUT1 deficiency syndrome|not specified|Dystonia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2021)	criteria provided, conflicting interpretations	VCV000198543	1	43394874	1	42929203	198543	195704	rs531385270	NC_000001.11:42929202:G:
NM_006516.2(SLC2A1):c.19_28delAAGCTGACGG (p.Lys7Valfs)	SLC2A1		GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159924	1	43408983 - 43408992	1	42943312 - 42943321	159924	167996	rs587784393	NC_000001.11:42943311:CCGTCAGCTTC:C
NM_006516.4(SLC2A1):c.1089del (p.Pro362_Trp363insTer)	SLC2A1		GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: May 7, 2014)	criteria provided, single submitter	VCV000159922	1	43393465	1	42927794	159922	167987	rs587784391	NC_000001.11:42927793:CC:C
NM_006516.4(SLC2A1):c.1007_1009del (p.Leu336del)	SLC2A1	L336del	GLUT1 deficiency syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159920	1	43394668 - 43394670	1	42928997 - 42928999	159920	167988	rs587784389	NC_000001.11:42928996:GCAG:G
NM_006516.4(SLC2A1):c.283_284delinsAT (p.Ser95Ile)	SLC2A1	S95I	GLUT1 deficiency syndrome 2	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000016116	1	43396529 - 43396530	1	42930858 - 42930859	16116	31155	rs267607060	NC_000001.11:42930857:GA:AT
SLC2A1, 12-BP DEL, NT1022	SLC2A1		GLUT1 deficiency syndrome 2	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000016112					16112	31151		
NC_000001.11:g.(?_42925375)_(42959176_?)del	SLC2A1|SLC2A1-DT		GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000016105	1	43391046 - 43424847	1	42925375 - 42959176	16105	31144		
NM_003042.4(SLC6A1):c.1191+17del	SLC6A1		Myoclonic-atonic epilepsy|not provided	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV001166941	3	11070543	3	11028857	1166941	1154273		NC_000003.12:11028856:CCCCCCCC:CCCCCCC
NM_003042.4(SLC6A1):c.566del (p.Val189fs)	SLC6A1	V11fs, V189fs, V69fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001074164	3	11061993	3	11020307	1074164	1059566		NC_000003.12:11020306:T:
NM_003042.4(SLC6A1):c.370+2del	SLC6A1|SLC6A1-AS1		Myoclonic-atonic epilepsy	Likely pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001066405	3	11059662	3	11017976	1066405	1055281		NC_000003.12:11017975:T:
NM_003042.4(SLC6A1):c.109_110delinsGC (p.Lys37Ala)	SLC6A1|SLC6A1-AS1	K37A	Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001043596	3	11059006 - 11059007	3	11017320 - 11017321	1043596	1024906		NC_000003.12:11017319:AA:GC
NM_003042.4(SLC6A1):c.990_991delinsAG (p.Ser331Gly)	SLC6A1	S153G, S211G, S331G	Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV001025339	3	11067957 - 11067958	3	11026271 - 11026272	1025339	1004411		NC_000003.12:11026270:CA:AG
NM_003042.4(SLC6A1):c.25del (p.Ala9fs)	SLC6A1|SLC6A1-AS1	A9fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000956975	3	11058921	3	11017235	956975	943250		NC_000003.12:11017234:GG:G
NM_003042.4(SLC6A1):c.197del (p.Asn66fs)	SLC6A1|SLC6A1-AS1	N66fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000938280	3	11059093	3	11017407	938280	931683		NC_000003.12:11017406:AA:A
NM_003042.4(SLC6A1):c.1640del (p.Leu547fs)	SLC6A1	L547fs, L369fs, L427fs	Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000853909	3	11076329	3	11034643	853909	827316		NC_000003.12:11034642:T:
NM_003042.4(SLC6A1):c.1191+3del	SLC6A1		Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000842836	3	11070536	3	11028850	842836	851260		NC_000003.12:11028849:G:
NM_003042.4(SLC6A1):c.1711del (p.Val571fs)	SLC6A1	V451fs, V393fs, V571fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689789	3	11078562	3	11036876	689789	677414	rs1574929097	NC_000003.12:11036875:GG:G
NM_003042.4(SLC6A1):c.801del (p.Ile268fs)	SLC6A1	I268fs, I148fs, I90fs	Myoclonic-atonic epilepsy	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666324	3	11067221	3	11025535	666324	653856	rs1574906665	NC_000003.12:11025534:C:
NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs)	SLC6A1	L36fs, L94fs, L214fs	Myoclonic-atonic epilepsy|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000475488	3	11064071 - 11064089	3	11022385 - 11022403	475488	451621	rs1553688970	NC_000003.12:11022384:CGCTGGCCACTGGCCATCACGCTGGCCA:CGCTGGCCA
NM_003042.4(SLC6A1):c.1426+3_1426+6del	SLC6A1		Myoclonic-atonic epilepsy	Uncertain significance(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000475472	3	11072966 - 11072969	3	11031280 - 11031283	475472	451980	rs1553691139	NC_000003.12:11031279:GTGAGT:GT
NM_003042.4(SLC6A1):c.1255del (p.Arg419fs)	SLC6A1	R299fs, R241fs, R419fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000475470	3	11070969	3	11029283	475470	451927	rs1553690583	NC_000003.12:11029282:CC:C
NM_003042.4(SLC6A1):c.1369_1370del (p.Gly457fs)	SLC6A1	G337fs, G279fs, G457fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000192371	3	11072908 - 11072909	3	11031222 - 11031223	192371	190158	rs876657401	NC_000003.12:11031221:GG:
NM_004211.5(SLC6A5):c.1738-8_1738-7del	SLC6A5		Hyperekplexia 3	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV001140000	11	20658710 - 20658711	11	20637164 - 20637165	1140000	1121279		NC_000011.10:20637163:GG:
NM_004211.4(SLC6A5):c.-82del	SLC6A5		Hyperekplexia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000303989	11	20621137	11	20599591	303989	326885	rs886048106	NC_000011.10:20599590:G:
NM_004211.5(SLC6A5):c.323del (p.Pro108fs)	SLC6A5	P108fs	Hyperekplexia 3	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000038371	11	20622990	11	20601444	38371	46932	rs281864923	NC_000011.10:20601443:CCCCC:CCCC
NM_004211.5(SLC6A5):c.1294delinsTT (p.Val432fs)	SLC6A5	V198fs, V432fs	Hyperekplexia 3	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000005762	11	20648287	11	20626741	5762	20801	rs281864924	NC_000011.10:20626740:G:TT
NM_005629.4(SLC6A8):c.942_944del (p.Phe315del)	SLC6A8	F200del, F315del	Creatine transporter deficiency	Pathogenic	criteria provided, single submitter	VCV000983532	X	152958745 - 152958747	X	153693290 - 153693292	983532	971599		NC_000023.11:153693289:TTCTT:TT
NC_000023.10:g.(?_135104735)_(135106652_?)del	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001074430	X	135104735 - 135106652			1074430	1058183		
NM_001379110.1(SLC9A6):c.1599_1603del (p.Arg534fs)	SLC9A6	R472fs, R556fs, R504fs, R524fs, R534fs	Christianson syndrome	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000807688	X	135115588 - 135115592	X	136033429 - 136033433	807688	798807	rs1603219805	NC_000023.11:136033428:GAAAGGA:GA
NM_001379110.1(SLC9A6):c.71_88del (p.Ile24_Leu29del)	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000653174	X	135067881 - 135067898	X	135985722 - 135985739	653174	649713	rs1603184929	NC_000023.11:135985721:CTGCTCATCTTCATCCTGCTGCTCA:CTGCTCA
NM_001379110.1(SLC9A6):c.1143_1144del (p.Phe382fs)	SLC9A6	F350fs, F382fs, F402fs, F434fs	Gastrostomy tube feeding in infancy|Recurrent respiratory infections|Seizures|Sleep disturbance|Scoliosis|Global developmental delay|Christianson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2015)	criteria provided, multiple submitters, no conflicts	VCV000418996	X	135098865 - 135098866	X	136016706 - 136016707	418996	411132	rs1064793575	NC_000023.11:136016705:TGT:T
NM_001379110.1(SLC9A6):c.726del (p.Ala243fs)	SLC9A6	A243fs, A263fs, A211fs, A295fs	Christianson syndrome	Pathogenic	no assertion criteria provided	VCV000375585	X	135084354	X	136002195	375585	362395	rs1057519394	NC_000023.11:136002194:TT:T
NM_001042537:c.916delC	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000246605					246605	245213		
NM_001379110.1(SLC9A6):c.370-9_370-5del	SLC9A6		Intellectual disability|not specified|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 27, 2016)	criteria provided, conflicting interpretations	VCV000207248	X	135080254 - 135080258	X	135998095 - 135998099	207248	203985	rs796053290	NC_000023.11:135998094:TTTATTTTA:TTTA
NM_001379110.1(SLC9A6):c.27del (p.Lys9fs)	SLC9A6	K9fs, K61fs	Christianson syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159931	X	135067844	X	135985685	159931	169938	rs587784398	NC_000023.11:135985684:G:
NM_001379110.1(SLC9A6):c.856_864del (p.Gly286_Ala288del)	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000029949	X	135092713 - 135092721	X	136010554 - 136010562	29949	38904	rs398122849	NC_000023.11:136010553:GGTGCTGCT:
NM_001379110.1(SLC9A6):c.452_453del (p.His151fs)	SLC9A6	H119fs, H151fs, H203fs, H171fs	Christianson syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011479	X	135080645 - 135080646	X	135998486 - 135998487	11479	26518	rs730882188	NC_000023.11:135998485:AT:
NM_001379110.1(SLC9A6):c.447+3_447+4delinsCC	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011478	X	135080347 - 135080348	X	135998188 - 135998189	11478	26517	rs730882187	NC_000023.11:135998187:AA:CC
NM_001379110.1(SLC9A6):c.704_709del (p.Glu235_Ser236del)	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Oct 15, 2009)	no assertion criteria provided	VCV000011476	X	135084330 - 135084335	X	136002171 - 136002176	11476	26515	rs886037619	NC_000023.11:136002170:GTGAAAGTG:GTG
GRCh37/hg19 12p12.2-12.1(chr12:21000817-21415824)x1	SLCO1B1|SLCO1B3|SLCO1B7		not provided	Uncertain significance(Last reviewed: Dec 29, 2017)	no assertion criteria provided	VCV000688941	12	21000817 - 21415824			688941	676533		
NM_006306.4(SMC1A):c.2853_2856del (p.Ser951fs)	SMC1A	S951fs, S929fs	Developmental and epileptic encephalopathy, 85, with or without midline brain defects|Congenital muscular hypertrophy-cerebral syndrome|not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208626	X	53423153 - 53423156	X	53396233 - 53396236	208626	205198	rs863225458	NC_000023.11:53396232:CTGACT:CT
GRCh37/hg19 9q34.3(chr9:139268640-139329037)x1	SNAPC4|ENTR1|PMPCA|INPP5E		not provided	Uncertain significance(Last reviewed: Apr 11, 2018)	no assertion criteria provided	VCV000688176	9	139268640 - 139329037			688176	675768		
GRCh37/hg19 2p25.3(chr2:1131015-1345948)x1	SNTG2		not provided	Uncertain significance(Last reviewed: Aug 30, 2017)	no assertion criteria provided	VCV000686579	2	1131015 - 1345948			686579	674171		
NM_001330723.2(SNX27):c.873del (p.Lys293fs)	SNX27	K293fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000955542	1	151634712	1	151662236	955542	941450		NC_000001.11:151662235:TT:T
NM_001330723.2(SNX27):c.106_120del (p.Gly36_Gly40del)	SNX27		Severe myoclonic epilepsy in infancy	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000853884	1	151584776 - 151584790	1	151612300 - 151612314	853884	822720		NC_000001.11:151612299:CGGCGGCGGGGGAGGCGGCGGC:CGGCGGC
NM_003114.5(SPAG1):c.2542del (p.Asp848fs)	SPAG1	D848fs	Ciliary dyskinesia, primary, 28|Epilepsy, nocturnal frontal lobe, 5	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000088684	8	101252889	8	100240661	88684	94264	rs886037653	NC_000008.11:100240660:GGGG:GGG
NM_145207.3(SPATA5):c.505+10del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Benign(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV001168052	4	123854660	4	122933505	1168052	1154640		NC_000004.12:122933504:AAA:AA
NC_000004.11:g.(?_123977532)_(123978453_?)del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001075383	4	123977532 - 123978453			1075383	1057084		
NC_000004.11:g.(?_124011714)_(124011880_?)del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001075382	4	124011714 - 124011880			1075382	1057085		
NC_000004.11:g.(?_124011724)_(124177345_?)del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001068007	4	124011724 - 124177345			1068007	1054345		
NM_145207.3(SPATA5):c.1147+1_1147+5del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV001067234	4	123855890 - 123855894	4	122934735 - 122934739	1067234	1055401		NC_000004.12:122934734:TATGGTATG:TATG
NM_145207.3(SPATA5):c.2306del (p.Leu769fs)	SPATA5	L768fs, L769fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV001031192	4	124011823	4	123090668	1031192	1016377		NC_000004.12:123090667:TTTT:TTT
NM_145207.3(SPATA5):c.1822_1824del (p.Asp608del)	SPATA5	D607del, D608del	Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV000984704	4	123900492 - 123900494	4	122979337 - 122979339	984704	972784		NC_000004.12:122979336:ATGAT:AT
NM_145207.3(SPATA5):c.1964del (p.Arg655fs)	SPATA5	R654fs, R655fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000951542	4	123949435	4	123028280	951542	923419		NC_000004.12:123028279:G:
NM_145207.3(SPATA5):c.785del (p.Asn262fs)	SPATA5	N262fs, N261fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, single submitter	VCV000949726	4	123855529	4	122934374	949726	923409		NC_000004.12:122934373:AAA:AA
NM_145207.3(SPATA5):c.421del (p.Ala141fs)	SPATA5	A140fs, A141fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000946570	4	123850326	4	122929171	946570	923407		NC_000004.12:122929170:GG:G
NM_145207.3(SPATA5):c.2145_2151del (p.Ala716fs)	SPATA5	A715fs, A716fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000934221	4	123978374 - 123978380	4	123057219 - 123057225	934221	932162		NC_000004.12:123057218:AAGCAAGA:A
NM_145207.3(SPATA5):c.1820del (p.Asn607fs)	SPATA5	N606fs, N607fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000651167	4	123900491	4	122979336	651167	631935	rs1578612173	NC_000004.12:122979335:AA:A
NC_000004.12:g.(?_123056387)_(123057288_?)del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000583652	4	123977542 - 123978443	4	123056387 - 123057288	583652	559545		
NM_145207.3(SPATA5):c.2409_2410del (p.Glu804fs)	SPATA5	E803fs, E804fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000575536	4	124177238 - 124177239	4	123256083 - 123256084	575536	561895	rs1560667008	NC_000004.12:123256082:GGG:G
NC_000004.12:g.(?_123056367)_(123057308_?)del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000542396	4	123977522 - 123978463	4	123056367 - 123057308	542396	519936		
NM_145207.3(SPATA5):c.2225del (p.Ala742fs)	SPATA5	A741fs, A742fs	Epilepsy, hearing loss, and mental retardation syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503811	4	124011745	4	123090590	503811	495217	rs1553983667	NC_000004.12:123090589:C:
NM_145207.3(SPATA5):c.1334+6_1334+9del	SPATA5		not provided|Epilepsy, hearing loss, and mental retardation syndrome	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000475718	4	123857316 - 123857319	4	122936161 - 122936164	475718	453345	rs752274594	NC_000004.12:122936160:TCTTT:T
NM_145207.3(SPATA5):c.1073del (p.Gly357_Leu358insTer)	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373135	4	123855818	4	122934663	373135	359478	rs751291521	NC_000004.12:122934662:TT:T
NM_145207.3(SPATA5):c.1574_1578del (p.Asn525fs)	SPATA5	N525fs, N524fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000203529	4	123868503 - 123868507	4	122947348 - 122947352	203529	199929	rs796051891	NC_000004.12:122947347:ATGCT:
NM_001130438.3(SPTAN1):c.6273_6274delinsTT (p.Arg2092Cys)	SPTAN1	R2067C, R2087C, R2072C, R2092C	not specified	Uncertain significance(Last reviewed: Aug 17, 2014)	criteria provided, single submitter	VCV000207368	9	131388251 - 131388252	9	128625972 - 128625973	207368	202427	rs796053333	NC_000009.12:128625971:CC:TT
NM_001130438.3(SPTAN1):c.6605_6607del (p.Gln2202del)	SPTAN1	Q2202del, Q2182del, Q2197del, Q2177del	not provided|Early infantile epileptic encephalopathy 5	Pathogenic(Last reviewed: Jul 10, 2020)	criteria provided, single submitter	VCV000035483	9	131389692 - 131389694	9	128627413 - 128627415	35483	44156	rs398122865	NC_000009.12:128627412:CAGC:C
NM_014467.3(SRPX2):c.659+8_659+22del	SRPX2		Rolandic epilepsy with mental retardation and speech dyspraxia, X-linked	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001118902	X	99920371 - 99920385	X	100665374 - 100665388	1118902	1107902		NC_000023.11:100665373:GCCTGAATAATGGATGCC:GCC
NC_000023.11:g.(?_100644166)_(100671299_?)del	SRPX2		Rolandic epilepsy with mental retardation and speech dyspraxia, X-linked	Uncertain significance(Last reviewed: May 30, 2016)	criteria provided, single submitter	VCV000417465	X	99899163 - 99926296	X	100644166 - 100671299	417465	404398		
NM_014467.3(SRPX2):c.660-16del	SRPX2		not specified	Benign(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	VCV000207382	X	99920517	X	100665520	207382	203967	rs764480482	NC_000023.11:100665519:A:
NM_003896.4(ST3GAL5):c.353del (p.Lys118fs)	ST3GAL5	K118fs, K90fs, K95fs	GM3 synthase deficiency	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000577410	2	86075293	2	85848170	577410	560987	rs754643632	NC_000002.12:85848169:TT:T
NM_003896.4(ST3GAL5):c.*140del	ST3GAL5		GM3 synthase deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000337330	2	86067127	2	85840004	337330	287444	rs550737011	NC_000002.12:85840003:TTTTTTTT:TTTTTTT
NM_213622.4(STAMBP):c.843_844del (p.Cys282fs)	STAMBP	C282fs, C147fs	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV001034283	2	74076590 - 74076591	2	73849463 - 73849464	1034283	1019692		NC_000002.12:73849462:AT:
NM_213622.4(STAMBP):c.1259_1261del (p.Ile420del)	STAMBP	I420del, I285del	Microcephaly-capillary malformation syndrome	Uncertain significance(Last reviewed: Dec 30, 2013)	criteria provided, single submitter	VCV000160043	2	74089368 - 74089370	2	73862241 - 73862243	160043	168080	rs587784446	NC_000002.12:73862240:CATCA:CA
NM_213622.4(STAMBP):c.411del (p.Ile138fs)	STAMBP	I3fs, I138fs	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000050797	2	74074548	2	73847421	50797	59806	rs886037633	NC_000002.12:73847420:CC:C
NM_001003787.4(STRADA):c.189_190delinsCT (p.Pro64Ser)	STRADA	P27S, P35S, P56S, P64S, P6S	Polyhydramnios, megalencephaly, and symptomatic epilepsy	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001060344	17	61791402 - 61791403	17	63714042 - 63714043	1060344	1050485		NC_000017.11:63714041:GC:AG
NM_001003787.4(STRADA):c.1144del (p.Ile382fs)	STRADA	I345fs, D279fs, I353fs, I324fs, I374fs, I382fs	Polyhydramnios, megalencephaly, and symptomatic epilepsy	Uncertain significance(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV001038348	17	61781111	17	63703751	1038348	1033502		NC_000017.11:63703750:T:
NM_001003787.4(STRADA):c.1023_1024del (p.His342fs)	STRADA	H284fs, H305fs, H313fs, H334fs, H342fs	Polyhydramnios, megalencephaly, and symptomatic epilepsy	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001025876	17	61781777 - 61781778	17	63704417 - 63704418	1025876	1012955		NC_000017.11:63704416:GGG:G
NM_001003787.4(STRADA):c.754-10del	STRADA		Polyhydramnios, megalencephaly, and symptomatic epilepsy	Uncertain significance(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000582565	17	61784109	17	63706749	582565	571979	rs763317382	NC_000017.11:63706748:AAAAAAAA:AAAAAAA
STRADA, 7-KB DEL	STRADA		Polyhydramnios, megalencephaly, and symptomatic epilepsy	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000002186					2186	17225		
NM_052874.5(STX1B):c.334del (p.Leu112fs)	STX1B	L112fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001070577	16	31008843	16	30997522	1070577	1063632		NC_000016.10:30997521:GG:G
NC_000016.9:g.(?_31003278_31004694del	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV001054511					1054511	1039201		
NM_052874.5(STX1B):c.252_257delinsAT (p.Ala85fs)	STX1B	A85fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, single submitter	VCV000968105	16	31012272 - 31012277	16	31000951 - 31000956	968105	957735		NC_000016.10:31000950:TTGGCC:AT
NM_052874.5(STX1B):c.852del (p.Thr285fs)	STX1B	T285fs	Generalized epilepsy with febrile seizures plus, type 9	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000963594	16	31004157	16	30992836	963594	949371		NC_000016.10:30992835:CCCCCC:CCCCC
NM_052874.5(STX1B):c.205+2_205+3del	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000961985	16	31012412 - 31012413	16	31001091 - 31001092	961985	960156		NC_000016.10:31001090:CAC:C
NM_052874.5(STX1B):c.281-41_294del	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Likely pathogenic(Last reviewed: Sep 22, 2019)	criteria provided, single submitter	VCV000960621	16	31008883 - 31008937	16	30997562 - 30997616	960621	960155		
NM_052874.5(STX1B):c.382del (p.Glu128fs)	STX1B	E128fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000813789	16	31008353	16	30997032	813789	802012		NC_000016.10:30997031:CC:C
NM_052874.5(STX1B):c.686_688del (p.Ile229_Asp230delinsAsn)	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803252	16	31004549 - 31004551	16	30993228 - 30993230	803252	791585	rs1596714579	NC_000016.10:30993227:CAA:
NC_000016.10:g.(?_31000908)_(31001623_?)del	STX1B		Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000661190	16	31012229 - 31012944	16	31000908 - 31001623	661190	652846		
NM_052874.5(STX1B):c.404del (p.Ala135fs)	STX1B	A135fs	Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000657728	16	31008331	16	30997010	657728	644611	rs1596716888	NC_000016.10:30997009:G:
NM_001032221.6(STXBP1):c.993del (p.Lys332fs)	STXBP1	K296fs, K318fs, K329fs, K332fs	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, single submitter	VCV001299648	9	130434359	9	127672080	1299648	1289702		NC_000009.12:127672079:G:
NM_001032221.6(STXBP1):c.1493_1505del (p.His498fs)	STXBP1	H462fs, H484fs, H495fs, H498fs	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV001298374	9	130442467 - 130442479	9	127680188 - 127680200	1298374	1288236		NC_000009.12:127680187:ACTACCCTTATAT:
NM_003165.6(STXBP1):c.664-1delG	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV001298371	9	130428444	9	127666165	1298371	1288233		NC_000009.12:127666164:GGG:GG
NM_001032221.6(STXBP1):c.1227_1229del (p.Leu410del)	STXBP1	L374del, L396del, L407del, L410del	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV001298370	9	130438197 - 130438199	9	127675918 - 127675920	1298370	1288232		NC_000009.12:127675917:CTTCT:CT
NM_001032221.6(STXBP1):c.25delinsCT (p.Val9fs)	STXBP1	V9fs	Early infantile epileptic encephalopathy 4	Pathogenic	no assertion criteria provided	VCV001202628	9	130374707	9	127612428	1202628	1192637		NC_000009.12:127612427:G:CT
NM_001032221.6(STXBP1):c.1473_1475del (p.Glu491del)	STXBP1	E455del, E477del, E488del, E491del	Infantile epilepsy syndrome	Likely pathogenic(Last reviewed: Jan 19, 2018)	no assertion criteria provided	VCV000984902	9	130442445 - 130442447	9	127680166 - 127680168	984902	972951		NC_000009.12:127680165:GAGGA:GA
NM_001032221.6(STXBP1):c.1574del (p.Asn525fs)	STXBP1	N489fs, N511fs, N522fs, N525fs	Infantile epilepsy syndrome	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000984835	9	130444710	9	127682431	984835	972952		NC_000009.12:127682430:AA:A
GRCh37/hg19 9q34.11(chr9:130431762-130432190)x1	STXBP1		Infantile epilepsy syndrome	Pathogenic(Last reviewed: Nov 12, 2018)	no assertion criteria provided	VCV000984761	9	130431762 - 130432190			984761	972849		
NM_001032221.6(STXBP1):c.374_375del (p.Lys125fs)	STXBP1	K111fs, K122fs, K125fs	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000976064	9	130423428 - 130423429	9	127661149 - 127661150	976064	964306		NC_000009.12:127661148:AAA:A
NM_001032221.6(STXBP1):c.624del (p.Lys208fs)	STXBP1	K194fs, K205fs, K208fs	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000974572	9	130427571	9	127665292	974572	962862		NC_000009.12:127665291:G:
GRCh37/hg19 9q34.11(chr9:130435492-130485618)x1	STXBP1|PTRH1|TTC16|CFAP157		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV000932281	9	130435492 - 130485618			932281	920585		
NC_000009.12:g.(?_127612384)_(127690877_?)del	STXBP1		Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000831100	9	130374663 - 130453156			831100	820051		
NM_001032221.6(STXBP1):c.246+2_325+14del	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV000827636	9	130420732 - 130422401	9	127658453 - 127660122	827636	815840		
NM_001032221.6(STXBP1):c.1030del (p.Tyr344fs)	STXBP1	Y330fs, Y344fs, Y308fs, Y341fs	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000812177	9	130435460	9	127673181	812177	800669		NC_000009.12:127673180:T:
NM_001032221.6(STXBP1):c.1236del (p.Phe413_Leu414insTer)	STXBP1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802514	9	130438208	9	127675929	802514	790841	rs1588339898	NC_000009.12:127675928:C:
NM_001032221.6(STXBP1):c.303_305del (p.Ala102del)	STXBP1	A102del, A88del	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802509	9	130422363 - 130422365	9	127660084 - 127660086	802509	790836	rs1588306876	NC_000009.12:127660083:GCTGC:GC
GRCh37/hg19 9q34.11(chr9:130335766-130517907)	STXBP1|SH2D3C|TOR2A|NIBAN2|PTRH1|TTC16|CFAP157		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625638	9	130335766 - 130517907			625638	613942		
Single allele	STXBP1|NIBAN2|LRSAM1		Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000598748	9	130248090 - 130388197			598748	589818		
NM_001032221.6(STXBP1):c.298del (p.Arg100fs)	STXBP1	R100fs, R86fs	Infantile epilepsy syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 24, 2015)	criteria provided, single submitter	VCV000520745	9	130422359	9	127660080	520745	511783	rs1554776842	NC_000009.12:127660079:CC:C
NM_001032221.6(STXBP1):c.1569_1570del (p.His523fs)	STXBP1	H523fs, H487fs, H509fs, H520fs	Infantile epilepsy syndrome|not provided	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000503942	9	130444705 - 130444706	9	127682426 - 127682427	503942	495398	rs1554778928	NC_000009.12:127682425:ATA:A
NM_001032221.6(STXBP1):c.1597del (p.Ser533fs)	STXBP1	S533fs, S497fs, S519fs, S530fs	Infantile epilepsy syndrome|not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000450231	9	130444734	9	127682455	450231	444353	rs1554778930	NC_000009.12:127682454:A:
NM_001032221.6(STXBP1):c.1381_1390del (p.Lys461fs)	STXBP1	K461fs, K425fs, K447fs, K458fs	Early infantile epileptic encephalopathy 4|Early infantile epileptic encephalopathy with suppression bursts|not provided	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449337	9	130440723 - 130440732	9	127678444 - 127678453	449337	444351	rs1554778657	NC_000009.12:127678443:GCCGGAGCAAGCCGGAGC:GCCGGAGC
NM_001032221.6(STXBP1):c.754_755del (p.Met252fs)	STXBP1	M252fs, M238fs, M249fs	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	VCV000160071	9	130428534 - 130428535	9	127666255 - 127666256	160071	168754	rs587784454	NC_000009.12:127666254:TAT:T
NM_003850.3(SUCLA2):c.887del (p.Gln296fs)	SUCLA2	Q296fs	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802962	13	48528608	13	47954473	802962	791345	rs1593479845	NC_000013.11:47954472:T:
SUCLA2, 43-BP DEL AND 5-BP INS	SUCLA2		Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000005975					5975	21014		
NM_003849.4(SUCLG1):c.532-12_532-10del	SUCLG1		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV001081491	2	84668238 - 84668240	2	84441114 - 84441116	1081491	1070039		NC_000002.12:84441113:ATCAT:AT
NC_000002.11:g.(?_84650850)_(84686413_?)del	SUCLG1		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV001071175	2	84650850 - 84686413			1071175	1057020		
NM_003849.4(SUCLG1):c.532_533delinsAA (p.Pro178Asn)	SUCLG1	P178N	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001030715	2	84668227 - 84668228	2	84441103 - 84441104	1030715	1016110		NC_000002.12:84441102:GG:TT
NM_003849.4(SUCLG1):c.457_458delinsTA (p.Val153Ter)	SUCLG1	V153*	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Feb 16, 2020)	criteria provided, single submitter	VCV000818207	2	84668444 - 84668445	2	84441320 - 84441321	818207	806417	rs1573369929	NC_000002.12:84441319:AC:TA
NM_003849.4(SUCLG1):c.152_153del (p.Tyr51fs)	SUCLG1	Y51fs	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000632365	2	84676821 - 84676822	2	84449697 - 84449698	632365	620094	rs1308442327	NC_000002.12:84449696:ATA:A
NM_003849.4(SUCLG1):c.826-8del	SUCLG1		not specified|Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)|not provided	Likely benign(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000516711	2	84652735	2	84425611	516711	500357	rs1176620455	NC_000002.12:84425610:G:
NM_003849.4(SUCLG1):c.98-14_98-11del	SUCLG1		not provided|Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Benign(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000440310	2	84676887 - 84676890	2	84449763 - 84449766	440310	433946	rs56733272	NC_000002.12:84449762:AAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAA
NM_003849.4(SUCLG1):c.98-13_98-11del	SUCLG1		not provided|Mitochondrial DNA depletion syndrome|Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Benign(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000337162	2	84676887 - 84676889	2	84449763 - 84449765	337162	290735	rs56733272	NC_000002.12:84449762:AAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAA
NM_003849.4(SUCLG1):c.98-10_98-8del	SUCLG1		Mitochondrial DNA depletion syndrome|Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000337161	2	84676884 - 84676886	2	84449760 - 84449762	337161	287323	rs886056350	NC_000002.12:84449759:GTT:
NM_003849.4(SUCLG1):c.*13del	SUCLG1		Mitochondrial DNA depletion syndrome|Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000337152	2	84650857	2	84423733	337152	288067	rs527774382	NC_000002.12:84423732:TTTTTTTTTT:TTTTTTTTT
NM_003849.4(SUCLG1):c.507del (p.Asn171fs)	SUCLG1	N171fs	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	VCV000212328	2	84668395	2	84441271	212328	207028	rs797046017	NC_000002.12:84441270:CCC:CC
SUCLG1, 2-BP DEL, 113AT	SUCLG1		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000000988					988	16027		
NM_006950.3(SYN1):c.433_434del (p.Gln145fs)	SYN1	Q145fs	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV001074864	X	47466541 - 47466542	X	47607142 - 47607143	1074864	1065429		NC_000023.11:47607141:TGT:T
NM_006950.3(SYN1):c.1471del (p.Gln491fs)	SYN1	Q491fs	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Likely pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001067040	X	47433912	X	47574513	1067040	1056789		NC_000023.11:47574512:G:
NC_000023.10:g.(?_47460607_47464667del	SYN1		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Likely pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV001066825					1066825	1054716		
NC_000023.10:g.(?_47432243)_(47436920_?)del	SYN1		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Likely pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001066824	X	47432243 - 47436920			1066824	1054715		
NM_006950.3(SYN1):c.112_126del (p.His38_Ala42del)	SYN1		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV001034821	X	47479002 - 47479016	X	47619603 - 47619617	1034821	1035550		NC_000023.11:47619602:GGCTCCGGGGCTGTGGGC:GGC
NM_006950.3(SYN1):c.1269_1270delinsTT (p.Gln423_Arg424delinsHisTrp)	SYN1		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000998962	X	47434562 - 47434563	X	47575163 - 47575164	998962	999799		NC_000023.11:47575162:GC:AA
NM_006950.3(SYN1):c.248_264del (p.Ala83fs)	SYN1	A83fs	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000954957	X	47478864 - 47478880	X	47619465 - 47619481	954957	951812		NC_000023.11:47619464:CGTGGTCTGCTTGACCGCGT:CGT
NM_006950.3(SYN1):c.1648_1649delinsTT (p.Ala550Phe)	SYN1	A550F	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000944089	X	47433734 - 47433735	X	47574335 - 47574336	944089	929741		NC_000023.11:47574334:GC:AA
NM_006950.3(SYN1):c.1001del (p.Asn334fs)	SYN1	N334fs	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000827798	X	47435785	X	47576386	827798	816013	rs1603051674	NC_000023.11:47576385:TT:T
NM_006950.3(SYN1):c.314del (p.Gly105fs)	SYN1	G105fs	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Likely pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000812162	X	47478814	X	47619415	812162	800411	rs1603078587	NC_000023.11:47619414:CCCCC:CCCC
NC_000023.11:g.(?_47572844)_(47605399_?)del	SYN1|TIMP1|MIR4769|LOC119369039		Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Uncertain significance(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000583809	X	47432243 - 47464798	X	47572844 - 47605399	583809	574220		
NM_006950.3(SYN1):c.1056-14_1056-8del	SYN1		not provided|Epilepsy, X-linked, with variable learning disabilities and behavior disorders|not specified	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000199183	X	47435640 - 47435646	X	47576241 - 47576247	199183	196342	rs377385507	NC_000023.11:47576240:GACAAAGG:G
NM_006772.3(SYNGAP1):c.3156_3167del (p.1053SGGG[1])	SYNGAP1		Mental retardation, autosomal dominant 5	Likely benign(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001084214	6	33411483 - 33411494	6	33443706 - 33443717	1084214	1073445		NC_000006.12:33443705:GGGAGCGGTGGGGG:GG
NM_006772.3(SYNGAP1):c.1022_1023del (p.Gly341fs)	SYNGAP1	G341fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001075709	6	33405704 - 33405705	6	33437927 - 33437928	1075709	1060659		NC_000006.12:33437926:GC:
NM_006772.3(SYNGAP1):c.2717del (p.Leu906fs)	SYNGAP1	L892fs, L906fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001073426	6	33411046	6	33443269	1073426	1060665		NC_000006.12:33443268:T:
NM_006772.3(SYNGAP1):c.2234del (p.Pro745fs)	SYNGAP1	P745fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001071251	6	33409475	6	33441698	1071251	1060663		NC_000006.12:33441697:CC:C
NM_006772.3(SYNGAP1):c.3632del (p.Met1211fs)	SYNGAP1	M1195fs, M1211fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001069446	6	33414401	6	33446624	1069446	1060666		NC_000006.12:33446623:T:
NM_006772.3(SYNGAP1):c.654_655del (p.Phe218fs)	SYNGAP1	F218fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV001030154	6	33403072 - 33403073	6	33435295 - 33435296	1030154	1016738		NC_000006.12:33435294:TCT:T
NC_000006.11:g.(?_33415675_33422480del	SYNGAP1		Mental retardation, autosomal dominant 5	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV001024831					1024831	1001521		
NC_000006.12:g.33438775_33438777del	SYNGAP1		Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000975475	6	33406550 - 33406552	6	33438773 - 33438775	975475	964030		NC_000006.12:33438772:AGGAG:AG
NM_006772.3(SYNGAP1):c.745del (p.Ala249fs)	SYNGAP1	A249fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 8, 2019)	criteria provided, single submitter	VCV000957365	6	33403371	6	33435594	957365	944981		NC_000006.12:33435593:GGG:GG
NM_006772.3(SYNGAP1):c.1139del (p.Gly380fs)	SYNGAP1	G380fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000956582	6	33405819	6	33438042	956582	944984		NC_000006.12:33438041:GGG:GG
NM_006772.3(SYNGAP1):c.3606del (p.His1203fs)	SYNGAP1	H1187fs, H1203fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000948310	6	33414374	6	33446597	948310	924342		NC_000006.12:33446596:TT:T
NM_006772.3(SYNGAP1):c.1744del (p.Glu582fs)	SYNGAP1	E582fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000938605	6	33408571	6	33440794	938605	933294		NC_000006.12:33440793:GGG:GG
NM_006772.3(SYNGAP1):c.3732_3735del (p.Ser1244fs)	SYNGAP1	S1228fs, S1244fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 10, 2020)	criteria provided, single submitter	VCV000935700	6	33414498 - 33414501	6	33446721 - 33446724	935700	933305		NC_000006.12:33446720:GAGTGAG:GAG
NM_006772.3(SYNGAP1):c.1127del (p.Gly376fs)	SYNGAP1	G376fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000933951	6	33405805	6	33438028	933951	933291		NC_000006.12:33438027:GGGGG:GGGG
NM_006772.3(SYNGAP1):c.1253_1254del (p.Lys418fs)	SYNGAP1	K418fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000932044	6	33405934 - 33405935	6	33438157 - 33438158	932044	919024		NC_000006.12:33438156:AAA:A
NM_006772.3(SYNGAP1):c.359_381del (p.Gly120fs)	SYNGAP1	G120fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000869442	6	33399999 - 33400021	6	33432222 - 33432244	869442	857646		NC_000006.12:33432221:GGGTGCCCCTGCTGCGCCCTTCCGG:GG
NM_006772.3(SYNGAP1):c.1406_1426del (p.Ala469_Phe476delinsVal)	SYNGAP1		Mental retardation, autosomal dominant 5	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000863828	6	33406215 - 33406235	6	33438438 - 33438458	863828	831853		NC_000006.12:33438437:CCATGTCTGAGGTAGACCGGT:
NM_006772.3(SYNGAP1):c.1273_1274del (p.Thr425fs)	SYNGAP1	T425fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000841446	6	33405954 - 33405955	6	33438177 - 33438178	841446	831851		NC_000006.12:33438176:CAC:C
NC_000006.12:g.(?_33435132)_(33438311_?)del	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000833001	6	33402909 - 33406088			833001	819686		
NC_000006.12:g.(?_33420245)_(33451926_?)del	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000831495	6	33388022 - 33419703			831495	819685		
NM_006772.3(SYNGAP1):c.3179del (p.Gly1060fs)	SYNGAP1	G1046fs, G1060fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802203	6	33411504	6	33443727	802203	790618	rs1581996813	NC_000006.12:33443726:GGGGG:GGGG
NM_006772.3(SYNGAP1):c.2387del (p.Pro796fs)	SYNGAP1	P782fs, P796fs	Inborn genetic diseases|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802202	6	33410712	6	33442935	802202	790617	rs1581995425	NC_000006.12:33442934:CCCCC:CCCC
NM_006772.3(SYNGAP1):c.3168_3179del (p.1053_1056SGGG[1])	SYNGAP1		not provided|Mental retardation, autosomal dominant 5	Benign/Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000696180	6	33411486 - 33411497	6	33443709 - 33443720	696180	683780	rs774101585	NC_000006.12:33443708:AGCGGTGGGGGCAGCGGTGGGGG:AGCGGTGGGGG
NM_006772.3(SYNGAP1):c.3377del (p.Gly1126fs)	SYNGAP1	G1126fs, G1112fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000665761	6	33411702	6	33443925	665761	634864	rs1581997228	NC_000006.12:33443924:GGGGG:GGGG
NM_006772.3(SYNGAP1):c.410del (p.Leu137fs)	SYNGAP1	L137fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, single submitter	VCV000659379	6	33400484	6	33432707	659379	634840	rs1581980317	NC_000006.12:33432706:T:
NM_006772.3(SYNGAP1):c.1721del (p.Leu574fs)	SYNGAP1	L574fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000659250	6	33408550	6	33440773	659250	634849	rs1581991929	NC_000006.12:33440772:T:
NM_006772.3(SYNGAP1):c.781_784del (p.Asp261fs)	SYNGAP1	D261fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000651597	6	33405462 - 33405465	6	33437685 - 33437688	651597	634843	rs1581986872	NC_000006.12:33437684:AGACA:A
NM_006772.3(SYNGAP1):c.1823_1824del (p.Phe608fs)	SYNGAP1	F608fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000643448	6	33408651 - 33408652	6	33440874 - 33440875	643448	634850	rs1581992099	NC_000006.12:33440873:TTT:T
NM_006772.3(SYNGAP1):c.1094del (p.Val365fs)	SYNGAP1	V365fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000643101	6	33405776	6	33437999	643101	634846	rs1581987476	NC_000006.12:33437998:T:
NM_006772.3(SYNGAP1):c.1453del (p.Arg485fs)	SYNGAP1	R485fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620026	6	33406261	6	33438484	620026	611394		NC_000006.12:33438483:CC:C
NM_006772.3(SYNGAP1):c.1736_1740del (p.Arg579fs)	SYNGAP1	R579fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	VCV000619991	6	33408563 - 33408567	6	33440786 - 33440790	619991	611395		NC_000006.12:33440785:GCGAGGC:GC
NM_006772.3(SYNGAP1):c.878del (p.Arg293fs)	SYNGAP1	R293fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000582839	6	33405560	6	33437783	582839	565592	rs1561784560	NC_000006.12:33437782:G:
NM_006772.3(SYNGAP1):c.2818_2852del (p.Gly940fs)	SYNGAP1	G940fs, G926fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000576152	6	33411142 - 33411176	6	33443365 - 33443399	576152	560801	rs1561789313	NC_000006.12:33443364:GGCCAGGTCCCCCAGGCGGCCATGGAGGGGGCGGTGGCCA:GGCCA
NM_006772.3(SYNGAP1):c.2635_2636delinsAA (p.Ala879Lys)	SYNGAP1	A865K, A879K	not provided|Mental retardation, autosomal dominant 5	Likely benign(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000575856	6	33410964 - 33410965	6	33443187 - 33443188	575856	565618	rs1561789088	NC_000006.12:33443186:GC:AA
NM_006772.3(SYNGAP1):c.2135_2142del (p.Gly712fs)	SYNGAP1	G712fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000574599	6	33409376 - 33409383	6	33441599 - 33441606	574599	565594	rs1561787690	NC_000006.12:33441598:GGTCCACTG:G
NM_006772.3(SYNGAP1):c.1001del (p.Lys334fs)	SYNGAP1	K334fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000571977	6	33405679	6	33437902	571977	560690	rs1561784687	NC_000006.12:33437901:AAAAA:AAAA
NM_006772.3(SYNGAP1):c.2726del (p.Met909fs)	SYNGAP1	M895fs, M909fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000568262	6	33411055	6	33443278	568262	563535	rs1561789215	NC_000006.12:33443277:T:
NM_006772.3(SYNGAP1):c.2562_2578del (p.Leu855fs)	SYNGAP1	L855fs, L841fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561122	6	33410890 - 33410906	6	33443113 - 33443129	561122	552106	rs1561788984	NC_000006.12:33443112:GCCTCAACAGCAGCAGTG:G
NM_006772.3(SYNGAP1):c.67+15del	SYNGAP1		Mental retardation, autosomal dominant 5	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV000537014	6	33388118	6	33420341	537014	521871	rs753367470	NC_000006.12:33420340:GGGGGG:GGGGG
NM_006772.3(SYNGAP1):c.199del (p.Leu67fs)	SYNGAP1	L67fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000536999	6	33393580	6	33425803	536999	521880	rs1554119814	NC_000006.12:33425802:CCCCC:CCCC
NM_006772.3(SYNGAP1):c.3233_3236del (p.Val1078fs)	SYNGAP1	V1064fs, V1078fs	Mental retardation, autosomal dominant 5|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000536991	6	33411559 - 33411562	6	33443782 - 33443785	536991	521964	rs1554122341	NC_000006.12:33443781:CAGTCAG:CAG
NM_006772.3(SYNGAP1):c.3060del (p.Gln1021fs)	SYNGAP1	Q1021fs, Q1007fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000536990	6	33411388	6	33443611	536990	521962	rs1554122293	NC_000006.12:33443610:GG:G
NM_006772.3(SYNGAP1):c.34_35del (p.Ser12fs)	SYNGAP1	S12fs	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495269	6	33388074 - 33388075	6	33420297 - 33420298	495269	486745	rs1554304254	NC_000006.12:33420296:GAG:G
NM_006772.3(SYNGAP1):c.1053del (p.Thr352fs)	SYNGAP1	T352fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000469144	6	33405734	6	33437957	469144	455538	rs1554121228	NC_000006.12:33437956:CC:C
NM_006772.3(SYNGAP1):c.3722_3723del (p.Leu1241fs)	SYNGAP1	L1225fs, L1241fs	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000436927	6	33414491 - 33414492	6	33446714 - 33446715	436927	428629	rs1554122735	NC_000006.12:33446713:TG:
NM_006772.3(SYNGAP1):c.333del (p.Lys114fs)	SYNGAP1	K114fs	Mental retardation, autosomal dominant 5|Infantile epilepsy syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000430456	6	33399975	6	33432198	430456	421588	rs1131691979	NC_000006.12:33432197:A:
NM_006772.3(SYNGAP1):c.2104_2115+14del	SYNGAP1		Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000411590	6	33409137 - 33409162	6	33441360 - 33441385	411590	395233	rs1064792984	NC_000006.12:33441359:CCCCAGCTCAGCAAGGTCAGCAGATCCCC:CCC
NM_006772.3(SYNGAP1):c.1167_1168del (p.Gly391fs)	SYNGAP1	G391fs	not provided|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000411566	6	33405849 - 33405850	6	33438072 - 33438073	411566	395445	rs1060503378	NC_000006.12:33438071:AG:
NM_006772.3(SYNGAP1):c.1685del (p.Pro562fs)	SYNGAP1	P562fs	Mental retardation, autosomal dominant 5	Pathogenic	no assertion criteria provided	VCV000375621	6	33408512	6	33440735	375621	362435	rs1057519405	NC_000006.12:33440734:CCC:CC
NM_006772.3(SYNGAP1):c.1908_1909del (p.Ser637fs)	SYNGAP1	S637fs	Mental retardation, autosomal dominant 5	Pathogenic	no assertion criteria provided	VCV000375615	6	33408735 - 33408736	6	33440958 - 33440959	375615	362429	rs1057519400	NC_000006.12:33440957:TTTT:TT
NM_006772.3(SYNGAP1):c.3200del (p.Pro1067fs)	SYNGAP1	P1053fs, P1067fs	Mental retardation, autosomal dominant 5|Absent speech|Global developmental delay|Cerebellar ataxia	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000373952	6	33411528	6	33443751	373952	360878	rs1057518796	NC_000006.12:33443750:CC:C
NM_006772.3(SYNGAP1):c.3788_3794del (p.Ile1263fs)	SYNGAP1	I1247fs, I1263fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	VCV000224101	6	33414557 - 33414563	6	33446780 - 33446786	224101	225831	rs869312677	NC_000006.12:33446779:TTGGCAG:
NM_006772.3(SYNGAP1):c.896del (p.Arg299fs)	SYNGAP1	R299fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 14, 2014)	criteria provided, single submitter	VCV000217012	6	33405578	6	33437801	217012	213572	rs863224930	NC_000006.12:33437800:G:
NM_006772.3(SYNGAP1):c.3592del (p.Tyr1198fs)	SYNGAP1	Y1182fs, Y1198fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	VCV000212354	6	33414361	6	33446584	212354	207412	rs797046030	NC_000006.12:33446583:T:
NM_006772.3(SYNGAP1):c.2066_2071delinsC (p.Leu689fs)	SYNGAP1	L689fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000212349	6	33409102 - 33409107	6	33441325 - 33441330	212349	207407	rs797046029	NC_000006.12:33441324:TCTCCA:C
NM_006772.3(SYNGAP1):c.1576del (p.Glu525_Val526insTer)	SYNGAP1		Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000212348	6	33406595	6	33438818	212348	207406	rs797046028	NC_000006.12:33438817:GG:G
NM_006772.3(SYNGAP1):c.2602del (p.Asp868fs)	SYNGAP1	D854fs, D868fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Apr 10, 2013)	criteria provided, single submitter	VCV000130528	6	33410928	6	33443151	130528	135974	rs587780474	NC_000006.12:33443150:GGGG:GGG
NM_006772.3(SYNGAP1):c.1783del (p.Leu595fs)	SYNGAP1	L595fs	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000130525	6	33408611	6	33440834	130525	135971	rs587780470	NC_000006.12:33440833:CC:C
NM_006772.3(SYNGAP1):c.2677del (p.Gln893fs)	SYNGAP1	Q879fs, Q893fs	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000041459	6	33411004	6	33443227	41459	49895	rs1581995953	NC_000006.12:33443226:CCC:CC
NM_006772.3(SYNGAP1):c.2438del (p.Leu813fs)	SYNGAP1	L799fs, L813fs	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006394	6	33410767	6	33442990	6394	21433	rs397515320	NC_000006.12:33442989:T:
GRCh37/hg19 12q21.2(chr12:79367903-79786505)x1	SYT1		not provided	Uncertain significance(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000686557	12	79367903 - 79786505			686557	674149		
NM_025185.4(TANC2):c.3828del (p.Glu1277fs)	TANC2	E1277fs	Developmental delay|Epilepsy	Likely pathogenic	no assertion criteria provided	VCV000982237	17	61492948	17	63415587	982237	970340		NC_000017.11:63415586:A:
NM_144628.2(TBC1D20):c.71-?_*1+?del	TBC1D20		Warburg micro syndrome 4	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000100778			20	435480 - 448074	100778	106644		
NM_144628.4(TBC1D20):c.352_353del (p.Gln118fs)	TBC1D20	Q118fs	Warburg micro syndrome 4	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000100776	20	422672 - 422673	20	442028 - 442029	100776	106642	rs587777159	NC_000020.11:442027:TGT:T
NM_001199107.2(TBC1D24):c.715del (p.Val239fs)	TBC1D24	V239fs	Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001072207	16	2546863	16	2496862	1072207	1063617		NC_000016.10:2496861:GG:G
NM_001199107.2(TBC1D24):c.642_793del (p.Trp215fs)	TBC1D24	W215fs	Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001071941	16	2546786 - 2546937	16	2496785 - 2496936	1071941	1063616		
NM_001199107.2(TBC1D24):c.820_822del (p.Arg274del)	TBC1D24	R274del	Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001060035	16	2546969 - 2546971	16	2496968 - 2496970	1060035	1049541		NC_000016.10:2496967:AGA:
NM_001199107.2(TBC1D24):c.76_77delinsTT (p.Glu26Leu)	TBC1D24	E26L	Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65	Uncertain significance(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV001026209	16	2546225 - 2546226	16	2496224 - 2496225	1026209	1012056		NC_000016.10:2496223:GA:TT
NM_001199107.2(TBC1D24):c.172del (p.Arg57_Leu58insTer)	TBC1D24		Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000541316	16	2546320	16	2496319	541316	530198	rs1555501140	NC_000016.10:2496318:CC:C
NC_000016.10:g.(?_2496129)_(2500978_?)del	TBC1D24		Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000474299	16	2546130 - 2550979	16	2496129 - 2500978	474299	465533		
NM_001199107.2(TBC1D24):c.554_559del (p.Asp185_Leu186del)	TBC1D24		Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1|not provided	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000448645	16	2546701 - 2546706	16	2496700 - 2496705	448645	441891	rs1215641557	NC_000016.10:2496699:GGACCTGG:GG
NM_001199107.2(TBC1D24):c.*2850_*2851del	TBC1D24		Myoclonic epilepsy, familial infantile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318673	16	2553803 - 2553804	16	2503802 - 2503803	318673	342572	rs376511845	NC_000016.10:2503801:CCCCCCCC:CCCCCC
NM_001199107.2(TBC1D24):c.*2851del	TBC1D24		Myoclonic epilepsy, familial infantile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318672	16	2553803	16	2503802	318672	341045	rs376511845	NC_000016.10:2503801:CCCCCCCC:CCCCCCC
NM_001199107.2(TBC1D24):c.*2540del	TBC1D24		Myoclonic epilepsy, familial infantile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318661	16	2553487	16	2503486	318661	341038	rs58172016	NC_000016.10:2503485:AAAAAAAAAAAAA:AAAAAAAAAAAA
NM_001199107.2(TBC1D24):c.475del (p.Leu159fs)	TBC1D24	L159fs	Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207507	16	2546623	16	2496622	207507	203229	rs796053403	NC_000016.10:2496621:CC:C
NM_001199107.2(TBC1D24):c.1008del (p.His336fs)	TBC1D24	H330fs, H336fs	DOORS syndrome|not provided|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000091398	16	2548263	16	2498262	91398	96874	rs398122967	NC_000016.10:2498261:T:
NM_005149.3(TBX19):c.665+1del	TBX19		Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Jun 12, 2014)	no assertion criteria provided	VCV000560675	1	168267023	1	168297785	560675	551686	rs1558192351	NC_000001.11:168297784:GG:G
NM_005149.3(TBX19):c.265del (p.Leu89fs)	TBX19	L89fs	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Oct 22, 2012)	no assertion criteria provided	VCV000560673	1	168260457	1	168291219	560673	551684	rs1558190339	NC_000001.11:168291218:CCC:CC
NM_005149.3(TBX19):c.782del (p.Asn261fs)	TBX19	N261fs	not provided|Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005443	1	168274299	1	168305061	5443	20482	rs730880274	NC_000001.11:168305060:AA:A
NM_001083962.2(TCF4):c.1772_1776delinsCT (p.Leu591_Gly592delinsPro)	TCF4		Inborn genetic diseases	Likely pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000520970	18	52896181 - 52896185	18	55228950 - 55228954	520970	512362	rs1555710416	NC_000018.10:55228949:GCCGA:AG
NM_001083962.2(TCF4):c.680_682delinsT (p.Trp227fs)	TCF4	W156fs, W227fs, W202fs, W233fs, W329fs, W67fs, W11fs, W185fs, W203fs, W225fs, W226fs, W97fs	not provided	Pathogenic(Last reviewed: Jan 10, 2013)	criteria provided, single submitter	VCV000207541	18	52942957 - 52942959	18	55275726 - 55275728	207541	203510	rs796053425	NC_000018.10:55275725:TCC:A
NM_014844.5(TECPR2):c.2829del (p.Asn944fs)	TECPR2	N944fs	Spastic paraplegia 49, autosomal recessive	Likely pathogenic(Last reviewed: Jun 11, 2020)	criteria provided, single submitter	VCV000973501	14	102910059	14	102443722	973501	961811		NC_000014.9:102443721:GG:G
GRCh38/hg38 Xq25(chrX:124464328-124702529)x1	TENM1		See cases	Likely benign(Last reviewed: Apr 5, 2012)	no assertion criteria provided	VCV000148999	X	123598178 - 123836379	X	124464328 - 124702529	148999	158750		
GRCh37/hg19 21q22.3(chr21:43757247-43879787)x1	TFF1|TFF2|UBASH3A|TMPRSS3		not provided	Uncertain significance(Last reviewed: Jun 20, 2018)	no assertion criteria provided	VCV000685698	21	43757247 - 43879787			685698	673290		
GRCh37/hg19 3p24.1(chr3:30684776-30698392)x1	TGFBR2		not provided	Uncertain significance(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000687755	3	30684776 - 30698392			687755	675347		
GRCh37/hg19 22q12.3(chr22:33067984-33370145)x1	TIMP3|SYN3		not provided	Uncertain significance(Last reviewed: Apr 28, 2017)	no assertion criteria provided	VCV000689040	22	33067984 - 33370145			689040	676632		
Single allele	TMEM132C|TMEM132D|SLC15A4|GLT1D1		not provided	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000560129	12	126890818 - 129898639			560129	550845		
NC_000009.11:g.(?_138645763)_(140729425_?)del	TMEM203|PTGDS|KCNT1|NACC2|CCDC183|LRRC26|ZMYND19|ANAPC2|EDF1|PAXX|SLC34A3|RABL6|TPRN|CLIC3|CAMSAP1|FUT7|TMEM141|LOC651337|GPSM1|LCN10|DPP7|AGPAT2|NDOR1|CARD9|ARRDC1|ENTR1|STPG3|PHPT1|RNF208|LCN12|NOTCH1|PMPCA|RNF224|QSOX2|DPH7|LCNL1|SNAPC4|LCN8|EXD3|NRARP|GRIN1|SEC16A|TOR4A|PNPLA7|TRAF2|TUBB4B|DNLZ|AJM1|FBXW5|UAP1L1|C9orf163|C8G|LHX3|SSNA1|MAMDC4|LCN6|SAPCD2|CYSRT1|UBAC1|NPDC1|MRPL41|INPP5E|NELFB|ENTPD2|ENTPD8|DIPK1B|EHMT1|ABCA2|TMEM210|LCN15|EGFL7|LINC02908|NOXA1|FAM166A|MAN1B1|SNHG7|MIR126|NSMF|TMEM250		Kleefstra syndrome 1|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2019)	criteria provided, conflicting interpretations	VCV000831360	9	138645763 - 140729425			831360	820033		
NM_003701.4(TNFSF11):c.828_829del (p.Val277fs)	TNFSF11	V204fs, V277fs	Autosomal recessive osteopetrosis 2	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000006975	13	43180928 - 43180929	13	42606792 - 42606793	6975	22014	rs863223288	NC_000013.11:42606791:CG:
TNFSF11, 5-BP DEL, IVS7+4	TNFSF11		Autosomal recessive osteopetrosis 2	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000006973					6973	22012		
GRCh37/hg19 9q33.3-34.11(chr9:128512347-130702572)x1	TOR2A|RPL12|ANGPTL2|PTRH1|LRSAM1|GARNL3|FPGS|SH2D3C|STXBP1|DPM2|TTC16|ZBTB43|AK1|ENG|MVB12B|CDK9|CFAP157|ZBTB34|PIP5KL1|LMX1B|NRON|ZNF79|SLC2A8|ST6GALNAC6|MIR2861|ST6GALNAC4|RALGPS1|NIBAN2|PBX3		Early infantile epileptic encephalopathy 4|Nail-patella syndrome	Pathogenic(Last reviewed: Nov 22, 2018)	no assertion criteria provided	VCV000983307	9	128512347 - 130702572			983307	971377		
NC_000009.12:g.(?_137139467)_(137834973_?)del	TOR4A|CYSRT1|RNF224|TPRN|PNPLA7|NOXA1|NELFB|EHMT1|TMEM203|TMEM210|ANAPC2|SLC34A3|ZMYND19|LRRC26|NRARP|RNF208|GRIN1|ENTPD8|FAM166A|NDOR1|MRPL41|NSMF|DPH7|ARRDC1|STPG3|EXD3|LOC651337|TUBB4B|SSNA1		Kleefstra syndrome 1	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000830975	9	140033919 - 140729425			830975	820106		
NM_000391.4(TPP1):c.1087delinsTT (p.Ala363fs)	TPP1	A363fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000969357	11	6637294	11	6616063	969357	956594		NC_000011.10:6616062:C:AA
NM_000391.4(TPP1):c.1397_1408delinsGACACCGA (p.Val466fs)	TPP1	V466fs	Neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000967557	11	6636419 - 6636430	11	6615188 - 6615199	967557	956592		NC_000011.10:6615187:ATGGAATGGGCA:TCGGTGTC
NM_000391.4(TPP1):c.1222_1224del (p.Ser408del)	TPP1	S408del	Neuronal ceroid lipofuscinosis	Uncertain significance(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000846307	11	6636715 - 6636717	11	6615484 - 6615486	846307	838788		NC_000011.10:6615483:ACT:
NM_000391.4(TPP1):c.1552-4del	TPP1		Neuronal ceroid lipofuscinosis|not provided	Uncertain significance(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000659259	11	6635921	11	6614690	659259	652230	rs1589947372	NC_000011.10:6614689:GGG:GG
GRCh37/hg19 3p22.1(chr3:42160760-42183807)x1	TRAK1		not provided	Uncertain significance(Last reviewed: Mar 14, 2018)	no assertion criteria provided	VCV000685451	3	42160760 - 42183807			685451	673043		
NC_000006.11:g.116734559_123648104del	TRAPPC3L|CLVS2|CALHM4|ZUP1|FAM162B|TBC1D32|VGLL2|CALHM5|SERINC1|CEP85L|CALHM6|ROS1|TRDN|SMPDL3A|ASF1A|DSE|RWDD1|GOPC|FAM184A|NUS1|FABP7|GPRC6A|RFX6|SLC35F1|MCM9|DCBLD1|RSPH4A|GJA1|HSF2|KPNA5|MAN1A1|PLN|PKIB		Seizures|Intellectual disability	Pathogenic(Last reviewed: Mar 13, 2020)	criteria provided, single submitter	VCV000978186	6	116734559 - 123648104			978186	966219		
NM_016146.6(TRAPPC4):c.638_*4del (p.Gly213_Ter220delinsXaa)	TRAPPC4		Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy	Likely pathogenic(Last reviewed: Apr 27, 2020)	no assertion criteria provided	VCV000916549	11	118894081 - 118894107	11	119023371 - 119023397	916549	904882		NC_000011.10:119023370:AGGCTGGAACTTTTGGACCTGGGTCATAGGCTG:AGGCTG
GRCh38/hg38 7q11.1-11.21(chr7:61006478-62410831)x1	TRH-GTG2-1		See cases	Pathogenic(Last reviewed: Feb 14, 2018)	no assertion criteria provided	VCV000146428	1	146143189 - 149232481	7	61006478 - 62410831	146428	156179		
GRCh37/hg19 9q33.1(chr9:119403686-119473087)x1	TRIM32|ASTN2		not provided	Uncertain significance(Last reviewed: Nov 20, 2017)	no assertion criteria provided	VCV000686145	9	119403686 - 119473087			686145	673737		
NM_182916.3(TRNT1):c.1252del (p.Ser418fs)	TRNT1	S398fs, S418fs	Retinitis pigmentosa and erythrocytic microcytosis	Pathogenic(Last reviewed: May 26, 2016)	no assertion criteria provided	VCV000234933	3	3189779	3	3148095	234933	236730	rs876661298	NC_000003.12:3148094:AAAAAAA:AAAAAA
NM_182916.3(TRNT1):c.128_130del (p.Glu43del)	TRNT1	E43del	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay|Retinitis pigmentosa and erythrocytic microcytosis	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000234932	3	3170850 - 3170852	3	3129166 - 3129168	234932	236729	rs876661297	NC_000003.12:3129165:AGAAG:AG
GRCh37/hg19 9q21.12(chr9:73086964-73286551)x1	TRPM3		not provided	Uncertain significance(Last reviewed: Jun 15, 2018)	no assertion criteria provided	VCV000686131	9	73086964 - 73286551			686131	673723		
NM_000368.5(TSC1):c.2559_2562del (p.Leu853fs)	TSC1	L732fs, L802fs, L852fs	Tuberous sclerosis syndrome|Tuberous sclerosis 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000048976	9	135776165 - 135776168	9	132900778 - 132900781	48976	58138	rs118203711	NC_000009.12:132900777:AACCAAC:AAC
NM_000368.5(TSC1):c.1152del (p.Gly385fs)	TSC1	G334fs, G264fs, G384fs, G385fs	Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Sep 19, 2014)	criteria provided, single submitter	VCV000048748	9	135786069	9	132910682	48748	57910	rs118203501	NC_000009.12:132910681:TTTT:TTT
NM_000548.5(TSC2):c.5262del (p.Cys1755fs)	TSC2	C1640fs, C1688fs, C1699fs, C1712fs, C1732fs, C1511fs, C1708fs, C1755fs, C1652fs, C1689fs, C1711fs	not provided	Pathogenic(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	VCV000207777	16	2138449	16	2088448	207777	203213	rs796053507	NC_000016.10:2088447:C:
NM_000548.5(TSC2):c.3401del (p.Gly1134Alafs)	TSC2		Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	Pathogenic(Last reviewed: Jun 18, 2013)	criteria provided, multiple submitters, no conflicts	VCV000050076	16	2130169	16	2080164	50076	59238	rs137854314	NC_000016.10:2080163:GGGGG:GGGG
NM_000548.5(TSC2):c.1283_1285del (p.Ser428del)	TSC2	S428del, S228del, S379del, S391del, S439del	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|none provided	Likely pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000049644	16	2112521 - 2112523	16	2062520 - 2062522	49644	58806	rs137853983	NC_000016.10:2062519:CTCCT:CT
GRCh37/hg19 Xp22.33-q28(chrX:168546-155233731)x1	TSC22D3|DUSP9|EDA|EFNB1|EIF1AX|EIF2S3|ELF4|ELK1|EMD|F8|F9|ACSL4|FANCB|GPC4|FGD1|FGF13|FHL1|VEGFD|FLNA|FMR1|AFF2|CENPI|G6PD|GAGE1|GABRA3|GABRE|GAGE2C|GATA1|OPN1MW|GDI1|GJB1|GK|GLA|GPC3|GLRA2|GLUD2|GPM6B|CXCR3|LPAR4|GPR34|GRIA3|GRPR|GUCY2F|HSD17B10|SPANXB1|SPANXA2|CT45A2|SPACA5B|GAGE12J|GAGE2D|HCCS|HCFC1|HMGB3|HNRNPH2|HPRT1|GAGE12C|GAGE12B|GAGE12E|GAGE12H|GAGE2A|GAGE12F|GAGE8|ERAS|HTR2C|IDH3G|IDS|IGBP1|IGSF1|FMR1-AS1|MIR509-3|ARMCX3-AS1|GPR50-AS1|CXorf51A|HSFX2|IL2RG|IL13RA1|IL13RA2|IRAK1|ANOS1|KCND1|SUPT20HL1|CXorf49|PRR32|ARMCX4|GAGE12D|SMIM9|L1CAM|LAMP2|PRICKLE3|SH2D1A|MAGEA1|CXorf49B|CXorf51B|CMC4|FTX|TRPC5OS|MTRNR2L10|MAGEA2|MAGEA3|MAGEA4|MAGEA6|MAGEA8|MAGEA9|HSFX1|ARSD-AS1|CT47A12|LOC100509091|ARMCX5-GPRASP2|RPL36A-HNRNPH2|MAGEA10|MAGEA11|MAGEA12|MAGEB1|MAGEB2|MAGEB3|TCP11X2|MAGEB4|MAOA|MAOB|MCF2|MECP2|MID1|FOXO4|MPP1|CITED1|MSN|MTCP1|MTM1|NAP1L2|NAP1L3|NDP|NDUFA1|NHS|NONO|GPR143|TBC1D25|OCRL|OPHN1|OTC|P2RY4|PAK3|CDK16|PDHA1|PDK3|CFP|PFKFB1|PGK1|PHEX|PHKA1|PHKA2|PIGA|PIN4|PLP1|PLP2|PLS3|PLXNB3|POLA1|POU3F4|PPEF1|PRKX|PRPS1|PRPS2|PRRG1|PSMD10|RBBP7|RBM3|OPN1LW|RENBP|RP2|RPGR|RPL10|RPL39|RPL36A|RPS4X|RPS6KA3|RS1|SAT1|SCML1|TRAPPC2|SH3BGRL|SLC6A8|SLC16A2|SMARCA1|SMS|SOX3|SSR4|SSX1|SSX2|SSX5|SSX4|CDKL5|SUV39H1|SYN1|SYP|TAF1|TAFAZZIN|SERPINA7|TBL1X|DYNLT3|TFE3|TIMP1|TSPAN7|TSPAN6|TMSB4X|TRO|TRPC5|UBA1|UBE2A|SLC35A2|KDM6A|VBP1|WAS|XG|XIST|XK|XPNPEP2|ZFX|ZIC3|ZNF711|ZNF182|ZNF41|ZNF75D|ZNF157|RNF113A|ZNF185|ZXDA|PUDP|PNPLA4|ZRSR2|USP11|USP9X|RBM10|KDM5C|SMC1A|NAA10|F8A1|UBL4A|TMEM187|LAGE3|SLC10A3|TKTL1|SRPX|UXT|CUL4B|IRS4|OGT|OFD1|IKBKG|PIR|INE2|INE1|CASK|PAGE1|MTMR1|FGF16|AKAP4|APLN|AP1S2|GYG2|RTL8C|SLC25A14|CLDN2|RGN|FAM50A|AIFM1|REPS2|ZMYM3|BMP15|GPR50|MED14|TCEAL1|RAB33A|RAB9A|TSIX|ITM2A|ARHGEF6|PCYT1B|MAGED1|XAGE2|PAGE4|MORF4L2|GPRASP1|STARD8|FRMPD4|JADE3|ARMCX2|HEPH|MAGEC1|AMMECR1|MED12|ZBTB33|HDAC6|MAMLD1|HUWE1|PQBP1|BCAP31|ADGRG2|ATP6AP2|TENM1|SSX3|TIMM17B|RRAGB|SCML2|SLC9A6|ENOX2|PRDX4|EBP|STAG2|RAI2|PLAC1|CYSLTR1|UTP14A|ZNF275|PGRMC1|MAGED2|MSL3|TMSB15A|PIM2|MID2|SLC6A14|IL1RAPL1|WDR45|TREX2|PRAF2|CA5B|KLF8|VSIG4|CNKSR2|IQSEC2|PHF8|SEPTIN6|ARHGEF9|ATP1B4|ACOT9|KCNE5|LDOC1|SMPX|GSPT2|KIF4A|FTSJ1|H2AP|MXRA5|EGFL6|RTL8A|IL1RAPL2|ITGB1BP2|SRPK3|VCX|GAGE12I|GAGE2E|BEX3|NOX1|NALF2|GPR82|GPKOW|SRPX2|APEX2|RBMX|PCDH11X|RPS6KA6|P2RY10|HTATSF1|PCSK1N|CCDC22|MCTS1|MAGEH1|FAM156A|C1GALT1C1|SNX12|RPA4|PNMA3|UBQLN2|SH3KBP1|SPANXA1|CTAG2|NSDHL|FOXP3|TBX22|ZDHHC9|RLIM|TCEAL9|RAB9B|LUZP4|PDZD11|PBDC1|TFDP3|TLR7|ARMCX1|TLR8|MBTPS2|MAGEC2|VGLL1|VCX2|VCX3A|ARMCX3|TAF9B|RBMX2|STK26|CPXCR1|CHIC1|FTHL17|GPR173|NLGN3|SASH3|TAF7L|SPIN2A|ARMCX6|WDR44|NDUFB11|GNL3L|ERCC6L|NUP62CL|GDPD2|BCOR|TBC1D8B|FAM120C|GEMIN8|CT55|TMEM255A|RADX|NUDT11|TMLHE|RBM41|SAGE1|PLXNA3|HAUS7|OTUD5|ZNF280C|MTMR8|KRBOX4|TXLNG|MBNL3|WWC3|BEX1|HDAC8|GABRQ|ZC4H2|NXT2|NKRF|NXF5|NXF3|NXF2|KLHL4|TEX13B|TEX13A|TEX11|MOSPD1|BEX4|CTPS2|CHST7|TCEAL7|GRIPAP1|THOC2|ZNF630|CLTRN|SHROOM4|KIAA1210|MAGEE1|NLGN4X|PCDH19|RTL9|PDZD4|LRCH2|RAP2C|MID1IP1|ACE2|TMEM35A|FAM3A|EDA2R|NYX|BCORL1|DUSP21|STEEP1|DMRTC1|TSPYL2|TNMD|PJA1|SPANXD|SPANXC|WDR13|PORCN|ARMCX5|UPF3B|WNK3|FUNDC2|PRRG3|APOO|BRCC3|HMGN5|NKAP|RNF128|MAP7D3|MORC4|DIPK2B|LONRF3|ALG13|MAGIX|TCEAL4|TRMT2B|POF1B|TASL|EFHC2|KLHL15|ESX1|BHLHB9|MAGED4B|LAS1L|GPR101|TMEM47|CD99L2|H2AB3|USP26|MAGT1|TMEM164|PHF6|FRMPD3|ZMAT1|RHOXF2|TMEM185A|SLITRK2|GPR174|SLC9A7|BEX2|SLC7A3|PNMA6A|TCEAL3|CCNB3|PPP1R3F|FATE1|CCDC120|TSR2|HS6ST2|FRMD7|KLHL13|TGIF2LX|FAM104B|PAGE5|TCEAL8|CHRDL1|EOLA1|CCNQ|RIPPLY1|ATXN3L|SLC38A5|MMGT1|GCNA|SYAP1|SYTL4|SYTL5|PNMA5|GPRASP2|ATG4A|RAB39B|DACH2|SLITRK4|SPANXN3|MAGEC3|BEND2|PASD1|DCAF12L1|DGKK|DNAAF6|PWWP3B|FAM199X|AMER1|APOOL|HDX|FUNDC1|ADGRG4|PTCHD1|MAGEB10|DCAF8L1|OTUD6A|UPRT|MAGEE2|MAGEB16|FOXR2|GAB3|PNCK|ZFP92|ACTRT1|GPR119|PAGE3|RBMXL3|DOCK11|SPIN4|ASB11|ASB9|TCEAL2|PABPC5|RAB40A|ASB12|AMOT|CBLL2|CSAG1|FMR1NB|FAAH2|ZXDB|FAM47A|MOSPD2|ARHGAP36|RIBC1|AKAP14|RHOXF1|MAGEB6|CXorf65|AWAT1|AWAT2|ZDHHC15|USP51|TCEAL6|H2BW1|CXorf38|PABIR2|PABIR3|DDX53|TENT5D|SPIN3|FAM47B|CXorf22|SUPT20HL2|TCEANC|ZCCHC12|ARX|XAGE3|XAGE5|NUDT10|FAM9A|FAM9B|FAM9C|CT83|LINC01560|SLC25A43|RTL3|NRK|INTS6L|ZNF449|VMA21|TMEM31|PAGE2|CTAG1A|BRWD3|CXorf58|CT47A11|BCLAF3|MAP7D2|KLHL34|TAB3|MAGEA2B|SSX7|RAB40AL|ATP11C|H2BW2|YIPF6|CFAP47|FAM133A|MAGEB18|TMSB15B|RTL5|NHSL2|PABPC1L2A|NEXMIF|BEX5|TCEAL5|VSIG1|ZC3H12B|SATL1|DCAF12L2|RTL4|LHFPL1|ZNF81|ITIH6|LANCL3|MPC1L|DCAF8L2|SOWAHD|OR13H1|CCDC160|CXorf66|DGAT2L6|RAB41|ARSH|MAGEB5|MAP3K15|SPACA5|USP27X|PAGE2B|ZCCHC13|UBE2NL|CSAG3|GLOD5|ARL13A|SLC25A53|XKRX|YY2|MIRLET7F2|MIR105-1|MIR105-2|MIR106A|MIR19B2|MIR221|MIR222|ABCB7|AGTR2|NR0B1|ALAS2|MIR223|MIR224|MIR98|VCX3B|RTL8B|CT45A3|ABCD1|AMELX|SLC25A5|XIAP|SHROOM2|CT45A5|SPANXN4|PGAM4|FAM47C|SPIN2B|H2AB2|AR|ARAF|ARHGAP4|ARHGAP6|ARR3|ATP6AP1|H2AB1|F8A2|F8A3|SPANXN1|SPANXN2|SPANXN5|STS|ARSD|ARSL|ARSF|ATP2B3|MIR424|CT45A6|CT45A1|EOLA2|SSX4B|JPX|ATP7A|ATRX|AVPR2|BGN|BMX|MIR448|MIR502|MIR503|MIR506|MIR508|MIR509-1|BRS3|BTK|CACNA1F|S100G|CAPN6|MIR510|ZNF674|DANT2|CT47B1|ZCCHC18|SMIM10|CD40LG|CDR1|CDX4|CETN2|CHM|GAGE2B|GAGE13|GAGE12G|CXorf30|MAGEB17|PABPC1L2B|CLCN4|CLCN5|CLIC2|CNGA2|COL4A5|PNMA6E|XAGE1B|XAGE1A|CT47A7|SNORA11|MIR532|COL4A6|COX7B|CSTF2|CTAG1B|TEX28|CYBB|SSX2B|FAM156B|RHOXF2B|CT47A10|CT47A9|CT47A8|CYLC1|DCX|DDX3X|TIMM8A|DIAPH2|CT47A6|CT47A5|CT47A4|CT47A3|CT47A2|DKC1|DLG3|DMD|DNASE1L1|DRP2|CT47A1|MAGED4|MAGEA9B|NXF2B|OPN1MW2|DMRTC1B		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	no assertion criteria provided	VCV000688137	X	168546 - 155233731			688137	675729		
NM_025265.4(TSEN2):c.770_776delinsCA (p.Tyr257fs)	TSEN2	Y257fs, Y198fs	Pontocerebellar hypoplasia type 2B	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV001031439	3	12545222 - 12545228	3	12503723 - 12503729	1031439	1019736		NC_000003.12:12503722:ACGTGCT:CA
NM_025265.4(TSEN2):c.353_354del (p.Gln118fs)	TSEN2	Q118fs	Pontocerebellar hypoplasia type 2B	Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000495253	3	12544805 - 12544806	3	12503306 - 12503307	495253	486741	rs755246924	NC_000003.12:12503305:AG:
NM_025265.4(TSEN2):c.960+1_960+5del	TSEN2		Pontocerebellar hypoplasia type 2B	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000180669	3	12558158 - 12558162	3	12516659 - 12516663	180669	178837	rs886037738	NC_000003.12:12516658:AAGGTAAG:AAG
NM_207346.3(TSEN54):c.940del (p.Leu314fs)	TSEN54	L314fs	Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561138	17	73518100	17	75522019	561138	552207	rs1012275384	NC_000017.11:75522018:CCC:CC
NM_207346.3(TSEN54):c.823del (p.Val275fs)	TSEN54	V275fs	Pontocerebellar hypoplasia type 2A	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212454	17	73517981	17	75521900	212454	208416	rs797046057	NC_000017.11:75521899:GGGGG:GGGG
NM_207346.3(TSEN54):c.1172_1185del (p.Gln391fs)	TSEN54	Q391fs	Pontocerebellar hypoplasia type 4	Pathogenic(Last reviewed: Oct 19, 2010)	no assertion criteria provided	VCV000030751	17	73518332 - 73518345	17	75522251 - 75522264	30751	39708	rs886037629	NC_000017.11:75522250:GCAGAGGAGCCAGCGC:GC
NC_000023.10:g.(?_99551255)_(99905882_?)del	TSPAN6|SRPX2|PCDH19|TNMD		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000832571	X	99551255 - 99905882			832571	821534		
GRCh37/hg19 Xq22.1(chrX:99430457-100047314)x1	TSPAN6|SRPX2|PCDH19|TNMD|SYTL4		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	no assertion criteria provided	VCV000685130	X	99430457 - 100047314			685130	672722		
NM_003309.4(TSPYL1):c.236del (p.Gly79fs)	TSPYL1|DSE	G79fs	Sudden infant death with dysgenesis of the testes syndrome	Likely pathogenic(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV000988762	6	116600758	6	116279595	988762	976692		NC_000006.12:116279594:CC:C
NM_006009.4(TUBA1A):c.1288_1302del (p.Lys430_Glu434del)	TUBA1A		Lissencephaly 3	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV001065497	12	49578847 - 49578861	12	49185064 - 49185078	1065497	1053779		NC_000012.12:49185063:CTCCTCATAATCCTTCTC:CTC
NM_006009.4(TUBA1A):c.196_206delinsACGTGTGTCGC (p.Val66_Asp69delinsThrCysValAla)	TUBA1A		Lissencephaly 3	Likely pathogenic	no assertion criteria provided	VCV000977831	12	49580414 - 49580424	12	49186631 - 49186641	977831	965987		NC_000012.12:49186630:TCTACAAACAC:GCGACACACGT
NM_021830.5(TWNK):c.49del (p.Leu17fs)	TWNK	L17fs	Infantile onset spinocerebellar ataxia	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000694436	10	102748013	10	100988256	694436	682347	rs779142717	NC_000010.11:100988255:CCCC:CCC
NM_021830.5(TWNK):c.333del (p.Leu112fs)	TWNK	L112fs	Infantile onset spinocerebellar ataxia	Pathogenic(Last reviewed: Mar 20, 2016)	no assertion criteria provided	VCV000225837	10	102748298	10	100988541	225837	227652	rs886037832	NC_000010.11:100988540:TTT:TT
GRCh37/hg19 9p23(chr9:12552814-12700251)x1	TYRP1		not provided	Uncertain significance(Last reviewed: Jul 2, 2018)	no assertion criteria provided	VCV000685301	9	12552814 - 12700251			685301	672893		
NM_001204077.2(UBE4A):c.1185_1186del (p.Lys396fs)	UBE4A	K396fs, K403fs	Pervasive developmental disorder|Epilepsy|Moderate global developmental delay	Likely pathogenic(Last reviewed: Oct 26, 2018)	no assertion criteria provided	VCV000617553	11	118245679 - 118245680	11	118374964 - 118374965	617553	608922	rs1565532385	NC_000011.10:118374963:CA:
GRCh37/hg19 16p12.2(chr16:21884192-22288219)	UQCRC2|EEF2K|VWA3A|PDZD9|MOSMO|SDR42E2		Chromosome 16p12.1 deletion syndrome, 520kb	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625576	16	21884192 - 22288219			625576	613880		
NM_014777.4(URB2):c.1949del (p.Gly650fs)	URB2	G650fs	Epilepsy	Uncertain significance(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000976393	1	229772308	1	229636561	976393	964150		NC_000001.11:229636560:GG:G
NM_001379403.1(WDR26):c.454del (p.Asp152fs)	WDR26	D52fs, D152fs	Skraban-Deardorff syndrome	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000827809	1	224621654	1	224433952	827809	815976	rs1572227260	NC_000001.11:224433951:CCCCC:CCCC
NM_001379403.1(WDR26):c.1204_1205del (p.Gln402fs)	WDR26	Q302fs, Q286fs, Q402fs	Skraban-Deardorff syndrome	Pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000433009	1	224606076 - 224606077	1	224418374 - 224418375	433009	426511	rs1553359034	NC_000001.11:224418373:TGT:T
NM_001379403.1(WDR26):c.1757del (p.Val586fs)	WDR26	V486fs, V470fs, V586fs	Skraban-Deardorff syndrome	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000433008	1	224586699	1	224398997	433008	426510	rs1553353378	NC_000001.11:224398996:A:
NM_001379403.1(WDR26):c.1461_1462del (p.His489fs)	WDR26	H373fs, H389fs, H489fs	Skraban-Deardorff syndrome	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000433007	1	224592269 - 224592270	1	224404567 - 224404568	433007	426509	rs1553354980	NC_000001.11:224404566:TAT:T
NM_001136157.2(OTUD5):c.689-839_1060-3983del	WDR45|OTUD5		Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: Jun 19, 2019)	no assertion criteria provided	VCV000635108			X	48930033 - 48935857	635108	622945		
NM_001029896.2(WDR45):c.131-11_145del	WDR45		Cerebral-cerebellar-coloboma syndrome, X-linked	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560932	X	48935392 - 48935417	X	49077733 - 49077758	560932	552261	rs1569523544	NC_000023.11:49077732:CCACCTGCTCGTGGTCTGGACAGGGACCA:CCA
hg18chrX:g.(48,802,381_48,809,279)_(48,829,265_48,854,335)del	WDR45|PRAF2|CCDC120		Early onset epileptic encephalopathy	Pathogenic(Last reviewed: Oct 1, 2014)	criteria provided, single submitter	VCV000190973	X	48915437 - 48967391			190973	188779		
NM_016373.4(WWOX):c.516+6_516+7delinsCT	WWOX		Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12	Likely benign(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV001157774	16	78198192 - 78198193	16	78164295 - 78164296	1157774	1146548		NC_000016.10:78164294:TG:CT
NC_000016.9:g.(?_78420747)_(78466659_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001076470	16	78420747 - 78466659			1076470	1057799		
NC_000016.9:g.(?_78420747)_(78458962_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001076469	16	78420747 - 78458962			1076469	1057798		
NC_000016.9:g.(?_78133671)_(78149061_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001076468	16	78133671 - 78149061			1076468	1057797		
NM_016373.4(WWOX):c.605+6_605+18del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001057515	16	78420848 - 78420860	16	78386951 - 78386963	1057515	1049891		NC_000016.10:78386950:GAGTGTTCCAGTGGAG:GAG
Single allele	WWOX		Epilepsy|Intellectual disability	Pathogenic(Last reviewed: Feb 25, 2021)	no assertion criteria provided	VCV000997824	16	78149052 - 78420756			997824	985542		
NC_000016.10:g.(?_78278583)_(78386968_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000833164	16	78312480 - 78420865			833164	820880		
NC_000016.10:g.(?_78099759)_(78432772_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000832849	16	78133656 - 78466669			832849	820879		
NC_000016.10:g.(?_78424850)_(78432772_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000832198	16	78458747 - 78466669			832198	820884		
NC_000016.10:g.(?_78278583)_(78432772_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000832075	16	78312480 - 78466669			832075	820881		
NC_000016.10:g.(?_78099759)_(78099909_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000831561	16	78133656 - 78133806			831561	820877		
NC_000016.10:g.(?_78099759)_(78115174_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV000830545	16	78133656 - 78149071			830545	820878		
GRCh37/hg19 16q23.1(chr16:78402398-78504169)x1	WWOX		not provided	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000685382	16	78402398 - 78504169			685382	672974		
NC_000016.10:g.(?_79211588)_(79211816_?)del	WWOX|MAF		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000657908	16	79245485 - 79245713	16	79211588 - 79211816	657908	653150		
NC_000016.10:g.(?_78164163)_(78164309_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000584160	16	78198060 - 78198206	16	78164163 - 78164309	584160	569817		
NC_000016.10:g.(?_78386840)_(78386968_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000583631	16	78420737 - 78420865	16	78386840 - 78386968	583631	567543		
NC_000016.10:g.(?_78432468)_(78432772_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000540247	16	78466365 - 78466669	16	78432468 - 78432772	540247	529276		
NC_000016.10:g.(?_78424850)_(78425075_?)del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Likely pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000473016			16	78424850 - 78425075	473016	465453		
NM_016373.4(WWOX):c.1043del (p.Phe348fs)	WWOX	F348fs, F235fs	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421407	16	78466634	16	78432737	421407	409742	rs1064795117	NC_000016.10:78432736:TTT:TT
NM_016373.4(WWOX):c.108-12del	WWOX		Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|not specified	Benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419900	16	78142308	16	78108411	419900	409739	rs149533117	NC_000016.10:78108410:G:
NM_030799.9(YIPF5):c.317_319del (p.Lys106del)	YIPF5	K106del, K52del	Microcephaly, epilepsy, and diabetes syndrome 2	Pathogenic(Last reviewed: Apr 16, 2021)	no assertion criteria provided	VCV001064543	5	143543785 - 143543787	5	144164221 - 144164223	1064543	1052781		NC_000005.10:144164220:TTTTTT:TTT
NM_014795.4(ZEB2):c.1653del (p.Ser552fs)	ZEB2	S552fs, S528fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000189287	2	145157101	2	144399534	189287	187160	rs786204820	NC_000002.12:144399533:G:
NM_014795.4(ZEB2):c.2228_2229del (p.Ser743fs)	ZEB2	S719fs, S743fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000181754	2	145156525 - 145156526	2	144398958 - 144398959	181754	178980	rs730881211	NC_000002.12:144398957:AGA:A
NM_001109809.5(ZFP57):c.898_905del (p.Gly299_Thr300insTer)	ZFP57		Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000721	6	29640983 - 29640990	6	29673206 - 29673213	721	15760	rs606231123	NC_000006.12:29673205:GCCTGGGTGCCTGG:GCCTGG
NM_001109809.5(ZFP57):c.1383del (p.Tyr462fs)	ZFP57	Y390fs, Y462fs	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000717	6	29640505	6	29672728	717	15756	rs606231122	NC_000006.12:29672727:G:
NM_001370100.5(ZMYND11):c.1129del (p.Ser377fs)	ZMYND11	S220fs, S258fs, S275fs, S283fs, S292fs, S301fs, S322fs, S323fs, S337fs, S346fs, S351fs, S355fs, S360fs, S376fs, S377fs	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Apr 13, 2021)	criteria provided, single submitter	VCV001064584	10	292884	10	246944	1064584	1052832		NC_000010.11:246943:T:
NM_001370100.5(ZMYND11):c.383del (p.Ser128fs)	ZMYND11	S128fs, S88fs, S106fs, S111fs	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431092	10	267241	10	221301	431092	424615	rs1135401771	NC_000010.11:221300:C:
NC_000016.10:g.(?_30992801)_(31068051_?)del	ZNF668|STX4|STX1B		Generalized epilepsy with febrile seizures plus, type 9	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000475337	16	31004122 - 31079372	16	30992801 - 31068051	475337	464840		
GRCh37/hg19 2q24.3-32.3(chr2:167329586-192756373)x1	ZSWIM2|ZNF385B|KLHL23|PPP1R1C|GPR155|FAM171B|HNRNPA3|CERS6|METAP1D|CCDC141|ERICH2|EVX2|CERKL|SP5|FSIP2|MIR10B|PHOSPHO2|PJVK|NEMP2|SP9|MIR1258|ATP5MC3|CHN1|CHRNA1|COL3A1|COL5A2|ATF2|DLX1|DLX2|DYNC1I2|FRZB|GAD1|MSTN|GLS|HOXD1|HOXD3|HOXD4|HOXD8|HOXD9|HOXD10|HOXD11|HOXD12|HOXD13|INPP1|ITGA6|ITGA4|ITGAV|LRP2|MYO1B|NAB1|NEUROD1|NFE2L2|PDE1A|PDK1|PMS1|SCN7A|SP3|SSB|ITPRID2|STAT1|STAT4|TFPI|TTN|WIPF1|CAVIN2|HAT1|AGPS|PRKRA|SLC25A12|ABCB11|B3GALT1|PPIG|CIR1|TLK1|DHRS9|CALCRL|KLHL41|UBE2E3|MTX2|NCKAP1|RAPGEF4|GORASP2|HIBCH|STK39|METTL5|OLA1|SLC40A1|PDE11A|GULP1|FKBP7|MAP3K20|DNAJC10|ASNSD1|MFSD6|ZC3H15|SPC25|CWC22|G6PC2|OSGEPL1|NABP1|PLEKHA3|SCRN3|FASTKD1|METTL8|CYBRD1|DCAF17|LNPK|CDCA7|WDR75|C2orf88|SESTD1|ZNF804A|TTC30A|ORMDL1|OSBPL6|NOSTRIN|DIRC1|NUP35|XIRP2|RBM45|BBS5|CCDC173|UBR3|MYO3B|DUSP19|ANKAR|TTC30B		not provided	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000687517	2	167329586 - 192756373			687517	675109		
